Cat. No. |
产品名 |
作用方式
|
纯度 |
是否罕见病
|
HY-13259 |
MG-132 |
|
99.97% |
否 |
HY-12320 |
Cycloheximide |
Inhibitor |
99.82% |
否 |
HY-100218A |
RSL3 |
|
99.90% |
否 |
HY-10182 |
Laduviglusib |
|
99.76% |
否 |
HY-15141 |
Staurosporine |
|
99.98% |
否 |
HY-12318 |
IBMX |
Inhibitor |
99.99% |
否 |
HY-10432 |
A 83-01 |
Inhibitor |
99.33% |
否 |
HY-13027 |
DAPT |
|
99.97% |
否 |
HY-10256 |
Adezmapimod |
|
99.96% |
否 |
HY-12041 |
SP600125 |
|
99.73% |
否 |
HY-13818 |
Stattic |
|
99.58% |
否 |
HY-10295 |
SB 202190 |
|
99.89% |
否 |
HY-15608 |
MPTP hydrochloride |
Inducer |
99.54% |
否 |
HY-12815A |
MCC950 sodium |
Inhibitor |
99.75% |
否 |
HY-100545 |
BAPTA-AM |
Inhibitor |
99.68% |
否 |
HY-12815 |
MCC950 |
Inhibitor |
99.62% |
否 |
HY-18982 |
Anisomycin |
|
99.82% |
否 |
HY-10197 |
Wortmannin |
Inhibitor |
99.86% |
否 |
HY-107455 |
A-485 |
Inhibitor |
99.87% |
否 |
HY-Y0703 |
Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) |
|
99.61% |
否 |
HY-50846 |
SCH772984 |
Inhibitor |
99.45% |
否 |
HY-W011500 |
TCEP hydrochloride |
|
99.8% |
否 |
HY-100681 |
GSK2837808A |
Inhibitor |
≥99.0% |
否 |
HY-P0018 |
Pepstatin |
Inhibitor |
99.90% |
否 |
HY-123033A |
Nicotinamide riboside chloride |
Activator |
99.90% |
是 |
HY-13067 |
Celastrol |
|
99.90% |
否 |
HY-50907 |
ABT-737 |
|
99.72% |
否 |
HY-12031A |
U0126 |
Inhibitor |
98.45% |
否 |
HY-12031 |
U0126-EtOH |
Inhibitor |
99.41% |
否 |
HY-100741 |
S63845 |
Inhibitor |
99.94% |
否 |
HY-100514 |
GSK484 hydrochloride |
Inhibitor |
99.48% |
否 |
HY-B1081A |
Oxidopamine hydrobromide |
|
99.95% |
否 |
HY-136927 |
MSA-2 |
Agonist |
99.81% |
否 |
HY-10514 |
BX795 |
|
99.84% |
否 |
HY-10941 |
VER-155008 |
Inhibitor |
99.91% |
否 |
HY-100526 |
XMU-MP-1 |
Inhibitor |
99.24% |
否 |
HY-103401 |
Blasticidin S hydrochloride |
Inhibitor |
99.93% |
否 |
HY-13319 |
JNK-IN-8 |
Inhibitor |
99.67% |
否 |
HY-13814 |
PR-619 |
|
99.38% |
否 |
HY-100461 |
C29 |
Inhibitor |
≥98.0% |
否 |
HY-10038 |
A 922500 |
Inhibitor |
99.33% |
否 |
HY-10627A |
GW3965 hydrochloride |
Agonist |
99.96% |
否 |
HY-11006 |
KU-57788 |
|
99.95% |
否 |
HY-12273 |
DMH-1 |
Inhibitor |
99.95% |
否 |
HY-136057 |
iFSP1 |
Activator |
99.96% |
否 |
HY-16995 |
Pirinixic acid |
Agonist |
99.80% |
否 |
HY-B1081 |
Oxidopamine hydrochloride |
|
99.91% |
否 |
HY-100388 |
SHP099 |
Inhibitor |
99.81% |
否 |
HY-15648B |
GSK-J4 |
|
99.64% |
否 |
HY-19528 |
SAH |
|
99.89% |
否 |
HY-131454 |
SR-717 |
Agonist |
99.89% |
否 |
HY-15915 |
DTNB |
|
98.67% |
否 |
HY-12186 |
3-Deazaneplanocin A hydrochloride |
Inhibitor |
99.98% |
否 |
HY-112921B |
diABZI STING agonist-1 trihydrochloride |
Agonist |
99.92% |
否 |
HY-13805 |
PP2 |
Inhibitor |
98.34% |
否 |
HY-15319 |
AMG 487 |
Inhibitor |
99.80% |
否 |
HY-16966 |
SBI-0206965 |
|
99.92% |
否 |
HY-106376A |
L-Buthionine-(S,R)-sulfoximine |
Activator |
99.35% |
否 |
HY-100742A |
(R)-GNE-140 |
Inhibitor |
99.73% |
否 |
HY-13259C |
(R)-MG-132 |
Inhibitor |
99.97% |
否 |
HY-119374 |
BRM/BRG1 ATP Inhibitor-1 |
Inhibitor |
99.61% |
否 |
HY-136254 |
BzATP triethylammonium salt |
Agonist |
98.57% |
否 |
HY-14622A |
Necrostatin 2 racemate |
Inhibitor |
99.65% |
否 |
HY-12012 |
SB 216763 |
|
99.37% |
否 |
HY-15823 |
CAY10566 |
Inhibitor |
99.82% |
否 |
HY-15176A |
Pyridostatin hydrochloride |
Inducer |
98.53% |
否 |
HY-10355 |
AKT inhibitor VIII |
|
98.97% |
否 |
HY-107632 |
GYY4137 |
|
98.08% |
否 |
HY-16938 |
5'-Methylthioadenosine |
|
99.71% |
否 |
HY-14176 |
Compound E |
Inhibitor |
99.97% |
否 |
HY-123999 |
CD38 inhibitor 1 |
|
99.83% |
否 |
HY-15066 |
CNQX |
Antagonist |
99.65% |
否 |
HY-15146 |
NSC 74859 |
Inhibitor |
98.35% |
否 |
HY-D0972 |
Thioflavine S |
|
/ |
否 |
HY-N2117 |
Isoginkgetin |
|
99.95% |
否 |
HY-10588 |
Bay K 8644 |
Agonist |
99.96% |
否 |
HY-15682 |
TTNPB |
|
99.85% |
否 |
HY-50752 |
LY-411575 |
|
98.68% |
否 |
HY-10587 |
BIX-01294 |
|
98.44% |
否 |
HY-15677 |
INT-777 |
Agonist |
≥98.0% |
否 |
HY-108688 |
GSK2033 |
Antagonist |
99.37% |
否 |
HY-10256A |
Adezmapimod hydrochloride |
|
99.71% |
否 |
HY-12990 |
Spautin-1 |
|
99.54% |
否 |
HY-16989 |
SR9009 |
Inhibitor |
99.46% |
否 |
HY-103618 |
THZ531 |
Inhibitor |
99.86% |
否 |
HY-10182A |
Laduviglusib monohydrochloride |
|
99.93% |
否 |
HY-19824 |
3PO |
Inhibitor |
99.56% |
否 |
HY-15064 |
HC-030031 |
Inhibitor |
99.72% |
否 |
HY-N0751 |
Scutellarin |
Inhibitor |
98.56% |
否 |
HY-10532 |
SRT 1720 |
|
99.90% |
否 |
HY-129047 |
Trypsin |
Activator |
/ |
否 |
HY-N0529 |
Rosmarinic acid |
|
99.73% |
否 |
HY-12302 |
Kenpaullone |
Inhibitor |
98.20% |
否 |
HY-W015229 |
3-Indolepropionic acid |
|
99.89% |
否 |
HY-100411 |
MLi-2 |
Inhibitor |
99.80% |
否 |
HY-13018 |
MRT67307 |
Inhibitor |
99.44% |
否 |
HY-112921A |
diABZI STING agonist-1 |
Agonist |
99.86% |
否 |
HY-100626 |
WNK463 |
Inhibitor |
99.75% |
否 |
HY-19989A |
MK-571 sodium |
|
99.75% |
否 |
HY-12755 |
ML141 |
|
99.96% |
否 |
HY-112066 |
SHIN1 |
Inhibitor |
99.11% |
否 |
HY-139665 |
VB124 |
Inhibitor |
99.86% |
否 |
HY-13861 |
GW7647 |
Agonist |
99.45% |
否 |
HY-12686 |
5Z-7-Oxozeaenol |
Inhibitor |
99.60% |
否 |
HY-139214 |
IXA4 |
Inhibitor |
98.83% |
否 |
HY-12497 |
ANA-12 |
Antagonist |
99.90% |
否 |
HY-10115 |
PI-103 |
|
99.82% |
否 |
HY-19956 |
GI254023X |
Inhibitor |
99.67% |
否 |
HY-D0837 |
Imidazole |
Inhibitor |
99.94% |
否 |
HY-10510 |
BI-D1870 |
|
99.72% |
否 |
HY-107454 |
OSS_128167 |
Inhibitor |
98.63% |
否 |
HY-111558 |
Bobcat339 |
Inhibitor |
99.44% |
否 |
HY-100720 |
GSK2193874 |
Antagonist |
99.91% |
否 |
HY-128359 |
ACBI1 |
|
99.92% |
否 |
HY-133916 |
G140 |
Inhibitor |
99.17% |
否 |
HY-13962 |
SGI-1027 |
|
99.77% |
否 |
HY-12050 |
CP-673451 |
Inhibitor |
99.69% |
否 |
HY-122122 |
ML-60218 |
Inhibitor |
99.85% |
否 |
HY-10182B |
Laduviglusib trihydrochloride |
|
99.35% |
否 |
HY-N6718 |
Filipin III |
Inhibitor |
99.0% |
否 |
HY-107738 |
Guggulsterone |
|
99.95% |
否 |
HY-W040233 |
L-Lactic acid sodium |
|
99.82% |
否 |
HY-19615 |
MS023 |
Inhibitor |
99.73% |
否 |
HY-100578 |
AGK2 |
|
99.62% |
否 |
HY-13687 |
IKK 16 |
Inhibitor |
99.88% |
否 |
HY-15646 |
UNC1999 |
|
99.83% |
否 |
HY-115670 |
GW280264X |
Inhibitor |
98.28% |
否 |
HY-14711 |
Reversine |
|
99.22% |
否 |
HY-18998 |
LMK-235 |
Inhibitor |
99.61% |
否 |
HY-30008 |
Cycloleucine |
Antagonist |
≥98.0% |
否 |
HY-100675 |
JTE-013 |
|
99.92% |
否 |
HY-13953 |
JIB-04 |
|
98.29% |
否 |
HY-N2020 |
Anacardic Acid |
Inhibitor |
98.86% |
否 |
HY-121526 |
S-Nitroso-N-acetyl-DL-penicillamine |
Agonist |
98.84% |
否 |
HY-12600 |
AZD5582 |
|
98.75% |
否 |
HY-N0643 |
Carnosol |
|
99.90% |
否 |
HY-10459 |
PF-562271 |
Inhibitor |
99.68% |
否 |
HY-15655 |
GW1929 |
Agonist |
99.93% |
否 |
HY-15773 |
PF-4708671 |
|
99.87% |
否 |
HY-145597 |
KL-11743 |
|
98.77% |
否 |
HY-10432A |
A 83-01 sodium |
Inhibitor |
98.43% |
否 |
HY-13812 |
QNZ |
Inhibitor |
99.50% |
否 |
HY-10474 |
Torkinib |
|
99.03% |
否 |
HY-N0376 |
Liquiritin |
|
99.68% |
否 |
HY-15776 |
HG-9-91-01 |
Inhibitor |
99.77% |
否 |
HY-15425 |
PF-543 |
|
99.85% |
否 |
HY-134495 |
N-Acetyl-L-cysteine ethyl ester |
|
≥98.0% |
否 |
HY-13521 |
SB-505124 |
Inhibitor |
99.99% |
否 |
HY-70059 |
LY341495 |
Antagonist |
99.50% |
否 |
HY-115445 |
LCS-1 |
|
99.81% |
否 |
HY-10442 |
3-Deazaneplanocin A |
Inhibitor |
99.97% |
否 |
HY-12342 |
ML216 |
Inhibitor |
99.89% |
否 |
HY-111558A |
Bobcat339 hydrochloride |
Inhibitor |
99.59% |
否 |
HY-112461A |
NF449 octasodium |
Antagonist |
≥99.0% |
否 |
HY-14595 |
Biochanin A |
Inhibitor |
99.29% |
否 |
HY-P0221 |
PACAP (1-38), human, ovine, rat |
|
99.88% |
否 |
HY-14615 |
[6]-Gingerol |
|
99.45% |
否 |
HY-103371 |
DCPIB |
|
99.83% |
否 |
HY-10329 |
JNJ-7706621 |
|
99.91% |
否 |
HY-10863 |
Anandamide |
|
≥99.0% |
否 |
HY-112258 |
IMP-1088 |
Inhibitor |
99.16% |
否 |
HY-13447A |
PF429242 dihydrochloride |
Inhibitor |
99.80% |
否 |
HY-120394 |
TVB-3166 |
|
99.69% |
否 |
HY-19567 |
PK 11195 |
Inhibitor |
≥99.0% |
否 |
HY-108677 |
L-368,899 hydrochloride |
Antagonist |
99.36% |
否 |
HY-126124 |
AP39 |
|
95.98% |
否 |
HY-104048 |
QC6352 |
Inhibitor |
99.48% |
否 |
HY-13928 |
GW0742 |
Agonist |
99.94% |
否 |
HY-101147 |
YKL-05-099 |
Inhibitor |
99.76% |
否 |
HY-101842 |
ND-646 |
Inhibitor |
99.13% |
否 |
HY-112584 |
JBSNF-000088 |
Inhibitor |
99.94% |
否 |
HY-18100A |
PRE-084 hydrochloride |
|
99.92% |
否 |
HY-N0605 |
Ginsenoside Rh2 |
|
98.87% |
否 |
HY-112842 |
MBQ-167 |
Inhibitor |
99.86% |
否 |
HY-W013332 |
3-Deazaadenosine |
Inhibitor |
≥99.0% |
否 |
HY-111925 |
BI-749327 |
Antagonist |
99.91% |
否 |
HY-112680A |
Carboxy pyridostatin trifluoroacetate salt |
|
99.13% |
否 |
HY-Y0698 |
Thioacetamide |
|
≥98.0% |
否 |
HY-103019 |
(+)-Enitociclib |
Inhibitor |
99.66% |
否 |
HY-108696 |
GNE-781 |
Inhibitor |
98.16% |
否 |
HY-120821 |
Endosidin-2 |
Modulator |
99.17% |
否 |
HY-10875 |
LRRK2-IN-1 |
|
99.42% |
否 |
HY-135969 |
Glycol chitosan |
Inhibitor |
61.22% |
否 |
HY-141537 |
ABR-238901 |
Inhibitor |
98.71% |
否 |
HY-12583 |
A-366 |
Inhibitor |
98.01% |
否 |
HY-136144 |
FIDAS-5 |
|
98.46% |
否 |
HY-12494 |
LDC1267 |
Inhibitor |
99.58% |
否 |
HY-12275 |
FR 180204 |
|
99.65% |
否 |
HY-100224 |
SANT-1 |
|
99.87% |
否 |
HY-124696 |
PU139 |
Inhibitor |
99.14% |
否 |
HY-15594A |
Phen-DC3 Trifluoromethanesulfonate |
Inhibitor |
98.99% |
否 |
HY-P2093B |
S961 acetate |
Antagonist |
99.96% |
否 |
HY-101979 |
Numidargistat |
Inhibitor |
≥98.0% |
否 |
HY-103254 |
ML221 |
|
99.55% |
否 |
HY-18360 |
TMP269 |
Inhibitor |
98.05% |
否 |
HY-151361 |
AMPK-IN-3 |
Inhibitor |
98.51% |
否 |
HY-42424 |
(S,R,S)-AHPC-Me hydrochloride |
|
99.59% |
否 |
HY-108347 |
CP-100356 hydrochloride |
Inhibitor |
99.68% |
否 |
HY-15614 |
SC144 |
|
99.48% |
否 |
HY-19996 |
AH-7614 |
Antagonist |
99.73% |
否 |
HY-15490 |
PF-670462 dihydrochloride |
Inhibitor |
99.96% |
否 |
HY-16594 |
Lactacystin |
Inhibitor |
98.20% |
否 |
HY-B1184A |
(S)-Mephenytoin |
|
99.85% |
否 |
HY-N0610A |
Cinnamic acid |
|
99.99% |
否 |
HY-108467 |
GGsTop |
Inhibitor |
99.35% |
否 |
HY-107500 |
UVI 3003 |
Inhibitor |
99.57% |
否 |
HY-15317 |
RI-1 |
Inhibitor |
99.83% |
否 |
HY-15556 |
GSK269962A |
Inhibitor |
99.83% |
否 |
HY-124798 |
Rheb inhibitor NR1 |
Inhibitor |
99.03% |
否 |
HY-18644 |
CWHM-12 |
Inhibitor |
99.94% |
否 |
HY-108577 |
XE991 dihydrochloride |
Inhibitor |
99.96% |
否 |
HY-124293 |
AA147 |
Activator |
99.89% |
否 |
HY-139426 |
ML-SI3 |
Inhibitor |
99.91% |
否 |
HY-Y1889A |
Sodium carboxymethyl cellulose (MW 250000) |
|
/ |
否 |
HY-12486 |
FL118 |
|
99.40% |
否 |
HY-129420 |
WSP-5 |
|
99.31% |
否 |
HY-101925 |
CM-272 |
|
98.70% |
否 |
HY-B0789 |
SU6656 |
Inhibitor |
99.01% |
否 |
HY-126675A |
AS2863619 |
|
99.94% |
否 |
HY-N0087 |
Gambogic Acid |
|
98.79% |
否 |
HY-122575 |
Aurintricarboxylic acid |
|
≥92.0% |
否 |
HY-139330 |
MGH-CP1 |
Inducer |
99.56% |
否 |
HY-103319 |
Calmidazolium chloride |
Antagonist |
99.69% |
否 |
HY-137516 |
LC-2 |
Inhibitor |
98.16% |
否 |
HY-101920 |
Autophinib |
Inhibitor |
99.95% |
否 |
HY-13104 |
MRS 2578 |
|
98.15% |
否 |
HY-15589 |
GW9508 |
|
99.33% |
否 |
HY-124691 |
D-I03 |
Inhibitor |
99.70% |
否 |
HY-12072 |
Lck Inhibitor |
Inhibitor |
99.45% |
否 |
HY-136570 |
GSK778 |
|
98.93% |
否 |
HY-U00459 |
GSK2850163 |
Inhibitor |
98.43% |
否 |
HY-103546 |
BETP |
Agonist |
99.48% |
否 |
HY-12336 |
NIBR189 |
Inhibitor |
99.71% |
否 |
HY-15648F |
GSK-J4 hydrochloride |
Inhibitor |
99.01% |
否 |
HY-130750 |
Phycocyanobilin |
Inhibitor |
98.90% |
否 |
HY-13746B |
Sardomozide dihydrochloride |
Inhibitor |
99.76% |
否 |
HY-Y1889 |
Sodium carboxymethyl cellulose (Viscosity:5000-15000 mPa.s) |
|
≥97.0% |
否 |
HY-N0033 |
Poliumoside |
Inhibitor |
99.80% |
否 |
HY-112136 |
TAO Kinase inhibitor 1 |
Inhibitor |
99.46% |
否 |
HY-117370 |
USP25/28 inhibitor AZ1 |
Inhibitor |
≥98.0% |
否 |
HY-N1472 |
Levistolide A |
|
99.26% |
否 |
HY-144896 |
FHT-1015 |
Inhibitor |
98.41% |
否 |
HY-10262 |
BMS-536924 |
|
99.83% |
否 |
HY-107569 |
Garcinol |
|
≥99.0% |
否 |
HY-11004 |
AZ 628 |
|
99.85% |
否 |
HY-13515 |
Sirtinol |
|
≥98.0% |
否 |
HY-18613 |
CAY10603 |
Inhibitor |
≥98.0% |
否 |
HY-10128 |
ZM-447439 |
|
99.19% |
否 |
HY-123076 |
Pifithrin-α, p-Nitro, Cyclic |
p53 Inhibitor |
99.73% |
否 |
HY-13076 |
CHIR-98014 |
Inhibitor |
≥98.0% |
否 |
HY-15542B |
FRAX486 |
Inhibitor |
98.01% |
否 |
HY-101257 |
YKL-5-124 |
Inhibitor |
98.79% |
否 |
HY-108681 |
680C91 |
Inhibitor |
99.54% |
否 |
HY-101763A |
(S,R,S)-AHPC monohydrochloride |
|
99.83% |
否 |
HY-11012 |
TDZD-8 |
Inhibitor |
99.76% |
否 |
HY-12492 |
VER-246608 |
Inhibitor |
99.10% |
否 |
HY-110397 |
KP-457 |
Inhibitor |
99.18% |
否 |
HY-N0365 |
Sennoside A |
Inhibitor |
99.71% |
否 |
HY-112416 |
AZD4320 |
Inhibitor |
99.66% |
否 |
HY-116304 |
1G244 |
|
98.66% |
否 |
HY-15067 |
DNQX |
Antagonist |
99.26% |
否 |
HY-15425A |
PF-543 Citrate |
|
99.47% |
否 |
HY-50710 |
KU-0063794 |
Inhibitor |
99.55% |
否 |
HY-145322 |
TMX-4116 |
Inhibitor |
99.76% |
否 |
HY-16661 |
Skp2 Inhibitor C1 |
Inhibitor |
98.21% |
否 |
HY-101312 |
Cilostamide |
Inhibitor |
99.64% |
否 |
HY-18627A |
PFI-2 hydrochloride |
Inhibitor |
99.52% |
否 |
HY-14435 |
Pyridone 6 |
Inhibitor |
98.13% |
否 |
HY-15764A |
A 419259 trihydrochloride |
|
99.21% |
否 |
HY-149004 |
SLF1081851 |
Inhibitor |
98.11% |
否 |
HY-100672 |
SR59230A |
Antagonist |
≥98.0% |
否 |
HY-107647 |
(S)-(+)-Dimethindene maleate |
Antagonist |
99.94% |
否 |
HY-124409 |
WSP-1 |
|
99.03% |
否 |
HY-Y0703C |
Sodium carboxymethyl cellulose (Viscosity:300-800mpa.s) |
|
≥99.0% |
否 |
HY-133117 |
BAY-985 |
Inhibitor |
99.88% |
否 |
HY-19369 |
L-685458 |
|
99.37% |
否 |
HY-19564 |
JX06 |
|
99.78% |
否 |
HY-13643 |
Daminozide |
Inhibitor |
99.79% |
否 |
HY-124729 |
BL-918 |
|
99.72% |
否 |
HY-N0215S12 |
L-Phenylalanine-d5 |
Antagonist |
99.15% |
否 |
HY-15154 |
NG 52 |
Inhibitor |
99.88% |
否 |
HY-18962 |
AMI-1 |
Inhibitor |
≥98.0% |
否 |
HY-115470 |
CLK-IN-T3 |
Inhibitor |
98.63% |
否 |
HY-13866 |
Ro 31-8220 mesylate |
Inhibitor |
99.57% |
否 |
HY-12030 |
PIK-90 |
Inhibitor |
99.70% |
否 |
HY-125845 |
(S,R,S)-AHPC |
|
99.13% |
否 |
HY-116451 |
PF-04859989 hydrochloride |
Inhibitor |
99.90% |
否 |
HY-13595 |
Chrysophanol |
Inhibitor |
99.77% |
否 |
HY-19736 |
TY-52156 |
Antagonist |
99.42% |
否 |
HY-100611 |
CaCCinh-A01 |
Inhibitor |
99.76% |
否 |
HY-15529 |
S0859 |
Inhibitor |
99.69% |
否 |
HY-106301 |
Devazepide |
Antagonist |
99.58% |
否 |
HY-128067 |
5-(N,N-Hexamethylene)-amiloride |
|
98.47% |
否 |
HY-15761 |
AZD2858 |
Inhibitor |
98.42% |
否 |
HY-101979A |
Numidargistat dihydrochloride |
Inhibitor |
98.65% |
否 |
HY-120323 |
DRI-C21045 |
Inhibitor |
99.02% |
否 |
HY-W008947 |
SEW2871 |
|
99.77% |
否 |
HY-101213 |
OSW-1 |
Antagonist |
99.66% |
否 |
HY-12493A |
LY-2584702 tosylate salt |
Inhibitor |
99.50% |
否 |
HY-147308 |
Zelenirstat |
Inhibitor |
99.05% |
否 |
HY-16670 |
Dafadine-A |
Inhibitor |
98.94% |
否 |
HY-111388A |
SEL120-34A monohydrochloride |
Inhibitor |
99.29% |
否 |
HY-128206 |
I3MT-3 |
Inhibitor |
99.98% |
否 |
HY-13263 |
CHIR-124 |
|
99.05% |
否 |
HY-18305 |
BMS-5 |
Inhibitor |
99.51% |
否 |
HY-16558 |
Butein |
|
99.95% |
否 |
HY-112146 |
MMG-11 |
Antagonist |
99.24% |
否 |
HY-107427 |
PF-3644022 |
Inhibitor |
99.65% |
否 |
HY-116044 |
BCATc Inhibitor 2 |
Inhibitor |
99.83% |
否 |
HY-124760 |
hSMG-1 inhibitor 11e |
Inhibitor |
99.81% |
否 |
HY-134819A |
(1R,2R)-ML-SI3 |
Inhibitor |
99.45% |
否 |
HY-15166 |
(E/Z)-Zotiraciclib |
Inhibitor |
99.96% |
否 |
HY-P1925A |
GO-203 TFA |
|
99.28% |
否 |
HY-19327 |
ACY-738 |
Inhibitor |
99.92% |
否 |
HY-40135 |
L-Hydroxyproline |
|
99.89% |
否 |
HY-W013332A |
3-Deazaadenosine hydrochloride |
Inhibitor |
99.67% |
否 |
HY-W062835 |
CGP77675 |
Inhibitor |
99.00% |
否 |
HY-108435 |
GNE-049 |
Inhibitor |
99.40% |
否 |
HY-126303C |
GS-443902 trisodium |
Inhibitor |
99.98% |
否 |
HY-19989 |
MK-571 |
|
98.66% |
否 |
HY-13329 |
IRAK-1-4 Inhibitor I |
Inhibitor |
99.90% |
否 |
HY-N0904 |
Ginsenoside C-K |
Inhibitor |
99.92% |
否 |
HY-Y0479S |
L-Lactic acid-13C3 |
|
99.9% |
否 |
HY-101507 |
Zerencotrep |
Inhibitor |
99.40% |
否 |
HY-12239 |
CID755673 |
Inhibitor |
99.13% |
否 |
HY-103353 |
SID 26681509 |
Inhibitor |
98.70% |
否 |
HY-77839 |
Cortodoxone |
Antagonist |
98.74% |
否 |
HY-N0636 |
Eriocitrin |
Inducer |
99.84% |
否 |
HY-102047B |
KDOAM-25 citrate |
Inhibitor |
98.11% |
否 |
HY-136571 |
GSK046 |
Inhibitor |
99.65% |
否 |
HY-19744 |
T6167923 |
Inhibitor |
99.40% |
否 |
HY-107522 |
DL-TBOA |
Inhibitor |
99.60% |
否 |
HY-12316 |
20(S)-Hydroxycholesterol |
Activator |
99.29% |
否 |
HY-100011 |
SR-3029 |
Inhibitor |
99.73% |
否 |
HY-12438 |
G007-LK |
Inhibitor |
99.24% |
否 |
HY-13020 |
GSK1838705A |
Inhibitor |
99.21% |
否 |
HY-15515 |
SEA0400 |
Inhibitor |
99.96% |
否 |
HY-136252 |
BSJ-04-132 |
Inhibitor |
99.07% |
否 |
HY-149302 |
MC4033 |
|
99.77% |
否 |
HY-W015114 |
L-2-Hydroxyglutaric acid disodium |
Inhibitor |
99.12% |
否 |
HY-112701 |
CCR6 inhibitor 1 |
Inhibitor |
99.60% |
否 |
HY-13942 |
1-NM-PP1 |
Inhibitor |
99.17% |
否 |
HY-15260A |
XL413 monohydrochloride |
Inhibitor |
99.72% |
否 |
HY-B0617S |
S-Adenosyl-L-methionine-d3 |
Inducer |
99.55% |
否 |
HY-N0166 |
Gramine |
|
99.80% |
否 |
HY-N0638 |
Dendrobine |
|
99.92% |
否 |
HY-P0220A |
PACAP (6-38), human, ovine, rat TFA |
|
98.72% |
否 |
HY-W011102 |
S-Trityl-L-cysteine |
|
99.10% |
否 |
HY-15124 |
(S)-(-)-Bay-K-8644 |
Agonist |
98.81% |
否 |
HY-101395 |
W146 |
|
99.83% |
否 |
HY-111530 |
GSTO1-IN-1 |
Inhibitor |
99.47% |
否 |
HY-145667 |
Biotinylated-JQ1 |
Inhibitor |
98.43% |
否 |
HY-D0186 |
2'-Deoxyuridine |
Inhibitor |
99.98% |
否 |
HY-N0639 |
Punicalin |
|
99.89% |
否 |
HY-Y0479AS |
L-Lactic acid-13C3 (sodium) (20% in water) |
|
≥98.0% |
否 |
HY-N0835 |
(20S)-Protopanaxatriol |
|
99.91% |
否 |
HY-19712 |
LJH685 |
|
99.99% |
否 |
HY-101044 |
PPADS tetrasodium |
|
≥95.0% |
否 |
HY-124634 |
PZ-2891 |
Modulator |
99.38% |
否 |
HY-15426 |
PF-04957325 |
Inhibitor |
99.55% |
否 |
HY-18961 |
PD 407824 |
Inhibitor |
99.00% |
否 |
HY-130709 |
PROTAC CDK2/9 Degrader-1 |
Inhibitor |
99.85% |
否 |
HY-148030 |
XL01126 |
Inhibitor |
99.81% |
否 |
HY-100231 |
Cathepsin inhibitor 1 |
Inhibitor |
99.28% |
否 |
HY-111673 |
8-CPT-Cyclic AMP sodium |
|
99.92% |
否 |
HY-N2166 |
Tomatine |
|
99.90% |
否 |
HY-136532 |
ZT-1a |
Inhibitor |
99.97% |
否 |
HY-U00064 |
AZD2098 |
Inhibitor |
99.84% |
否 |
HY-12811 |
PF-04856264 |
Inhibitor |
≥99.0% |
否 |
HY-136250 |
BSJ-03-204 |
Inhibitor |
99.76% |
否 |
HY-125798 |
2,3-Dehydro-2-deoxy-N-acetylneuraminic acid |
Inhibitor |
≥99.0% |
否 |
HY-136684 |
BrBzGCp2 |
Inhibitor |
98.68% |
否 |
HY-W015239 |
KAT8-IN-1 |
|
99.40% |
否 |
HY-106224B |
Orexin A (human, rat, mouse) (acetate) |
Agonist |
99.93% |
否 |
HY-112078 |
(S,R,S)-AHPC-Me |
|
99.48% |
否 |
HY-101442 |
SR9238 |
Antagonist |
99.89% |
否 |
HY-115594 |
Erasin |
|
96.02% |
否 |
HY-136465 |
A2ti-1 |
Inhibitor |
99.84% |
否 |
HY-16425 |
RG2833 |
Inhibitor |
99.86% |
否 |
HY-B2152 |
Hemicholinium 3 |
Inhibitor |
99.71% |
否 |
HY-P0109A |
Z-FA-FMK |
Inhibitor |
99.14% |
否 |
HY-120877 |
MRT199665 |
|
99.74% |
否 |
HY-13466 |
MK-4256 |
Antagonist |
98.01% |
否 |
HY-13915 |
NSC348884 |
Inducer |
≥98.0% |
否 |
HY-19562 |
PF-06260933 |
Inhibitor |
99.67% |
否 |
HY-100953 |
CYM-5520 |
Agonist |
99.48% |
否 |
HY-103444 |
ARP-100 |
Inhibitor |
≥99.0% |
否 |
HY-10835 |
DG-041 |
Antagonist |
≥99.0% |
否 |
HY-Y0134 |
(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid |
|
99.93% |
否 |
HY-15764 |
A 419259 |
|
99.75% |
否 |
HY-N0043 |
Ginsenoside Rd |
Inhibitor |
99.88% |
否 |
HY-19713 |
LJI308 |
Inhibitor |
99.07% |
否 |
HY-112151A |
EG01377 dihydrochloride |
Inhibitor |
98.98% |
否 |
HY-111126 |
K67 |
Inhibitor |
98.26% |
否 |
HY-127104 |
FMF-04-159-2 |
Inhibitor |
99.48% |
否 |
HY-110313 |
SB-747651A dihydrochloride |
Inhibitor |
≥99.0% |
否 |
HY-13941 |
1-Naphthyl PP1 |
Inhibitor |
99.08% |
否 |
HY-B1532 |
Anabasine |
Agonist |
99.87% |
否 |
HY-N1441 |
Afzelin |
|
99.62% |
否 |
HY-N1463 |
Luteolin 7-O-glucuronide |
Inhibitor |
99.80% |
否 |
HY-P1548A |
β-CGRP, human TFA |
|
99.17% |
否 |
HY-W008364 |
Olivetol |
Inhibitor |
99.81% |
否 |
HY-103045 |
CMPD101 |
Inhibitor |
98.95% |
否 |
HY-12278 |
K02288 |
Inhibitor |
99.73% |
否 |
HY-107424 |
BAY-299 |
Inhibitor |
99.40% |
否 |
HY-10864 |
URB-597 |
Inhibitor |
99.15% |
否 |
HY-117596 |
UNC569 |
Inhibitor |
99.87% |
否 |
HY-103194 |
KH7 |
Inhibitor |
≥99.0% |
否 |
HY-103200 |
SR59230A hydrochloride |
Antagonist |
99.87% |
否 |
HY-107436 |
LE135 |
|
99.03% |
否 |
HY-108625 |
SHA 68 |
Antagonist |
99.84% |
否 |
HY-119401 |
CAY10444 |
Antagonist |
≥98.0% |
否 |
HY-120722 |
TCH-165 |
Modulator |
99.32% |
否 |
HY-131034 |
LP-922056 |
Activator |
99.63% |
否 |
HY-N0707 |
(S)-Indoximod |
Inhibitor |
99.47% |
否 |
HY-N6825 |
Hydroxy-α-sanshool |
Agonist |
99.57% |
否 |
HY-W040329 |
2'-Deoxyadenosine |
Activator |
99.99% |
否 |
HY-Y1069 |
(S)-Malic acid |
|
99.62% |
否 |
HY-116856 |
SRPKIN-1 |
Inhibitor |
98.02% |
否 |
HY-13914 |
Roniciclib |
Inhibitor |
98.09% |
否 |
HY-19975 |
RN-1734 |
Antagonist |
99.86% |
否 |
HY-101972 |
AZ-PFKFB3-67 |
Inhibitor |
97.03% |
否 |
HY-10295A |
SB 202190 hydrochloride |
|
99.84% |
否 |
HY-103641A |
(2S)-Octyl-α-hydroxyglutarate |
Control |
≥98.0% |
否 |
HY-109586 |
BRL-50481 |
Inhibitor |
99.85% |
否 |
HY-139004 |
SGC-CK2-1 |
Inhibitor |
99.67% |
否 |
HY-153034 |
LONP1-IN-2 |
Inhibitor |
99.74% |
否 |
HY-B2144C |
Chitosan (≥95% deacetylated,viscosity 100-200 mPa.s) |
Inhibitor |
97.28% |
否 |
HY-N0233 |
Bavachin |
Agonist |
99.94% |
否 |
HY-Y0313 |
p-Hydroxybenzaldehyde |
Antagonist |
99.98% |
否 |
HY-13461A |
PHA-767491 hydrochloride |
|
99.49% |
否 |
HY-100014 |
KDM5A-IN-1 |
Inhibitor |
99.80% |
否 |
HY-100359 |
CL-82198 |
Inhibitor |
99.71% |
否 |
HY-112852 |
TL02-59 |
|
99.84% |
否 |
HY-120856 |
ARN-3236 |
Inhibitor |
98.60% |
否 |
HY-111818 |
TH34 |
Inhibitor |
99.52% |
否 |
HY-115497 |
BRD5529 |
Inhibitor |
98.94% |
否 |
HY-12059 |
AT7867 |
Inhibitor |
99.88% |
否 |
HY-123055 |
Adenosine dialdehyde |
|
≥99.0% |
否 |
HY-12774 |
IC261 |
|
99.54% |
否 |
HY-128554 |
N-Desethyl amodiaquine |
Inhibitor |
99.98% |
否 |
HY-133168 |
Englerin A |
Activator |
99.50% |
否 |
HY-135231 |
NL-1 |
|
99.72% |
否 |
HY-135982 |
GPR81 agonist 1 |
Inhibitor |
99.73% |
否 |
HY-150795 |
SY-LB-35 |
|
≥98.0% |
否 |
HY-130248 |
BAY-899 |
|
99.93% |
否 |
HY-18299A |
Purvalanol A |
|
98.30% |
否 |
HY-150523 |
Ristocetin |
|
≥98.0% |
否 |
HY-103364 |
C-021 |
Inhibitor |
99.95% |
否 |
HY-122136 |
S26131 |
Antagonist |
99.57% |
否 |
HY-135318 |
NBDHEX |
|
98.56% |
否 |
HY-150602 |
20S Proteasome activator 1 |
Activator |
99.83% |
否 |
HY-B0793 |
AZ-5104 |
Inhibitor |
99.69% |
否 |
HY-Y1310A |
Sodium alginate (Viscosity 200±20mpa.s) |
|
99.02% |
否 |
HY-107658 |
SN 6 |
Inhibitor |
99.79% |
否 |
HY-15259 |
CP-640186 |
Inhibitor |
99.72% |
否 |
HY-108539 |
CE3F4 |
Inhibitor |
≥98.0% |
否 |
HY-112639 |
Aristeromycin |
Inhibitor |
99.34% |
否 |
HY-18095 |
CX-6258 |
Inhibitor |
98.71% |
否 |
HY-U00448 |
ADDA 5 hydrochloride |
Inhibitor |
≥99.0% |
否 |
HY-16787 |
ICA-121431 |
Inhibitor |
98.65% |
否 |
HY-N0226A |
Epiberberine chloride |
Inhibitor |
99.02% |
否 |
HY-N0847 |
Micheliolide |
Inhibitor |
99.84% |
否 |
HY-N1963 |
Curzerene |
|
98.00% |
否 |
HY-N6769 |
Radicicol |
Inhibitor |
99.63% |
否 |
HY-N7560 |
Safranal |
|
98.04% |
否 |
HY-122895 |
E64FC26 |
|
98.10% |
否 |
HY-13281 |
PIK-75 hydrochloride |
|
99.72% |
否 |
HY-15775 |
Arginase inhibitor 1 |
Inhibitor |
≥98.0% |
否 |
HY-101419 |
CYM-5541 |
Agonist |
≥98.0% |
否 |
HY-10214 |
SNX-2112 |
|
99.49% |
否 |
HY-101794 |
2-(Pyridyldithio)ethylamine hydrochloride |
|
99.93% |
否 |
HY-107004A |
Amotosalen hydrochloride |
Inhibitor |
98.99% |
否 |
HY-110137 |
Furamidine dihydrochloride |
Inhibitor |
≥99.0% |
否 |
HY-117427 |
D5D-IN-326 |
|
99.60% |
否 |
HY-126047A |
(R,S)-Anatabine |
|
98.34% |
否 |
HY-12632 |
GNE 2861 |
Inhibitor |
99.20% |
否 |
HY-128669 |
Abemaciclib metabolite M2 |
Inhibitor |
99.94% |
否 |
HY-135233 |
N-Succinimidyl-S-acetylthioacetate |
|
≥95.0% |
否 |
HY-B0027 |
Valnemulin hydrochloride |
Inhibitor |
98.03% |
否 |
HY-N0316 |
Mollugin |
|
99.48% |
否 |
HY-N0455AS8 |
L-Arginine-13C6,15N4 hydrochloride |
Activator |
≥99.0% |
否 |
HY-N1996 |
Chebulagic acid |
Inhibitor |
99.67% |
否 |
HY-P2268 |
RAGE antagonist peptide |
Antagonist |
98.81% |
否 |
HY-11003 |
GW843682X |
Inhibitor |
99.89% |
否 |
HY-114322 |
VZ185 |
Inhibitor |
98.00% |
否 |
HY-16531 |
YF-2 |
Activator |
98.76% |
否 |
HY-15434 |
NG25 |
Inhibitor |
99.35% |
否 |
HY-15730 |
Poziotinib |
|
99.96% |
否 |
HY-105008 |
Secoisolariciresinol diglucoside |
|
99.85% |
否 |
HY-108552 |
MG-115 |
|
98.69% |
否 |
HY-110282 |
S3QEL-2 |
Inhibitor |
99.54% |
否 |
HY-117474 |
MJN110 |
Inhibitor |
99.49% |
否 |
HY-139604 |
PCC0208017 |
|
99.56% |
否 |
HY-143404 |
PI3K-IN-30 |
Inhibitor |
98.21% |
否 |
HY-N0252 |
Catharanthine |
Inhibitor |
99.65% |
否 |
HY-N5077 |
Sinapine |
Inhibitor |
99.96% |
否 |
HY-N6742 |
Borrelidin |
|
99.80% |
否 |
HY-123921 |
Gefitinib-based PROTAC 3 |
Inhibitor |
99.98% |
否 |
HY-137742 |
SBP-7455 |
Inhibitor |
98.24% |
否 |
HY-11010 |
AS601245 |
Inhibitor |
98.83% |
否 |
HY-103504 |
(S)-SNAP5114 |
Inhibitor |
98.16% |
否 |
HY-107545 |
Dynole 34-2 |
|
98.16% |
否 |
HY-111380 |
EHT 1610 |
Inhibitor |
98.16% |
否 |
HY-121282 |
Mepazine |
|
99.91% |
否 |
HY-123402 |
GSK3987 |
Agonist |
99.19% |
否 |
HY-129589 |
Thailanstatin A |
|
99.71% |
否 |
HY-141512 |
JB170 |
Inhibitor |
98.97% |
否 |
HY-14229 |
TGR5 Receptor Agonist |
Agonist |
99.71% |
否 |
HY-18304 |
BMS-3 |
Inhibitor |
99.71% |
否 |
HY-18962A |
AMI-1 free acid |
Inhibitor |
99.70% |
否 |
HY-78131S |
Ibuprofen-d3 |
|
99.18% |
否 |
HY-N0649 |
Narcissin |
Inhibitor |
99.82% |
否 |
HY-N2085 |
L-Perillaldehyde |
|
≥97.0% |
否 |
HY-W008079 |
(S)-2-Amino-6-((tert-butoxycarbonyl)amino)hexanoic acid |
|
≥98.0% |
否 |
HY-Y0152 |
Cinchonine |
|
99.56% |
否 |
HY-18303 |
AMG-47a |
Inhibitor |
99.34% |
否 |
HY-100213 |
EAI045 |
Inhibitor |
99.08% |
否 |
HY-12680 |
PRN694 |
Inhibitor |
≥99.0% |
否 |
HY-10579 |
Pluripotin |
Inhibitor |
98.86% |
否 |
HY-133120 |
INY-03-041 |
Inhibitor |
99.74% |
否 |
HY-18629 |
SU9516 |
|
99.81% |
否 |
HY-P0018B |
Pepstatin Ammonium |
Inhibitor |
99.76% |
否 |
HY-101395A |
W146 TFA |
|
98.13% |
否 |
HY-117778 |
SF2312 |
Inhibitor |
≥95.0% |
否 |
HY-13260 |
CCT128930 |
|
99.69% |
否 |
HY-15066A |
CNQX disodium |
Antagonist |
99.95% |
否 |
HY-103100 |
SB-699551 |
|
99.53% |
否 |
HY-106369 |
HMR 1556 |
Inhibitor |
99.90% |
否 |
HY-108689 |
Broflanilide |
Antagonist |
99.36% |
否 |
HY-123772 |
CDK5 inhibitor 20-223 |
Inhibitor |
99.78% |
否 |
HY-129079A |
TFMB-(S)-2-HG |
Inhibitor |
99.62% |
否 |
HY-131249 |
MK2-IN-3 |
Inhibitor |
99.58% |
否 |
HY-136462 |
CYM50358 |
Antagonist |
98.04% |
否 |
HY-13704S |
SN-38-d3 |
|
99.07% |
否 |
HY-142295 |
GNF2133 |
Inhibitor |
98.32% |
否 |
HY-14307 |
Necrocide 1 |
Inducer |
98.84% |
否 |
HY-19615B |
MS023 dihydrochloride |
Inhibitor |
99.30% |
否 |
HY-N0797 |
(20S)-Protopanaxadiol |
|
99.85% |
否 |
HY-N2350 |
Cynaropicrin |
Inhibitor |
99.79% |
否 |
HY-U00439A |
Protein kinase inhibitor 1 hydrochloride |
Inhibitor |
≥98.0% |
否 |
HY-100583A |
(±)-Equol |
|
99.62% |
否 |
HY-10968 |
CYM5442 |
Agonist |
98.83% |
否 |
HY-112302 |
HC-070 |
Antagonist |
99.73% |
否 |
HY-119939 |
CHDI-390576 |
Inhibitor |
98.07% |
否 |
HY-128350 |
FGTI-2734 |
Inhibitor |
99.64% |
否 |
HY-19807 |
Indirubin-3'-monoxime |
Inhibitor |
99.76% |
否 |
HY-16969 |
Dihexa |
Activator |
98.92% |
否 |
HY-18299 |
Purvalanol B |
Inhibitor |
≥97.0% |
否 |
HY-100815A |
(S)-AMPA |
Agonist |
≥99.0% |
否 |
HY-103226 |
SC-57461A |
Inhibitor |
99.93% |
否 |
HY-108618 |
BC11-38 |
Inhibitor |
99.42% |
否 |
HY-110177 |
SP-100030 |
Inhibitor |
99.86% |
否 |
HY-111827 |
S-1-Propenyl-L-cysteine |
|
99.81% |
否 |
HY-116683 |
116-9e |
Inhibitor |
98.55% |
否 |
HY-120601 |
Alizarin Red S sodium |
|
≥95.0% |
否 |
HY-120645 |
BMS-986122 |
Agonist |
99.94% |
否 |
HY-122818 |
BpV(phen) trihydrate |
|
≥98.0% |
否 |
HY-126074 |
Z433927330 |
|
98.11% |
否 |
HY-129047A |
Trypsin (MS grade) |
Activator |
95.00% |
否 |
HY-139605 |
GLUT inhibitor-1 |
Inhibitor |
98.01% |
否 |
HY-148814 |
BI-3231 |
Inhibitor |
99.83% |
否 |
HY-15237 |
SL 0101-1 |
Inhibitor |
≥98.0% |
否 |
HY-15706 |
H2L 5765834 |
Antagonist |
98.66% |
否 |
HY-D1450 |
IR-1048 |
|
≥97.0% |
否 |
HY-N0455AS6 |
L-Arginine-13C6 hydrochloride |
Activator |
99.00% |
否 |
HY-N0507 |
Rosavin |
Inhibitor |
99.99% |
否 |
HY-N0690 |
Schisandrin C |
|
99.95% |
否 |
HY-N1312 |
Sinapaldehyde |
Inhibitor |
99.96% |
否 |
HY-N1454 |
Apigenin-7-glucuronide |
Inhibitor |
99.74% |
否 |
HY-W087830 |
L-p-Boronophenylalanine |
|
99.84% |
否 |
HY-10942 |
VER-82576 |
Inhibitor |
98.76% |
否 |
HY-123053 |
Z-Leu-Leu-Glu-AMC |
|
99.91% |
否 |
HY-15770 |
TR-14035 |
Antagonist |
98.06% |
是 |
HY-P0018A |
Pepstatin Trifluoroacetate |
Inhibitor |
98.77% |
否 |
HY-100406 |
(S)-MCPG |
Antagonist |
99.02% |
否 |
HY-100483 |
A-804598 |
Antagonist |
98.55% |
否 |
HY-103286 |
PD176252 |
Antagonist |
99.38% |
否 |
HY-103309 |
ML218 |
Inhibitor |
99.49% |
否 |
HY-108699 |
TM-N1324 |
Agonist |
99.91% |
否 |
HY-13203 |
NVP-TAE 226 |
|
99.77% |
否 |
HY-13237 |
GSK2578215A |
|
99.78% |
否 |
HY-13487 |
USP7/USP47 inhibitor |
Inhibitor |
98.58% |
否 |
HY-101971 |
AZ PFKFB3 26 |
Inhibitor |
99.23% |
否 |
HY-133121 |
WDR5-IN-1 |
|
≥98.0% |
否 |
HY-P0072 |
Microcystin-LR |
Inhibitor |
98.0% |
否 |
HY-100559 |
SecinH3 |
Inducer |
99.66% |
否 |
HY-103430A |
SKF-83566 |
Antagonist |
99.86% |
否 |
HY-103598 |
(S,R,S)-AHPC-PEG3-N3 |
|
99.67% |
否 |
HY-103601 |
(S,R,S)-AHPC-PEG4-N3 |
|
99.93% |
否 |
HY-12443 |
PF-5006739 |
Inhibitor |
99.56% |
否 |
HY-13431 |
KU-0060648 |
Inhibitor |
99.62% |
否 |
HY-13634B |
TLK117 |
Inhibitor |
99.89% |
否 |
HY-139212 |
IXA6 |
Activator |
99.29% |
否 |
HY-155360 |
MY-1076 |
|
99.32% |
否 |
HY-N0481 |
Roburic acid |
Inhibitor |
≥98.0% |
否 |
HY-N1365 |
Isoscopoletin |
Inhibitor |
99.94% |
否 |
HY-N2187 |
Deoxyshikonin |
|
99.96% |
否 |
HY-P1080A |
ω-Agatoxin IVA TFA |
Inhibitor |
99.10% |
否 |
HY-W004864 |
Fmoc-(S)-2-(4-pentenyl)Ala-OH |
|
99.92% |
否 |
HY-79457 |
S-Methylisothiourea sulfate |
Inhibitor |
≥98.0% |
否 |
HY-W012531 |
2-Hydroxycinnamic acid |
Inhibitor |
98.30% |
否 |
HY-100352 |
BI-9564 |
Inhibitor |
98.73% |
否 |
HY-100742 |
GNE-140 racemate |
Inhibitor |
99.38% |
否 |
HY-132166 |
M4205 |
Inhibitor |
99.47% |
否 |
HY-10372 |
PP121 |
|
98.67% |
否 |
HY-122562 |
MT-802 |
Inhibitor |
98.94% |
否 |
HY-15250 |
JZL195 |
Inhibitor |
99.75% |
否 |
HY-B0852 |
Tebuconazole |
Inhibitor |
99.66% |
否 |
HY-108318 |
RK-24466 |
Inhibitor |
98.53% |
否 |
HY-111443 |
TR antagonist 1 |
Antagonist |
99.57% |
否 |
HY-12023 |
GTx-007 |
Modulator |
99.61% |
否 |
HY-130271 |
(S,R,S)-AHPC-PEG5-COOH |
|
99.80% |
否 |
HY-130735 |
Janelia Fluor® 646, SE |
|
96.42% |
否 |
HY-133028 |
CKI-7 free base |
Inhibitor |
99.80% |
否 |
HY-144439 |
HTS07545 |
|
99.67% |
否 |
HY-14478 |
UPF 1069 |
Inhibitor |
99.10% |
否 |
HY-150644 |
S07-2010 |
Inhibitor |
99.79% |
否 |
HY-15590 |
AZ-23 |
Inhibitor |
98.92% |
否 |
HY-B1161A |
S-Methoprene |
Antagonist |
98.58% |
否 |
HY-N0650S |
L-Serine-13C3 |
|
98.9% |
否 |
HY-N10503 |
Norartocarpetin |
|
98.92% |
否 |
HY-10524 |
GSK1904529A |
|
99.03% |
否 |
HY-80002 |
BMX-IN-1 |
Inhibitor |
99.04% |
否 |
HY-B0392 |
(S)-(+)-Rolipram |
|
99.77% |
否 |
HY-134968 |
TTBK1-IN-1 |
Inhibitor |
99.53% |
否 |
HY-16940 |
24(S)-Hydroxycholesterol |
Agonist |
99.55% |
否 |
HY-18371 |
TC-S 7009 |
Inhibitor |
99.64% |
否 |
HY-104050 |
M-31850 |
|
99.94% |
否 |
HY-112719 |
BRD 4354 |
Inhibitor |
99.66% |
否 |
HY-13250 |
Silvestrol aglycone |
|
99.84% |
否 |
HY-13335 |
PKCβ inhibitor 1 |
|
99.40% |
否 |
HY-135748A |
Poly (I:C):Kanamycin (1:1) (sodium) |
|
/ |
否 |
HY-136181 |
YNT-185 dihydrochloride |
Agonist |
99.78% |
否 |
HY-145685 |
RECQL5-IN-1 |
Inhibitor |
98.40% |
否 |
HY-15381 |
Fingolimod phosphate |
Agonist |
99.22% |
否 |
HY-15510 |
Tenovin-6 |
|
98.33% |
否 |
HY-155950 |
TH9619 |
|
99.33% |
否 |
HY-18009 |
(Z)-LFM-A13 |
Inhibitor |
99.80% |
否 |
HY-N3540 |
Caraphenol A |
Inhibitor |
92.57% |
否 |
HY-P2268A |
RAGE antagonist peptide TFA |
Antagonist |
99.71% |
否 |
HY-W145522 |
Pullulan, Viscosity(10%):15-180mPa.s |
|
≥98.0% |
否 |
HY-W002198 |
2-Hydroxyacetophenone |
Inhibitor |
99.91% |
否 |
HY-104008 |
ACY-957 |
Inhibitor |
99.66% |
否 |
HY-111108 |
LDH-IN-1 |
Inhibitor |
99.84% |
否 |
HY-111388B |
SEL120-34A hydrochloride |
Inhibitor |
99.98% |
否 |
HY-12026 |
WZ4002 |
Inhibitor |
98.99% |
否 |
HY-101843 |
ML213 |
Activator |
99.79% |
否 |
HY-145696 |
SJ10542 |
Inhibitor |
99.92% |
否 |
HY-148788 |
Osivelotor |
|
99.83% |
否 |
HY-18609 |
PD158780 |
Inhibitor |
99.56% |
否 |
HY-A0104J |
HPMC (Type II,Viscosity:5mPa.s) |
|
/ |
否 |
HY-100708 |
NSC632839 |
Inhibitor |
98.87% |
否 |
HY-106376C |
L-Buthionine-(S,R)-sulfoximine hydrochloride |
Activator |
≥98.0% |
否 |
HY-108333 |
SB-633825 |
Inhibitor |
98.52% |
否 |
HY-108570 |
AUDA |
Inhibitor |
≥98.0% |
否 |
HY-110042 |
CCT018159 |
|
99.94% |
否 |
HY-115673 |
LAS17 |
Inhibitor |
97.46% |
否 |
HY-116147 |
Ceranib-2 |
|
99.25% |
否 |
HY-118590 |
ICRF-193 |
Inhibitor |
≥98.0% |
否 |
HY-121629 |
PS210 |
Activator |
98.30% |
否 |
HY-122614 |
S29434 |
Inducer |
99.25% |
否 |
HY-124751 |
YTX-465 |
Inhibitor |
99.06% |
否 |
HY-136379 |
CID44216842 |
Inhibitor |
99.84% |
否 |
HY-147051 |
Nelremagpran |
|
99.64% |
否 |
HY-152947 |
ELOVL6-IN-4 |
|
98.63% |
否 |
HY-15382 |
FTY720 (S)-Phosphate |
Agonist |
99.57% |
否 |
HY-18991 |
CCG215022 |
Inhibitor |
98.69% |
否 |
HY-N1029 |
Norathyriol |
Inhibitor |
99.83% |
否 |
HY-W000795 |
(S)-2-amino-3-(4-benzoylphenyl)propanoic acid |
|
99.47% |
否 |
HY-14722 |
NVP-BSK805 |
Inhibitor |
99.89% |
否 |
HY-15916 |
DTE |
|
≥98.0% |
否 |
HY-16903 |
PKC-IN-1 |
Inhibitor |
99.79% |
否 |
HY-12830 |
M-110 |
Inhibitor |
99.14% |
否 |
HY-19336 |
BAZ2-ICR |
Inhibitor |
99.95% |
否 |
HY-112209 |
VU0467154 |
Agonist |
99.56% |
否 |
HY-112424 |
Tinodasertib |
Inhibitor |
99.69% |
否 |
HY-145964 |
INE963 |
Inhibitor |
98.43% |
否 |
HY-148258 |
GDC-2394 |
Inhibitor |
99.54% |
否 |
HY-50875 |
BCX 1470 methanesulfonate |
Inhibitor |
99.87% |
否 |
HY-100984 |
HA-100 |
Inhibitor |
99.80% |
否 |
HY-103076 |
EZ-482 |
|
97.11% |
否 |
HY-108359 |
Alsterpaullone |
|
99.85% |
否 |
HY-111974 |
β-D-Glucopyranosyl abscisate |
Agonist |
95.04% |
否 |
HY-112415 |
Lith-O-Asp |
|
≥98.0% |
否 |
HY-125861B |
Methyl cellulose(Viscosity:400mPa.s) |
|
/ |
否 |
HY-136521 |
AZ13824374 |
Inhibitor |
98.86% |
否 |
HY-148904 |
Allylic-SAM |
|
≥80.0% |
否 |
HY-153188 |
JNJ-1013 |
|
99.80% |
否 |
HY-16104 |
BIX 02565 |
Inhibitor |
99.61% |
否 |
HY-30215 |
(S)-Leucic acid |
|
99.17% |
否 |
HY-B0905 |
Tilmicosin |
|
≥98.0% |
否 |
HY-D0904 |
Acetylthiocholine iodide |
|
99.87% |
否 |
HY-N0553 |
Gypenoside XVII |
Activator |
99.69% |
否 |
HY-N3513 |
Mulberrin |
Inhibitor |
99.86% |
否 |
HY-W011338 |
Benzyl butyl phthalate |
Activator |
≥97.0% |
否 |
HY-W013573 |
S-Allyl-L-cysteine |
Inducer |
98.64% |
否 |
HY-Y0337S |
L-Cysteine-13C3,15N |
|
99.9% |
否 |
HY-15260 |
XL413 |
Inhibitor |
99.76% |
否 |
HY-12434 |
INT-767 |
Agonist |
99.81% |
否 |
HY-100895 |
SAR-20347 |
Inhibitor |
97.12% |
否 |
HY-102037 |
SSTR5 antagonist 1 |
Antagonist |
99.91% |
否 |
HY-10319 |
BAY-549 |
Inhibitor |
99.46% |
否 |
HY-103479 |
GOAT-IN-1 |
Inhibitor |
99.38% |
否 |
HY-110346 |
AZD5582 dihydrochloride |
|
98.67% |
否 |
HY-12846 |
CCT196969 |
Inhibitor |
99.36% |
否 |
HY-131447 |
KY19382 |
|
≥98.0% |
否 |
HY-135401 |
VU6015929 |
Inhibitor |
99.50% |
否 |
HY-14403 |
ERK5-IN-1 |
Inhibitor |
99.33% |
否 |
HY-120051 |
Afizagabar |
Antagonist |
98.40% |
否 |
HY-123892 |
RK-287107 |
Inhibitor |
99.81% |
否 |
HY-124772 |
BI-2545 |
Inhibitor |
99.77% |
否 |
HY-13488 |
HG-10-102-01 |
Inhibitor |
99.55% |
否 |
HY-137048 |
PF-00835231 |
Inhibitor |
98.23% |
否 |
HY-139310 |
GLPG2938 |
Antagonist |
99.93% |
否 |
HY-10115A |
PI-103 Hydrochloride |
|
98.55% |
否 |
HY-103602 |
(S,R,S)-AHPC-PEG3-NH2 hydrochloride |
|
99.01% |
否 |
HY-107587 |
A-286982 |
Inhibitor |
99.33% |
否 |
HY-108490 |
VPC 23019 |
Modulator |
99.90% |
否 |
HY-108495 |
CYM50308 |
Agonist |
≥98.0% |
否 |
HY-110125 |
ML-193 |
Antagonist |
99.82% |
否 |
HY-111836 |
NRX-252114 |
Inhibitor |
99.07% |
否 |
HY-112472 |
S3969 |
Activator |
98.38% |
否 |
HY-117154 |
INH154 |
|
99.89% |
否 |
HY-122113 |
PD173952 |
|
99.44% |
否 |
HY-129492 |
GNF4877 |
Inhibitor |
99.41% |
否 |
HY-133413 |
DBCO-CONH-S-S-NHS ester |
|
99.18% |
否 |
HY-153343A |
(S)-BAY 2965501 |
|
99.88% |
否 |
HY-154970A |
BMPR2-IN-1 TFA |
Inhibitor |
99.40% |
否 |
HY-N1916 |
Coniferyl ferulate |
Inhibitor |
98.73% |
否 |
HY-P5712 |
Gramicidin S |
Inhibitor |
99.19% |
否 |
HY-10943 |
GNF-7 |
Inhibitor |
99.70% |
否 |
HY-107670 |
Dihydro-β-erythroidine hydrobromide |
Antagonist |
98.85% |
否 |
HY-111139 |
MS417 |
Inhibitor |
99.79% |
否 |
HY-112158 |
NSC139021 |
Inhibitor |
99.86% |
否 |
HY-114263 |
NXT629 |
Antagonist |
99.07% |
否 |
HY-124876 |
SynuClean-D |
Inhibitor |
99.89% |
否 |
HY-108672 |
NF157 |
Antagonist |
92.9% |
否 |
HY-108709 |
CC-671 |
Inhibitor |
99.06% |
否 |
HY-112144 |
TP0463518 |
Inhibitor |
99.25% |
否 |
HY-135892 |
GNE-1858 |
Inhibitor |
99.42% |
否 |
HY-136250A |
BSJ-03-204 triTFA |
Inhibitor |
99.76% |
否 |
HY-145694 |
CDK5-IN-3 |
Inhibitor |
99.49% |
否 |
HY-145785A |
ADH-6 TFA |
|
99.91% |
否 |
HY-147183B |
JBJ-09-063 hydrochloride |
Inhibitor |
99.37% |
否 |
HY-14899 |
Taprenepag |
Agonist |
98.79% |
否 |
HY-18662 |
RQ-00203078 |
Antagonist |
99.84% |
否 |
HY-100804 |
L-Cysteinesulfinic acid |
Agonist |
99.87% |
否 |
HY-103362 |
CCR2 antagonist 4 hydrochloride |
Antagonist |
99.86% |
否 |
HY-103600 |
(S,R,S)-AHPC-PEG1-N3 |
|
98.18% |
否 |
HY-10497 |
BMS-794833 |
Inhibitor |
99.52% |
否 |
HY-10804 |
CCT 137690 |
|
99.54% |
否 |
HY-111400 |
SR-4370 |
Inhibitor |
99.95% |
否 |
HY-111615A |
J-2156 TFA |
Agonist |
99.59% |
否 |
HY-111655 |
SKA-31 |
Activator |
99.66% |
否 |
HY-113262 |
8-Hydroxyguanosine |
Inhibitor |
99.91% |
否 |
HY-124607B |
BRD3731 |
Inhibitor |
98.21% |
否 |
HY-12489 |
Ponceau S |
|
≥98.0% |
否 |
HY-125845A |
(S,S,S)-AHPC hydrochloride |
|
99.42% |
否 |
HY-128554A |
N-Desethyl amodiaquine dihydrochloride |
Inhibitor |
99.45% |
否 |
HY-13561 |
AZM475271 |
Inhibitor |
99.85% |
否 |
HY-145532 |
S-Allylmercaptocysteine |
|
≥95.0% |
否 |
HY-145963 |
DRB18 |
Inhibitor |
99.58% |
否 |
HY-14654S |
Aspirin-d3 |
|
98.51% |
否 |
HY-147158 |
ZXH-1-161 |
Modulator |
98.43% |
否 |
HY-149979 |
SLC7A11-IN-1 |
Inducer |
95.93% |
否 |
HY-152149 |
CTP Synthetase-IN-1 |
Inhibitor |
99.56% |
否 |
HY-153898 |
rTRD01 |
Ligand |
≥97.0% |
否 |
HY-16273 |
L-778123 |
|
99.91% |
否 |
HY-19527 |
IST5-002 |
|
99.36% |
否 |
HY-19528S |
SAH-d4 |
|
≥99.0% |
否 |
HY-D1716 |
S0456 |
|
99.44% |
否 |
HY-N0110B |
Palmatine hydroxide |
|
99.64% |
否 |
HY-N2116 |
Ginkgolic acid C17:1 |
|
99.90% |
否 |
HY-119323 |
7-Azido-4-methylcoumarin |
|
99.11% |
否 |
HY-12049 |
CCT129202 |
Inhibitor |
≥98.0% |
否 |
HY-N0078 |
Ginkgolic Acid (C13:0) |
Inhibitor |
99.92% |
否 |
HY-107779 |
BI-882370 |
Inhibitor |
99.16% |
否 |
HY-112818 |
S130 |
|
99.43% |
否 |
HY-135902A |
Synucleozid hydrochloride |
Inhibitor |
98.23% |
否 |
HY-10133 |
β-Secretase Inhibitor IV |
Inhibitor |
99.19% |
否 |
HY-101786 |
KZR-504 |
Inhibitor |
99.12% |
否 |
HY-129550 |
BI-4020 |
Inhibitor |
99.28% |
否 |
HY-12975 |
AZ6102 |
Inhibitor |
99.65% |
否 |
HY-13687A |
IKK 16 hydrochloride |
Inhibitor |
99.95% |
否 |
HY-145321 |
TMX-4100 |
Inhibitor |
98.18% |
否 |
HY-16992A |
W-54011 |
|
≥98.0% |
否 |
HY-108015 |
RO5263397 |
|
98.87% |
否 |
HY-108476 |
INDY |
Inhibitor |
99.51% |
否 |
HY-108597 |
TC-S 7005 |
Inhibitor |
99.68% |
否 |
HY-108628 |
SU16f |
Inhibitor |
99.09% |
否 |
HY-113284 |
Succinyladenosine |
|
99.60% |
否 |
HY-117026 |
LKY-047 |
Inhibitor |
99.94% |
否 |
HY-120940 |
AZ13705339 |
Inhibitor |
98.90% |
否 |
HY-121389 |
Hexadecanamide |
|
≥97.0% |
否 |
HY-13683R |
Mifepristone (Standard) |
|
98.49% |
否 |
HY-139434 |
JMJD6-IN-1 |
Inhibitor |
99.69% |
否 |
HY-140128 |
DBCO-S-S-PEG3-biotin |
|
≥95.0% |
否 |
HY-146695 |
S100P-IN-1 |
Inhibitor |
99.74% |
否 |
HY-147831 |
EIF2α activator 1 |
Activator |
98.77% |
否 |
HY-15569 |
NU6102 |
Inhibitor |
99.23% |
否 |
HY-15614A |
SC144 hydrochloride |
|
99.34% |
否 |
HY-16988 |
SR9011 |
|
99.78% |
否 |
HY-18071 |
BI-9627 |
Inhibitor |
≥99.0% |
否 |
HY-18702 |
Targocil |
Inhibitor |
98.84% |
否 |
HY-30216 |
(R)-Leucic acid |
|
≥97.0% |
否 |
HY-B0927 |
Hydrastine |
Control |
99.57% |
否 |
HY-N0656A |
(+)-Usnic acid |
|
99.63% |
否 |
HY-N9480 |
Vinaxanthone |
Inhibitor |
98.77% |
否 |
HY-P1540 |
Angiotensin III, human, mouse |
Agonist |
98.27% |
否 |
HY-P2106 |
Elabela(19-32) |
|
99.64% |
否 |
HY-W013579 |
(S)-(+)-Carvone |
|
99.26% |
否 |
HY-W013665 |
(S)-2-Aminohexanedioic acid |
|
≥97.0% |
否 |
HY-W021040 |
Fludioxonil |
|
99.94% |
否 |
HY-Z0424 |
(S)-2-[(tert-Butoxycarbonyl)amino]-3-iodopropionic acid methyl ester |
|
99.42% |
否 |
HY-13968 |
JW 55 |
Inhibitor |
98.95% |
否 |
HY-148013 |
K284-6111 |
Inhibitor |
99.94% |
否 |
HY-16690 |
BTS |
Inhibitor |
99.74% |
否 |
HY-E70069 |
Endo S2, Streptococcus pyogenes |
|
/ |
否 |
HY-100360 |
MS049 |
Inhibitor |
≥98.0% |
否 |
HY-101257B |
YKL-5-124 TFA |
Inhibitor |
99.74% |
否 |
HY-112443 |
AZD3458 |
Inhibitor |
99.71% |
否 |
HY-135457 |
JMS-053 |
|
≥98.0% |
否 |
HY-135516 |
Dalosirvat |
Activator |
98.22% |
否 |
HY-18779 |
PF-4840154 |
Agonist |
98.15% |
否 |
HY-10483 |
SCH-1473759 hydrochloride |
Inhibitor |
99.79% |
否 |
HY-108329 |
AM-0902 |
Antagonist |
99.73% |
否 |
HY-129995A |
TSHR antagonist S37a |
Antagonist |
98.00% |
否 |
HY-145231 |
FGFR2-IN-2 |
Inhibitor |
98.25% |
否 |
HY-15259A |
CP-640186 hydrochloride |
Inhibitor |
99.90% |
否 |
HY-15997 |
(-)-U-50488 hydrochloride |
Inhibitor |
99.71% |
否 |
HY-N0215S1 |
L-Phenylalanine-d8 |
Antagonist |
99.62% |
否 |
HY-100349 |
SU4312 |
Inhibitor |
99.76% |
否 |
HY-100510 |
RAF709 |
Inhibitor |
99.45% |
否 |
HY-101451 |
PBIT |
Inhibitor |
99.46% |
否 |
HY-10815 |
σ1 Receptor antagonist-1 |
|
99.87% |
否 |
HY-108518 |
SB-772077B dihydrochloride |
Inhibitor |
99.33% |
否 |
HY-108648 |
2-MeS-ADP trisodium |
Agonist |
99.90% |
否 |
HY-113330 |
12S-HHT |
Agonist |
≥99.0% |
否 |
HY-114454 |
INH14 |
Inhibitor |
≥98.0% |
否 |
HY-121282A |
Mepazine hydrochloride |
|
99.94% |
否 |
HY-124346 |
T-3364366 |
|
99.80% |
否 |
HY-125098 |
Illudin S |
|
98.01% |
否 |
HY-15356 |
BIO-acetoxime |
|
≥98.0% |
是 |
HY-154789 |
RTIOXA-43 |
Agonist |
99.94% |
否 |
HY-15521 |
ETP-46464 |
Inhibitor |
99.55% |
否 |
HY-16561A |
cis-Resveratrol |
Inhibitor |
98.79% |
否 |
HY-40229 |
(S)-(-)-tert-Butylsulfinamide |
|
99.94% |
否 |
HY-P0176 |
PACAP (1-27), human, ovine, rat |
|
99.79% |
否 |
HY-P2979 |
Invertase, baker's yeast (S. cerevisiae) |
|
0.00% |
否 |
HY-W013268 |
(S)-(+)-N-3-Benzylnirvanol |
Inhibitor |
99.82% |
否 |
HY-Y0399 |
L-Norvaline |
|
≥98.0% |
否 |
HY-15564 |
AR 231453 |
Agonist |
99.70% |
否 |
HY-B2031 |
Pyriproxyfen |
|
99.00% |
否 |
HY-50767S |
Palbociclib-d8 |
Inhibitor |
99.84% |
否 |
HY-101146 |
SF2523 |
Inhibitor |
98.25% |
否 |
HY-128341 |
ERK5-IN-2 |
Inhibitor |
98.96% |
否 |
HY-129035 |
PFI-653 |
Inhibitor |
99.92% |
否 |
HY-15889 |
AMG 925 |
Inhibitor |
98.20% |
否 |
HY-121832 |
DDX3-IN-1 |
Inhibitor |
99.67% |
否 |
HY-133512 |
NCGC00249987 |
Inhibitor |
99.91% |
否 |
HY-19537 |
NI-57 |
Inhibitor |
99.96% |
否 |
HY-103603 |
(S,R,S)-AHPC-PEG2-NH2 hydrochloride |
|
99.77% |
否 |
HY-103645 |
GW779439X |
|
99.85% |
否 |
HY-107532 |
N-Nonyldeoxynojirimycin |
Inhibitor |
≥99.0% |
否 |
HY-110190 |
VU0422288 |
Modulator |
99.88% |
否 |
HY-110243 |
CAIX Inhibitor S4 |
Inhibitor |
99.04% |
否 |
HY-111532B |
(3S,4S)-A2-32-01 |
Inhibitor |
98.15% |
否 |
HY-111898 |
Epirosmanol |
|
99.38% |
否 |
HY-115903 |
HIF-1α-IN-2 |
Inhibitor |
98.45% |
否 |
HY-116216 |
PD 168368 |
Antagonist |
≥99.0% |
否 |
HY-119397A |
KDM5-C49 hydrochloride |
Inhibitor |
99.95% |
否 |
HY-119591 |
BPDBA |
Inhibitor |
98.45% |
否 |
HY-120897 |
NS-3-008 hydrochloride |
Inhibitor |
99.65% |
否 |
HY-121885 |
LMD-009 |
Agonist |
99.35% |
否 |
HY-123905 |
LIN28 inhibitor LI71 |
Inhibitor |
98.20% |
否 |
HY-124832 |
δ-Secretase inhibitor 11 |
Inhibitor |
99.06% |
否 |
HY-128522 |
ARS-1323-alkyne |
Inhibitor |
99.59% |
否 |
HY-128712 |
NCGC00029283 |
Inhibitor |
98.88% |
否 |
HY-13455 |
LDN-192960 |
Inhibitor |
99.56% |
否 |
HY-135906 |
CK2/ERK8-IN-1 |
|
≥99.0% |
否 |
HY-14550 |
TP-10 |
Inhibitor |
99.88% |
否 |
HY-146887 |
USP7-IN-9 |
|
98.10% |
否 |
HY-153627 |
GK13S |
Inhibitor |
≥98.0% |
否 |
HY-15800A |
CZC-25146 |
Inhibitor |
99.10% |
否 |
HY-19333 |
OG-L002 |
Inhibitor |
99.81% |
否 |
HY-19350 |
BML-210 |
|
98.06% |
否 |
HY-B2188 |
S-Methyl-L-cysteine |
|
≥98.0% |
否 |
HY-N0455AS2 |
L-Arginine-d7 hydrochloride |
Activator |
99.72% |
否 |
HY-N1458 |
Isoschaftoside |
Inhibitor |
99.95% |
否 |
HY-N2391 |
p-Hydroxycinnamic acid |
|
99.94% |
否 |
HY-N6002 |
3'-Hydroxypterostilbene |
Inducer |
99.89% |
否 |
HY-P10284 |
S7 |
Antagonist |
99.12% |
否 |
HY-P1548 |
β-CGRP, human |
|
98.17% |
否 |
HY-W010255 |
Phenylglyoxylic acid |
|
99.66% |
否 |
HY-W018499 |
(S)-2-Hydroxybutanoic acid |
|
≥98.0% |
否 |
HY-16708A |
ZLN024 hydrochloride |
Activator |
98.47% |
否 |
HY-15191 |
Sabutoclax |
Inhibitor |
99.80% |
否 |
HY-101354 |
R-IMPP |
Inhibitor |
98.42% |
否 |
HY-101963 |
AD80 |
Inhibitor |
99.88% |
否 |
HY-130122 |
MG-277 |
Inducer |
98.66% |
否 |
HY-103604A |
(S,R,S)-AHPC-PEG4-NH2 |
|
99.51% |
否 |
HY-111379 |
EHT 5372 |
Inhibitor |
98.12% |
否 |
HY-120882 |
BM-1197 |
Inhibitor |
99.48% |
否 |
HY-144897 |
FHT-1204 |
Inhibitor |
99.81% |
否 |
HY-79256 |
MMAF-OMe |
|
99.62% |
否 |
HY-101445B |
(S)-Trolox |
|
99.36% |
否 |
HY-101762 |
TyK2-IN-2 |
Inhibitor |
98.64% |
否 |
HY-103599 |
(S,R,S)-AHPC-PEG2-N3 |
|
99.74% |
否 |
HY-108036A |
(S)-Pro-xylane |
|
≥98.0% |
否 |
HY-108264 |
TCS 21311 |
Inhibitor |
99.18% |
否 |
HY-110120 |
DSR-6434 |
Agonist |
99.55% |
否 |
HY-112257 |
S-23 |
Modulator |
99.93% |
否 |
HY-112825 |
TSI-01 |
Inhibitor |
98.31% |
否 |
HY-114204 |
GSK8814 |
Inhibitor |
99.60% |
否 |
HY-114858 |
Epiblastin A |
Inhibitor |
99.51% |
否 |
HY-120252 |
ABC44 |
Inhibitor |
98.7% |
否 |
HY-12059A |
AT7867 dihydrochloride |
Inhibitor |
99.75% |
否 |
HY-123607 |
UniPR129 |
Antagonist |
99.23% |
否 |
HY-125861A |
Methyl cellulose(Viscosity:15mPa.s) |
|
/ |
否 |
HY-135841 |
CM010 |
Inhibitor |
99.70% |
否 |
HY-136310 |
PIP4K-IN-a131 |
Inhibitor |
98.92% |
否 |
HY-139983 |
SDH-IN-1 |
Inhibitor |
99.95% |
否 |
HY-145001 |
20-HC-Me-Pyrrolidine |
Inhibitor |
97.66% |
否 |
HY-146584 |
Cathepsin C-IN-5 |
Inhibitor |
95.70% |
否 |
HY-14658A |
(S)-Thalidomide |
Inducer |
99.65% |
否 |
HY-153918 |
(R)-SKBG-1 |
Inhibitor |
99.50% |
否 |
HY-15745A |
PSI-7409 tetrasodium |
Inhibitor |
99.31% |
否 |
HY-158155 |
CVN293 |
Inhibitor |
99.91% |
否 |
HY-16677A |
Mofegiline hydrochloride |
Inhibitor |
99.57% |
否 |
HY-19351 |
MN-64 |
Inhibitor |
99.61% |
否 |
HY-30152 |
Xanthotoxol |
Antagonist |
99.75% |
否 |
HY-41094 |
cis-Isolimonenol |
|
99.02% |
否 |
HY-76274 |
(1S,2R)-2-Amino-1,2-diphenylethanol |
|
99.93% |
否 |
HY-N0610AS |
Cinnamic acid-d6 |
|
99.94% |
否 |
HY-N0650S1 |
L-Serine-13C |
|
≥99.0% |
否 |
HY-N1374 |
Magnolin |
Inhibitor |
99.98% |
否 |
HY-N7715 |
Ferulic acid acyl-β-D-glucoside |
|
99.33% |
否 |
HY-W008446 |
(2S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid |
|
99.80% |
否 |
HY-W011927 |
4,4'-Sulfonyldiphenol |
|
99.92% |
否 |
HY-W048918 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-trityl-L-homocysteine |
|
99.77% |
否 |
HY-12001 |
WZ-3146 |
Inhibitor |
99.63% |
否 |
HY-N0598 |
Ginsenoside F1 |
Inhibitor |
≥99.0% |
否 |
HY-15528 |
kb NB 142-70 |
Inhibitor |
98.08% |
否 |
HY-12473 |
Vps34-IN-2 |
Inhibitor |
99.81% |
否 |
HY-19798 |
PI4KIIIbeta-IN-9 |
Inhibitor |
99.01% |
否 |
HY-101396 |
ICA-069673 |
Activator |
99.65% |
否 |
HY-112113 |
SLV-2436 |
Inhibitor |
98.53% |
否 |
HY-124586 |
Streptonigrin |
Inhibitor |
99.20% |
否 |
HY-15798 |
UNC2881 |
Inhibitor |
99.79% |
否 |
HY-15971 |
AMD 3465 hexahydrobromide |
|
≥98.0% |
否 |
HY-101466 |
E7090 |
Inhibitor |
99.64% |
否 |
HY-10644 |
Lck inhibitor 2 |
Inhibitor |
99.73% |
否 |
HY-130249 |
BAY-298 |
|
99.96% |
否 |
HY-131064 |
RIPK3-IN-1 |
Inhibitor |
99.19% |
否 |
HY-145061 |
ADAMTS-5-IN-3 |
Inhibitor |
98.90% |
否 |
HY-146683 |
KS106 |
|
99.31% |
否 |
HY-15714 |
NMS-859 |
Inhibitor |
98.05% |
否 |
HY-100228A |
SKF89976A hydrochloride |
Inhibitor |
99.70% |
否 |
HY-100434 |
PD-161570 |
Inhibitor |
99.82% |
否 |
HY-101964 |
SPI-112 |
Inhibitor |
97.06% |
否 |
HY-10408 |
Ki20227 |
Inhibitor |
99.51% |
否 |
HY-108235B |
(Rac)-Lanicemine |
Antagonist |
99.63% |
否 |
HY-108323 |
CCR2 antagonist 4 |
Antagonist |
99.89% |
否 |
HY-112534 |
GSTO-IN-2 |
Inhibitor |
≥98.0% |
否 |
HY-113138 |
3-Methyluridine |
|
99.05% |
否 |
HY-113438 |
15(S)-HPETE |
|
97.3% |
否 |
HY-113974 |
trans-AUCB |
Inhibitor |
98.16% |
否 |
HY-114091 |
PF-00356231 hydrochloride |
Inhibitor |
99.52% |
否 |
HY-114374 |
RO5461111 |
Antagonist |
98.17% |
否 |
HY-115669 |
Pentachloropseudilin |
Inhibitor |
98.88% |
否 |
HY-118144 |
PD166326 |
Inhibitor |
99.99% |
否 |
HY-120179 |
LP-922761 |
|
98.21% |
否 |
HY-121138 |
1,8-Dihydroxy-4,5-dinitroanthraquinone |
Inhibitor |
98.00% |
否 |
HY-12158 |
VU0238441 |
Activator |
99.88% |
否 |
HY-123052 |
Ac-PAL-AMC |
|
≥98.0% |
否 |
HY-124309 |
NHI-2 |
|
99.30% |
否 |
HY-125018 |
QM31 |
Inhibitor |
98.50% |
否 |
HY-125861E |
Methyl cellulose(Viscosity:4000mPa.s) |
|
/ |
否 |
HY-128153 |
Thienopyridone |
|
98.05% |
否 |
HY-12928 |
ML336 |
Inhibitor |
99.09% |
否 |
HY-131027 |
Janelia Fluor® 646, Azide |
|
99.87% |
否 |
HY-132857A |
ZXH-4-130 TFA |
|
99.71% |
否 |
HY-13631I |
(1S,9R)-Exatecan mesylate |
|
98.23% |
否 |
HY-13838 |
PLX647 |
Inhibitor |
99.79% |
否 |
HY-145267 |
OM-153 |
Inhibitor |
99.59% |
否 |
HY-145919 |
hGPR91 antagonist 3 |
|
98.82% |
否 |
HY-147025 |
(S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine |
|
99.06% |
否 |
HY-147832 |
EIF2α activator 2 |
Activator |
99.88% |
否 |
HY-15292 |
S107 |
Ligand |
99.77% |
否 |
HY-153372 |
93-O17S |
|
≥98.0% |
否 |
HY-18095A |
CX-6258 hydrochloride hydrate |
Inhibitor |
99.23% |
否 |
HY-20302 |
(2S,3AS,7aS)-Octahydroindole-2-carboxylic acid |
|
≥98.0% |
否 |
HY-45609 |
L-Cysteine S-sulfate sodium hydrate |
Agonist |
≥98.0% |
否 |
HY-N0450 |
Sinapine thiocyanate |
Inhibitor |
99.74% |
否 |
HY-N0650S11 |
L-Serine-d7 |
|
99.97% |
否 |
HY-N0650S8 |
L-Serine-d3 |
|
99.75% |
否 |
HY-N6792 |
T-2 Toxin |
|
99.23% |
否 |
HY-W006064 |
(S)-2-Aminopent-4-ynoic acid |
|
99.91% |
否 |
HY-W007825 |
(1R,2S)-2-Amino-1,2-diphenylethanol |
|
99.95% |
否 |
HY-Y0337S5 |
L-Cysteine-d3 |
|
99.2% |
否 |
HY-12235 |
PI-3065 |
Inhibitor |
98.97% |
否 |
HY-P1389 |
Neuropeptide S (human) |
Agonist |
99.71% |
否 |
HY-100491 |
H3B-6527 |
Inhibitor |
≥98.0% |
否 |
HY-19752A |
VU0357017 hydrochloride |
Agonist |
99.91% |
否 |
HY-100521 |
GKI-1 |
Inhibitor |
99.89% |
否 |
HY-107419 |
NU6140 |
Inhibitor |
99.07% |
否 |
HY-111507 |
PDGFRα kinase inhibitor 1 |
Inhibitor |
99.78% |
否 |
HY-111652 |
S-Gboxin |
Inhibitor |
99.62% |
否 |
HY-135674 |
SR-318 |
Inhibitor |
99.89% |
否 |
HY-135976 |
P2X3 antagonist 34 |
Antagonist |
99.71% |
否 |
HY-162284 |
BAY-9835 |
Antagonist |
99.46% |
否 |
HY-112277 |
NCT-505 |
Inhibitor |
99.37% |
否 |
HY-12034 |
WYE-354 |
|
98.04% |
否 |
HY-137472 |
SAR502250 |
Inhibitor |
99.63% |
否 |
HY-138563 |
GSK973 |
Inhibitor |
99.97% |
否 |
HY-148799 |
Sevasemten |
Inhibitor |
99.46% |
否 |
HY-100443A |
trans-PX20606 |
Agonist |
99.24% |
否 |
HY-101445A |
(R)-Trolox |
Inhibitor |
99.91% |
否 |
HY-103352 |
L-006235 |
Inhibitor |
99.96% |
否 |
HY-103547 |
L-168049 |
Antagonist |
99.93% |
否 |
HY-103647 |
K00546 |
Inhibitor |
98.08% |
否 |
HY-107405 |
TC-N 1752 |
Inhibitor |
99.67% |
否 |
HY-109897 |
CV-6209 |
|
≥98.0% |
否 |
HY-111263 |
NIAD-4 |
|
99.11% |
否 |
HY-111820 |
CK1-IN-1 |
Inhibitor |
99.35% |
否 |
HY-112478 |
PTP Inhibitor IV |
Inhibitor |
99.90% |
否 |
HY-114933 |
VU0119498 |
Modulator |
99.52% |
否 |
HY-115403 |
FKGK18 |
Inhibitor |
≥99.0% |
否 |
HY-119093 |
Halopemide |
|
99.65% |
否 |
HY-123051 |
Ac-WLA-AMC |
|
99.79% |
否 |
HY-12333 |
Denfivontinib |
|
≥98.0% |
否 |
HY-126456 |
(S,R,S)-AHPC-propargyl |
|
99.46% |
否 |
HY-128971 |
LHVS |
Inhibitor |
98.03% |
否 |
HY-145147 |
AAA-10 |
Inhibitor |
≥98.0% |
否 |
HY-145728B |
(R/S)-Alicaforsen |
Inhibitor |
97.08% |
否 |
HY-146148 |
KDM4C-IN-1 |
Inhibitor |
98.99% |
否 |
HY-146682 |
KS100 |
|
99.61% |
否 |
HY-147319 |
RTI-7470-44 |
|
99.85% |
否 |
HY-148152A |
PSMA I&S TFA |
|
98.15% |
否 |
HY-148602 |
KH-4-43 |
Inhibitor |
99.99% |
否 |
HY-150640 |
Rho-Kinase-IN-2 |
Inhibitor |
99.29% |
否 |
HY-15176B |
Pyridostatin TFA |
Activator |
99.54% |
否 |
HY-160972 |
MM0299 |
Inhibitor |
98.51% |
否 |
HY-16616 |
SIRT-IN-2 |
Inhibitor |
98.08% |
否 |
HY-18086 |
TCS PIM-1 1 |
Inhibitor |
98.01% |
否 |
HY-41650 |
Boc-Ala-NMe(OMe) |
|
/ |
否 |
HY-79334 |
(S)-(+)-1,2-Propanediol |
|
99.97% |
否 |
HY-B0536 |
Clinafloxacin |
Inhibitor |
≥98.0% |
否 |
HY-I0034 |
(S)-Quinuclidin-3-amine dihydrochloride |
|
≥98.0% |
否 |
HY-I0678 |
Regorafénib N-oxyde (M2) |
|
99.32% |
否 |
HY-N0346A |
(E)-Ethyl p-methoxycinnamate |
Inhibitor |
99.53% |
否 |
HY-N0455AS1 |
L-Arginine-15N4 hydrochloride |
Activator |
99.85% |
否 |
HY-N0802 |
Tenuigenin |
Inhibitor |
99.24% |
否 |
HY-N2176 |
S-(+)-Marmesin |
Inhibitor |
99.04% |
否 |
HY-N3945 |
Glaucine |
|
99.57% |
否 |
HY-N8060A |
Orotidine 5′-monophosphate trisodium |
|
99.86% |
否 |
HY-N8723 |
(1′S,2′S)-Nicotine-1'-oxide |
|
≥99.0% |
否 |
HY-P2106A |
Elabela(19-32) TFA |
|
98.78% |
否 |
HY-P5601A |
Thanatin TFA |
Inhibitor |
99.51% |
否 |
HY-W001538 |
S-Propargylcysteine |
|
≥97.0% |
否 |
HY-W014590 |
(S)-Thioctic acid |
|
99.79% |
否 |
HY-W021425 |
D-Mannosamine hydrochloride |
|
≥98.0% |
否 |
HY-W050031 |
(S)-3-Hydroxybutanoic acid |
|
≥97.0% |
否 |
HY-Y0982 |
(S)-BINAP |
|
99.71% |
否 |
HY-155108B |
OATD-02 hydrochloride |
Inhibitor |
99.88% |
否 |
HY-156048 |
Trifluoromethyl-tubercidin |
Inhibitor |
99.12% |
否 |
HY-100114 |
TA-01 |
Inhibitor |
99.86% |
否 |
HY-103636 |
PROTAC Sirt2 Degrader-1 |
Inhibitor |
98.71% |
否 |
HY-109069 |
Petesicatib |
Inhibitor |
99.66% |
否 |
HY-112713 |
SMS2-IN-2 |
Inhibitor |
≥98.0% |
否 |
HY-12437 |
BDP5290 |
Inhibitor |
98.80% |
否 |
HY-12475 |
Mutant IDH1-IN-1 |
Inhibitor |
99.43% |
否 |
HY-126326 |
SWE101 |
Inhibitor |
99.41% |
否 |
HY-16780 |
Gemilukast |
Antagonist |
99.49% |
否 |
HY-109042 |
Relacorilant |
Antagonist |
99.12% |
是 |
HY-112705 |
VU0529331 |
Inhibitor |
99.81% |
否 |
HY-114339 |
CDK4/6-IN-2 |
Inhibitor |
99.82% |
否 |
HY-128570 |
FD-IN-1 |
Inhibitor |
99.24% |
否 |
HY-130983 |
N-piperidine Ibrutinib hydrochloride |
Inhibitor |
98.06% |
否 |
HY-132841A |
Sucunamostat hydrochloride |
Inhibitor |
98.14% |
否 |
HY-137191 |
CH7233163 |
Inhibitor |
99.61% |
否 |
HY-147405 |
Tinlorafenib |
Inhibitor |
98.20% |
否 |
HY-156419 |
PARP7-IN-16 |
Inhibitor |
99.91% |
否 |
HY-17590 |
Radafaxine hydrochloride |
Inhibitor |
99.01% |
否 |
HY-19982 |
AKT-IN-6 |
Inhibitor |
99.08% |
否 |
HY-P2454 |
CSP1 |
Inhibitor |
98.26% |
否 |
HY-100604 |
JNJ-40418677 |
|
≥99.0% |
否 |
HY-101219 |
VEGFR-IN-1 |
Inhibitor |
98.42% |
否 |
HY-108494 |
CYM50260 |
Agonist |
99.70% |
否 |
HY-108533 |
CD2314 |
Agonist |
99.84% |
否 |
HY-112820 |
Chlorantraniliprole |
|
98.06% |
否 |
HY-113976A |
Endothall |
Antagonist |
≥95.0% |
否 |
HY-117147A |
GSK2945 hydrochloride |
Activator |
99.69% |
否 |
HY-122858A |
PKCiota-IN-2 formic |
Inhibitor |
99.04% |
否 |
HY-123275B |
H-D-Phe-Pip-Arg-pNA acetate |
|
98.90% |
否 |
HY-125962 |
X-34 |
|
96.2% |
否 |
HY-126145 |
S1PR1 modulator 1 |
Inhibitor |
99.44% |
否 |
HY-12885C |
2’3’-c-di-AM(PS)2 (Rp,Rp) enantiomer ammonium salt |
Inducer |
98.94% |
否 |
HY-12927 |
SX-517 |
Antagonist |
99.88% |
否 |
HY-129942 |
S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate |
|
≥95.0% |
否 |
HY-130347 |
H2S Donor 5a |
|
98.82% |
否 |
HY-132579A |
Tominersen sodium |
|
97.34% |
否 |
HY-135831 |
AHR antagonist 2 |
Antagonist |
99.91% |
否 |
HY-136528 |
RA-9 |
|
98.67% |
否 |
HY-136882 |
TM-1 |
Inhibitor |
95.04% |
否 |
HY-139218 |
(S,R,S)-AHPC-Me-C6-NH2 |
|
99.14% |
否 |
HY-139254 |
Indirubin-3′-oxime |
Inhibitor |
99.10% |
否 |
HY-139345 |
(S,R,S)-AHPC-CO-C9-acid |
Chemical |
97.64% |
否 |
HY-143403 |
PI3K-IN-31 |
Inhibitor |
99.55% |
否 |
HY-143466 |
ULK1-IN-2 |
|
99.09% |
否 |
HY-14362 |
GSK-25 |
Inhibitor |
99.68% |
否 |
HY-144501 |
D18 |
|
98.79% |
否 |
HY-14722A |
NVP-BSK805 dihydrochloride |
Inhibitor |
99.36% |
否 |
HY-148818 |
S-Me-DM4 |
|
99.03% |
否 |
HY-151499A |
PXS-6302 hydrochloride |
Inhibitor |
99.83% |
否 |
HY-151500B |
JBSNF-000028 hydrochloride |
Inhibitor |
95.83% |
否 |
HY-153584 |
MRK-898 |
Modulator |
99.48% |
否 |
HY-155339 |
Anticancer agent 168 |
|
97.44% |
否 |
HY-155874 |
ZNL-05-044 |
Inhibitor |
99.91% |
否 |
HY-158113 |
CBPD-409 |
Degrader |
97.47% |
否 |
HY-15813 |
FIIN-1 |
Inhibitor |
99.11% |
否 |
HY-158975 |
VRK1/CK1-IN-1 |
Inhibitor |
98.69% |
否 |
HY-16938S1 |
5'-Methylthioadenosine-d3 |
|
99.81% |
否 |
HY-N0173 |
Cinchonidine |
Inhibitor |
≥98.0% |
否 |
HY-N1673 |
2,5-Dihydroxybenzaldehyde |
Inhibitor |
99.78% |
否 |
HY-N1926 |
Dihydrocoumarin |
Inhibitor |
99.81% |
否 |
HY-N2070 |
Acevaltrate |
Inhibitor |
99.56% |
否 |
HY-N2551 |
Vitamin U chloride |
|
99.86% |
否 |
HY-N7046 |
Silybin B |
Inhibitor |
99.90% |
否 |
HY-P0176A |
PACAP (1-27), human, ovine, rat TFA |
|
99.87% |
否 |
HY-P2265A |
SAH-SOS1A TFA |
Inhibitor |
99.16% |
否 |
HY-W001189 |
1,3-Dithiane |
Inhibitor |
99.95% |
否 |
HY-W003445 |
4-Bromo-3-hydroxybenzoic acid |
|
99.25% |
否 |
HY-W009177 |
S-Methylglutathione |
Inhibitor |
≥99.0% |
否 |
HY-W018849 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,3-dimethylbutanoic acid |
|
99.92% |
否 |
HY-W018865 |
Methyl D-cysteinate hydrochloride |
|
≥98.0% |
否 |
HY-W074541 |
Girard’s reagent T |
|
99.83% |
否 |
HY-10185 |
TG 100572 Hydrochloride |
Inhibitor |
98.96% |
否 |
HY-10811 |
GNE-493 |
Inhibitor |
99.81% |
否 |
HY-128111 |
ASN02563583 |
Activator |
99.21% |
否 |
HY-145376 |
Cholera autoinducer 1 |
|
≥99.0% |
否 |
HY-17035 |
Doramectin |
Inhibitor |
98.83% |
否 |
HY-D0221 |
2,4,6-Tri-2-pyridinyl-1,3,5-triazine |
|
99.87% |
否 |
HY-D0307A |
Amaranth |
|
99.15% |
否 |
HY-P3180 |
Hemoglobin S |
|
≥99.0% |
否 |
HY-U00425 |
PROTAC ERRα ligand 1 |
Antagonist |
99.47% |
否 |
HY-111099 |
GLPG1837 |
Agonist |
99.86% |
否 |
HY-10178 |
PHA-680632 |
Inhibitor |
98.07% |
否 |
HY-107414 |
SKA-121 |
Activator |
99.69% |
否 |
HY-114414 |
HDACs/mTOR Inhibitor 1 |
|
99.01% |
否 |
HY-115881 |
SR-1114 |
|
99.04% |
否 |
HY-117286 |
(S)-JQ-35 |
Inhibitor |
99.46% |
否 |
HY-124131 |
DS-437 |
Inhibitor |
98.00% |
否 |
HY-12498 |
GV-58 |
Agonist |
99.22% |
否 |
HY-126675 |
AS2863619 free base |
|
99.87% |
否 |
HY-128350A |
FGTI-2734 mesylate |
Inhibitor |
99.65% |
否 |
HY-109177 |
Icenticaftor |
Activator |
99.87% |
否 |
HY-114504 |
RVX-297 |
Inhibitor |
95.00% |
否 |
HY-123851 |
MSC2504877 |
Inhibitor |
98.50% |
否 |
HY-126130 |
LysRs-IN-2 |
Inhibitor |
99.92% |
否 |
HY-128879A |
VP3.15 dihydrobromide |
Inhibitor |
98.01% |
否 |
HY-144634 |
DDO-7263 |
Activator |
99.83% |
否 |
HY-15873A |
FTI 276 TFA |
Inhibitor |
98.06% |
否 |
HY-100741A |
(S,R)-S63845 |
Control |
98.54% |
否 |
HY-100781A |
L-AP4 |
Agonist |
99.01% |
否 |
HY-10162S |
Olaparib-d5 |
|
≥99.0% |
否 |
HY-103274 |
PD180970 |
|
99.27% |
否 |
HY-103364A |
C-021 dihydrochloride |
Antagonist |
99.92% |
否 |
HY-107664A |
SR 142948 dihydrochloride |
Antagonist |
98.6% |
否 |
HY-107834 |
PIK-75 |
|
99.94% |
否 |
HY-108348 |
BML-259 |
Inhibitor |
98.78% |
否 |
HY-108485 |
Damnacanthal |
|
≥98.0% |
否 |
HY-110166 |
PD 90780 |
|
≥99.0% |
否 |
HY-110173 |
TC-G 1005 |
Agonist |
99.83% |
否 |
HY-117386 |
Methoxyfenozide |
Inhibitor |
98.10% |
否 |
HY-120025 |
CRT0105950 |
Inhibitor |
99.91% |
否 |
HY-120086 |
RO-5963 |
|
99.97% |
否 |
HY-12185 |
BRD7389 |
Inhibitor |
99.75% |
否 |
HY-122751 |
(R)-DNMDP |
Inhibitor |
99.59% |
否 |
HY-12439 |
ML380 |
Agonist |
99.91% |
否 |
HY-126536 |
ChemR23-IN-1 |
|
98.82% |
否 |
HY-128677 |
NCC007 |
Inhibitor |
99.73% |
否 |
HY-131021 |
Janelia Fluor® 549, Azide |
|
/ |
否 |
HY-131881 |
JHU37160 |
Agonist |
99.98% |
否 |
HY-132135 |
(1E)-CFI-400437 dihydrochloride |
Inhibitor |
98.08% |
否 |
HY-13827 |
JAK-IN-1 |
Inhibitor |
99.44% |
否 |
HY-13954 |
A 839977 |
Antagonist |
98.74% |
否 |
HY-142076 |
CDK4/6-IN-15 |
Inhibitor |
99.32% |
否 |
HY-143791 |
ALOX15-IN-2 |
Inhibitor |
99.88% |
否 |
HY-146725 |
FBPase-IN-1 |
Inhibitor |
98.30% |
否 |
HY-148234 |
M4K2234 |
Inhibitor |
98.71% |
否 |
HY-148877 |
AT-533 |
Inhibitor |
98.86% |
否 |
HY-148896 |
(S,R,S)-AHPC-C2-PEG3-BCN |
|
99.22% |
否 |
HY-149924 |
CST626 |
Degrader |
95.87% |
否 |
HY-149974 |
CDK8-IN-13 |
|
99.14% |
否 |
HY-152189 |
S19-1035 |
|
99.77% |
否 |
HY-153050 |
JAK-IN-24 |
Inhibitor |
99.27% |
否 |
HY-153937 |
Skp2 inhibitor 2 |
|
/ |
否 |
HY-15505 |
RWJ-67657 |
Inhibitor |
99.75% |
否 |
HY-155659 |
4A7C-301 |
Agonist |
99.86% |
否 |
HY-19396 |
Ingliforib |
Inhibitor |
99.07% |
否 |
HY-34597 |
(S)-2-Amino-3-(4-bromophenyl)propanoic acid |
|
99.91% |
否 |
HY-40029 |
(S)-1-Boc-3-aminopiperidine |
|
99.95% |
否 |
HY-41919 |
Mal-L-PA-NH-Boc |
|
99.30% |
否 |
HY-44153 |
KV2 channel inhibitor-1 |
Inhibitor |
98.46% |
否 |
HY-79106 |
L-Biphenylalanine |
|
99.95% |
否 |
HY-B1184AR |
(S)-Mephenytoin (Standard) |
|
/ |
否 |
HY-B1786A |
(E/Z)-Sulindac sulfide |
|
99.88% |
否 |
HY-N0224 |
Epigoitrin |
Inhibitor |
99.91% |
否 |
HY-N0650S10 |
L-Serine-15N |
|
≥98.0% |
否 |
HY-N0651 |
Spinosin |
Inhibitor |
99.89% |
否 |
HY-N4297 |
Baicalin methyl ester |
|
99.05% |
否 |
HY-P0323A |
GP(33-41) TFA |
Inhibitor |
99.62% |
否 |
HY-P1206 |
CH 275 |
Agonist |
99.71% |
否 |
HY-P1482 |
α-Factor Mating Pheromone, yeast |
|
99.89% |
否 |
HY-P1482A |
α-Factor Mating Pheromone, yeast TFA |
|
99.68% |
否 |
HY-P2274 |
Argifin |
Inhibitor |
98.46% |
否 |
HY-U00422 |
K-756 |
Inhibitor |
99.25% |
否 |
HY-W002530 |
(1S,2R)-1-Aminoindan-2-ol |
|
99.96% |
否 |
HY-W007401 |
(1R,2S)-1-Amino-2-indanol |
|
99.93% |
否 |
HY-W013754 |
S-Hexylglutathione |
|
99.94% |
否 |
HY-W053705 |
(S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid |
|
98.52% |
否 |
HY-Y0337S4 |
L-Cysteine-13C3 |
|
99.90% |
否 |
HY-Y0366S1 |
Lauric acid-d23 |
Inhibitor |
≥98.0% |
否 |
HY-110277 |
S2101 |
Inhibitor |
99.73% |
否 |
HY-116290 |
Zaragozic acid A |
|
99.2% |
否 |
HY-117049 |
Leucettine L41 |
Inhibitor |
98.70% |
否 |
HY-13895 |
WHI-P154 |
|
99.39% |
否 |
HY-15704 |
LH846 |
Inhibitor |
98.18% |
否 |
HY-134877 |
BAY 2476568 |
Inhibitor |
99.88% |
否 |
HY-112616 |
NAMPT inhibitor-linker 2 |
Inhibitor |
99.35% |
否 |
HY-136563 |
RA375 |
|
99.31% |
否 |
HY-16531A |
YF-2 hydrochloride |
Activator |
99.61% |
否 |
HY-D0215 |
Safranin |
Inhibitor |
/ |
否 |
HY-111508 |
PI3K/mTOR Inhibitor-2 |
Inhibitor |
99.10% |
否 |
HY-111904 |
EHMT2-IN-2 |
Inhibitor |
≥99.0% |
否 |
HY-113854 |
AZD2906 |
Agonist |
99.90% |
否 |
HY-120596 |
PPARδ/γ agonist 1 sodium |
Agonist |
99.91% |
否 |
HY-130616 |
EGFR-IN-11 |
|
99.30% |
否 |
HY-130798 |
(S,R,S)-AHPC-amido-C5-acid |
|
99.58% |
否 |
HY-133123 |
EP4 receptor antagonist 1 |
Antagonist |
99.66% |
否 |
HY-133551 |
WF-47-JS03 |
Inhibitor |
99.63% |
否 |
HY-136350 |
BRD9500 |
Modulator |
99.46% |
否 |
HY-136578 |
RP101988 |
Agonist |
98.80% |
否 |
HY-150254A |
SLB1122168 formic |
Inhibitor |
99.91% |
否 |
HY-10011 |
SCH 563705 |
Antagonist |
99.86% |
否 |
HY-100249 |
XEN723 |
Inhibitor |
99.90% |
否 |
HY-100271 |
Org41841 |
Agonist |
99.77% |
否 |
HY-103195 |
NKY80 |
Inhibitor |
99.69% |
否 |
HY-103440 |
EGFR/ErbB-2/ErbB-4 inhibitor-3 |
Inhibitor |
98.19% |
否 |
HY-103605 |
(S,R,S)-AHPC-C6-PEG3-C4-Cl |
|
97.01% |
否 |
HY-104020A |
Philanthotoxin 74 dihydrochloride |
Antagonist |
99.72% |
否 |
HY-107982 |
VU6005649 |
Agonist |
99.53% |
否 |
HY-108261 |
Tomeglovir |
Inhibitor |
99.71% |
否 |
HY-108317 |
ABL127 |
Inhibitor |
99.91% |
否 |
HY-111253 |
CYM-5478 |
Agonist |
99.90% |
否 |
HY-111323 |
ASN06917370 |
|
99.23% |
否 |
HY-112256 |
ACP-105 |
Modulator |
98.99% |
否 |
HY-114645 |
PDK1-IN-RS2 |
Inhibitor |
98.50% |
否 |
HY-116146 |
CYM50179 |
Agonist |
96.06% |
否 |
HY-117366 |
PS432 |
Inhibitor |
≥99.0% |
否 |
HY-118052 |
BPKDi |
Inhibitor |
99.60% |
否 |
HY-119171 |
GSK 366 |
Inhibitor |
99.80% |
否 |
HY-120348 |
ML67-33 |
Activator |
≥99.0% |
否 |
HY-121401A |
(−)-Myrtenal |
|
99.11% |
否 |
HY-121862 |
CM03 |
Inhibitor |
99.73% |
否 |
HY-122470 |
Stampidine |
Inhibitor |
99.96% |
否 |
HY-12331 |
KRCA-0008 |
|
96.19% |
否 |
HY-12370 |
TY-51469 |
Inhibitor |
99.79% |
否 |
HY-124825 |
iGOT1-01 |
Inhibitor |
99.77% |
否 |
HY-12598 |
(S)-3,5-DHPG |
Agonist |
≥99.0% |
否 |
HY-126113 |
KIN101 |
Inhibitor |
99.44% |
否 |
HY-126126 |
S-Adenosyl-DL-methionine |
|
99.84% |
否 |
HY-12783A |
SCH 50911 |
Antagonist |
≥98.0% |
否 |
HY-129624A |
Bisindolylmaleimide VIII acetate |
|
99.68% |
否 |
HY-131028 |
Janelia Fluor® 646 TFA |
|
≥95.0% |
否 |
HY-132850 |
Dazcapistat |
Inhibitor |
≥98.0% |
否 |
HY-136065 |
bpV(phen) |
|
≥98.0% |
否 |
HY-136181A |
YNT-185 |
Agonist |
98.36% |
否 |
HY-136466 |
A2ti-2 |
Inhibitor |
99.27% |
否 |
HY-136909 |
SR33805 |
Antagonist |
99.19% |
否 |
HY-137346 |
DD-03-156 |
Degrader |
99.63% |
否 |
HY-143398 |
PARP10/15-IN-1 |
Inhibitor |
95.00% |
否 |
HY-143787 |
ALOX15-IN-1 |
Inhibitor |
98.09% |
否 |
HY-14418 |
VU0361737 |
Agonist |
99.79% |
否 |
HY-144305 |
KPH2f |
Inhibitor |
99.22% |
否 |
HY-144691 |
PP-C8 |
Inhibitor |
99.99% |
否 |
HY-14682 |
GSK319347A |
Inhibitor |
99.25% |
否 |
HY-146980 |
GLUT4-IN-2 |
Inhibitor |
99.90% |
否 |
HY-147066 |
Dyrk1A-IN-4 |
Inhibitor |
99.90% |
否 |
HY-148236 |
BAY-390 |
Inhibitor |
99.74% |
否 |
HY-148671 |
(S,R,S)-AHPC-amido-C7-acid |
|
98.28% |
否 |
HY-149526 |
cGAS-IN-1 |
Inhibitor |
98.29% |
否 |
HY-153254 |
BMS905 |
Inhibitor |
99.59% |
否 |
HY-153894 |
SRX3177 |
Inhibitor |
99.59% |
否 |
HY-15452A |
(S)-Selisistat |
Inhibitor |
99.39% |
否 |
HY-155035 |
S07-1066 |
Inhibitor |
99.48% |
否 |
HY-156617A |
(αR)-Cyclopropaneacetamide-Exatecan |
Inhibitor |
99.75% |
否 |
HY-15879 |
LB42708 |
|
≥99.0% |
否 |
HY-16106A |
(8R,9S)-Talazoparib |
Inhibitor |
98.28% |
否 |
HY-18285 |
Longdaysin |
Inhibitor |
99.83% |
否 |
HY-18302 |
c-Kit-IN-5-1 |
Inhibitor |
98.16% |
否 |
HY-19316 |
NU2058 |
Inhibitor |
99.66% |
否 |
HY-30167A |
L-Valinol |
|
99.98% |
否 |
HY-32933 |
4-Acetylphenylboronic acid |
Inhibitor |
99.96% |
否 |
HY-40040 |
(S)-1-Boc-3-methylpiperazine |
|
99.97% |
否 |
HY-40354AS |
Tofacitinib-d3 citrate |
|
99.14% |
否 |
HY-59140 |
(S)-2-Amino-3,3-dimethylbutanoic acid |
|
≥98.0% |
否 |
HY-79130 |
Fmoc-(S)-phenylglycine |
|
99.95% |
否 |
HY-B0006B |
(S)-Carvedilol |
Inhibitor |
99.64% |
否 |
HY-B0580A |
(S)-Ketorolac |
Inhibitor |
99.27% |
否 |
HY-B0589C |
(3S,5S)-Atorvastatin |
Activator |
≥95.0% |
否 |
HY-D0905 |
S-n-Butyrylthiocholine iodide |
|
≥98.0% |
否 |
HY-N0215S8 |
L-Phenylalanine-13C6 |
Antagonist |
≥99.0% |
否 |
HY-N0455AS |
L-Arginine-15N2 hydrochloride |
Activator |
≥98.0% |
否 |
HY-N2237 |
Piceatannol 3'-O-glucoside |
|
99.87% |
否 |
HY-N2553 |
4-Deoxypyridoxine 5'-phosphate |
Inhibitor |
≥98.0% |
否 |
HY-N7062 |
JNJ-1661010 |
Inhibitor |
99.77% |
否 |
HY-P1217 |
[D-Trp8]-γ-MSH |
Agonist |
99.57% |
否 |
HY-P1258 |
PSI |
Inhibitor |
≥97.0% |
否 |
HY-P2016 |
Ac-Nle-Pro-Nle-Asp-AMC |
|
99.85% |
否 |
HY-P5376 |
MeO-Suc-Arg-Pro-Tyr-pNA |
Substrate |
98.50% |
否 |
HY-W007573 |
(S)-4-(tert-Butoxy)-3-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid |
|
≥98.0% |
否 |
HY-W009110 |
(S)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid |
|
99.73% |
否 |
HY-W412175 |
Coproporphyrin III dihydrochloride |
|
99.57% |
否 |
HY-Y0219 |
1,2,4-Triazole |
|
≥97.0% |
否 |
HY-Y0703D |
Sodium carboxymethyl cellulose (average Mw 90000) |
|
99.50% |
否 |
HY-15510B |
Tenovin-6 Hydrochloride |
|
98.88% |
否 |
HY-16025 |
EOC317 |
Inhibitor |
98.05% |
否 |
HY-164793 |
TGFBR1-IN-2 |
|
/ |
否 |
HY-22055B |
AN-12-H5 intermediate-1 |
|
99.72% |
否 |
HY-W028350 |
NSC727447 |
Inhibitor |
≥95.0% |
否 |
HY-W039865 |
1-Thio-beta-D-glucose tetraacetate |
|
99.88% |
否 |
HY-Y1126 |
(2S)-2-Pyrrolidinemethanol |
|
99.41% |
否 |
HY-13941B |
1-Naphthyl PP1 hydrochloride |
Inhibitor |
99.83% |
否 |
HY-111778 |
EHMT2-IN-1 |
Inhibitor |
99.85% |
否 |
HY-112164 |
IACS-8968 |
Inhibitor |
98.46% |
否 |
HY-129681 |
MCL-1/BCL-2-IN-1 |
Inhibitor |
99.86% |
否 |
HY-132813 |
Evifacotrep |
Antagonist |
99.55% |
否 |
HY-141016 |
(S,R,S)-AHPC-PEG2-acid |
|
98.88% |
否 |
HY-156460 |
CMKLR1 antagonist 1 |
Antagonist |
99.44% |
否 |
HY-18748 |
BQR-695 |
Inhibitor |
99.92% |
否 |
HY-101281 |
VU 6008667 |
Inhibitor |
99.53% |
否 |
HY-109046 |
Tulrampator |
Agonist |
99.39% |
否 |
HY-114331 |
DLK-IN-1 |
Inhibitor |
99.18% |
否 |
HY-123976 |
MPT0G211 |
Inhibitor |
99.79% |
否 |
HY-147414 |
Vamotinib |
Inhibitor |
98.69% |
否 |
HY-148103 |
SR12418 |
|
99.93% |
否 |
HY-15958 |
VBY-825 |
Inhibitor |
99.81% |
否 |
HY-15036S |
Diclofenac-d4 |
|
99.79% |
否 |
HY-10002A |
(1S)-Calcitriol |
|
98.94% |
否 |
HY-100218C |
(1R,3R)-RSL3 |
Control |
99.52% |
否 |
HY-100509 |
NPS-1034 |
|
≥98.0% |
否 |
HY-100588 |
VU0364770 |
Agonist |
99.94% |
否 |
HY-101450 |
PF-6274484 |
Inhibitor |
98.76% |
否 |
HY-101460 |
Tz-Thalidomide |
Degrader |
98.01% |
否 |
HY-103359 |
Ceranib1 |
|
99.38% |
否 |
HY-104070 |
LG-100064 |
Agonist |
99.66% |
否 |
HY-107646 |
PD 102807 |
Antagonist |
98.52% |
否 |
HY-107664 |
SR 142948 |
Antagonist |
99.16% |
否 |
HY-108254 |
Bisindolylmaleimide IV |
Inhibitor |
99.62% |
否 |
HY-108626 |
ML154 |
Antagonist |
99.59% |
否 |
HY-110109 |
ETP-45658 |
Inhibitor |
98.97% |
否 |
HY-110128 |
Sulfidefluor 7-AM |
|
≥99.0% |
否 |
HY-11080 |
PKI-179 |
Inhibitor |
≥98.0% |
否 |
HY-111789A |
(S)-Subasumstat |
|
99.63% |
否 |
HY-112102 |
(22S,23S)-Homobrassinolide |
Activator |
99.80% |
否 |
HY-113316B |
(S)-Salsolinol |
|
99.64% |
否 |
HY-113380 |
(S)-b-aminoisobutyric acid |
|
≥98.0% |
否 |
HY-113884B |
(S)-Coriolic acid |
Activator |
≥99.0% |
否 |
HY-114080 |
Patamostat |
Inhibitor |
98.13% |
否 |
HY-114759 |
MS-PPOH |
Inhibitor |
99.27% |
否 |
HY-114962 |
S-22153 |
Antagonist |
99.85% |
否 |
HY-116214 |
Cyprodinil |
|
99.36% |
否 |
HY-117025A |
Manzamine A hydrochloride |
Inhibitor |
99.66% |
否 |
HY-117196 |
GW 9578 |
Agonist |
99.6% |
否 |
HY-117743 |
Eprosartan |
Antagonist |
99.87% |
否 |
HY-119257 |
ABT-100 |
|
98.18% |
否 |
HY-120033 |
RY796 |
Inhibitor |
98.59% |
否 |
HY-120299 |
KC01 |
Inhibitor |
≥99.0% |
否 |
HY-120823 |
PF-05381941 |
Inhibitor |
99.73% |
否 |
HY-120909 |
YK5 |
|
99.66% |
否 |
HY-121538 |
CUDA |
|
≥98.0% |
否 |
HY-122376 |
S-Bioallethrin |
|
98.16% |
否 |
HY-123275A |
H-D-Phe-Pip-Arg-pNA hydrochloride |
|
99.40% |
否 |
HY-124729A |
(Rac)-BL-918 |
|
98.88% |
否 |
HY-125703 |
Ferutinin |
|
99.23% |
否 |
HY-125904 |
4-Hydroxyretinoic acid |
Activator |
95.11% |
否 |
HY-128554S |
N-Desethyl amodiaquine-d5 |
Inhibitor |
99.60% |
否 |
HY-128888B |
(S,R)-GSK321 |
Inhibitor |
98.78% |
否 |
HY-130189 |
S-Phenylmercapturic acid |
|
99.38% |
否 |
HY-131029 |
Janelia Fluor® 646, Maleimide |
|
≥95.0% |
否 |
HY-134819 |
(1S,2S)-ML-SI3 |
Inhibitor |
99.82% |
否 |
HY-135659 |
BSH-IN-1 |
Inhibitor |
99.08% |
否 |
HY-137541 |
2-Nitro-5-thiocyanatobenzoic acid |
|
98.44% |
否 |
HY-13785 |
ZM 306416 |
Inhibitor |
99.80% |
否 |
HY-142076A |
CDK4/6-IN-15 hydrochloride |
Inhibitor |
99.04% |
否 |
HY-145433 |
17β-HSD1-IN-1 |
Inhibitor |
99.34% |
否 |
HY-147060 |
Dyrk1A-IN-3 |
Inhibitor |
99.96% |
否 |
HY-149010 |
NXPZ-2 |
Inhibitor |
98.18% |
否 |
HY-149202 |
UT-11 |
Inhibitor |
99.62% |
否 |
HY-149213 |
LSD1-IN-24 |
Inhibitor |
99.20% |
否 |
HY-150510 |
MS8511 |
Inhibitor |
/ |
否 |
HY-151810 |
TP0472993 |
Inhibitor |
98.69% |
否 |
HY-152026 |
NADPH oxidase-IN-1 |
Inhibitor |
99.60% |
否 |
HY-153100A |
(S)-mchm5U |
|
98.87% |
否 |
HY-153556 |
GW297361 |
Inhibitor |
98.13% |
否 |
HY-154851 |
GSK-3 inhibitor 3 |
Inhibitor |
98.72% |
否 |
HY-155943 |
AMPK-IN-4 |
Inhibitor |
97.16% |
否 |
HY-156776 |
HAPSBC |
|
≥95.0% |
否 |
HY-15801 |
HG-14-10-04 |
Inhibitor |
99.09% |
否 |
HY-15883 |
GNE-900 |
|
99.21% |
否 |
HY-162655 |
SLF80821178 |
Inhibitor |
99.70% |
否 |
HY-18313 |
S6K1-IN-1 |
Inhibitor |
99.44% |
否 |
HY-18901 |
RIPK1-IN-4 |
Inhibitor |
98.89% |
否 |
HY-19587 |
Ditercalinium chloride |
Inhibitor |
96.12% |
否 |
HY-19986 |
AAL993 |
Inhibitor |
99.50% |
否 |
HY-22024 |
5-Hydroxyflavone |
|
99.83% |
否 |
HY-22062 |
Fmoc-Chg-OH |
|
99.87% |
否 |
HY-23020 |
Boc3Arg |
|
≥96.0% |
否 |
HY-40098 |
(S)-1-Boc-3-aminopyrrolidine |
|
99.95% |
否 |
HY-50878S |
Crizotinib-d5 |
|
99.60% |
否 |
HY-69348 |
(S)-(-)-3-Boc-2,2-dimethyloxazolidine-4-carboxaldehyde |
|
98.57% |
否 |
HY-75095 |
(S)-(-)-1-Phenylethanamine |
Chemical |
99.58% |
否 |
HY-77026 |
(S)-Ethyl 2-amino-4-fluoro-4-methylpentanoate sulfate |
|
99.88% |
否 |
HY-79333 |
L-Alanine, N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-, 1-methylethyl ester |
|
98.32% |
否 |
HY-A0036D |
Bazedoxifene (acetate)-D |
|
99.93% |
否 |
HY-B2144F |
Chitosan (≥80% deacetylated, Medium viscosity,200-400mPa.s) |
|
/ |
否 |
HY-B2226 |
Sodium copper chlorophyllin B |
Inhibitor |
/ |
否 |
HY-D0249 |
Sunset Yellow FCF |
|
≥98.0% |
否 |
HY-D1056H |
Lipopolysaccharides, from S. marcescens |
Activator |
/ |
否 |
HY-E70234 |
Sortase A, S. aureus |
Inhibitor |
95.00% |
否 |
HY-I0591 |
N-Formyl-L-leucine |
|
99.99% |
否 |
HY-N0331 |
Ziyuglycoside I |
|
99.42% |
否 |
HY-N0363A |
(+)-Columbianetin acetate |
|
99.83% |
否 |
HY-N0374 |
Licochalcone C |
Inhibitor |
99.55% |
否 |
HY-N0548 |
α-Angelica lactone |
Activator |
99.93% |
否 |
HY-N0650S5 |
L-Serine-13C3,15N |
|
≥99.0% |
否 |
HY-N1976 |
(+)-(3R,8S)-Falcarindiol |
Inhibitor |
98.53% |
否 |
HY-N2258 |
Poncirin |
Inducer |
99.55% |
否 |
HY-P0273A |
Histatin 5 TFA |
Inhibitor |
99.98% |
否 |
HY-P1437 |
Neuropeptide S (mouse) |
Agonist |
98.83% |
否 |
HY-W005388 |
(S)-2-(Methylamino)-3-phenylpropanoic acid |
|
97.70% |
否 |
HY-W006185 |
(S)-5-Benzyl 1-tert-butyl 2-aminopentanedioate hydrochloride |
|
≥97.0% |
否 |
HY-W007978 |
(R)-[1,1'-Binaphthalene]-2,2'-diamine |
|
99.95% |
否 |
HY-W010600 |
(S)-Tetrahydrofurfurylamine |
|
≥95.0% |
否 |
HY-W011056 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(furan-2-yl)propanoic acid |
|
99.64% |
否 |
HY-W011500S |
TCEP-d16 hydrochloride |
|
≥97.0% |
否 |
HY-W012126 |
2,6-Dichlorodiphenylamine |
Inhibitor |
99.71% |
否 |
HY-W014663 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoic acid |
|
99.85% |
否 |
HY-W017069 |
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(allyloxy)-4-oxobutanoic acid |
|
98.65% |
否 |
HY-W042016 |
(S)-2-Amino-3-(3,5-dichloro-4-hydroxyphenyl)propanoic acid |
|
99.86% |
否 |
HY-Y0366S3 |
Lauric acid-d3 |
Inhibitor |
98.92% |
否 |
HY-15375 |
Allitinib |
Inhibitor |
99.36% |
否 |
HY-15971A |
AMD 3465 |
|
99.59% |
否 |
HY-40354C |
(3S,4S)-Tofacitinib |
Inhibitor |
99.75% |
否 |
HY-41076 |
Ca2+ channel agonist 1 |
|
99.71% |
否 |
HY-B0905A |
Tilmicosin phosphate |
Inhibitor |
≥98.0% |
否 |
HY-G0014A |
Quetiapine sulfoxide dihydrochloride |
|
99.27% |
否 |
HY-N0909 |
Notoginsenoside R2 |
|
98.78% |
否 |
HY-U00460 |
3,6-DMAD hydrochloride |
Inhibitor |
99.50% |
否 |
HY-101265 |
Icanbelimod |
Agonist |
99.90% |
否 |
HY-101918 |
DS-1040 Tosylate |
Inhibitor |
99.51% |
否 |
HY-117273 |
AZ304 |
Inhibitor |
99.96% |
否 |
HY-16742A |
Gepotidacin (S enantiomer) |
Inhibitor |
98.27% |
否 |
HY-100948 |
ATM-3507 |
Inhibitor |
98.16% |
否 |
HY-110339 |
RKI-1447 dihydrochloride |
|
98.04% |
否 |
HY-111552 |
PIM1-IN-1 |
Inhibitor |
99.83% |
否 |
HY-114303 |
CM-675 |
Inhibitor |
99.53% |
否 |
HY-119123A |
Voxvoganan trihydrochloride |
Inhibitor |
98.13% |
否 |
HY-124295 |
Imofinostat |
|
99.40% |
否 |
HY-132981 |
Lu AF27139 |
Antagonist |
99.71% |
否 |
HY-139920 |
Oritinib |
Inhibitor |
99.59% |
否 |
HY-144266 |
TP-060 |
|
99.31% |
否 |
HY-145835 |
PERK-IN-5 |
Inhibitor |
99.40% |
否 |
HY-157133 |
TAS0612 |
Inhibitor |
98.70% |
否 |
HY-159706 |
S9-A13 |
Inhibitor |
99.68% |
否 |
HY-18095B |
CX-6258 hydrochloride |
Inhibitor |
99.03% |
否 |
HY-44809 |
Izilendustat |
Inhibitor |
99.20% |
否 |
HY-100560S |
Abscisic acid-d6 |
Inhibitor |
98.69% |
否 |
HY-100742B |
(S)-GNE-140 |
Inhibitor |
99.07% |
否 |
HY-101261 |
ATPA |
Agonist |
≥98.0% |
否 |
HY-10182R |
Laduviglusib (Standard) |
|
/ |
否 |
HY-101834 |
ACT-462206 |
Antagonist |
99.60% |
否 |
HY-107660 |
SIRT2-IN-8 |
Inhibitor |
99.32% |
否 |
HY-108319 |
DPP-IV-IN-2 |
Inhibitor |
99.35% |
否 |
HY-108606 |
PI-828 |
Inhibitor |
99.62% |
否 |
HY-108933 |
JK-P3 |
Inhibitor |
99.72% |
否 |
HY-10936 |
S 18986 |
Agonist |
99.24% |
否 |
HY-110263 |
EML 425 |
Inhibitor |
98.04% |
否 |
HY-110291 |
A-971432 |
Agonist |
≥99.0% |
否 |
HY-11034 |
CVT-12012 |
Inhibitor |
99.16% |
否 |
HY-111427 |
CDK8/19-IN-1 |
Inhibitor |
98.03% |
否 |
HY-111826 |
γ-Glutamyl-S-1-propenyl cysteine |
|
99.27% |
否 |
HY-112099 |
Mc-Val-Cit-PAB-Cl |
|
99.67% |
否 |
HY-113039 |
L-2-Hydroxyglutaric acid |
Inhibitor |
≥95.0% |
否 |
HY-113304A |
(S)-3,4-Dihydroxybutyric acid lithium hydrate |
|
98.1% |
否 |
HY-113434 |
5(S)-HETE |
|
≥99.0% |
否 |
HY-113616A |
VU0364572 TFA |
Agonist |
99.27% |
否 |
HY-113638 |
CVT-11127 |
|
99.88% |
否 |
HY-114330A |
ZK824859 hydrochloride |
Inhibitor |
99.03% |
否 |
HY-115481 |
EphB1-IN-1 |
Inhibitor |
99.87% |
否 |
HY-115726 |
FRM-024 |
Modulator |
99.45% |
否 |
HY-116514 |
(S)-(−)-Perillyl alcohol |
Inducer |
≥98.0% |
否 |
HY-122255 |
LY487379 |
Inhibitor |
98.92% |
否 |
HY-123081 |
Eburicol |
Inhibitor |
≥98.0% |
否 |
HY-123346 |
SW155246 |
Inhibitor |
98.31% |
否 |
HY-124645 |
QL-X-138 |
Inhibitor |
99.77% |
否 |
HY-128034 |
PPIase-Parvulin inhibitor |
Inhibitor |
99.79% |
否 |
HY-131011 |
Furanone C-30 |
Inhibitor |
≥98.0% |
否 |
HY-131452 |
1-Ethynylpyrene |
Inhibitor |
97.10% |
否 |
HY-133152S |
Brexpiprazole S-oxide-d8 |
|
98.72% |
否 |
HY-13333 |
NVP-BAG956 |
Inhibitor |
99.21% |
否 |
HY-13455A |
LDN-192960 hydrochloride |
Inhibitor |
99.78% |
否 |
HY-136182 |
YM-244769 dihydrochloride |
Inhibitor |
98.57% |
否 |
HY-143793 |
RBP4 inhibitor 1 |
Inhibitor |
99.74% |
否 |
HY-147193 |
Nampt-IN-10 TFA |
Inhibitor |
98.70% |
否 |
HY-147204 |
Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE |
|
98.26% |
否 |
HY-148754 |
PARP10-IN-3 |
Inhibitor |
98.89% |
否 |
HY-149006 |
CK156 |
Inhibitor |
99.91% |
否 |
HY-149420 |
BRD7-IN-2 |
Inhibitor |
99.21% |
否 |
HY-150693 |
Estrogen receptor β antagonist 2 |
Antagonist |
98.39% |
否 |
HY-15133 |
PTP1B-IN-3 |
Inhibitor |
99.35% |
否 |
HY-15271 |
WYE-687 |
Inhibitor |
98.05% |
否 |
HY-152944 |
S6K1-IN-DG2 |
Inhibitor |
99.70% |
否 |
HY-153446 |
Tegeprotafib |
Inhibitor |
99.30% |
否 |
HY-15439 |
(24S)-24,25-Dihydroxyvitamin D3 |
|
98.98% |
否 |
HY-156681A |
(S)-STX-478 |
Control |
99.18% |
否 |
HY-156816 |
ON 108600 |
Inhibitor |
99.73% |
否 |
HY-162299 |
EGFR kinase inhibitor 3 |
Inhibitor |
98.05% |
否 |
HY-162308 |
NSD-IN-3 |
|
≥98.0% |
否 |
HY-164099 |
LSD1/HDAC6-IN-2 |
Inhibitor |
99.66% |
否 |
HY-16637D |
Folic acid disodium |
|
99.15% |
否 |
HY-16657A |
(S,S)-TAPI-1 |
Inhibitor |
99.46% |
否 |
HY-16936 |
JH-II-127 |
Inhibitor |
≥98.0% |
否 |
HY-17610 |
Enerisant |
Antagonist |
99.79% |
否 |
HY-18166 |
NIBR0213 |
Antagonist |
99.38% |
否 |
HY-18169 |
MUT056399 |
Inhibitor |
99.87% |
否 |
HY-19760 |
I-BET282 |
Inhibitor |
99.12% |
否 |
HY-40028 |
(S)-3-Boc-aminopiperidine |
|
99.92% |
否 |
HY-41414 |
(S)-(+)-2-Phenylglycinol |
|
99.29% |
否 |
HY-42424A |
(S,R,S)-AHPC-Me dihydrochloride |
|
99.84% |
否 |
HY-50055 |
EtDO-P4 |
Inhibitor |
98.75% |
否 |
HY-77251 |
TAK1/MAP4K2 inhibitor 1 |
Inhibitor |
99.90% |
否 |
HY-A0104D |
HPMC (Type I,Viscosity:4000mPa.s) |
|
/ |
否 |
HY-B0101S |
Fluconazole-d4 |
Inhibitor |
99.66% |
否 |
HY-B0400S1 |
D-Sorbitol-13C |
|
≥98.0% |
否 |
HY-B0580S |
Ketorolac-d5 |
Inhibitor |
98.31% |
否 |
HY-B0589S |
Atorvastatin-d5 hemicalcium |
|
≥98.0% |
否 |
HY-B0637S |
Bezafibrate-d6 |
Agonist |
≥98.0% |
否 |
HY-B2144I |
Chitosan (≥90% deacetylated,viscosity 10 mPa.s) |
Inhibitor |
/ |
否 |
HY-N0215S10 |
L-Phenylalanine-13C9 |
Antagonist |
98% |
否 |
HY-N0215S3 |
L-Phenylalanine-d2 |
Antagonist |
99.00% |
否 |
HY-N0215S5 |
L-Phenylalanine-15N |
Antagonist |
98.10% |
否 |
HY-N1050 |
Zederone |
Inhibitor |
99.61% |
否 |
HY-N1150S1 |
Thymidine-d4 |
Inhibitor |
≥99.0% |
否 |
HY-N2357 |
Eudesmin |
Inhibitor |
99.96% |
否 |
HY-N4201 |
β-Hydroxyisovalerylshikonin |
Inhibitor |
99.83% |
否 |
HY-P10375 |
BMS-986189 |
Inhibitor |
98.16% |
否 |
HY-P1096 |
A71623 |
Agonist |
99.90% |
否 |
HY-P4704A |
α-Synuclein (61-95) (human) TFA |
|
94.80% |
否 |
HY-P5723A |
Api137 TFA |
Inhibitor |
98.96% |
否 |
HY-U00432A |
S-MTC dihydrochloride |
Inhibitor |
99.00% |
否 |
HY-W000843 |
(2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid |
|
99.75% |
否 |
HY-W012885 |
(S)-Methyl 3-hydroxybutanoate |
|
99.67% |
否 |
HY-W040233B |
L-Lactic acid (sodium) (purity≥90%) |
|
≥98.0% |
否 |
HY-W040430 |
(S)-Nornicotine |
|
99.30% |
否 |
HY-W091734 |
Methyl 4-iodo-L-phenylalaninate hydrochloride |
|
≥95.0% |
否 |
HY-W110927 |
Alizarin Red S Indicator (4.3-6.3), IND |
|
/ |
否 |
HY-Y0337S1 |
L-Cysteine-15N |
|
≥98.0% |
否 |
HY-Y0703A |
Sodium carboxymethyl cellulose (Viscosity:1200-1400 mPa.s) |
|
99.79% |
否 |
HY-128554S1 |
N-Desethyl amodiaquine-d5 dihydrochloride |
Inhibitor |
98.76% |
否 |
HY-13521A |
SB-505124 hydrochloride |
Inhibitor |
99.34% |
否 |
HY-14622B |
Necrostatin 2 S enantiomer |
Inhibitor |
99.65% |
否 |
HY-79080 |
(3R,5S)-5-([1,1′-Biphenyl]-4-ylmethyl)-3-methyl-2-pyrrolidinone |
Control |
98.65% |
否 |
HY-B0792 |
CZC-54252 |
Inhibitor |
99.38% |
否 |
HY-N1428R |
Citric acid (standard) |
Inducer |
/ |
否 |
HY-U00437 |
Pz-1 |
Inhibitor |
99.90% |
否 |
HY-W015515 |
L-Citronellol |
|
99.92% |
否 |
HY-W251393 |
S-(2-Carboxypropyl)-L-cysteine |
|
≥98.0% |
否 |
HY-103048A |
PD-1/PD-L1-IN 3 TFA |
Inhibitor |
99.34% |
否 |
HY-111905 |
BRD7-IN-1 |
Inhibitor |
99.77% |
否 |
HY-120083 |
Rodatristat |
Inhibitor |
99.11% |
否 |
HY-120137 |
CMP-5 |
Inhibitor |
99.02% |
否 |
HY-132173 |
GL0388 |
Activator |
98.01% |
否 |
HY-133487B |
(S,R,S)-AHPC-C8-NH2 |
|
97.04% |
否 |
HY-146302 |
14-3-3η Protein inhibitor 1 |
Inducer |
99.00% |
否 |
HY-16918A |
Heptamidine dimethanesulfonate |
Inhibitor |
99.82% |
否 |
HY-100233 |
IQ-1S free acid |
Inhibitor |
99.28% |
否 |
HY-100390 |
(S)-ML753286 |
Inhibitor |
99.39% |
否 |
HY-101121 |
NI-42 |
Inhibitor |
99.53% |
否 |
HY-112145 |
FLT3-IN-3 |
Inhibitor |
99.95% |
否 |
HY-123109 |
(S,R,S)-AHPC-Boc |
|
95.21% |
否 |
HY-13016S |
Cabozantinib-d6 |
|
98.14% |
否 |
HY-131349 |
CCR4-351 |
Antagonist |
98.95% |
否 |
HY-131906 |
JAK2-IN-7 |
|
99.15% |
否 |
HY-133120A |
INY-03-041 trihydrochloride |
Inhibitor |
99.27% |
否 |
HY-138555 |
PROTAC BRD4 Degrader-8 |
Inhibitor |
98.08% |
否 |
HY-147183A |
JBJ-09-063 TFA |
Inhibitor |
99.64% |
否 |
HY-14926 |
Levonadifloxacin |
Inhibitor |
99.79% |
否 |
HY-100754B |
(2R,5S)-Ritlecitinib |
Inhibitor |
99.77% |
否 |
HY-100809 |
Guvacine hydrochloride |
Inhibitor |
99.73% |
否 |
HY-101313A |
(S)-Remoxipride hydrochloride |
Antagonist |
99.93% |
否 |
HY-101335 |
DCG-IV |
Agonist |
≥99.0% |
否 |
HY-101548 |
OGT-IN-1 |
Inhibitor |
98.14% |
否 |
HY-10162S1 |
Olaparib-d8 |
|
99.57% |
否 |
HY-103308 |
TRAM-39 |
Inhibitor |
99.66% |
否 |
HY-103604 |
(S,R,S)-AHPC-PEG4-NH2 hydrochloride |
|
98.06% |
否 |
HY-103607 |
(S,R,S)-AHPC-PEG2-C4-Cl |
|
98.21% |
否 |
HY-10528S |
Tasquinimod-d3 |
Modulator |
99.34% |
否 |
HY-106991A |
Amustaline dihydrochloride |
Inhibitor |
≥95.0% |
否 |
HY-107198 |
(2S)-6-Prenylnaringenin |
Agonist |
99.43% |
否 |
HY-107412 |
Proteasome inhibitor IX |
Inhibitor |
99.43% |
否 |
HY-108312A |
AC-VEID-CHO TFA |
Inhibitor |
98.7% |
否 |
HY-110258B |
(R,S,R)-ML334 |
Control |
98.57% |
否 |
HY-110264 |
MI-192 |
|
≥99.0% |
否 |
HY-110280 |
MC1742 |
|
99.20% |
否 |
HY-111678 |
ML230 |
Inhibitor |
99.60% |
否 |
HY-112019 |
L-Methionine-34S |
|
99.84% |
否 |
HY-112345 |
PD-089828 |
Inhibitor |
98.07% |
否 |
HY-112388 |
GSK-3b Inhibitor XI |
Inhibitor |
99.10% |
否 |
HY-112420 |
EGFR/ErbB-2/ErbB-4 inhibitor-2 |
Inhibitor |
99.45% |
否 |
HY-112505 |
Efflux inhibitor-1 |
Inhibitor |
≥98.0% |
否 |
HY-112855 |
PF-06454589 |
Inhibitor |
99.91% |
否 |
HY-114271A |
T3-ATA (S-isomer) |
|
99.50% |
否 |
HY-115658 |
VU0420373 |
Inhibitor |
99.99% |
否 |
HY-116076 |
S-15535 |
Modulator |
99.82% |
否 |
HY-116399 |
MMP-2/MMP-9-IN-1 |
Inhibitor |
99.25% |
否 |
HY-117102 |
ANI-7 |
Activator |
98.13% |
否 |
HY-117143 |
TK05 |
Inhibitor |
98.00% |
否 |
HY-117393 |
Bisindolylmaleimide III |
Inhibitor |
98.95% |
否 |
HY-118567 |
Bis(maltolato)oxovanadium(IV) |
Inhibitor |
99.34% |
否 |
HY-118946 |
BPH-1358 |
Inhibitor |
99.12% |
否 |
HY-120184 |
VU0467485 |
Agonist |
≥99.0% |
否 |
HY-120458 |
LCAHA |
Inhibitor |
99.91% |
否 |
HY-120967 |
(2S)-OMPT (triethylamine), in ethanol:chloroform (1:1), 98% |
|
≥99.0% |
否 |
HY-120986 |
(S)-Bromoenol lactone |
Inhibitor |
≥99.0% |
否 |
HY-122203 |
PCS1055 dihydrochloride |
|
98.88% |
否 |
HY-122936 |
Tanshindiol C |
|
98.47% |
否 |
HY-123194 |
SIRT2/6-IN-1 |
Inhibitor |
98.44% |
否 |
HY-123418 |
PKUMDL-WQ-2201 |
Inhibitor |
98.72% |
否 |
HY-124502 |
UNC4203 |
Inhibitor |
99.80% |
否 |
HY-12489A |
Ponceau S, BS |
|
/ |
否 |
HY-12567 |
ML375 |
Inhibitor |
99.70% |
否 |
HY-128678 |
ORM-10103 |
Inhibitor |
99.97% |
否 |
HY-12954 |
PTACH |
|
99.65% |
否 |
HY-13017S3 |
Ivacaftor-d4 |
Agonist |
≥96.0% |
否 |
HY-130248B |
(R)-BAY-899 |
|
99.89% |
否 |
HY-13057 |
O6BTG-octylglucoside |
Inhibitor |
≥95.0% |
否 |
HY-130711B |
(S,R,S)-AHPC-C3-NH2 hydrochloride |
|
96.38% |
否 |
HY-135119 |
Salmeterol-d3 |
Inhibitor |
98.91% |
否 |
HY-13514 |
TG 100713 |
Inhibitor |
99.49% |
否 |
HY-135489 |
(±)-Reticuline |
|
99.47% |
否 |
HY-136072A |
(1R,2S)-Xeruborbactam disodium |
|
99.26% |
否 |
HY-136363 |
MDR-652 |
Agonist |
99.02% |
否 |
HY-139094 |
A6770 |
Inhibitor |
≥99.0% |
否 |
HY-142512 |
EGFR-IN-24 |
Inhibitor |
/ |
否 |
HY-14417 |
VU0155041 |
Agonist |
99.10% |
否 |
HY-144619 |
TLR7/8 antagonist 2 |
Antagonist |
99.68% |
否 |
HY-144652 |
IDO1-IN-19 |
Inhibitor |
98.52% |
否 |
HY-145313 |
TTBK1-IN-2 |
Inhibitor |
99.91% |
否 |
HY-145580A |
(S)-Minzasolmin |
Control |
/ |
否 |
HY-146179 |
IMP2-IN-2 |
Inhibitor |
99.93% |
否 |
HY-14679 |
GSK3β inhibitor II |
Inhibitor |
99.76% |
否 |
HY-147512 |
CB1/2 agonist 1 |
Agonist |
99.20% |
否 |
HY-148070 |
FLT3-IN-17 |
Inhibitor |
99.56% |
否 |
HY-148867 |
UCM-1306 |
Modulator |
99.61% |
否 |
HY-149902 |
USP8-IN-3 |
Inhibitor |
99.17% |
否 |
HY-150236 |
FITC-labeled Tominersen sodium |
Inhibitor |
95.72% |
否 |
HY-15031 |
l-Naproxen |
Inhibitor |
99.63% |
否 |
HY-15035 |
S-Diclofenac |
Inhibitor |
99.20% |
否 |
HY-15037S1 |
Diclofenac-d4 sodium |
|
99.29% |
否 |
HY-15197 |
ABT-046 |
Inhibitor |
98.57% |
否 |
HY-153100 |
(R)-mchm5U |
|
99.43% |
否 |
HY-15319B |
AMG 487 (S-enantiomer) |
Antagonist |
99.94% |
否 |
HY-153568 |
JAK1-IN-11 |
Inhibitor |
98.27% |
否 |
HY-155539 |
Cisd2 agonist 2 |
Agonist |
99.17% |
否 |
HY-157581 |
MS39 |
Degrader |
99.89% |
否 |
HY-16115 |
BPH-652 |
Inhibitor |
98.97% |
否 |
HY-161672 |
G-5758 |
Inhibitor |
98.91% |
否 |
HY-162704 |
JMV7048 |
Degrader |
99.12% |
否 |
HY-163462 |
Poacic acid |
Inhibitor |
97.21% |
否 |
HY-16434 |
DGAT1-IN-3 |
Inhibitor |
99.92% |
否 |
HY-164838 |
ABC47 |
Inhibitor |
/ |
否 |
HY-17038S |
Agomelatine-d6 |
|
98.57% |
否 |
HY-17356R |
Fenofibrate (Standard) |
|
99.91% |
否 |
HY-17468S |
Bumetanide-d5 |
Inhibitor |
99.82% |
否 |
HY-17499 |
EGFR-IN-12 |
|
99.40% |
否 |
HY-18071A |
BI-9627 hydrochloride |
Inhibitor |
98.01% |
否 |
HY-19269 |
FK706 |
Inhibitor |
99.12% |
否 |
HY-20841 |
Boc-(2S)-Gly-4-pyranoyl |
|
≥97.0% |
否 |
HY-21629 |
N-Boc-4-piperidinemethanol |
Inhibitor |
99.91% |
否 |
HY-30220 |
(S)-2-Hydroxy-3-phenylpropanoic acid |
|
99.95% |
否 |
HY-32291 |
Methyl L-pyroglutamate |
Inhibitor |
99.62% |
否 |
HY-34519 |
(S)-2-Amino-3-(4-hydroxyphenyl)propionic acid tert-butyl ester |
|
99.87% |
否 |
HY-40102 |
(S)-1-Boc-2-(aminomethyl)pyrrolidine |
|
98.26% |
否 |
HY-50882 |
ELN318463 |
Inhibitor |
99.45% |
否 |
HY-52101C |
FMK-MEA |
Inhibitor |
99.40% |
否 |
HY-77839S |
Cortodoxone-d5 |
Agonist |
99.90% |
否 |
HY-B0227S |
Ketoprofen-d3 |
|
≥99.0% |
否 |
HY-D1270 |
Direct Violet 1 |
Inhibitor |
/ |
否 |
HY-N0223 |
Epibetulinic acid |
Inhibitor |
≥98.0% |
否 |
HY-N0455AS7 |
L-Arginine-13C hydrochloride |
Activator |
99.30% |
否 |
HY-N0650S2 |
L-Serine-1-13C |
|
≥98.0% |
否 |
HY-N1196 |
Suberosin |
Inhibitor |
99.84% |
否 |
HY-N1467 |
(-)-α-Terpineol |
|
≥98.0% |
否 |
HY-N2037C |
(S)-Higenamine hydrobromide |
|
97.85% |
否 |
HY-N2417 |
Stearyl glycyrrhetinate |
Inhibitor |
99.92% |
否 |
HY-N2584 |
(2S)-Isoxanthohumol |
|
99.42% |
否 |
HY-N4005 |
Isoastilbin |
Inhibitor |
99.80% |
否 |
HY-N7850 |
6PGD-IN-1 |
|
99.15% |
否 |
HY-N8151 |
Sanguisorbigenin |
Inhibitor |
99.11% |
否 |
HY-P1423A |
BA 1 TFA |
Agonist |
99.76% |
否 |
HY-P3055A |
Dendrotoxin-I TFA |
Inhibitor |
97.24% |
否 |
HY-W004695 |
(S)-3-Fluoropyrrolidine hydrochloride |
|
99.95% |
否 |
HY-W007978A |
(S)-[1,1'-Binaphthalene]-2,2'-diamine |
|
99.97% |
否 |
HY-W007978B |
1,1'-Binaphthyl-2,2'-diamine |
|
99.17% |
否 |
HY-W009693 |
(S)-2-Amino-3-(4-nitrophenyl)propanoic acid hydrate |
|
99.91% |
否 |
HY-W011927S |
4,4'-Sulfonyldiphenol-d8 |
|
98.88% |
否 |
HY-W012699 |
(+)-Solketal |
|
99.20% |
否 |
HY-W013108 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoic acid |
|
≥98.0% |
否 |
HY-W013207 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)pentanoic acid |
|
99.34% |
否 |
HY-W013292 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid |
|
99.99% |
否 |
HY-W017765A |
(S)-1,1'-Bi-2,2'-naphthol |
|
99.93% |
否 |
HY-W019806 |
Lacto-N-fucopentaose I |
|
99.92% |
否 |
HY-W022047 |
nNOS-IN-1 |
Inhibitor |
99.53% |
否 |
HY-W036322 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-S-trityl-L-cysteine |
|
99.29% |
否 |
HY-W040240 |
(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one |
|
≥97.0% |
否 |
HY-W111226 |
Fmoc-His(3-Me)-OH |
Inhibitor |
≥98.0% |
否 |
HY-W250120 |
Konjac glucomannan (Viscosity≥15000mPa.s) |
|
≥90.0% |
否 |
HY-W286743 |
Nε-(Carboxymethyl)-L-lysine |
|
99.70% |
否 |
HY-Y0168 |
L-(-)-Phenylalaninol |
|
99.11% |
否 |
HY-Y0337S2 |
L-Cysteine-3-13C |
|
99.51% |
否 |
HY-Y0749 |
Glutamic acid dimethyl ester hydrochloride |
|
≥97.0% |
否 |
HY-Y0816 |
(S)-Mandelic acid |
|
99.75% |
否 |
HY-Y1030 |
tert-Butyl L-valinate hydrochloride |
|
≥98.0% |
否 |
HY-10482 |
SCH-1473759 |
Inhibitor |
98.20% |
否 |
HY-131409 |
D-Val-Leu-Lys-pNA dihydrochloride |
|
99.55% |
否 |
HY-134353B |
ADP-β-S trilithium |
Activator |
85.30% |
否 |
HY-160610A |
Carbamoyl phosphate dilithium salt |
|
/ |
否 |
HY-18179 |
AZD2932 |
Inhibitor |
99.04% |
否 |
HY-76475 |
(S)-(-)-Butane-1,2,4-triol |
|
99.35% |
否 |
HY-76971 |
Dechloro Rivaroxaban |
Inhibitor |
99.94% |
否 |
HY-A0104K |
HPMC (Type II,Viscosity:3mPa.s) |
|
/ |
否 |
HY-W011360 |
S-(-)-Warfarin |
|
≥99.0% |
否 |
HY-W099648 |
4-Methylumbelliferyl octanoate |
|
99.82% |
否 |
HY-W143698 |
PDGFRα kinase inhibitor 2 |
Inhibitor |
98.95% |
否 |
HY-Z0425 |
(S)-Methyl 2-oxooxazolidine-4-carboxylate |
Control |
/ |
否 |
HY-128717 |
GSK3368715 |
Inhibitor |
99.24% |
否 |
HY-101284 |
DMU2105 |
Inhibitor |
99.54% |
否 |
HY-10517A |
(Z)-Orantinib |
Inhibitor |
99.44% |
否 |
HY-108539A |
(R)-CE3F4 |
Inhibitor |
≥99.0% |
否 |
HY-111767 |
BAY-545 |
Inhibitor |
98.18% |
否 |
HY-112146A |
MMG-11 quarterhydrate |
Antagonist |
99.09% |
否 |
HY-112700 |
SHIP2-IN-1 |
Inhibitor |
99.72% |
否 |
HY-114357A |
DS-1205b free base |
Inhibitor |
99.92% |
否 |
HY-120478 |
ASP6432 |
Antagonist |
95.50% |
否 |
HY-122895A |
(E/Z)-E64FC26 |
|
98.09% |
否 |
HY-124618A |
FGI-106 tetrahydrochloride |
Inhibitor |
99.68% |
否 |
HY-133119 |
PK150 |
Inhibitor |
99.43% |
否 |
HY-144267 |
Glucosylceramide synthase-IN-2 |
|
98.45% |
否 |
HY-144645 |
SP-471P |
Inhibitor |
99.46% |
否 |
HY-145666 |
Myt1-IN-3 |
Inhibitor |
99.14% |
否 |
HY-16988A |
SR9011 hydrochloride |
|
99.39% |
否 |
HY-101217 |
BI 689648 |
Inhibitor |
99.20% |
否 |
HY-111050 |
JNJ-38877618 |
Inhibitor |
98.76% |
否 |
HY-111415 |
EGFR-IN-5 |
Inhibitor |
99.49% |
否 |
HY-112436 |
PF-6683324 |
Inhibitor |
99.41% |
否 |
HY-123475A |
Sisunatovir hydrochloride |
Inhibitor |
98.61% |
否 |
HY-126248 |
Tankyrase-IN-2 |
Inhibitor |
99.06% |
否 |
HY-126257 |
AKT-IN-3 |
Inhibitor |
99.29% |
否 |
HY-127102 |
GSK3494245 |
Inhibitor |
98.56% |
否 |
HY-130606 |
Nampt-IN-5 |
Inhibitor |
98.02% |
否 |
HY-130849 |
(S,R,S)-AHPC-Me-C5-COOH |
|
96.87% |
否 |
HY-132231 |
FD223 |
|
98.05% |
否 |
HY-13260A |
CCT128930 hydrochloride |
|
98.97% |
否 |
HY-13402A |
Varespladib sodium |
Inhibitor |
≥98.0% |
是 |
HY-136163 |
(S,R,S)-AHPC-C2-NH2 dihydrochloride |
|
98.63% |
否 |
HY-137315 |
TML-6 |
|
99.01% |
否 |
HY-137451 |
Sivopixant |
Antagonist |
99.90% |
否 |
HY-145260 |
BRD4/CK2-IN-1 |
|
98.62% |
否 |
HY-145280 |
IDO1/2-IN-1 |
Inhibitor |
98.06% |
否 |
HY-147660 |
IMMH001 |
Agonist |
98.10% |
否 |
HY-150612 |
(R)-STU104 |
Inhibitor |
99.91% |
否 |
HY-15769 |
WHI-P180 |
Inhibitor |
99.84% |
否 |
HY-100238 |
Antihistamine-1 |
Inhibitor |
99.45% |
否 |
HY-100246 |
CI-1044 |
Inhibitor |
98.02% |
否 |
HY-100499 |
Tyrphostin AG 528 |
Inhibitor |
≥98.0% |
否 |
HY-100606 |
l-Pindolol |
|
99.89% |
否 |
HY-10065S1 |
Axitinib-d3 |
|
98.03% |
否 |
HY-100672B |
(2R)-SR59230A |
Antagonist |
99.88% |
否 |
HY-100741C |
(R,R)-S63845 |
Control |
99.32% |
否 |
HY-100968 |
GBR 12783 dihydrochloride |
Inhibitor |
99.14% |
否 |
HY-101042 |
AG-494 |
Inhibitor |
99.31% |
否 |
HY-10162S3 |
Olaparib-d4-1 |
|
98.59% |
否 |
HY-101698B |
Alniditan dihydrochloride |
Agonist |
99.70% |
否 |
HY-101710 |
Benzgalantamine |
|
99.51% |
否 |
HY-101986A |
BIIE-0246 hydrochloride |
Antagonist |
≥99.0% |
否 |
HY-102029 |
Sarafotoxin S6c |
Agonist |
98.19% |
否 |
HY-103097 |
ST271 |
Inhibitor |
98.00% |
否 |
HY-103461 |
FAAH-IN-6 |
Inhibitor |
99.70% |
否 |
HY-103608 |
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl |
|
99.89% |
否 |
HY-105545 |
Dexetimide |
Antagonist |
99.94% |
否 |
HY-105689 |
AGN 192870 |
Antagonist |
98.10% |
否 |
HY-10569S1 |
Ponesimod-d7 |
|
96.50% |
否 |
HY-107514 |
(RS)-PPG |
Agonist |
99.76% |
否 |
HY-108496S |
Sphingosine-1-phosphate-d7 |
Agonist |
99.00% |
否 |
HY-10865 |
LY2183240 |
Inhibitor |
98.01% |
否 |
HY-111055 |
BIP-135 |
Inhibitor |
99.86% |
否 |
HY-111930 |
5-Iodo-indirubin-3'-monoxime |
Inhibitor |
99.50% |
否 |
HY-112355 |
Aurora kinase inhibitor-2 |
Inhibitor |
99.08% |
否 |
HY-112423 |
CE-245677 |
Inhibitor |
98.14% |
否 |
HY-112433A |
(S)-NIK SMI1 |
|
99.28% |
否 |
HY-113416AS |
Dehydroepiandrosterone sulfate-d6 sodium dihydrate |
|
98.00% |
否 |
HY-113492 |
5(S)15(S)-DiHETE |
Activator |
≥99.0% |
否 |
HY-114653 |
SRPIN803 |
Inhibitor |
99.17% |
否 |
HY-115038 |
ELN484228 |
Antagonist |
99.50% |
否 |
HY-115661 |
Bisdionin C |
Inhibitor |
98.97% |
否 |
HY-115726A |
(-)-FRM-024 |
Modulator |
/ |
否 |
HY-117610A |
Bisindolylmaleimide XI hydrochloride |
Inhibitor |
≥98.0% |
否 |
HY-117970 |
MMPI-1154 |
Inhibitor |
99.87% |
否 |
HY-118152 |
Org-12962 |
Agonist |
99.93% |
否 |
HY-118858 |
UCPH-102 |
|
99.20% |
否 |
HY-119694 |
Rotenolone |
|
≥97.0% |
否 |
HY-121161B |
(2S,3R)-Brassinazole |
|
99.94% |
否 |
HY-121476 |
Arachidonoyl Serinol |
Inhibitor |
≥98.0% |
否 |
HY-12273R |
DMH-1 (Standard) |
Inhibitor |
/ |
否 |
HY-12296A |
(3S,5S,6R)-Navtemadlin |
Control |
97.01% |
否 |
HY-124053 |
BRD2492 |
Inhibitor |
99.18% |
否 |
HY-125028 |
Hck-IN-1 |
Inhibitor |
98.53% |
否 |
HY-125365 |
Rifamycin S |
|
98.82% |
否 |
HY-126275 |
HSD1590 |
Inhibitor |
99.54% |
否 |
HY-128026 |
MMP-9/MMP-13 Inhibitor I |
Inhibitor |
99.90% |
否 |
HY-128171 |
Diflapolin |
Inhibitor |
99.67% |
否 |
HY-128758A |
DYRKs-IN-1 hydrochloride |
Inhibitor |
99.71% |
否 |
HY-12908 |
Bcl-xL antagonist 2 |
|
98.86% |
否 |
HY-131864 |
SJF-1528 |
Degrader |
99.71% |
否 |
HY-131891 |
JHU37152 |
Agonist |
99.45% |
否 |
HY-132247B |
(S)-ErSO |
Control |
99.40% |
否 |
HY-133021 |
Arazine |
|
≥98.0% |
否 |
HY-133780 |
Afatinib impurity 11 |
|
99.10% |
否 |
HY-13456 |
LY-404187 |
Modulator |
98.00% |
否 |
HY-134635 |
Dehydrozingerone |
Inhibitor |
99.98% |
否 |
HY-134807 |
Indophagolin |
|
98.05% |
否 |
HY-134851 |
HIV-1 inhibitor-6 |
Inhibitor |
99.10% |
否 |
HY-136182A |
YM-244769 |
Inhibitor |
98.04% |
否 |
HY-136593 |
(S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid |
Inhibitor |
99.77% |
否 |
HY-137231B |
(S)-UFR2709 hydrochloride |
Antagonist |
98.10% |
否 |
HY-138659 |
Janelia Fluor® 646, Tetrazine |
|
95.29% |
否 |
HY-138678 |
(R,S,S)-VH032 |
|
≥95.0% |
否 |
HY-139703 |
Se-DMC |
|
98.88% |
否 |
HY-14113 |
2-Acetyl-4-tetrahydroxybutyl imidazole |
Inhibitor |
97.89% |
否 |
HY-141627 |
Heparin disaccharide I-S tetrasodium |
|
99.00% |
否 |
HY-14201 |
Lazabemide |
Inhibitor |
99.95% |
否 |
HY-143312E |
(S)-V-0219 hydrochloride |
Modulator |
99.71% |
否 |
HY-143338 |
ART-IN-1 |
Inhibitor |
98.91% |
否 |
HY-144549 |
LXR agonist 1 |
Agonist |
99.95% |
否 |
HY-14566S1 |
Donepezil-d5 |
Inhibitor |
99.30% |
否 |
HY-146446 |
PXYC1 |
Inhibitor |
98.98% |
否 |
HY-14649S4 |
Retinoic acid-d5 |
Agonist |
98.25% |
否 |
HY-147134 |
GSK-3β inhibitor 10 |
Inhibitor |
98.04% |
否 |
HY-147943 |
PROTAC BTK Degrader-1 |
|
98.87% |
否 |
HY-148242A |
BAY-252 |
|
99.83% |
否 |
HY-14855A |
(S)-Tedizolid |
Inhibitor |
98.21% |
否 |
HY-149234 |
MAO-B-IN-18 |
Inhibitor |
99.84% |
否 |
HY-151388 |
hMAO-B/MB-COMT-IN-1 |
Inhibitor |
98.04% |
否 |
HY-152205 |
JB061 |
Inhibitor |
99.27% |
否 |
HY-152240 |
PD-1/PD-L1-IN-29 |
Inhibitor |
99.96% |
否 |
HY-153603 |
B-Raf IN 15 |
Inhibitor |
≥98.0% |
否 |
HY-153901 |
PROTAC EGFR degrader 8 |
Inhibitor |
98.90% |
否 |
HY-153977 |
GLX481304 |
Inhibitor |
99.90% |
否 |
HY-15458A |
(S)-SAR131675 |
Inhibitor |
99.72% |
否 |
HY-154970 |
BMPR2-IN-1 |
Inhibitor |
/ |
否 |
HY-15543A |
CP-809101 hydrochloride |
Agonist |
99.37% |
否 |
HY-156255 |
MAO-B-IN-25 |
Inhibitor |
99.11% |
否 |
HY-156285 |
ZZM-1220 |
|
98.74% |
否 |
HY-156328 |
NSC 48160 |
Inducer |
99.75% |
否 |
HY-156419A |
PARP7-IN-16 free base |
Inhibitor |
99.40% |
否 |
HY-157327 |
AKE-72 |
Inhibitor |
98.29% |
否 |
HY-157480 |
EGFR/AURKB-IN-1 |
Inhibitor |
99.43% |
否 |
HY-158031 |
PLK1/BRD4-IN-5 |
|
99.55% |
否 |
HY-15814 |
HG-7-85-01 |
|
99.94% |
否 |
HY-160851 |
GDC-3280 |
Inhibitor |
98.82% |
否 |
HY-160939 |
ASK1-IN-6 |
Inhibitor |
98.13% |
否 |
HY-161440 |
SIK-IN-1 |
Inhibitor |
98.91% |
否 |
HY-161723 |
LH2-051 |
Inhibitor |
99.85% |
否 |
HY-162457 |
Mn007 |
|
≥90.0% |
否 |
HY-163299 |
pan-KRAS-IN-5 |
|
/ |
否 |
HY-164605 |
(6S)-CP-470711 |
Inhibitor |
98.75% |
否 |
HY-16615 |
SIRT-IN-1 |
Inhibitor |
98.58% |
否 |
HY-17466 |
Sancycline |
Inhibitor |
98.01% |
否 |
HY-18063 |
ML252 |
Inhibitor |
99.9% |
否 |
HY-19306 |
SB-267268 |
Antagonist |
99.85% |
否 |
HY-20074 |
(+)-Pinanediol |
|
99.98% |
否 |
HY-402237 |
Nampt-IN-15 |
Inhibitor |
99.49% |
否 |
HY-41051 |
(2S)-2-[[(tert-Butoxy)carbonyl](methyl)amino]-3-methylbutanoic acid |
|
≥98.0% |
否 |
HY-46568 |
CDK7/12-IN-1 |
Inhibitor |
99.52% |
否 |
HY-50904S1 |
Nintedanib-13C,d3 |
Inhibitor |
≥99.0% |
否 |
HY-70013S |
Abiraterone-d4 |
Inhibitor |
≥98.0% |
否 |
HY-79691 |
(S)-3-(Boc-amino)pyrrolidine |
|
≥98.0% |
否 |
HY-79863 |
(6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate |
|
99.71% |
否 |
HY-A0036B |
Bazedoxifene (acetate)-B |
|
/ |
否 |
HY-B0102B |
(S)-Fluoxetine hydrochloride |
Inhibitor |
99.5% |
否 |
HY-B0261S |
Meloxicam-d3 |
|
≥99.0% |
否 |
HY-B0479S |
Thiamphenicol-d3 |
Inhibitor |
99.51% |
否 |
HY-B0631S |
Alendronic acid-d6 |
|
≥98.0% |
否 |
HY-B0760R |
Fenofibric acid (Standard) |
|
99.16% |
否 |
HY-B0760S |
Fenofibric acid-d6 |
|
99.58% |
否 |
HY-B1803A |
Tracazolate hydrochloride |
Modulator |
99.24% |
否 |
HY-D1275 |
CAY10731 |
|
≥95.0% |
否 |
HY-D1634 |
Bz-FVR-AMC |
|
99.83% |
否 |
HY-I0115 |
(S)-2-((S)-2-Cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoic acid |
|
99.85% |
否 |
HY-I0775 |
(S)-methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate |
|
99.39% |
否 |
HY-N0215S7 |
L-Phenylalanine-3-13C |
Antagonist |
99.48% |
否 |
HY-N0363 |
(+)-Columbianetin |
|
99.04% |
否 |
HY-N0394S3 |
L-Cystine-34S2 |
Activator |
≥98.0% |
否 |
HY-N1150S9 |
Thymidine-15N2 |
|
≥99.0% |
否 |
HY-N2378 |
(2R,3S)-3-Phenylisoserine hydrochloride |
|
99.99% |
否 |
HY-N2413 |
Gomisin D |
Inhibitor |
99.41% |
否 |
HY-N2511 |
Trimyristin |
Inhibitor |
99.72% |
否 |
HY-N5056 |
DL-Goitrin |
|
99.79% |
否 |
HY-N6044 |
Isoanhydroicaritin |
|
99.69% |
否 |
HY-N6079 |
Timosaponin A1 |
Inhibitor |
99.24% |
否 |
HY-N7227 |
Anonaine |
Inhibitor |
≥95.0% |
否 |
HY-N8009 |
Rebaudioside O |
|
≥98.0% |
否 |
HY-P5149 |
αC-Conotoxin PrXA |
Antagonist |
98.44% |
否 |
HY-W002410 |
(S)-2-((tert-Butoxycarbonyl)amino)-2-cyclohexylacetic acid |
|
≥98.0% |
否 |
HY-W002899 |
(S)-Boc-nipecotic acid |
|
99.42% |
否 |
HY-W006152 |
(S)-Methyl 3-amino-2-((tert-butoxycarbonyl)amino)propanoate hydrochloride |
|
≥98.0% |
否 |
HY-W007586 |
1-Boc-L-azetidine-2-carboxylic acid |
|
99.74% |
否 |
HY-W007620 |
(S)-3-(4-Aminophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid |
|
99.48% |
否 |
HY-W008467 |
(S)-2-amino-3-hydroxy-2-methylpropanoic acid |
|
≥98.0% |
否 |
HY-W011280 |
(S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid |
|
97.23% |
否 |
HY-W014259 |
(S)-2-((tert-Butoxycarbonyl)amino)pent-4-ynoic acid |
|
≥97.0% |
否 |
HY-W015616 |
Benzylacetone |
Inhibitor |
99.78% |
否 |
HY-W017230 |
L-Cysteinesulfinic acid monohydrate |
Agonist |
99.81% |
否 |
HY-W021482 |
(4S)-1-Boc-4-fluoro-D-proline |
|
≥97.0% |
否 |
HY-W022405 |
(S)-2-Amino-3-(pyridin-4-yl)propanoic acid dihydrochloride |
|
98.43% |
否 |
HY-W023145 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(tert-butylthio)-L-cysteine |
|
99.91% |
否 |
HY-W037976 |
Tyrosinase-IN-22 |
|
99.75% |
否 |
HY-W048708 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-methyl-L-cysteine |
|
99.74% |
否 |
HY-W051093 |
(S)-1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid |
|
99.81% |
否 |
HY-W053503 |
(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid |
|
99.11% |
否 |
HY-W067716 |
Spinacine |
|
≥97.0% |
否 |
HY-W074930 |
(S)-Tenofovir |
Inhibitor |
98.34% |
否 |
HY-W110126 |
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid |
|
99.09% |
否 |
HY-W141774 |
S-(2-Carboxyethyl)-L-cysteine |
|
98.64% |
否 |
HY-W250146 |
Locust bean gum, from Ceratonia siliqua seeds |
|
/ |
否 |
HY-W348485 |
WRX606 |
Inhibitor |
95.65% |
否 |
HY-W790014 |
Z-FG-NHO-BzOME |
Inhibitor |
98.14% |
否 |
HY-Y0337S3 |
L-Cysteine-1-13C |
|
≥99.0% |
否 |
HY-Y0837 |
L-Alaninol |
|
99.97% |
否 |
HY-Y1069S |
(S)-Malic acid-d3 |
|
99.64% |
否 |
HY-Y1088S2 |
Hydrocinnamic acid-d9 |
|
99.61% |
否 |
HY-103383 |
(R)-DRF053 dihydrochloride |
Inhibitor |
99.30% |
否 |
HY-109037S3 |
Mavacamten-d5 |
Modulator |
98.61% |
否 |
HY-110289 |
(R)-Citalopram oxalate |
Inhibitor |
99.52% |
否 |
HY-111825A |
(R)-1-PeCSO |
|
99.50% |
否 |
HY-120964 |
N-Stearoyl Taurine |
|
99.00% |
否 |
HY-12835 |
S1P1 agonist III |
Agonist |
99.64% |
否 |
HY-131864A |
SJF-1528 hemihydrate |
Degrader |
98.90% |
否 |
HY-13950 |
S186 |
|
99.01% |
否 |
HY-149190 |
GPR35 agonist 5 |
Agonist |
98.86% |
否 |
HY-154840 |
4-Thiouridine 5′-triphosphate tetralithium |
Agonist |
87.53% |
否 |
HY-156778 |
Antitumor agent-120 |
|
≥96.0% |
否 |
HY-157299 |
PDK-IN-3 |
Inhibitor |
99.87% |
否 |
HY-164051 |
1650-M15 |
Inhibitor |
99.33% |
否 |
HY-401257 |
Methyl (1S,3R)-2-(2-iodoacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
Control |
98.36% |
否 |
HY-76144 |
4-Aminobenzothioamide |
|
/ |
否 |
HY-N12625 |
(R)-(+)-O-Demethylbuchenavianine |
Inhibitor |
98.67% |
否 |
HY-P2048 |
MOTS-c (human) |
Inhibitor |
99.90% |
否 |
HY-U00377 |
Cathepsin Inhibitor 2 |
Inhibitor |
98.05% |
否 |
HY-W007140 |
2-Hydroxymethyl-5-hydroxypyridine |
|
99.67% |
否 |
HY-W009749CS |
(S)-Cystathionine-d4 |
|
97.11% |
否 |
HY-W018158 |
DHICA |
Activator |
≥97.0% |
否 |
HY-W039722 |
5-Fluorocytidine |
Inhibitor |
99.99% |
否 |
HY-W087207 |
Loxoprofen L-menthol ester |
Control |
/ |
否 |
HY-Y0313S |
p-Hydroxybenzaldehyde-d4 |
Antagonist |
99.65% |
否 |
HY-12965 |
S49076 |
Inhibitor |
99.44% |
否 |
HY-134903 |
(32-Carbonyl)-RMC-5552 |
Inhibitor |
95.41% |
否 |
HY-13740S |
Resiquimod-d5 |
|
99.84% |
否 |
HY-100948B |
ATM-3507 trihydrochloride |
Inhibitor |
/ |
否 |
HY-112801 |
F-1 |
Inhibitor |
98.03% |
否 |
HY-115489A |
GGTI-286 TFA |
Inhibitor |
/ |
否 |
HY-115688A |
(S)-TXNIP-IN-1 |
Control |
99.73% |
否 |
HY-12422B |
(2S,3R)-Voruciclib hydrochloride |
Inhibitor |
≥98.0% |
否 |
HY-124679 |
DS86760016 |
Inhibitor |
99.25% |
否 |
HY-128581 |
γ-Secretase modulator 4 |
Modulator |
99.47% |
否 |
HY-136857 |
BRD4 degrader-3 |
Degrader |
99.43% |
否 |
HY-145264 |
OARV-771 |
Inhibitor |
98.33% |
否 |
HY-145312 |
ATR-IN-4 |
Inhibitor |
99.17% |
否 |
HY-151622 |
PI3K/mTOR Inhibitor-11 |
Inhibitor |
98.74% |
否 |
HY-155815 |
MS9715 |
Inhibitor |
/ |
否 |
HY-101285 |
DMU2139 |
Inhibitor |
≥98.0% |
否 |
HY-101793 |
BMS-935177 |
Inhibitor |
99.11% |
否 |
HY-107732 |
JNJ-5207787 |
Antagonist |
98.00% |
否 |
HY-111875 |
SNIPER(BRD)-1 |
Inhibitor |
99.43% |
否 |
HY-112437 |
PF-06737007 |
Inhibitor |
99.70% |
否 |
HY-112615 |
NAMPT inhibitor-linker 1 |
|
98.08% |
否 |
HY-112719B |
BRD 4354 ditrifluoroacetate |
Inhibitor |
98.06% |
否 |
HY-112762A |
(E)-LHF-535 |
Inhibitor |
99.21% |
否 |
HY-114176B |
(S,R,S)-AHPC-C4-NH2 dihydrochloride |
|
/ |
否 |
HY-114269 |
(-)-(S)-B-973B |
Agonist |
99.22% |
否 |
HY-114483 |
AES-135 |
Inhibitor |
98.21% |
否 |
HY-115716 |
EGFR-IN-17 |
Inhibitor |
98.18% |
否 |
HY-116505 |
JAK1-IN-4 |
Inhibitor |
99.26% |
否 |
HY-121093 |
DC-S239 |
Inhibitor |
99.43% |
否 |
HY-128579 |
DW14800 |
Inhibitor |
99.63% |
否 |
HY-128859 |
EMT inhibitor-2 |
Inhibitor |
99.55% |
否 |
HY-131345A |
(S)-PI3Kα-IN-4 |
Inhibitor |
99.77% |
否 |
HY-131707 |
LEO 39652 |
Inhibitor |
99.51% |
否 |
HY-136183 |
(S,R,S)-AHPC-phenol-alkylC6-amine dihydrochloride |
|
98.16% |
否 |
HY-136184 |
(S,R,S)-AHPC-phenol-C4-NH2 dihydrochloride |
|
99.01% |
否 |
HY-136522 |
S2116 |
|
98.15% |
否 |
HY-142520 |
I-BET567 |
Inhibitor |
99.49% |
否 |
HY-142647 |
EB-42486 |
Inhibitor |
99.62% |
否 |
HY-144064 |
Adenosine receptor antagonist 2 |
Antagonist |
99.37% |
否 |
HY-W027553 |
Ipidacrine |
Inhibitor |
99.81% |
否 |
HY-15619 |
Hoechst S 769121 |
|
≥95.0% |
否 |
HY-100320 |
AVE5688 |
Inhibitor |
98.79% |
否 |
HY-100402 |
CFMTI |
Antagonist |
≥98.0% |
否 |
HY-100442S1 |
Paquinimod-d5-1 |
Inhibitor |
98.19% |
否 |
HY-101390 |
(+)-Niguldipine hydrochloride |
Antagonist |
98.06% |
否 |
HY-101676 |
RG-12525 |
|
98.31% |
否 |
HY-101775A |
9-Hydroxyellipticine hydrochloride |
Inhibitor |
≥99.0% |
否 |
HY-102070 |
NS13001 |
Agonist |
99.62% |
否 |
HY-103005S |
Ramelteon metabolite M-II-d3 |
Activator |
≥99.0% |
否 |
HY-103373 |
PE154 |
Inhibitor |
99.01% |
否 |
HY-103381 |
NSC693868 |
Inhibitor |
≥99.0% |
否 |
HY-103472 |
FPR-A14 |
Agonist |
99.90% |
否 |
HY-103572 |
MNI137 |
Modulator |
≥95.0% |
否 |
HY-10439 |
HPGDS inhibitor 1 |
Inhibitor |
99.04% |
否 |
HY-105692 |
DR2313 |
Inhibitor |
99.66% |
否 |
HY-106583 |
Piroxicam cinnamate |
Inhibitor |
99.19% |
否 |
HY-107624 |
ATC0175 |
Antagonist |
99.84% |
否 |
HY-107684 |
3-Bromocytisine |
Agonist |
99.90% |
否 |
HY-108258 |
PSN 375963 |
Agonist |
99.96% |
否 |
HY-108493 |
CS-2100 |
Agonist |
99.12% |
否 |
HY-108646 |
SX 011 |
Inhibitor |
99.33% |
否 |
HY-108671 |
NF110 |
Antagonist |
93.6% |
否 |
HY-110118 |
Edaglitazone |
Agonist |
99.58% |
否 |
HY-110157 |
AC-186 |
Agonist |
99.61% |
否 |
HY-110248 |
MI 14 |
Inhibitor |
99.30% |
否 |
HY-11053 |
S 24795 |
Agonist |
99.66% |
否 |
HY-11070 |
MK-0952 |
Inhibitor |
99.71% |
否 |
HY-111664A |
(S)-(-)-Citronellal |
|
99.66% |
否 |
HY-112280 |
Crozbaciclib |
Inhibitor |
99.94% |
否 |
HY-112371 |
(S)-CR8 |
Inhibitor |
≥99.0% |
否 |
HY-112543 |
S119-8 |
Inhibitor |
99.73% |
否 |
HY-112555 |
PDE7-IN-2 |
Inhibitor |
≥99.0% |
否 |
HY-112665 |
Virginiamycin Complex |
|
94.28% |
否 |
HY-112895A |
(R)-UT-155 |
Inhibitor |
98.09% |
否 |
HY-112929B |
(1S,2S,3R)-DT-061 |
|
99.77% |
否 |
HY-113018A |
(S)-Ibuprofen acyl-β-D-glucuronide |
|
98.47% |
否 |
HY-113336 |
15(S)-HETE |
|
≥98.0% |
否 |
HY-113455 |
9S-HODE |
Inducer |
≥98.0% |
否 |
HY-113471A |
(S)-(-)-Perillic acid |
|
≥95.0% |
否 |
HY-114272A |
T4-ATA (S-isomer) |
|
99.50% |
否 |
HY-114785 |
BPHA |
Inhibitor |
99.88% |
否 |
HY-114818 |
4-(tert-Butyl)-benzhydroxamic Acid |
Antagonist |
99.49% |
否 |
HY-115446A |
Lenalidomide-C4-NH2 hydrochloride |
|
98.85% |
否 |
HY-115682 |
(S)-ZINC-3573 |
|
99.89% |
否 |
HY-115741 |
3BrB-PP1 |
|
≥99.0% |
否 |
HY-115903A |
HIF-1α-IN-2 hydrochloride |
Inhibitor |
99.16% |
否 |
HY-115983 |
DMUP |
|
≥98.0% |
否 |
HY-118099 |
Florfenicol amine hydrochloride |
Inhibitor |
99.45% |
否 |
HY-118521 |
AS-041164 |
Inhibitor |
99.02% |
否 |
HY-119580B |
(+)-Leucocyanidin |
|
99.80% |
否 |
HY-119671 |
BW 755C |
Inhibitor |
≥95.0% |
否 |
HY-120696 |
SR9186 |
Inhibitor |
98.06% |
否 |
HY-121604 |
(Rac)-MEM 1003 |
Inhibitor |
99.64% |
否 |
HY-121955 |
FW1256 |
|
≥95.0% |
否 |
HY-122678 |
LQZ-7F |
|
97.13% |
否 |
HY-122742 |
HBT1 |
|
99.83% |
否 |
HY-123109A |
(S,S,S)-AHPC-Boc |
Control |
97.21% |
否 |
HY-123352 |
ZK 216348 |
Agonist |
98.59% |
否 |
HY-123352A |
(-)-ZK 216348 |
Agonist |
98.92% |
否 |
HY-123450 |
S116836 |
|
99.60% |
否 |
HY-12432S1 |
Gilteritinib-d8 |
Inhibitor |
≥98.0% |
否 |
HY-124404A |
12(S)-HETE |
Inducer |
≥99.0% |
否 |
HY-124429 |
FQI1 |
Inhibitor |
99.11% |
否 |
HY-124726 |
Aumitin |
Inhibitor |
99.78% |
否 |
HY-12508 |
CMPDA |
Agonist |
99.31% |
否 |
HY-125728 |
Micrococcin P1 |
Inhibitor |
≥95.0% |
否 |
HY-125777A |
α-Conotoxin Vc1.1 TFA |
Antagonist |
97.57% |
否 |
HY-126361A |
ZK824190 hydrochloride |
Inhibitor |
99.61% |
否 |
HY-126362 |
ML266 |
Activator |
99.70% |
否 |
HY-126419 |
Kobophenol A |
Inhibitor |
99.90% |
否 |
HY-128128 |
ASN04421891 |
Modulator |
99.00% |
否 |
HY-12843 |
Bohemine |
Inhibitor |
98.93% |
否 |
HY-128763 |
HDAC-IN-4 |
Inhibitor |
98.82% |
否 |
HY-128856 |
P7C3-OMe |
|
98.26% |
否 |
HY-130675A |
15(S)-HEPE |
|
≥99.0% |
否 |
HY-131020 |
Janelia Fluor® 525, SE |
|
≥95.0% |
否 |
HY-131259 |
Ibuprofen Impurity F |
Inhibitor |
97.56% |
否 |
HY-131866 |
(S,R,S)-CO-C2-acid |
|
≥98.0% |
否 |
HY-132593A |
Rovanersen sodium |
|
95.58% |
否 |
HY-133143 |
1,2-Bis(2-iodoethoxy)ethane |
|
98.66% |
否 |
HY-13317S |
Oseltamivir-d3 |
Inhibitor |
98.61% |
否 |
HY-133412 |
DBCO-NHCO-S-S-NHS ester |
|
96.02% |
否 |
HY-13342AS |
Apatinib-d8 free base |
|
92.56% |
否 |
HY-133536 |
PA Janelia Fluor® 549, SE |
|
98.02% |
否 |
HY-134661 |
(S)-CVN424 |
|
99.16% |
否 |
HY-135396 |
(1S,2S)-Bortezomib |
|
≥96.0% |
否 |
HY-136006B |
(S,R,S)-AHPC-C6-NH2 |
|
98.03% |
否 |
HY-136145 |
FIDAS-3 |
Inhibitor |
99.40% |
否 |
HY-13632R |
Exemestane (Standard) |
Inhibitor |
99.63% |
否 |
HY-136350B |
(S)-BRD9500 |
Control |
99.67% |
否 |
HY-136429A |
Ethylhydrocupreine hydrochloride |
Inhibitor |
99.72% |
否 |
HY-136726 |
CGP-82996 |
Inhibitor |
98.12% |
否 |
HY-138072 |
EMI1 |
Inhibitor |
99.78% |
否 |
HY-138550A |
(S,R,S)-AHPC-3-methylbutanyl acetate-methanesulfonothioate-PEG3-NH2 TFA |
|
99.42% |
否 |
HY-138621 |
Antibacterial agent 19 |
Inhibitor |
99.46% |
否 |
HY-138752A |
S-acetyl-PEG4-amine TFA |
|
≥98.0% |
否 |
HY-139108 |
DCH36_06 |
|
99.19% |
否 |
HY-139915 |
MPO-IN-1 |
Inhibitor |
99.02% |
否 |
HY-14227 |
LIMK-IN-1 |
Inhibitor |
99.33% |
否 |
HY-143412 |
MIR002 |
|
≥99.0% |
否 |
HY-143444 |
JAK-IN-20 |
Inhibitor |
99.63% |
否 |
HY-14372 |
BS-194 |
Inhibitor |
99.36% |
否 |
HY-144635 |
Nrf2-ARE/hMAO-B/QR2 modulator 1 |
Inhibitor |
98.44% |
否 |
HY-144636 |
Atg4B-IN-2 |
Inhibitor |
98.03% |
否 |
HY-144712 |
L5-DA |
Inducer |
≥98.0% |
否 |
HY-144770 |
SARS-CoV-2-IN-13 |
Inhibitor |
98.90% |
否 |
HY-145153 |
S-777469 |
Agonist |
98.83% |
否 |
HY-145259 |
HDAC6-IN-3 |
Inhibitor |
≥98.0% |
否 |
HY-145386 |
(S,S)-CPI-1612 |
Control |
99.88% |
否 |
HY-14566A |
(S)-Donepezil |
Inhibitor |
/ |
否 |
HY-14611 |
3,3'-Difluorobenzaldazine |
Agonist |
99.44% |
否 |
HY-146277A |
CBP/p300-IN-19 hydrochloride |
Inhibitor |
95.80% |
否 |
HY-146349 |
PROTAC EGFR degrader 4 |
Inhibitor |
99.70% |
否 |
HY-146411 |
microRNA-21-IN-1 |
|
98.03% |
否 |
HY-14654S1 |
Aspirin-d4 |
|
98.08% |
否 |
HY-14664F |
(3R,5S)-Fluvastatin sodium |
|
99.18% |
否 |
HY-146805 |
EB1 |
|
99.91% |
否 |
HY-146999 |
YM458 |
|
99.16% |
否 |
HY-147031 |
JAMM protein inhibitor 2 |
Inhibitor |
98.20% |
否 |
HY-147306A |
(S)-ZLc002 |
Inhibitor |
≥98.0% |
否 |
HY-148065 |
FMF-06-098-1 |
|
98.02% |
否 |
HY-148136 |
sEH inhibitor-7 |
Inhibitor |
99.71% |
否 |
HY-148446 |
eIF4A3-IN-12 |
Inhibitor |
99.70% |
否 |
HY-148450 |
eIF4A3-IN-16 |
Inhibitor |
98.37% |
否 |
HY-14864A |
(S)-Mapracorat |
Inhibitor |
99.85% |
否 |
HY-149048 |
Adenosylhomocysteinase |
|
/ |
否 |
HY-149804 |
S1R agonist 2 |
Agonist |
≥98.0% |
否 |
HY-149889 |
EGFR-IN-78 |
|
99.57% |
否 |
HY-151221 |
CID 697851 |
Inhibitor |
99.49% |
否 |
HY-151498A |
PXS-4787 hydrochloride |
Inhibitor |
99.71% |
否 |
HY-151500A |
JBSNF-000028 TFA |
Inhibitor |
99.47% |
否 |
HY-151809 |
CYP4A11/CYP4F2-IN-1 |
Inhibitor |
99.82% |
否 |
HY-152098 |
HX103 |
Inhibitor |
99.10% |
否 |
HY-152101 |
LY1 |
Inhibitor |
98.01% |
否 |
HY-152134 |
HDAC6 degrader-3 |
Degrader |
98.60% |
否 |
HY-152166 |
NaV1.2/1.6 channel blocker-1 |
Inhibitor |
98.89% |
否 |
HY-153111 |
EGFR/HER2-IN-9 |
Inhibitor |
98.73% |
否 |
HY-153695 |
TXA707 |
|
/ |
否 |
HY-15382A |
(S)-FTY720-phosphonate |
Agonist |
99.91% |
否 |
HY-153918A |
(S)-SKBG-1 |
|
99.01% |
否 |
HY-154914 |
GK16S |
|
/ |
否 |
HY-155140 |
BChE-IN-17 |
Inhibitor |
99.07% |
否 |
HY-155147 |
GLP-1 receptor agonist 13 |
Agonist |
/ |
否 |
HY-155493 |
CYP19A1/CYP11B2-IN-1 |
Inhibitor |
99.85% |
否 |
HY-15561B |
HOE-S 785026 trihydrochloride |
|
99.76% |
否 |
HY-156168 |
M190S |
Inhibitor |
99.84% |
否 |
HY-156284 |
EGFR-IN-89 |
Inhibitor |
98.75% |
否 |
HY-156331 |
VU6004909 |
Activator |
99.40% |
否 |
HY-156422 |
KPZ560 |
Inhibitor |
99.72% |
否 |
HY-156429 |
MK-1468 |
Inhibitor |
99.69% |
否 |
HY-156435 |
tau Protein/α-synuclein-IN-1 |
Inhibitor |
/ |
否 |
HY-156529 |
pan-KRAS-IN-2 |
Inhibitor |
98.01% |
否 |
HY-156601A |
(S)-Bexicaserin |
Agonist |
99.93% |
否 |
HY-156672 |
S6K2-IN-1 |
Inhibitor |
98.02% |
否 |
HY-15705 |
GPR35 agonist 2 |
|
98.84% |
否 |
HY-157518 |
OJT008 |
|
99.62% |
否 |
HY-158337 |
Nesosteine |
Inhibitor |
≥95.0% |
否 |
HY-159904 |
ChAT IN-1 |
Inhibitor |
/ |
否 |
HY-161101 |
MG degrader 1 |
Degrader |
99.83% |
否 |
HY-161126 |
EGFR-IN-98 |
Inhibitor |
99.12% |
否 |
HY-161275 |
BI-4732 |
Inhibitor |
99.30% |
否 |
HY-161536 |
PROTAC EGFR degrader 9 |
|
98.35% |
否 |
HY-161724 |
TFEB activator 2 |
Inhibitor |
98.84% |
否 |
HY-162076 |
AEP-IN-3 |
|
99.71% |
否 |
HY-162238 |
OSM-S-106 |
Inhibitor |
99.34% |
否 |
HY-162485 |
DV-B-120 |
Inhibitor |
98.49% |
否 |
HY-162683 |
(S)-PHA533533 |
Inhibitor |
/ |
否 |
HY-163094 |
EGFR-IN-95 |
Inhibitor |
98.76% |
否 |
HY-16713A |
(S)-(-)-5-Fluorowillardiine hydrochloride |
Agonist |
99.03% |
否 |
HY-167712 |
(2R,3S)-Azelaprag |
Agonist |
99.02% |
否 |
HY-16784 |
Samatasvir |
Inhibitor |
99.39% |
否 |
HY-16901A |
Firsocostat (S enantiomer) |
|
98.25% |
否 |
HY-16938S |
5'-Methylthioadenosine-13C6 |
|
98.45% |
否 |
HY-18081 |
PF 750 |
Inhibitor |
99.29% |
否 |
HY-18507 |
AD57 |
Inhibitor |
98.08% |
否 |
HY-19400 |
DPC-681 |
Inhibitor |
99.89% |
否 |
HY-19624 |
NVP-ACC789 |
Inhibitor |
99.52% |
否 |
HY-30120 |
tert-Butyl N-[(1S,2S)-2-aminocyclohexyl]carbamate |
|
≥97.0% |
否 |
HY-34222 |
7-Deazaguanine |
Inhibitor |
≥99.0% |
否 |
HY-41882 |
(S)-4-Benzyl-2-oxazolidone |
|
99.62% |
否 |
HY-50904S2 |
Nintedanib-d8 |
Inhibitor |
99.90% |
否 |
HY-59121 |
(S)-isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
|
98.03% |
否 |
HY-60264 |
(S)-Butoxycarbonylamino-cyclopropyl-acetic acid |
|
≥98.0% |
否 |
HY-76211 |
(1S,2S)-Cyclohexane-1,2-diamine |
|
99.94% |
否 |
HY-76476 |
(S)-Tetrahydrofuran-3-ol |
|
99.94% |
否 |
HY-76962 |
(S)-2-Methylpyrrolidine-2-carboxylic acid |
|
≥98.0% |
否 |
HY-77839S1 |
Cortodoxone-d2 |
Agonist |
99.00% |
否 |
HY-78907 |
(2S,3S)-2-(Benzyl(methyl)amino)-3-methylpentanoic acid |
|
99.15% |
否 |
HY-79680 |
(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid |
|
99.96% |
否 |
HY-90009C |
ent-Tadalafil |
Inhibitor |
98.17% |
否 |
HY-B0106A |
Etiracetam |
Agonist |
99.91% |
否 |
HY-B0753S |
Gliclazide-d4 |
Inhibitor |
≥98.0% |
否 |
HY-D0128 |
4-Methylherniarin |
Inhibitor |
98.02% |
否 |
HY-D2268A |
QM-FN-SO3 ammonium |
|
/ |
否 |
HY-E70068 |
Endo-β-N-acetylglucosaminidase (Endo S) |
|
/ |
否 |
HY-N0215S11 |
L-Phenylalanine-13C9,15N |
Antagonist |
99.52% |
否 |
HY-N0215S14 |
L-Phenylalanine-15N,d8 |
Antagonist |
99.90% |
否 |
HY-N0215S2 |
L-Phenylalanine-13C |
Antagonist |
99.66% |
否 |
HY-N0252A |
Catharanthine Tartrate |
Inhibitor |
98.88% |
否 |
HY-N1235 |
Skullcapflavone I |
Inhibitor |
96.44% |
否 |
HY-N2380 |
N-Benzoyl-(2R,3S)-3-phenylisoserine |
|
99.92% |
否 |
HY-N2432 |
Paederoside |
Inhibitor |
99.18% |
否 |
HY-N3045 |
(S,S)-Pisatin |
|
≥98.0% |
否 |
HY-N4130 |
25S-Inokosterone |
|
≥98.0% |
否 |
HY-N4184 |
Licoflavone B |
Inhibitor |
99.91% |
否 |
HY-N6020 |
(-)-Butin |
|
99.67% |
否 |
HY-N6908 |
Continentalic acid |
Inhibitor |
98.89% |
否 |
HY-N7654 |
(-)-Epipodophyllotoxin |
Inducer |
99.95% |
否 |
HY-N7926 |
Pentadecane |
Inhibitor |
98.88% |
否 |
HY-N8115 |
S-(4-Hydroxybenzyl)glutathione |
|
99.73% |
否 |
HY-N8189 |
Loureirin D |
|
99.05% |
否 |
HY-N9319 |
Fulvotomentoside A |
|
98.94% |
否 |
HY-P10030 |
DPLG3 |
Inhibitor |
99.18% |
否 |
HY-P1117 |
MMK1 |
|
99.22% |
否 |
HY-P1220A |
Huwentoxin-IV TFA |
Inhibitor |
98.52% |
否 |
HY-P1428 |
RFRP-1(human) |
Agonist |
99.67% |
否 |
HY-P1542B |
Urotensin I TFA |
Agonist |
95.77% |
否 |
HY-P1744 |
N-Formyl-Met-Leu-Phe-Lys |
|
98.98% |
否 |
HY-P1809A |
Velmupressin acetate |
Agonist |
99.47% |
否 |
HY-P2361 |
S12 |
|
99.70% |
否 |
HY-P2602 |
α-Casozepine |
|
99.36% |
否 |
HY-P2773 |
Nuclease S1, Aspergillus oryzae |
|
/ |
否 |
HY-P4200 |
Lugdunin |
Inhibitor |
95.44% |
否 |
HY-P4277 |
N,S-Bis-Fmoc-Glutathione |
Inhibitor |
99.89% |
否 |
HY-P4277A |
N,S-Bis-Fmoc-Glutathione TFA |
Inhibitor |
97.06% |
否 |
HY-U00041 |
Pivalopril |
Inhibitor |
99.19% |
否 |
HY-U00461 |
PF-06835919 |
Inhibitor |
99.75% |
否 |
HY-W002062 |
(S)-4-Isopropyl-2-oxazolidinone |
|
99.90% |
否 |
HY-W002597 |
(S)-(-)-4-Hydroxy-2-pyrrolidinone |
|
≥98.0% |
否 |
HY-W003321 |
(S)-tert-Butyl 5-oxopyrrolidine-2-carboxylate |
|
≥97.0% |
否 |
HY-W006629 |
(4S)-4-Hydroxy-D-proline methyl ester hydrochloride |
|
≥98.0% |
否 |
HY-W008077 |
(S)-2-Amino-3,3-diphenylpropanoic acid |
|
99.94% |
否 |
HY-W008234 |
N-Phthaloyl-β-alanine |
|
99.18% |
否 |
HY-W009008 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(tert-butyl)-L-cysteine |
|
99.52% |
否 |
HY-W009689 |
TbPTR1 inhibitor 2 |
Inhibitor |
99.73% |
否 |
HY-W010984 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(o-tolyl)propanoic acid |
|
99.76% |
否 |
HY-W011324 |
(S)-2-((tert-Butoxycarbonyl)amino)-4-(cyclohexyloxy)-4-oxobutanoic acid |
|
≥97.0% |
否 |
HY-W012071 |
(S)-Benzyl pyrrolidine-2-carboxylate hydrochloride |
|
≥97.0% |
否 |
HY-W012133 |
(S)-2-Amino-3-(4-(tert-butoxy)phenyl)propanoic acid |
|
99.89% |
否 |
HY-W012817 |
Methylhydroquinone |
Inhibitor |
99.88% |
否 |
HY-W013305 |
(S)-2-((tert-Butoxycarbonyl)amino)-5-guanidinopentanoic acid |
|
≥98.0% |
否 |
HY-W015229S |
3-Indolepropionic acid-d2 |
|
99.78% |
否 |
HY-W016798 |
(S)-2-acetamido-4-amino-4-oxobutanoic acid |
|
≥98.0% |
否 |
HY-W017882 |
(2R,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate |
|
≥98.0% |
否 |
HY-W019727 |
(S)-4-Phenyloxazolidin-2-one |
|
99.95% |
否 |
HY-W020826 |
S-Phenylcysteine |
|
98.80% |
否 |
HY-W040416 |
(S)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid |
|
/ |
否 |
HY-W040438 |
(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(3,4-dihydroxyphenyl)propanoate |
|
97.09% |
否 |
HY-W042478 |
(S)-3-(Boc-amino)-4-phenylbutyric acid |
|
≥95.0% |
否 |
HY-W048681 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(4-(tert-butoxy)-4-oxobutyl)-L-cysteine |
|
/ |
否 |
HY-W050122 |
S-(+)-GABOB |
|
/ |
否 |
HY-W054146 |
RAMB4 |
Inhibitor |
98.02% |
否 |
HY-W076441 |
Ethyl (S)-3-hydroxybutanoate |
|
99.97% |
否 |
HY-W091788 |
(2S,3R,5S)-7-Deaza-2'-deoxy-7-iodoadenosine |
|
99.56% |
否 |
HY-W112057 |
Fmoc-S-3-amino-4,4-diphenyl-butyric acid |
|
99.73% |
否 |
HY-Y0337S6 |
L-Cysteine-d2 |
|
98.67% |
否 |
HY-Y0366S |
Lauric acid-13C |
Inhibitor |
99.80% |
否 |
HY-Z0075 |
(Z)2S,4R-Sacubitril |
|
96.89% |
否 |
HY-101626 |
Sigma-LIGAND-1 |
|
99.67% |
否 |
HY-10502A |
Tipifarnib (S enantiomer) |
|
99.52% |
否 |
HY-120962 |
N-Arachidonoyl Taurine |
Activator |
≥99.0% |
否 |
HY-120965 |
N-Palmitoyl Taurine |
|
99.00% |
否 |
HY-121123 |
Adamantanine |
Inhibitor |
≥97.0% |
否 |
HY-124212 |
Thaxtomin A |
Chemical |
98.7% |
否 |
HY-126049 |
(S)-Oxiracetam |
Inhibitor |
98.78% |
否 |
HY-130723A |
AMPK activator 2 hydrochloride |
Activator |
99.65% |
否 |
HY-13461 |
PHA-767491 |
Inhibitor |
99.85% |
否 |
HY-137428 |
(S,S)-EDDS |
|
≥98.0% |
否 |
HY-144390 |
(S)-S007-1558 |
|
99.78% |
否 |
HY-147774 |
Cathepsin K inhibitor 6 |
Inhibitor |
98.18% |
否 |
HY-150058 |
Bocconoline |
|
≥95.0% |
否 |
HY-151702A |
(2S)-N3-IsoSer (DCHA) |
|
98.29% |
否 |
HY-15191B |
(S)-Sabutoclax |
Inhibitor |
98.03% |
否 |
HY-15193B |
EMD638683 S-Form |
Inhibitor |
99.95% |
否 |
HY-15764G |
A 419259 (GMP) |
|
/ |
否 |
HY-157802A |
(S)-LTGO-33 |
Inhibitor |
99.41% |
否 |
HY-157892 |
Antimalarial agent 38 |
Inhibitor |
/ |
否 |
HY-160227A |
ORN 06 sodium |
Activator |
90.78% |
否 |
HY-160558 |
PLK1/BRD4-IN-3 |
Inhibitor |
99.66% |
否 |
HY-160875 |
GST-FH.1 |
Inhibitor |
/ |
否 |
HY-160900 |
RN-1665 |
Antagonist |
99.93% |
否 |
HY-19322C |
(1S,3R,5R)-PIM447 dihydrochloride |
Inhibitor |
99.81% |
否 |
HY-30217 |
(S)-2-Hydroxy-3-methylbutanoic acid |
|
≥97.0% |
否 |
HY-30263 |
4-Heptyloxyphenol |
Inhibitor |
99.44% |
否 |
HY-401757 |
Anticaries agent-1 |
Inhibitor |
/ |
否 |
HY-49395A |
(S)-4-(4-((4-(4-((2,6-Dioxopiperidin-3-yl)carbamoyl)-3-fluorophenyl)piperazin-1-yl)methyl)piperidin-1-yl)benzoic acid hydrochloride |
Control |
98.80% |
否 |
HY-B0710S |
Betaine-13C3 |
|
/ |
否 |
HY-D2268 |
QM-FN-SO3 |
|
/ |
否 |
HY-I0834 |
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran |
|
99.49% |
否 |
HY-N12625A |
(S)-(-)-O-Demethylbuchenavianine |
Inhibitor |
/ |
否 |
HY-N1428S6 |
Citric acid-d4-1 |
Inducer |
≥97.0% |
否 |
HY-P1218B |
Phrixotoxin 3-NH2 TFA |
Inhibitor |
98.63% |
否 |
HY-RS12394 |
S1PR2 Human Pre-designed siRNA Set A |
|
/ |
否 |
HY-U00281 |
S16961 |
Agonist |
99.85% |
否 |
HY-W019710 |
(E,E)-RGFP966 |
Inhibitor |
99.31% |
否 |
HY-W025074 |
BML-278 |
Activator |
98.49% |
否 |
HY-W040150 |
(24S,25)-Epoxycholesterol |
Agonist |
98.10% |
否 |
HY-W093104 |
(S)-(-)-2-Methylbutanol |
|
99.85% |
否 |
HY-W100026 |
Galaxolide |
Activator |
/ |
否 |
HY-W420033 |
(S)-(+)-Etomoxir |
Control |
98.65% |
否 |
HY-W742564 |
Acacetin-7-O-β-D-galactopyranoside |
Inhibitor |
98.57% |
否 |
HY-10812 |
GNE-490 |
Inhibitor |
96.29% |
否 |
HY-15427A |
GDC-0834 Racemate |
|
98.04% |
否 |
HY-100368 |
MELK-8a |
Inhibitor |
98.32% |
否 |
HY-101392S |
Harmane-d1 |
Inhibitor |
98.01% |
否 |
HY-104077S |
Remdesivir-d5 |
Inhibitor |
99.86% |
否 |
HY-115489 |
GGTI-286 |
Inhibitor |
/ |
否 |
HY-12871C |
Atuveciclib S-Enantiomer |
Inhibitor |
99.38% |
否 |
HY-131454A |
SR-717 free acid |
Agonist |
98.05% |
否 |
HY-144881 |
(S)-HH2853 |
Inhibitor |
/ |
否 |
HY-163428 |
Perzebertinib |
Inhibitor |
/ |
否 |
HY-19981A |
Derazantinib Racemate |
Inhibitor |
99.38% |
否 |
HY-100740C |
(1α,1'S,4β)-Lanabecestat |
Inhibitor |
96.01% |
否 |
HY-101030A |
MBM-17S |
|
/ |
否 |
HY-101119 |
GLL398 |
Degrader |
/ |
否 |
HY-102034 |
Complement factor D-IN-1 |
|
98.85% |
否 |
HY-108656 |
MRS2365 |
Agonist |
/ |
否 |
HY-108701 |
Nampt-IN-3 |
|
98.97% |
否 |
HY-111540B |
(S)-LY-3381916 |
Inhibitor |
99.06% |
否 |
HY-112898 |
DC1SMe |
|
≥98.0% |
否 |
HY-119944 |
JND3229 |
Inhibitor |
99.78% |
否 |
HY-126303 |
GS-443902 |
Inhibitor |
99.87% |
否 |
HY-128355 |
IDO/TDO-IN-1 |
Inhibitor |
99.22% |
否 |
HY-128862 |
EGFR-IN-7 |
Inhibitor |
99.76% |
否 |
HY-129356A |
(S)-Seco-Duocarmycin SA |
|
≥99.0% |
否 |
HY-13018A |
MRT67307 hydrochloride |
Inhibitor |
/ |
否 |
HY-130985 |
9-Decyn-1-ol |
|
/ |
否 |
HY-131349A |
CCR4-351 hydrochloride |
Antagonist |
98.37% |
否 |
HY-131959 |
(S,R,S)-AHPC-PEG5-Boc |
|
95.29% |
否 |
HY-133012 |
GFB-8438 |
Inhibitor |
99.74% |
否 |
HY-135855 |
SARS-CoV-IN-1 |
Inhibitor |
99.88% |
否 |
HY-135856 |
SARS-CoV-IN-2 |
Inhibitor |
98.66% |
否 |
HY-135858 |
SARS-CoV-IN-3 |
Inhibitor |
99.36% |
否 |
HY-135902 |
Synucleozid |
Inhibitor |
/ |
否 |
HY-136531 |
XMU-MP-3 |
|
98.27% |
否 |
HY-143411 |
GEM144 |
|
/ |
否 |
HY-14417A |
(1R,2S)-VU0155041 |
Agonist |
95.09% |
否 |
HY-145912 |
RYL-552S |
Inhibitor |
98.28% |
否 |
HY-14649S3 |
Retinoic acid-d6 |
|
98.9% |
否 |
HY-160023 |
Elisrasib |
Inhibitor |
/ |
否 |
HY-168016 |
PROTAC YAP degrader-1 |
|
/ |
否 |
HY-17610A |
Enerisant hydrochloride |
Antagonist |
98.72% |
否 |
HY-18668 |
Integrin antagonist 27 |
Antagonist |
≥98.0% |
否 |
HY-19891A |
Pixatimod free acid |
|
/ |
否 |
HY-P1453A |
CMD178 TFA |
Inhibitor |
98.61% |
否 |
HY-100865 |
BPR1K871 |
Inhibitor |
99.12% |
否 |
HY-102047 |
KDOAM-25 |
Inhibitor |
/ |
否 |
HY-10259 |
PD 123319 |
Antagonist |
/ |
否 |
HY-103602A |
(S,R,S)-AHPC-PEG3-NH2 |
|
99.26% |
否 |
HY-103603A |
(S,R,S)-AHPC-PEG2-NH2 |
|
95.41% |
否 |
HY-103603B |
(S,R,S)-AHPC-PEG2-NH2 dihydrochloride |
|
≥95.0% |
否 |
HY-104003 |
S 38093 |
Antagonist |
99.86% |
否 |
HY-104069 |
S1P1 agonist 1 |
Agonist |
98.75% |
否 |
HY-108656A |
MRS2365 trisodium |
Agonist |
≥99.0% |
否 |
HY-112151 |
EG01377 |
Inhibitor |
/ |
否 |
HY-112601 |
IDH1 Inhibitor 1 |
Inhibitor |
99.96% |
否 |
HY-114177A |
(S)-Ebvaciclib |
Control |
98.18% |
否 |
HY-114739 |
MA-0204 |
Modulator |
99.31% |
否 |
HY-115867A |
(S)-GSK852 |
|
99.07% |
否 |
HY-117917 |
(Rac)-MGV354 |
Activator |
99.56% |
否 |
HY-119366 |
S18-000003 |
Inhibitor |
99.31% |
否 |
HY-120355A |
AP14145 hydrochloride |
Inhibitor |
98.3% |
否 |
HY-124607 |
(R)-BRD3731 |
Inhibitor |
98.22% |
否 |
HY-125784BS |
(S)-Viloxazine-d5 hydrochloride |
|
98.19% |
否 |
HY-12585 |
AM-4668 |
Agonist |
≥99.0% |
否 |
HY-130608 |
Mutated EGFR-IN-3 |
Inhibitor |
/ |
否 |
HY-130640 |
(S,R,S)-AHPC-Me-C7 ester |
|
95.49% |
否 |
HY-130642 |
(S,R,S)-AHPC-Me-C10-Br |
|
97.21% |
否 |
HY-130816 |
(S,R,S)-AHPC-O-Ph-PEG1-NH2 |
|
96.97% |
否 |
HY-131387 |
(S,R,S)-AHPC-Me-CO-CH2-PEG3-NH2 |
|
96.12% |
否 |
HY-131708A |
FNDR-20123 |
Inhibitor |
98.08% |
否 |
HY-132302 |
Hu7691 |
Inhibitor |
/ |
否 |
HY-13247 |
Setrobuvir |
Inhibitor |
/ |
否 |
HY-132842A |
(S)-Sunvozertinib |
Inhibitor |
99.14% |
否 |
HY-133080 |
BAY-784 |
Antagonist |
99.5% |
否 |
HY-133487A |
(S,R,S)-AHPC-C8-NH2 hydrochloride |
|
/ |
否 |
HY-135805 |
JBJ-04-125-02 |
Inhibitor |
/ |
否 |
HY-136006A |
(S,R,S)-AHPC-C6-NH2 hydrochloride |
|
/ |
否 |
HY-136165 |
(S,R,S)-AHPC-PEG3-propionic acid |
|
97.03% |
否 |
HY-136523 |
S2157 |
|
98.44% |
否 |
HY-137439 |
Fanotaprim |
|
98.89% |
否 |
HY-137451A |
(E/Z)-Sivopixant |
Antagonist |
98.64% |
否 |
HY-138067 |
SSAA09E2 |
Inhibitor |
98.37% |
否 |
HY-145734 |
AMXI-5001 |
|
98.43% |
否 |
HY-145785 |
ADH-6 |
|
/ |
否 |
HY-146069 |
ABBV-318 |
Inhibitor |
98.97% |
否 |
HY-147183 |
JBJ-09-063 |
Inhibitor |
/ |
否 |
HY-149051 |
BGB-8035 |
Inhibitor |
99.00% |
否 |
HY-150254 |
SLB1122168 |
Inhibitor |
/ |
否 |
HY-152080 |
TUL01101 |
Inhibitor |
99.71% |
否 |
HY-15427B |
GDC-0834 S-enantiomer |
|
98.03% |
否 |
HY-155108 |
OATD-02 |
Inhibitor |
/ |
否 |
HY-15873 |
FTI 276 |
Inhibitor |
/ |
否 |
HY-159613 |
PELP1-IN-1 |
Inducer |
98.99% |
否 |
HY-N2336 |
Rosmarinic acid racemate |
Inhibitor |
98.01% |
否 |
HY-P4669 |
LM-030 |
Inhibitor |
/ |
否 |
HY-132805S |
N-Acetyl-S-(2-hydroxyethyl)-L-cysteine-d4 dicyclohexylamine salt |
|
98.68% |
否 |
HY-14566S |
Donepezil-d7 hydrochloride |
Inhibitor |
≥99.0% |
否 |
HY-16560S |
Camptothecin-d5 |
|
99.61% |
否 |
HY-B0589S1 |
Atorvastatin-d5 sodium |
|
/ |
否 |
HY-B1455S |
Clindamycin-d3 hydrochloride |
Inhibitor |
99.62% |
否 |
HY-N0215S |
L-Phenylalanine-d7 |
Antagonist |
99.90% |
否 |
HY-N1150S |
Thymidine-d3 |
Inhibitor |
99.68% |
否 |
HY-100013B1 |
(1S,2S)-2-PCCA hydrochloride |
Control |
99.65% |
否 |
HY-10011A |
(S)-SCH 563705 |
Antagonist |
99.94% |
否 |
HY-100290 |
5-HT1A modulator 1 |
Modulator |
97.12% |
否 |
HY-100300 |
AGN 192836 |
Agonist |
99.49% |
否 |
HY-100504 |
S-methyl DM1 |
Inhibitor |
99.58% |
否 |
HY-100781B |
L-AP4 monohydrate |
Agonist |
≥99.0% |
否 |
HY-100822A |
(S)-(-)-HA 966 |
Antagonist |
≥98.0% |
否 |
HY-100839 |
(RS)-(Tetrazol-5-yl)glycine |
Agonist |
/ |
否 |
HY-10096 |
TCS2002 |
Inhibitor |
99.8% |
否 |
HY-101252 |
S-EIT hydrobromide |
|
≥98.0% |
否 |
HY-101489A |
GZD856 formic |
|
98.06% |
否 |
HY-101522 |
CHMFL-EGFR-202 |
Inhibitor |
99.75% |
否 |
HY-10158S |
Bosutinib-d8 |
|
≥99.0% |
否 |
HY-101939A |
RP-001 hydrochloride |
Agonist |
98.8% |
否 |
HY-101972A |
AZ-PFKFB3-67 quarterhydrate |
Inhibitor |
≥99.0% |
否 |
HY-10208S |
Pazopanib-d6 |
|
≥98.0% |
否 |
HY-10227S |
Bortezomib-d8 |
|
≥98.0% |
否 |
HY-10230S |
Midostaurin-d5 |
Inhibitor |
≥98.0% |
否 |
HY-10255AS |
Sunitinib-d10 |
|
99.89% |
否 |
HY-103005 |
Ramelteon metabolite M-II |
Activator |
98.24% |
否 |
HY-103035 |
BIO-32546 |
Modulator |
99.05% |
否 |
HY-103267 |
S32826 disodium |
Inhibitor |
98.85% |
否 |
HY-103353A |
SID 26681509 quarterhydrate |
Inhibitor |
98.02% |
否 |
HY-103430 |
SKF-83566 hydrobromide |
Antagonist |
/ |
否 |
HY-103512 |
TP003 |
Agonist |
98.99% |
否 |
HY-103534 |
CI-966 hydrochloride |
Inhibitor |
≥99.0% |
否 |
HY-103606 |
(S,R,S)-AHPC-PEG6-C4-Cl |
|
96.24% |
否 |
HY-10569S |
Ponesimod-d4 |
Agonist |
/ |
否 |
HY-105872 |
Trifenagrel |
|
99.35% |
否 |
HY-10620 |
PI3K-IN-22 |
Inhibitor |
99.50% |
否 |
HY-106784A |
(E)-Ajoene |
|
/ |
否 |
HY-107330 |
(6R,7S)-Cefminox sodium heptahydrate |
|
98.19% |
否 |
HY-107516 |
(S)-3,4-DCPG |
Agonist |
≥98.0% |
否 |
HY-107526 |
(Rac)-ALX 5407 |
Inhibitor |
/ |
否 |
HY-107659 |
YM-244769 hydrochloride |
Inhibitor |
99.02% |
否 |
HY-107676 |
SIB-1553A |
Agonist |
99.09% |
否 |
HY-107712 |
TCN 213 |
Antagonist |
99.16% |
否 |
HY-107728 |
S 25585 |
Antagonist |
99.13% |
否 |
HY-108262 |
UCN-02 |
Inhibitor |
≥98.0% |
否 |
HY-108263 |
3-Hydroxy Midostaurin |
Inhibitor |
97.02% |
否 |
HY-108549 |
clasto-Lactacystin β-lactone |
Inhibitor |
≥98.0% |
否 |
HY-108600 |
CGP-53353 |
Inhibitor |
98.87% |
否 |
HY-108601A |
(S)-Ro 32-0432 |
Inhibitor |
/ |
否 |
HY-10863S |
Anandamide-d8 |
|
99.90% |
否 |
HY-109001A |
(1S,2R)-Alicapistat |
Inhibitor |
≥98.0% |
否 |
HY-109004A |
(S)-Enzaplatovir |
Inhibitor |
99.73% |
否 |
HY-110002 |
LFM-A13 |
Inhibitor |
99.65% |
否 |
HY-110024 |
S-14506 hydrochloride |
|
99.92% |
否 |
HY-110094 |
BIMU 8 |
Agonist |
≥99.0% |
否 |
HY-110397G |
KP-457 (GMP) |
Inhibitor |
/ |
否 |
HY-111292 |
CYM-5482 |
Agonist |
98.29% |
否 |
HY-111388 |
SEL120-34A |
Inhibitor |
/ |
否 |
HY-111880 |
γ-Sanshool |
Inhibitor |
99.23% |
否 |
HY-111977 |
ZEN-3219 |
Inhibitor |
99.75% |
否 |
HY-112143 |
STOCK2S-26016 |
Inhibitor |
98.7% |
否 |
HY-112164B |
IACS-8968 S-enantiomer |
Inhibitor |
98.43% |
否 |
HY-112217A |
PSEM 89S TFA |
Agonist |
99.85% |
否 |
HY-112289 |
IDH889 |
Inhibitor |
99.96% |
否 |
HY-112401 |
p38 MAP Kinase Inhibitor IV |
Inhibitor |
98.0% |
否 |
HY-112583 |
MIV-247 |
Inhibitor |
/ |
否 |
HY-112653A |
(±)8-HETE |
|
≥99.0% |
否 |
HY-112792A |
(1S)-CCR2 antagonist 1 |
Antagonist |
98.03% |
否 |
HY-113308 |
Taurolithocholic acid |
Agonist |
99.7% |
否 |
HY-113434B |
5-HETE |
|
≥96.0% |
否 |
HY-113434S |
5(S)-HETE-d8 |
|
99.2% |
否 |
HY-113934 |
L-threo Lysosphingomyelin (d18:1) |
Agonist |
≥98.0% |
否 |
HY-114072A |
(S,S)-J-113397 |
Antagonist |
99.87% |
否 |
HY-114176 |
(S,R,S)-AHPC-C4-NH2 hydrochloride |
|
≥97.0% |
否 |
HY-114398A |
(S)-BAY-293 |
Control |
/ |
否 |
HY-114672 |
MBCQ |
Inhibitor |
99.80% |
否 |
HY-114866 |
Eritadenine |
|
97.9% |
否 |
HY-115498 |
ARN14494 |
Inhibitor |
99.08% |
否 |
HY-116494 |
ML753286 |
Inhibitor |
/ |
否 |
HY-116541 |
Acibenzolar-S-methyl |
Inhibitor |
99.77% |
否 |
HY-117025 |
Manzamine A |
Inhibitor |
/ |
否 |
HY-117147 |
GSK2945 |
Activator |
/ |
否 |
HY-117279 |
(S)-Metolachor |
|
99.09% |
否 |
HY-117608 |
ML 315 |
Inhibitor |
/ |
否 |
HY-117608A |
ML 315 hydrochloride |
Inhibitor |
98.75% |
否 |
HY-117720 |
OSU-2S |
|
/ |
否 |
HY-117935 |
GGTI-286 hydrochloride |
Inhibitor |
/ |
否 |
HY-118158 |
FAAH/MAGL-IN-4 |
Inhibitor |
99.83% |
否 |
HY-118480 |
4-MMPB |
|
98.54% |
否 |
HY-118486 |
LDL-IN-1 |
Inhibitor |
≥99.0% |
否 |
HY-118651 |
Griseoluteic acid |
|
≥95.0% |
否 |
HY-118980 |
Sorbitol dehydrogenase-IN-1 |
Inhibitor |
98.70% |
否 |
HY-119757 |
Tyrphostin AG1433 |
Inhibitor |
99.08% |
否 |
HY-119910 |
(E)-Aminoquinol |
|
99.70% |
否 |
HY-120179A |
LP-922761 hydrate |
|
≥98.0% |
否 |
HY-120268A |
SLM6031434 hydrochloride |
Inhibitor |
99.1% |
否 |
HY-12047S |
Ponatinib-d8 |
|
99.91% |
否 |
HY-120717 |
VU6001966 |
Inhibitor |
/ |
否 |
HY-120793 |
CMC2.24 |
|
97.48% |
否 |
HY-120940A |
AZ13705339 hemihydrate |
Inhibitor |
99.77% |
否 |
HY-121072 |
ASS234 |
Inhibitor |
99.6% |
否 |
HY-12163S |
Entinostat-d4 |
|
90.31% |
否 |
HY-121765 |
Dacisteine |
|
99.40% |
否 |
HY-122324 |
Tylophorine |
|
/ |
否 |
HY-124534 |
(1S,3R)-3-Aminocyclopentane carboxylic acid |
|
≥98.0% |
否 |
HY-124663 |
CBK289001 |
Inhibitor |
/ |
否 |
HY-12499 |
(S)-Willardiine |
Agonist |
99.27% |
否 |
HY-125111 |
PSB-SB-487 |
|
99.36% |
否 |
HY-125244 |
LEM-14-1189 |
Inhibitor |
99.57% |
否 |
HY-125733 |
Thiocillin I |
Inhibitor |
/ |
否 |
HY-125770 |
5(S)-HPETE |
|
≥98.0% |
否 |
HY-126319 |
SU5204 |
Inhibitor |
99.46% |
否 |
HY-126361 |
ZK824190 |
Inhibitor |
/ |
否 |
HY-12698 |
NNC 63-0532 |
Agonist |
99.81% |
否 |
HY-12788A |
(S)-PF-04449613 |
Inhibitor |
99.85% |
否 |
HY-12826 |
IMB-XH1 |
Inhibitor |
≥98.0% |
否 |
HY-128669S |
Abemaciclib metabolite M2-d6 |
Inhibitor |
99.25% |
否 |
HY-128720 |
Diethyl oxalpropionate |
|
≥95.0% |
否 |
HY-12872B |
Nazartinib S-enantiomer |
|
98.66% |
否 |
HY-128758 |
DYRKs-IN-1 |
Inhibitor |
/ |
否 |
HY-12895 |
SKI V |
|
98.95% |
否 |
HY-12940A |
(S)-GLPG0974 |
|
98.79% |
否 |
HY-12993A |
RSV604 racemate |
Inhibitor |
98.60% |
否 |
HY-13017S2 |
Ivacaftor-d18 |
|
92.92% |
否 |
HY-130221 |
(25S)-Δ7-Dafachronic acid |
|
95.40% |
否 |
HY-130239 |
14(S)-HDHA |
|
≥98.0% |
否 |
HY-13047 |
S-(+)-Mecamylamine hydrochloride |
Modulator |
/ |
否 |
HY-130736 |
Janelia Fluor® 549, SE |
|
/ |
否 |
HY-13100 |
PF 03716556 |
Antagonist |
99.10% |
否 |
HY-131022 |
Janelia Fluor® 549 TFA |
|
96.56% |
否 |
HY-131026 |
Janelia Fluor® 635, SE |
|
99.30% |
否 |
HY-131030 |
Janelia Fluor® 669, SE |
|
94.50% |
否 |
HY-131032 |
KI-7 |
Agonist |
99.16% |
否 |
HY-131258 |
Ibuprofen impurity 1 |
Inhibitor |
97.13% |
否 |
HY-131445 |
RJW100 |
Activator |
99.93% |
否 |
HY-131495 |
(S)-6-O-Desmethylnaproxen |
Inhibitor |
95.73% |
否 |
HY-131673A |
(S)-p-SCN-Bn-TCMC hydrochloride |
|
/ |
否 |
HY-131989 |
Desacetylcephapirin sodium |
Inhibitor |
≥97.0% |
否 |
HY-132094 |
Azido-PEG9-S-methyl ethanethioate |
|
/ |
否 |
HY-13272S2 |
Dacomitinib-d10 dihydrochloride |
|
≥95.0% |
否 |
HY-13302C |
CP-547632 TFA |
Inhibitor |
99.42% |
否 |
HY-133152 |
Brexpiprazole S-oxide |
|
96.19% |
否 |
HY-133158S |
(S)-Adenosylmethionine decarboxylated-d3 (sulfuric) |
|
94.71% |
否 |
HY-133776 |
Rivastigmine carbamate impurity |
Inhibitor |
99.98% |
否 |
HY-134008 |
Protoapigenone |
|
99.84% |
否 |
HY-13408 |
(+)-Apogossypol |
Inhibitor |
/ |
否 |
HY-134968A |
(R)-TTBK1-IN-1 |
Inhibitor |
98.93% |
否 |
HY-134977 |
Atrovastatin-PEG3-FITC |
Inhibitor |
98.17% |
否 |
HY-135383 |
(3S,5S)-Pitavastatin calcium |
Control |
99.94% |
否 |
HY-135871 |
BMT-124110 |
|
98.93% |
否 |
HY-135871A |
BMT-124110 formic |
Inhibitor |
/ |
否 |
HY-13605S |
Cytarabine-d2 |
|
≥98.0% |
否 |
HY-136207 |
TC-2559 difumarate |
Agonist |
98.4% |
否 |
HY-136267 |
HCV-IN-30 |
Inhibitor |
99.30% |
否 |
HY-13779A |
J147 |
Inhibitor |
99.90% |
否 |
HY-137851 |
S-Pyruvylglutathione |
|
/ |
否 |
HY-138551A |
(S,R,S)-AHPC-3-methylbutanyl acetate-methanesulfonothioate-Me-C10-NH2 TFA |
|
95.14% |
否 |
HY-138564 |
NOS-IN-1 |
Inhibitor |
98.18% |
否 |
HY-138862 |
(S,R,S)-AHPC-C1-Br |
|
≥98.0% |
否 |
HY-138879B |
CP-601932 |
Agonist |
99.74% |
否 |
HY-139038 |
TDRL-X80 |
|
99.6% |
否 |
HY-139331 |
20S Proteasome-IN-1 |
Inhibitor |
99.13% |
否 |
HY-139534A |
(S)-ARI-1 |
Control |
99.80% |
否 |
HY-139536 |
MAT2A inhibitor 4 |
|
99.84% |
否 |
HY-139612A |
(S)-JDQ-443 |
Inhibitor |
99.32% |
否 |
HY-139664B |
(S)-GSK-3685032 |
Inhibitor |
98.82% |
否 |
HY-139899 |
S6821 |
Antagonist |
/ |
否 |
HY-141341 |
S-acetyl-PEG4-alcohol |
|
/ |
否 |
HY-141350 |
S-acetyl-PEG4-propargyl |
|
≥97.0% |
否 |
HY-141602 |
Pinatuzumab vedotin |
Inhibitor |
/ |
否 |
HY-14176A |
(1R,3S)-Compound E |
Control |
99.82% |
否 |
HY-14280S |
Entacapone-d10 |
Inhibitor |
≥98.0% |
否 |
HY-142988 |
1-Stearoyl-2-myristoyl-sn-glycero-3-PC |
|
≥95.0% |
否 |
HY-143337 |
EGFR-IN-47 |
|
96.01% |
否 |
HY-14397S |
Indomethacin-d4 |
Inhibitor |
99.78% |
否 |
HY-144771 |
SARS-CoV-2-IN-14 |
Inhibitor |
99.02% |
否 |
HY-144820 |
JO146 |
Inhibitor |
98.49% |
否 |
HY-14520A |
(6S)-Tetrahydrofolic acid |
|
/ |
否 |
HY-14533 |
K 01-162 |
Inhibitor |
≥98.0% |
否 |
HY-145384 |
ROC-0929 |
Inhibitor |
99.48% |
否 |
HY-145969 |
β-S-ARCA |
|
/ |
否 |
HY-145969A |
β-S-ARCA triammonium |
|
99.48% |
否 |
HY-146393 |
PROTAC CYP1B1 degrader-1 |
Inhibitor |
98.09% |
否 |
HY-14664C |
(3S,5R)-Fluvastatin sodium |
Inhibitor |
98.16% |
否 |
HY-146672 |
ITK inhibitor 6 |
Inhibitor |
/ |
否 |
HY-147284 |
PI3K-IN-37 |
Inhibitor |
≥99.0% |
否 |
HY-147517 |
Keap1-Nrf2-IN-9 |
Inhibitor |
98.52% |
否 |
HY-14778A |
(S)-Retosiban |
Antagonist |
99.12% |
否 |
HY-148037 |
Thrombin inhibitor 5 |
Inhibitor |
99.82% |
否 |
HY-148060 |
JAK-IN-21 |
Inhibitor |
99.72% |
否 |
HY-148207 |
S-Benzylglutathione |
|
98.86% |
否 |
HY-148407 |
lucPpy-IN-1 |
|
99.48% |
否 |
HY-148443 |
eIF4A3-IN-9 |
Inhibitor |
99.71% |
否 |
HY-148444 |
eIF4A3-IN-10 |
Inhibitor |
97.87% |
否 |
HY-148445 |
eIF4A3-IN-11 |
Inhibitor |
99.24% |
否 |
HY-148447 |
eIF4A3-IN-13 |
Inhibitor |
99.92% |
否 |
HY-148448 |
eIF4A3-IN-14 |
Inhibitor |
99.81% |
否 |
HY-148449 |
eIF4A3-IN-15 |
Inhibitor |
/ |
否 |
HY-148451 |
eIF4A3-IN-17 |
Inhibitor |
99.56% |
否 |
HY-148753 |
PARP10-IN-2 |
Inhibitor |
98.02% |
否 |
HY-149056A |
(3S,4R)-GNE-6893 |
Inhibitor |
99.49% |
否 |
HY-149207 |
Tyrosinase-IN-11 |
Inhibitor |
98.12% |
否 |
HY-149278 |
Complement C1s-IN-1 |
Inhibitor |
/ |
否 |
HY-149803A |
S1R agonist 1 hydrochloride |
Agonist |
99.83% |
否 |
HY-150226 |
Enzyme-IN-1 |
Inhibitor |
/ |
否 |
HY-15036S1 |
Diclofenac-13C6 |
|
99.90% |
否 |
HY-150510A |
MS8511 hydrochloride |
Inhibitor |
≥98.0% |
否 |
HY-150513 |
SLP9101555 |
Inhibitor |
99.40% |
否 |
HY-150610 |
EGFR-IN-69 |
Inhibitor |
99.58% |
否 |
HY-150737 |
MI-1851 |
Inhibitor |
95.08% |
否 |
HY-150964S |
S-Adenosyl-L-methionine-d3 methylbenzenesulfonate |
|
/ |
否 |
HY-151159 |
DHFR-IN-4 |
Inhibitor |
99.19% |
否 |
HY-151261 |
HDAC6-IN-13 |
Inhibitor |
98.08% |
否 |
HY-15133A |
PTP1B-IN-3 diammonium |
Inhibitor |
95.38% |
否 |
HY-151368 |
AChE/BChE-IN-10 |
Inhibitor |
99.67% |
否 |
HY-151498 |
PXS-4787 |
Inhibitor |
/ |
否 |
HY-151499 |
PXS-6302 |
Inhibitor |
/ |
否 |
HY-151500 |
JBSNF-000028 free base |
Inhibitor |
99.20% |
否 |
HY-15176 |
Pyridostatin |
Activator |
/ |
否 |
HY-151916 |
Enpp/Carbonic anhydrase-IN-1 |
|
99.57% |
否 |
HY-152174 |
HDAC-IN-52 |
Inhibitor |
99.46% |
否 |
HY-15271A |
WYE-687 dihydrochloride |
Inhibitor |
≥98.0% |
否 |
HY-15315S1 |
Baricitinib-d3 |
Inhibitor |
≥99.0% |
否 |
HY-15321S |
Etoricoxib-d4 |
|
98.79% |
否 |
HY-153440 |
JAK-IN-25 |
Inhibitor |
98.44% |
否 |
HY-153543 |
TLR7/8 agonist 8 |
Agonist |
98.69% |
否 |
HY-153752 |
TAO Kinase inhibitor 2 |
Inhibitor |
≥97.0% |
否 |
HY-155005 |
EGFR mutant-IN-2 |
Inhibitor |
≥97.0% |
否 |
HY-155066 |
FD274 |
Inhibitor |
99.45% |
否 |
HY-155113 |
PROTAC Hsp90α degrader 1 |
Degrader |
/ |
否 |
HY-155128 |
LANA-DNA-IN-2 |
Inhibitor |
99.02% |
否 |
HY-155285 |
YS-363 |
|
99.52% |
否 |
HY-155358 |
Os30 |
|
98.34% |
否 |
HY-155480 |
PSB-22034 |
Agonist |
/ |
否 |
HY-155723 |
Leucettinib-92 |
Inhibitor |
/ |
否 |
HY-15592S1 |
Cabotegravir-d5 |
Inhibitor |
99.31% |
否 |
HY-155962 |
Tubulin polymerization-IN-47 |
Inhibitor |
99.51% |
否 |
HY-156038 |
(S)-p-SCN-Bn-DOTA |
|
99.75% |
否 |
HY-15677A |
INT-777 (R-enantiomer) |
Agonist |
98.73% |
否 |
HY-157413 |
YS-67 |
Inhibitor |
99.41% |
否 |
HY-157786 |
XPC-5462 |
Inhibitor |
/ |
否 |
HY-15790H |
(S)-Elobixibat |
Inhibitor |
98.75% |
否 |
HY-158024A |
(S)-NDT-19795 |
Inhibitor |
/ |
否 |
HY-158417 |
KSI-6666 |
Antagonist |
/ |
否 |
HY-158469 |
Disialylated Core 1 O-glycan (C1S(3,6)2), 2-AB labelled |
|
/ |
否 |
HY-158470 |
Disialylated Core 2 O-glycan (C2S(3,3)2), 2-AB labelled |
|
/ |
否 |
HY-158843 |
15(S)-Hete-biotin |
|
/ |
否 |
HY-15889A |
AMG 925 (HCl) |
Inhibitor |
/ |
否 |
HY-15895S |
Aprocitentan-d4 |
Antagonist |
97.39% |
否 |
HY-160811 |
hVEGF-IN-3 |
Inhibitor |
99.56% |
否 |
HY-160850 |
C18 Ceramide-1-phosphate (d18:1/18:0) ammonium salt |
|
99.0% |
否 |
HY-160887 |
FPT |
Agonist |
98.06% |
否 |
HY-161016 |
TNF/IFN-γ-IN-1 |
Inhibitor |
99.39% |
否 |
HY-161152 |
DNA relaxation-IN-1 |
Inhibitor |
99.37% |
否 |
HY-16122B |
CAL-130 Hydrochloride |
Inhibitor |
98.74% |
否 |
HY-162002A |
(S)-WSD0628 |
Inhibitor |
/ |
否 |
HY-162248 |
JAK1/2-IN-1 |
Inhibitor |
98.36% |
否 |
HY-162312 |
LLK203 |
|
98.58% |
否 |
HY-162618 |
PSB-KK1445 |
Agonist |
99.47% |
否 |
HY-162938 |
Skp2 inhibitor 3 |
Inhibitor |
/ |
否 |
HY-163384 |
(S)-CE-123 |
Inhibitor |
/ |
否 |
HY-163622 |
USP10-IN-3 |
Inducer |
98.00% |
否 |
HY-164982 |
S-N6-Methyladenosylhomocysteine |
Inhibitor |
/ |
否 |
HY-167739 |
(S,S)-Dehydroemetine |
|
/ |
否 |
HY-167920 |
Glutathione sulfonate |
|
≥95.0% |
否 |
HY-169093 |
MS41 |
|
97.14% |
否 |
HY-169325 |
(S)-ACE-OH |
|
/ |
否 |
HY-17034AS |
Dexmedetomidine-13C,d3 hydrochloride |
Agonist |
99.93% |
否 |
HY-17518A |
(S,S)-Valifenalate |
Inhibitor |
≥98.0% |
否 |
HY-17531 |
Pyraclonil |
|
97.02% |
否 |
HY-18085AS |
Quercetin-d3 hydrate |
|
96.44% |
否 |
HY-18137 |
PF-04995274 |
Agonist |
99.95% |
否 |
HY-18307 |
SYN1143 |
Inhibitor |
99.36% |
否 |
HY-18317 |
JNJ-38158471 |
Inhibitor |
97.02% |
否 |
HY-18710 |
BMS-066 |
Inhibitor |
99.09% |
否 |
HY-18745 |
BzATP triethylammonium |
Agonist |
/ |
否 |
HY-18941B |
(rel)-Eglumegad |
Agonist |
≥97.0% |
否 |
HY-19528S2 |
SAH-13C10 |
|
99.90% |
否 |
HY-19654C |
(-)-GSK598809 hydrochloride |
Antagonist |
99.64% |
否 |
HY-19822B |
Elacestrant S enantiomer dihydrochloride |
Inhibitor |
/ |
否 |
HY-19822D |
Elacestrant (S enantiomer) |
Inhibitor |
/ |
否 |
HY-19883S |
Lusutrombopag-d13 |
Agonist |
98.64% |
否 |
HY-19978 |
RO-3 |
Antagonist |
97.32% |
否 |
HY-20349 |
Monobehenin |
Inhibitor |
/ |
否 |
HY-20838B |
(S)-2-Amino-2-(tetrahydro-2H-pyran-4-yl)ethanoic acid |
|
≥98.0% |
否 |
HY-21292 |
SU5214 |
Inhibitor |
≥98.0% |
否 |
HY-23338 |
TNKS-2-IN-1 |
Inhibitor |
95.19% |
否 |
HY-30099 |
O,O,S-Trimethyl ester phosphorothioic acid |
|
/ |
否 |
HY-30215R |
(S)-Leucic acid (Standard) |
|
/ |
否 |
HY-33466 |
(S)-Methyl 2-amino-2-cyclopentylacetate hydrochloride |
|
≥97.0% |
否 |
HY-40023 |
(S)-1-Boc-3-hydroxypiperidine |
|
98.94% |
否 |
HY-40354S |
Tofacitinib-13C3 |
|
97% |
否 |
HY-41048 |
(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate |
|
98.30% |
否 |
HY-41318 |
N-Z-L-proline methyl ester |
|
99.88% |
否 |
HY-42066 |
L-Aspartic acid 1-benzyl ester |
|
/ |
否 |
HY-42448 |
tert-Butyl (2S,4R)-4-hydroxy-2-hydroxymethylpyrrolidine-1-carboxylate |
|
≥98.0% |
否 |
HY-43973 |
N-(tert-Butoxycarbonyl)-S-butylhomocysteine |
|
99.58% |
否 |
HY-44688 |
S.pombe lumazine synthase-IN-1 |
Inhibitor |
98.02% |
否 |
HY-50887 |
L-873724 |
Inhibitor |
98.93% |
否 |
HY-50935S |
Troglitazone-d4 |
|
98.19% |
否 |
HY-59135 |
(S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoic acid |
|
≥98.0% |
否 |
HY-75326 |
(S)-2-Aminopropanamide hydrochloride |
|
≥97.0% |
否 |
HY-75947 |
(S)-tert-butyl 1-hydroxy-3-phenylpropan-2-ylcarbamate |
|
99.94% |
否 |
HY-76366 |
(S)-N-Boc-3-hydroxypyrrolidine |
|
99.98% |
否 |
HY-77009 |
JNK-IN-13 |
Inhibitor |
95.92% |
否 |
HY-77021 |
(S)-ethyl 2-amino-4-fluoro-4-methylpentanoate |
|
/ |
否 |
HY-77584 |
(2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)non-8-enoyl)-4-hydroxypyrrolidine-2-carboxylic acid |
|
95.87% |
否 |
HY-77593 |
(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid |
|
≥98.0% |
否 |
HY-78828A |
(S)-Dolaphenine hydrochloride |
Inhibitor |
99.51% |
否 |
HY-78926 |
1-Boc-2-(S)-pyrrolidinemethanol |
|
99.94% |
否 |
HY-78931A |
(R,S,S,R,S)-Boc-Dap-NE |
|
/ |
否 |
HY-79046 |
Boc-L-2-aminobutanoic acid |
|
≥98.0% |
否 |
HY-79123 |
(2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate |
|
98.74% |
否 |
HY-79165 |
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3,4-difluorophenyl)propionic acid |
|
98.02% |
否 |
HY-79271 |
S-tert-Leucine N-methylamide |
|
≥98.0% |
否 |
HY-79288 |
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3-fluorophenyl)propionic acid |
|
≥95.0% |
否 |
HY-79404 |
N-(Tert-Butoxycarbonyl)-L-neopentylglycine |
|
98.52% |
否 |
HY-79417 |
(S)-N-Methyl-N-methoxy-2-(tert-butoxycarbonylamino)-4-methylpentanamide |
|
/ |
否 |
HY-79491 |
(S)-2-Aminobutyramide hydrochloride |
|
≥98.0% |
否 |
HY-90009D |
(6S,12aR)-Tadalafil |
Inhibitor |
99.34% |
否 |
HY-A0104B |
HPMC (Type I,Viscosity:100mPa.s) |
|
/ |
否 |
HY-A0104C |
HPMC (Type I,Viscosity:400mPa.s) |
|
/ |
否 |
HY-B0035S2 |
Sulfamethazine-13C6 |
|
99.10% |
否 |
HY-B0097R |
Floxuridine (Standard) |
|
/ |
否 |
HY-B0253S |
Piroxicam-d3 |
Inhibitor |
99.68% |
否 |
HY-B0261S2 |
Meloxicam-13C,d3 |
|
/ |
否 |
HY-B0287R |
Clofibrate (Standard) |
Agonist |
98.09% |
否 |
HY-B0352A |
(S)-Mirtazapine |
Antagonist |
99.76% |
否 |
HY-B0403AS |
Bupropion-d9 hydrochloride |
Inhibitor |
99.35% |
否 |
HY-B0578S |
Loxoprofen-d4 |
Inhibitor |
99.04% |
否 |
HY-B0975S |
Penicillin V-13C6 potassium |
Inhibitor |
99.8% |
否 |
HY-B0975S1 |
Penicillin V-d5 potassium |
|
98.10% |
否 |
HY-B1455S1 |
Clindamycin-13C,d3 |
Inhibitor |
≥99.0% |
否 |
HY-B1937 |
Sodium dodecylbenzenesulfonate |
|
90.2% |
否 |
HY-B2144E |
Chitosan (≥90% deacetylated, Low viscosity,<200mPa.s) |
Inhibitor |
/ |
否 |
HY-B2144K |
Chitosan (≥85% deacetylated, viscosity>90 mPa.s, MW 15000) |
|
/ |
否 |
HY-B2157S |
Robenidine-d8 hydrochloride |
Inhibitor |
≥99.0% |
否 |
HY-D0004 |
Azure B |
Inhibitor |
98.13% |
否 |
HY-D0798 |
Catechol violet |
|
≥90.0% |
否 |
HY-D0884 |
L-Lactic acid lithium |
|
≥98.0% |
否 |
HY-D0899 |
Taloxin |
|
99.96% |
否 |
HY-D1056C1 |
Lipopolysaccharides, from S. enterica serotype enteritidis |
Activator |
/ |
否 |
HY-D2192 |
Ag2S-PEG-NH2 (1200 nm) |
|
/ |
否 |
HY-I0102 |
(2S)-Methyl 2-(2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate |
|
99.84% |
否 |
HY-I0109 |
(S)-2-(((benzyloxy)carbonyl)amino)-2-cyclohexylacetic acid |
|
99.97% |
否 |
HY-I0749A |
(S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate |
|
99.31% |
否 |
HY-N0226 |
Epiberberine |
Inhibitor |
98.46% |
否 |
HY-N0394S2 |
(S)-L-Cystine-15N2 |
Activator |
99.00% |
否 |
HY-N0455AS5 |
L-Arginine-1,2-13C2 hydrochloride |
Activator |
98.9% |
否 |
HY-N0636R |
Eriocitrin (Standard) |
Inducer |
/ |
否 |
HY-N0650S6 |
L-Serine1-13C,15N |
|
/ |
否 |
HY-N0927 |
(-)-Isocorypalmine |
|
99.67% |
否 |
HY-N10087 |
Angustifoline |
Inhibitor |
≥95.0% |
否 |
HY-N10413 |
Diphlorethohydroxycarmalol |
Inhibitor |
98.46% |
否 |
HY-N10495 |
Seconeolitsine |
Inhibitor |
≥95.0% |
否 |
HY-N1074 |
Warangalone |
Inhibitor |
97.08% |
否 |
HY-N1150S8 |
Thymidine-13C10,15N2 |
|
99.90% |
否 |
HY-N12033 |
4'-Demethylpodophyllotoxone |
|
98.73% |
否 |
HY-N12486A |
(3S,8R,9R)-Isofalcarintriol |
|
/ |
否 |
HY-N1746 |
(2S)-2'-Methoxykurarinone |
|
98.86% |
否 |
HY-N2207 |
rel-(8R,8'R)-Dimethyl-(7S,7'R)-bis(3,4-methylenedioxyphenyl)tetrahydro-furan |
|
99.95% |
否 |
HY-N2273 |
Gymnestrogenin |
Antagonist |
99.32% |
否 |
HY-N2284 |
Sophoflavescenol |
Inhibitor |
98.78% |
否 |
HY-N2297 |
Kaji-ichigoside F1 |
|
≥98.0% |
否 |
HY-N2383 |
Validamine |
Inhibitor |
/ |
否 |
HY-N2560 |
Senecionine |
|
99.20% |
否 |
HY-N2983 |
Cajanin |
Inhibitor |
99.96% |
否 |
HY-N3504 |
Ophiopogonin D' |
Activator |
99.85% |
否 |
HY-N3628 |
Coronarin A |
Inhibitor |
≥98.0% |
否 |
HY-N3942 |
Glabranine |
Inhibitor |
≥98.0% |
否 |
HY-N3963 |
Gomisin M2 |
Inhibitor |
99.87% |
否 |
HY-N4200 |
S-Dihydrodaidzein |
|
/ |
否 |
HY-N5127 |
Nonacosane |
Inhibitor |
≥98.0% |
否 |
HY-N5136 |
25(R,S)-Ruscogenin |
Inhibitor |
99.83% |
否 |
HY-N6061 |
Ophiopogonin C |
|
≥99.0% |
否 |
HY-N6262 |
20(S),24(R)-Ocotillol |
|
99.89% |
否 |
HY-N6889 |
Rebaudioside I |
|
98.33% |
否 |
HY-N7010 |
(-)-Corynoxidine |
Inhibitor |
99.90% |
否 |
HY-N7020 |
Cinobufaginol |
|
99.75% |
否 |
HY-N7307 |
Pachybasin |
|
/ |
否 |
HY-N7394A |
(-)-Zuonin A |
Inhibitor |
99.99% |
否 |
HY-N7912 |
Pterosin A |
|
94.07% |
否 |
HY-N8091 |
Lehmannine |
Inhibitor |
98.89% |
否 |
HY-N8954 |
Kaempferol 7-O-neohesperidoside |
|
98.63% |
否 |
HY-N9895 |
3,5-Dicaffeoyl-epi-quinic acid |
|
97.73% |
否 |
HY-P0219 |
Microcystin-LA |
Inhibitor |
≥95.0% |
否 |
HY-P10224A |
G7-18NATE TFA |
|
98.59% |
否 |
HY-P10283 |
S1H |
Antagonist |
99.29% |
否 |
HY-P1051A |
β-Amyloid (12-28) (TFA) |
|
99.80% |
否 |
HY-P10714 |
Ub4ix |
|
99.32% |
否 |
HY-P1267A |
α-Conotoxin PnIA TFA |
Antagonist |
96.68% |
否 |
HY-P1268A |
α-Conotoxin PIA TFA |
Antagonist |
99.81% |
否 |
HY-P1438 |
Neuropeptide S(Rat) |
Agonist |
99.57% |
否 |
HY-P1454B |
Fz7-21S |
|
98.91% |
否 |
HY-P1495 |
Small Cardioactive Peptide B (SCPB) |
Activator |
99.69% |
否 |
HY-P1542 |
Urotensin I |
Agonist |
/ |
否 |
HY-P2093 |
S961 |
Antagonist |
/ |
否 |
HY-P2093A |
S961 TFA |
Antagonist |
97.60% |
否 |
HY-P3328A |
MDP1 acetate |
Inhibitor |
98.66% |
否 |
HY-P4680 |
(Phe13,Tyr19)-MCH (human, mouse, rat) |
Agonist |
98.30% |
否 |
HY-P4704 |
α-Synuclein (61-95) (human) |
|
/ |
否 |
HY-P4820A |
SYNV-cyclo(CGGYF) TFA |
Inhibitor |
97.08% |
否 |
HY-P5082 |
α-Synuclein 4554W |
Inhibitor |
99.53% |
否 |
HY-P5333A |
Aβ1-14-εK-KKK-MvF5 Th acetate |
Inhibitor |
99.93% |
否 |
HY-P5455 |
S3 Fragment |
Inhibitor |
/ |
否 |
HY-P5773 |
Jingzhaotoxin-34 |
Inhibitor |
/ |
否 |
HY-RS12382 |
S100A6 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-U00037 |
Ecopladib |
Inhibitor |
95.0% |
否 |
HY-U00427 |
PDE2/PDE10-IN-1 |
Inhibitor |
99.88% |
否 |
HY-W002301 |
(2S)-4-(benzyloxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid |
|
99.76% |
否 |
HY-W002519 |
(S)-2-Amino-2-(4-fluorophenyl)acetic acid |
|
99.84% |
否 |
HY-W002530A |
(1R,2R)-1-Aminoindan-2-ol |
|
99.70% |
否 |
HY-W004063 |
(S)-3-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)propanoic acid |
|
99.35% |
否 |
HY-W005143 |
(S)-2-((tert-Butoxycarbonyl)amino)-5-methoxy-5-oxopentanoic acid |
|
≥98.0% |
否 |
HY-W007136 |
(S)-methyl 2-amino-3-cyclohexylpropanoate hydrochloride |
|
99.81% |
否 |
HY-W007679 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-nitrophenyl)propanoic acid |
|
99.77% |
否 |
HY-W008028 |
(S)-2-Amino-3-cyclopropylpropanoic acid |
|
≥98.0% |
否 |
HY-W008261 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-cyclohexylpropanoic acid |
|
≥97.0% |
否 |
HY-W008437 |
(S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid dihydrate |
|
99.29% |
否 |
HY-W008610 |
GBR 12783 |
Inhibitor |
/ |
否 |
HY-W009197 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid |
|
99.45% |
否 |
HY-W010018 |
(S)-L-DABA dihydrochloride |
|
≥97.0% |
否 |
HY-W010255A |
Phenylglyoxylic acid sodium |
|
99.92% |
否 |
HY-W010277 |
(S)-2-(2-Aminopropanamido)acetic acid |
|
≥98.0% |
否 |
HY-W010706 |
N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine |
|
99.55% |
否 |
HY-W010747 |
(S)-2,3-Bis((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid |
|
≥98.0% |
否 |
HY-W010837 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3,3-diphenylpropanoic acid |
|
≥97.0% |
否 |
HY-W010958 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-cyanophenyl)propanoic acid |
|
≥98.0% |
否 |
HY-W011245 |
Ranitidine S-oxide |
|
99.03% |
否 |
HY-W011537 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid |
|
99.60% |
否 |
HY-W012293 |
3'-Deoxycytidine |
|
≥98.0% |
否 |
HY-W012537 |
(2S,4R)-2-amino-4-hydroxypentanedioic acid |
|
≥99.0% |
否 |
HY-W012707 |
(S)-2-Amino-2,3-dimethylbutanoic acid |
|
≥97.0% |
否 |
HY-W013665R |
(S)-2-Aminohexanedioic acid (Standard) |
|
/ |
否 |
HY-W014742 |
(S)-2-Amino-5-(tert-butoxy)-5-oxopentanoic acid |
|
≥98.0% |
否 |
HY-W015114R |
L-2-Hydroxyglutaric acid (disodium) (Standard) |
Inhibitor |
/ |
否 |
HY-W016099S |
3-Methyl-2-quinoxalinecarboxylic acid-d4 |
|
99.60% |
否 |
HY-W016552 |
(S)-2-Amino-2-methyl-3-phenylpropanoic acid |
|
99.62% |
否 |
HY-W016835 |
(2S,3S)-2-Acetamido-3-methylpentanoic acid |
|
≥97.0% |
否 |
HY-W016867 |
4-Chlorosalicylic acid |
Inhibitor |
99.95% |
否 |
HY-W018050 |
(S)-2-((tert-Butoxycarbonyl)amino)pent-4-enoic acid |
|
≥97.0% |
否 |
HY-W018628 |
(S)-2-((tert-Butoxycarbonyl)amino)-2-cyclopentylacetic acid |
|
≥97.0% |
否 |
HY-W019205 |
(4S)-1-Boc-4-amino-D-proline |
|
≥95.0% |
否 |
HY-W019679 |
(S)-N-Methylpyrrolidine-2-methanol |
|
99.91% |
否 |
HY-W019683 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-ethoxyphenyl)propanoic acid |
|
≥97.0% |
否 |
HY-W019684 |
(S)-2-(2-((tert-Butoxycarbonyl)amino)propanamido)acetic acid |
|
≥97.0% |
否 |
HY-W019714 |
(S)-(+)-2-Phenylglycine methyl ester hydrochloride |
|
99.73% |
否 |
HY-W020033S |
Lanosterol-d6 |
|
≥99.0% |
否 |
HY-W022471 |
(S)-2-Amino-3-(3-chlorophenyl)propanoic acid hydrochloride |
|
≥97.0% |
否 |
HY-W037120 |
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-((4-methoxyphenyl)diphenylmethyl)-D-cysteine |
|
99.39% |
否 |
HY-W039169 |
4-Chloroguaiacol |
Inhibitor |
99.89% |
否 |
HY-W040333 |
(2S,3R)-Ethyl 2-amino-3-hydroxybutanoate hydrochloride |
|
≥97.0% |
否 |
HY-W040432 |
(S)-3-Amino-4-hydroxybutanoic acid |
|
≥97.0% |
否 |
HY-W044620 |
(2S,4R)-4-Fluoropyrrolidine-2-carboxylic acid |
|
98.41% |
否 |
HY-W048199 |
(S)-N-FMoc-2-(6'-heptenyl)alanine |
|
98.74% |
否 |
HY-W048286 |
S-Allyl-D-cysteine |
|
≥97.0% |
否 |
HY-W050023 |
(S)-2-Amino-2-(2-chlorophenyl)acetic acid |
|
≥97.0% |
否 |
HY-W050494 |
(S)-2-Amino-3-(3-nitrophenyl)propanoic acid |
|
99.96% |
否 |
HY-W063269 |
(S)-1-Benzyl 2-methyl 4-oxopyrrolidine-1,2-dicarboxylate |
|
98.25% |
否 |
HY-W105506 |
Dimethylpropiothetin hydrochloride |
|
≥97.0% |
否 |
HY-W105506S |
Dimethylpropiothetin hydrochloride-d6 |
|
99.70% |
否 |
HY-W128028 |
(S)-4-Methyl-2-(methylamino)pentanoic acid hydrochloride |
|
≥97.0% |
否 |
HY-W141770 |
DL-Phenylmercapturic Acid |
|
99.80% |
否 |
HY-W141781 |
Cysteamine S-phosphate sodium |
|
≥97.0% |
否 |
HY-W145523 |
ι-Carrageenan |
|
≥98.0% |
否 |
HY-W338140 |
Methionine sulfoximine |
|
≥98.0% |
否 |
HY-W731085 |
MC-GGFG-NH-CH2-O-CH2-(s-cyclopropane)-COOH |
|
97.35% |
否 |
HY-Y0028 |
(S)-2-(tert-Butoxycarbonylamino)succinic acid benzyl ester |
|
98.35% |
否 |
HY-Y0117 |
(+)-Di-p-toluoyl-D-tartaric Acid |
|
99.81% |
否 |
HY-Y0366S2 |
Lauric acid-d2 |
Inhibitor |
/ |
否 |
HY-Z0615 |
(2S)-4-(Benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid |
|
99.92% |
否 |
HY-100443B |
(R,R)-PX20606 |
Agonist |
/ |
否 |
HY-100982 |
(E)-4-Hydroxycrotonic acid |
|
≥98.0% |
否 |
HY-101605 |
Prodipine hydrochloride |
Inhibitor |
99.84% |
否 |
HY-10184 |
TG 100572 |
Inhibitor |
/ |
否 |
HY-10627 |
GW3965 |
Agonist |
/ |
否 |
HY-107209 |
RKI-1313 |
Inhibitor |
98.2% |
否 |
HY-110184 |
PK-THPP |
Inhibitor |
≥99.0% |
否 |
HY-112921 |
diABZI STING agonist-1 (tautomerism) |
Agonist |
/ |
否 |
HY-113040A |
(17R,18S)-Epoxyeicosatetraenoic acid |
Inhibitor |
≥93.0% |
否 |
HY-113455S |
9S-HODE-d4 |
|
≥98.0% |
否 |
HY-116863 |
KKL-40 |
Inhibitor |
95.70% |
否 |
HY-117020 |
Methyl (S)-(-)-N-Z-aziridine-2-carboxylate |
|
/ |
否 |
HY-118149 |
9(S)-HpODE |
|
98.0% |
否 |
HY-119779 |
Pyridalyl |
|
95.14% |
否 |
HY-120877A |
(R)-MRT199665 |
|
98.70% |
否 |
HY-122489A |
(S)-Laudanosine |
Control |
99.95% |
否 |
HY-124344 |
Avenanthramide C |
Activator |
98.90% |
否 |
HY-126108A |
8(S)-HEPE |
|
≥98.0% |
否 |
HY-129121 |
ML-226 |
Inhibitor |
98.76% |
否 |
HY-132451S |
(R,S)-4-Hydroxy Cyclophosphamide-d4 Preparation Kit |
|
/ |
否 |
HY-135045 |
(S,R,S)-AHPC-C4-COOH |
|
≥95.0% |
否 |
HY-136498A |
T-705RMP ammonium |
|
95.34% |
否 |
HY-13952 |
TP-808 |
|
99.72% |
否 |
HY-144354S |
S-Benzyl-DL-cysteine-2,3,3-d3 |
Inhibitor |
/ |
否 |
HY-151702 |
(2S)-N3-IsoSer |
|
/ |
否 |
HY-151866 |
(2S)-N3-HABA |
|
/ |
否 |
HY-151866A |
(S)-N3-HABA (DCHA) |
|
≥95.0% |
否 |
HY-15238A |
ST-836 hydrochloride |
Agonist |
98.11% |
否 |
HY-15561 |
HOE-S 785026 |
|
98.76% |
否 |
HY-157719 |
S-Adenosylhomocysteine sulfoxide |
Inhibitor |
≥95.0% |
否 |
HY-160457 |
FABP4/5-IN-5 |
Inhibitor |
98.10% |
否 |
HY-160926 |
16-Oxocafestol |
Inducer |
≥98.0% |
否 |
HY-16713 |
(S)-(-)-5-Fluorowillardiine |
Agonist |
/ |
否 |
HY-16906 |
T338C Src-IN-2 |
Inhibitor |
/ |
否 |
HY-17494S |
(Rac)-Timolol-d5 maleate |
Antagonist |
≥99.0% |
否 |
HY-18627 |
PFI-2 |
Inhibitor |
/ |
否 |
HY-402383 |
O-(((2R,3S,5R)-5-(5-Bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl) O,S-dihydrogen phosphorothioate |
Control |
/ |
否 |
HY-402853 |
3-(Tritylthio)propylamine |
|
/ |
否 |
HY-47663 |
5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-1H-indole-2-carboxylic acid |
Control |
99.84% |
否 |
HY-50874 |
BCX 1470 |
Inhibitor |
/ |
否 |
HY-78931B |
(S,S,S,S,R)-Boc-Dap-NE |
|
/ |
否 |
HY-78931C |
(S,S,R,S,R)-Boc-Dap-NE |
|
/ |
否 |
HY-78931E |
(R,S,R,S,R)-Boc-Dap-NE |
|
/ |
否 |
HY-78931F |
(R,S,S,S,R)-Boc-Dap-NE |
|
/ |
否 |
HY-B0617AR |
S-Adenosyl-L-methionine (tosylate) (Standard) |
Inducer |
/ |
否 |
HY-B0617S2 |
S-Adenosyl-L-methionine-13C dihydrochloride |
Inducer |
/ |
否 |
HY-B1811AS1 |
Vasopressin-d5 TFA |
|
/ |
否 |
HY-D0205 |
(RS)-Carbocisteine |
|
/ |
否 |
HY-D0845R |
Nitrosoglutathione (Standard) |
Inhibitor |
/ |
否 |
HY-E70239A |
(S)-2-Methylbutyryl-CoA tetrasodium |
|
95.49% |
否 |
HY-N5019 |
Notoginsenoside S |
|
98.84% |
否 |
HY-N5158B |
(5S)-Neosamine C |
|
/ |
否 |
HY-N6802 |
Tigloylgomisin H |
Inducer |
/ |
否 |
HY-N8707 |
Homobutein |
Inhibitor |
98.35% |
否 |
HY-P2576 |
Polistes mastoparan |
Inhibitor |
98.93% |
否 |
HY-P5333 |
Aβ1-14-εK-KKK-MvF5 Th |
|
98.05% |
否 |
HY-P5594 |
Dermaseptin-S1 |
Inhibitor |
97.12% |
否 |
HY-RS12403 |
S1PR5 Human Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS16270 |
TANGO1-S Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS16310 |
S100a1 Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-U00125 |
CGP-53153 |
Inhibitor |
/ |
否 |
HY-W011176 |
(S)-3-Hydroxypropane-1,2-diyl dioctanoate |
|
98.42% |
否 |
HY-W013665S2 |
(S)-2-Aminohexanedioic acid-d4 |
|
/ |
否 |
HY-W020111 |
7-Chloro-4-(piperazin-1-yl)quinoline |
Inhibitor |
98.63% |
否 |
HY-W021016 |
(+)-1,2-Bis((2S,5S)-2,5-diphenylphospholano)ethane |
|
≥98.0% |
否 |
HY-W024365 |
3-tert-Butyl-4-methoxyphenol |
|
99.69% |
否 |
HY-W029719 |
[5-(2-Thienyl)-3-isoxazolyl]methanol |
Inhibitor |
99.88% |
否 |
HY-W037825 |
Pterin |
Inhibitor |
≥97.0% |
否 |
HY-W061761 |
(1R,3S)-3-Aminocyclopentane carboxylic acid |
|
/ |
否 |
HY-W076794 |
3-Bromo-1H-pyrrole-2,5-dione |
Inhibitor |
≥97.0% |
否 |
HY-W101682 |
(S)-Pregabalin methyl ester hydrochloride |
|
/ |
否 |
HY-W140900 |
Sodium (S)-3-amino-3-carboxypropanoate hydrate |
|
≥97.0% |
否 |
HY-W160679 |
7-(Carboxymethoxy)-4-methylcoumarin |
Inhibitor |
99.42% |
否 |
HY-W393243 |
3′-O-Methyladenosine |
|
≥97.0% |
否 |
HY-W585874 |
Nε-(Carboxyethyl)lysine |
Modulator |
/ |
否 |
HY-W718383 |
7(Z),10(Z),13(Z)-Hexadecatrienoic acid |
|
98.23% |
否 |
HY-W747072 |
3-Sulfo-taurocholic Acid Disodium Salt |
|
≥99.0% |
否 |
HY-13866A |
Ro 31-8220 |
Inhibitor |
/ |
否 |
HY-100022A |
Tomivosertib hydrochloride |
Inhibitor |
/ |
否 |
HY-100360A |
MS049 dihydrochloride |
Inhibitor |
/ |
否 |
HY-101798 |
MDVN1003 |
Inhibitor |
/ |
否 |
HY-103048 |
PD-1/PD-L1-IN 3 |
Inhibitor |
/ |
否 |
HY-103663A |
MAK683 hydrochloride |
Inhibitor |
/ |
否 |
HY-12965A |
S49076 hydrochloride |
Inhibitor |
/ |
否 |
HY-139982 |
OX11 |
Inhibitor |
/ |
否 |
HY-142163 |
S62798 |
Inhibitor |
/ |
否 |
HY-18750A |
Zorifertinib hydrochloride |
|
/ |
否 |
HY-19615A |
MS023 trihydrochloride |
Inhibitor |
/ |
否 |
HY-19981B |
Derazantinib dihydrochloride |
Inhibitor |
/ |
否 |
HY-101029A |
MBM-55S |
|
/ |
否 |
HY-101034 |
CHMFL-ABL/KIT-155 |
|
/ |
否 |
HY-108425 |
AMG8379 |
Antagonist |
/ |
否 |
HY-112467 |
Tivozanib hydrate |
Inhibitor |
≥99.0% |
否 |
HY-112900 |
DC41SMe |
|
/ |
否 |
HY-114320 |
BuChE-IN-TM-10 |
Inhibitor |
/ |
否 |
HY-118916A |
FTI-2148 diTFA |
Inhibitor |
/ |
否 |
HY-120088 |
PF-06446846 |
Inhibitor |
/ |
否 |
HY-124596 |
CD161 |
|
/ |
否 |
HY-124618 |
FGI-106 |
Inhibitor |
/ |
否 |
HY-128582 |
PI3K/HDAC-IN-1 |
Inhibitor |
/ |
否 |
HY-128594 |
BACE1-IN-4 |
Inhibitor |
/ |
否 |
HY-128905 |
MC-Val-Cit-PAB-dimethylDNA31 |
|
/ |
否 |
HY-129941 |
(S,R,S)-AHPC-C10-NH2 |
|
/ |
否 |
HY-12995A |
(S)-BI 665915 |
Inhibitor |
/ |
否 |
HY-130126 |
Sucunamostat hydrate |
Inhibitor |
/ |
否 |
HY-130609A |
Aβ42-IN-1 free base |
Modulator |
/ |
否 |
HY-130711A |
(S,R,S)-AHPC-C3-NH2 TFA |
|
/ |
否 |
HY-131708 |
FNDR-20123 free base |
Inhibitor |
/ |
否 |
HY-131971 |
AChE/BChE-IN-1 |
Inhibitor |
/ |
否 |
HY-132229 |
LPM4870108 |
Inhibitor |
/ |
否 |
HY-133869 |
cGMP-HTL |
Inducer |
/ |
否 |
HY-135122 |
DC10SMe |
|
/ |
否 |
HY-135123 |
DC4SMe |
|
/ |
否 |
HY-135124 |
DC44SMe |
|
/ |
否 |
HY-135184 |
Rifaquizinone |
Inhibitor |
/ |
否 |
HY-135509 |
Lorlatinib acetate |
|
/ |
否 |
HY-135860 |
SARS-CoV-2-IN-1 |
Inhibitor |
/ |
否 |
HY-138637 |
PROTAC BRD4 Degrader-14 |
Inhibitor |
/ |
否 |
HY-141411A |
Zevaquenabant |
Antagonist |
/ |
否 |
HY-145071 |
PROTAC ERα Y537S degrader-1 |
Inhibitor |
/ |
否 |
HY-145425 |
PAIR2 |
Antagonist |
/ |
否 |
HY-145663 |
HS-(CH2)3CO-L-Ala-D-Ala-L-Ala-NH-CH2-S-(CH2)5-CO-DM |
|
/ |
否 |
HY-148801 |
Tamuzimod |
Modulator |
/ |
否 |
HY-151407 |
CDK1-IN-3 |
Inhibitor |
/ |
否 |
HY-151409 |
CDK1-IN-5 |
Inhibitor |
/ |
否 |
HY-151436 |
ZLMT-12 |
|
/ |
否 |
HY-151808 |
JS25 |
Inhibitor |
98.37% |
否 |
HY-159147 |
SIAIS039 |
|
/ |
否 |
HY-160866 |
(Rac)-D3S-001 |
Control |
/ |
否 |
HY-19760B |
I-BET282E |
Inhibitor |
/ |
否 |
HY-P1809 |
Velmupressin |
Agonist |
/ |
否 |
HY-P1810 |
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm |
Agonist |
/ |
否 |
HY-W747491 |
Triclosan-13C12 |
|
/ |
否 |
HY-100233A |
IQ-1S |
Inhibitor |
/ |
否 |
HY-100866 |
F1324 |
Inhibitor |
/ |
否 |
HY-101071 |
(S)-Monastrol |
Inhibitor |
/ |
否 |
HY-101122 |
LX2761 |
Inhibitor |
/ |
否 |
HY-101282 |
Glutaminyl Cyclase Inhibitor 3 |
Inhibitor |
/ |
否 |
HY-101516 |
CYP17-IN-1 |
Inhibitor |
/ |
否 |
HY-102047A |
KDOAM-25 trihydrochloride |
Inhibitor |
/ |
否 |
HY-103233 |
DNQX disodium salt |
Antagonist |
/ |
否 |
HY-103309A |
ML218 hydrochloride |
Inhibitor |
/ |
否 |
HY-104003A |
S 38093 hydrochloride |
Antagonist |
/ |
否 |
HY-108239 |
BIX-01294 trihydrochloride |
|
/ |
否 |
HY-108425B |
(Rac)-AMG8379 |
Antagonist |
/ |
否 |
HY-10968A |
CYM5442 hydrochloride |
Agonist |
/ |
否 |
HY-111021A |
ASP-4058 hydrochloride |
Agonist |
99.71% |
否 |
HY-112807 |
SGLT inhibitor-1 |
Inhibitor |
/ |
否 |
HY-112852A |
TL02-59 dihydrochloride |
|
/ |
否 |
HY-113846 |
CMP-5 hydrochloride |
Inhibitor |
/ |
否 |
HY-113916 |
Onalespib lactate |
Inhibitor |
/ |
否 |
HY-114038 |
SB-747651A |
Inhibitor |
/ |
否 |
HY-114176A |
(S,R,S)-AHPC-C4-NH2 |
|
/ |
否 |
HY-116586 |
AF710B |
Agonist |
/ |
否 |
HY-119375 |
Syncytial Virus Inhibitor-1 |
Inhibitor |
/ |
否 |
HY-12059B |
AT7867 hydrochloride |
Inhibitor |
/ |
否 |
HY-12248A |
Telaglenastat hydrochloride |
|
/ |
否 |
HY-123976A |
MPT0G211 mesylate |
Inhibitor |
/ |
否 |
HY-125841 |
EGFR mutant-IN-1 |
Inhibitor |
/ |
否 |
HY-125846 |
(S,R,S)-AHPC-PEG1-OTs |
|
/ |
否 |
HY-125881 |
ASP1126 |
Agonist |
/ |
否 |
HY-128338 |
CETP-IN-3 |
Inhibitor |
/ |
否 |
HY-128349 |
MT-3014 |
Inhibitor |
/ |
否 |
HY-128354 |
CWHM-1552 |
Inhibitor |
/ |
否 |
HY-128573 |
RORγt Inverse agonist 3 |
Antagonist |
99.93% |
否 |
HY-128584 |
VU6005806 |
Agonist |
/ |
否 |
HY-128602 |
c-Kit-IN-2 |
Inhibitor |
/ |
否 |
HY-128685 |
FD 12-9 |
Inhibitor |
/ |
否 |
HY-128717B |
GSK3368715 trihydrochloride |
Inhibitor |
/ |
否 |
HY-128879 |
VP3.15 |
Inhibitor |
/ |
否 |
HY-129941A |
(S,R,S)-AHPC-C10-NH2 dihydrochloride |
|
/ |
否 |
HY-130233 |
S516 |
Inhibitor |
98.03% |
否 |
HY-130638 |
(S,R,S)-AHPC-O-Ph-PEG1-NH-Boc |
|
/ |
否 |
HY-130711 |
(S,R,S)-AHPC-C3-NH2 |
|
/ |
否 |
HY-130847 |
(S,R,S)-AHPC-Me-C10-NH2 |
|
96.19% |
否 |
HY-131909 |
CJ-2360 |
Inhibitor |
/ |
否 |
HY-132193 |
RET-IN-4 |
Inhibitor |
/ |
否 |
HY-132201 |
MK-8153 |
Inhibitor |
/ |
否 |
HY-132302A |
Hu7691 free base |
Inhibitor |
/ |
否 |
HY-132831A |
Selnoflast calcium |
Inhibitor |
/ |
否 |
HY-132847 |
Vibozilimod |
Agonist |
99.52% |
否 |
HY-132895 |
JNJ-67569762 |
Inhibitor |
/ |
否 |
HY-133018 |
HCV-IN-7 |
Inhibitor |
/ |
否 |
HY-13319G |
JNK-IN-8 (GMP) |
Inhibitor |
/ |
否 |
HY-133487 |
(S,R,S)-AHPC-C8-NH2 dihydrochloride |
|
/ |
否 |
HY-135432 |
Etrasimod arginine |
Modulator |
/ |
否 |
HY-136006 |
(S,R,S)-AHPC-C6-NH2 dihydrochloride |
|
/ |
否 |
HY-136008A |
(S,R,S)-AHPC-PEG1-NH2 dihydrochloride |
|
/ |
否 |
HY-136055 |
(S,R,S)-AHPC-C5-COOH |
Inhibitor |
98.81% |
否 |
HY-136459 |
NMDA receptor antagonist 2 |
Antagonist |
/ |
否 |
HY-136576 |
RP101075 |
Agonist |
/ |
否 |
HY-137849 |
RK-582 |
Inhibitor |
/ |
否 |
HY-139562 |
BMS-986318 |
Agonist |
/ |
否 |
HY-139583 |
Sunobinop |
Modulator |
/ |
否 |
HY-14166A |
MK-886 sodium salt |
|
/ |
否 |
HY-144212 |
SOS1-IN-8 |
Inhibitor |
/ |
否 |
HY-145015A |
Tuspetinib hydrate |
|
/ |
否 |
HY-145280A |
IDO1/2-IN-1 hydrochloride |
Inhibitor |
/ |
否 |
HY-145373 |
BMS-986143 |
Inhibitor |
/ |
否 |
HY-14560A |
(R,R)-Reboxetine mesylate |
|
/ |
否 |
HY-145734A |
AMXI-5001 hydrochloride |
|
98.05% |
否 |
HY-146094 |
Antitumor agent-63 |
Inhibitor |
/ |
否 |
HY-146407 |
Anticancer agent 53 |
Inducer |
/ |
否 |
HY-146544 |
KRAS inhibitor-14 |
Inhibitor |
/ |
否 |
HY-146546 |
KRAS inhibitor-16 |
Inhibitor |
/ |
否 |
HY-146749 |
FLT3/TrKA-IN-1 |
|
/ |
否 |
HY-14722C |
NVP-BSK805 trihydrochloride |
Inhibitor |
/ |
否 |
HY-147573 |
BRD4 Inhibitor-23 |
Inhibitor |
/ |
否 |
HY-148115 |
S1p receptor agonist 2 |
Agonist |
/ |
否 |
HY-148198 |
S1P5 receptor agonist-1 |
Agonist |
/ |
否 |
HY-150109 |
Purinostat mesylate |
|
99.45% |
否 |
HY-150681 |
SARS-CoV-2 nsp14-IN-2 |
Inhibitor |
/ |
否 |
HY-150926 |
G12Si-1 |
Inhibitor |
/ |
否 |
HY-150927 |
G12Si-2 |
Inhibitor |
/ |
否 |
HY-151978 |
ZC0109 |
|
99.32% |
否 |
HY-152097 |
(S)-ZG197 |
Inhibitor |
/ |
否 |
HY-153222 |
SEQ-9 |
Inhibitor |
/ |
否 |
HY-15425B |
PF-543 hydrochloride |
|
/ |
否 |
HY-16918 |
Heptamidine |
Inhibitor |
/ |
否 |
HY-18941C |
Eglumegad hydrochloride |
Agonist |
99.63% |
否 |
HY-20403 |
PF-562271 hydrochloride |
Inhibitor |
/ |
否 |
HY-B0975AS |
Penicillin V-d5 |
Inhibitor |
99.45% |
否 |
HY-P0109 |
(S,S)-Z-FA-FMK |
Inhibitor |
/ |
否 |
HY-P3492 |
SARS-CoV-2-IN-34 |
Inhibitor |
/ |
否 |
HY-100386S |
Ticlopidine-d4 |
Inhibitor |
/ |
否 |
HY-100633S |
N-Demethy Ivabradine-d6 hydrochloride |
|
/ |
否 |
HY-11063S1 |
Fingolimod-d4 hydrochloride |
|
≥99.0% |
否 |
HY-117743S |
Eprosartan-d3 |
Antagonist |
/ |
否 |
HY-123275 |
H-D-Phe-Pip-Arg-pNA |
|
/ |
否 |
HY-126121S |
2-Hydroxy Ibuprofen-d6 |
Inhibitor |
/ |
否 |
HY-12772S1 |
(2R,4S)-Hydroxy Itraconazole-d8 |
|
/ |
否 |
HY-12772S2 |
(2R,4S)-Hydroxy Itraconazole-d5 |
|
99.40% |
否 |
HY-132670S |
(R)-(-)-Felodipine-d5 |
|
/ |
否 |
HY-136907S |
(S)-(-)-Verapamil-d3 hydrochloride |
|
/ |
否 |
HY-13832S2 |
Atovaquone-d5 |
Inhibitor |
/ |
否 |
HY-139474S |
N-Acetyl-S-(carbamoylethyl)-L-cysteine-d3 |
|
/ |
否 |
HY-139491S |
N-(Acetyl-d3)-S-benzyl-L-cysteine |
|
/ |
否 |
HY-139532S |
(S)-Tomoxetine-d3 hydrochloride |
|
/ |
否 |
HY-141718S |
N-Acetyl-S-(trichlorovinyl)-L-cysteine-d3 |
|
/ |
否 |
HY-14258AS |
Escitalopram-d6 oxalate |
Inhibitor |
/ |
否 |
HY-14397S1 |
Indomethacin-d4 Methyl Ester |
Inhibitor |
98.38% |
否 |
HY-14744S |
Levamlodipine-d4 |
Inhibitor |
99.74% |
否 |
HY-15455S1 |
Roflumilast-d4 N-Oxide |
Inhibitor |
98.13% |
否 |
HY-15762S |
Valdecoxib-d3 |
Inhibitor |
/ |
否 |
HY-17038S1 |
Agomelatine-d4 |
|
/ |
否 |
HY-17503S2 |
(S)-Metoprolol-d7 |
Inhibitor |
/ |
否 |
HY-76326S |
(S)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole-d3 |
|
/ |
否 |
HY-B0814S |
Levocetirizine-d4 dihydrochloride |
Antagonist |
/ |
否 |
HY-B1190S |
Cefadroxil-d4 hydrate |
Inhibitor |
/ |
否 |
HY-100057 |
BMY 28674 |
Antagonist |
/ |
否 |
HY-100218B |
(1R,3S)-RSL3 |
Control |
/ |
否 |
HY-10025 |
(S)-SW IV-52 hydrochloride |
Inducer |
/ |
否 |
HY-100441S3 |
Treprostinil-d7 |
Agonist |
/ |
否 |
HY-100513A |
Dehydroaltenusin |
|
/ |
否 |
HY-100557B |
HPC, Viscosity(1%):150-400mPa.s |
|
/ |
否 |
HY-100557C |
HPC, Viscosity(1%):4000-6500mPa.s |
|
/ |
否 |
HY-100557D |
HPC, Viscosity(5%):75-150mPa.s |
|
/ |
否 |
HY-100557E |
HPC, Viscosity(1%):1275-3500mPa.s |
|
/ |
否 |
HY-100557H |
HPC, Viscosity(2%):95000-105000mPa.s |
|
/ |
否 |
HY-100617 |
(S)-4CPG |
Agonist |
/ |
否 |
HY-100617B |
(R)-4CPG |
Control |
/ |
否 |
HY-100682 |
T-3256336 |
Inhibitor |
/ |
否 |
HY-100785A |
gamma-DGG acetate |
Antagonist |
/ |
否 |
HY-100787 |
L-Cysteine S-sulfate sodium |
Agonist |
/ |
否 |
HY-100823 |
(1S,3R)-ACPD |
Agonist |
/ |
否 |
HY-100842A |
(S)-3C4HPG |
Antagonist |
/ |
否 |
HY-100847 |
AZ0108 |
Inhibitor |
/ |
否 |
HY-100866A |
F1324 TFA |
Inhibitor |
/ |
否 |
HY-100866B |
F1324 acetate |
Inhibitor |
/ |
否 |
HY-100935S |
Cimaterol-d7 |
Agonist |
/ |
否 |
HY-100984A |
HA-100 hydrochloride |
Inhibitor |
/ |
否 |
HY-101013 |
D-SNAP |
|
/ |
否 |
HY-101065 |
AJ-76 hydrochloride |
Antagonist |
98.55% |
否 |
HY-101077 |
Iso-PPADS tetrasodium |
Antagonist |
/ |
否 |
HY-10116 |
PI-540 |
Inhibitor |
/ |
否 |
HY-101185 |
T808 |
Chemical |
/ |
否 |
HY-101229 |
(2R,3S)-Chlorpheg |
|
/ |
否 |
HY-101258 |
Cardol triene |
|
/ |
否 |
HY-101313 |
(S)-Remoxipride |
Antagonist |
/ |
否 |
HY-101317A |
TAN-67 |
Agonist |
/ |
否 |
HY-101332 |
EGLU |
Antagonist |
/ |
否 |
HY-101339 |
(R)-RS 56812 |
|
/ |
否 |
HY-101339A |
(R)-RS 56812 hydrochloride |
|
/ |
否 |
HY-101355 |
CGP 20712 |
Agonist |
/ |
否 |
HY-101392R |
Harmane (Standard) |
Inhibitor |
/ |
否 |
HY-101392S1 |
Harmane-d2 |
Inhibitor |
/ |
否 |
HY-101544 |
ARQ 069 |
Inhibitor |
/ |
否 |
HY-101626A |
Sigma-LIGAND-1 hydrochloride |
|
99.13% |
否 |
HY-101725 |
Meclonazepam |
Inhibitor |
99.10% |
否 |
HY-101748 |
Tegadifur |
|
/ |
否 |
HY-101763B |
(S,R,S)-AHPC dihydrochloride |
|
/ |
否 |
HY-101780A |
Tinostamustine hydrochloride |
Inhibitor |
/ |
否 |
HY-101930A |
(Rac)-BMS-816336 |
Inhibitor |
/ |
否 |
HY-101930B |
(R)-BMS-816336 |
Inhibitor |
/ |
否 |
HY-101939 |
RP-001 |
Agonist |
/ |
否 |
HY-10201S1 |
Sorafenib-d4 |
|
/ |
否 |
HY-10201S2 |
Sorafenib-13C,d3 |
|
98.35% |
否 |
HY-102051 |
XIAP/cIAP1 antagonist-1 |
Inhibitor |
/ |
否 |
HY-102075B |
TMP780 |
Antagonist |
99.51% |
否 |
HY-10208S1 |
Pazopanib-13C,d3 |
|
/ |
否 |
HY-10261AS |
Afatinib-d6 dimaleate |
|
/ |
否 |
HY-10261S1 |
Afatinib-d4 |
|
/ |
否 |
HY-103067 |
A1899 |
|
99.72% |
否 |
HY-103117 |
S 32212 hydrochloride |
Inhibitor |
/ |
否 |
HY-103144 |
WAY 629 hydrochloride |
Agonist |
/ |
否 |
HY-103144A |
WAY 629 |
Agonist |
/ |
否 |
HY-103202A |
SNAP5089 Free base |
|
/ |
否 |
HY-10320G |
Doramapimod (GMP) |
Inhibitor |
/ |
否 |
HY-103216A |
RWJ52353 hydrochloride |
Agonist |
/ |
否 |
HY-103235 |
NPEC-caged-(S)-AMPA |
Activator |
/ |
否 |
HY-103267A |
S32826 |
Inhibitor |
/ |
否 |
HY-103309S |
ML218-d9 |
Inhibitor |
/ |
否 |
HY-103313 |
SR33805 oxalate |
Antagonist |
/ |
否 |
HY-10331S1 |
Regorafenib-13C,d3 |
|
/ |
否 |
HY-103453 |
(R)-DPN |
Chemical |
/ |
否 |
HY-103463 |
SA57 |
Inhibitor |
≥99.0% |
否 |
HY-103539 |
3,5-Bis(4-nitrophenoxy)benzoic acid |
Inhibitor |
/ |
否 |
HY-103552 |
LY487379 hydrochloride |
Modulator |
/ |
否 |
HY-103555 |
NPEC-caged-(1S,3R)-ACPD |
|
/ |
否 |
HY-103560 |
(S)-HexylHIBO |
Antagonist |
/ |
否 |
HY-103578 |
S-40503 |
Modulator |
/ |
否 |
HY-103602B |
(S,R,S)-AHPC-PEG3-NH2 dihydrochloride |
|
/ |
否 |
HY-10396A |
(2R,3S)-Emricasan |
Inhibitor |
/ |
否 |
HY-104028B |
(S)-BAY 73-6691 |
Control |
99.51% |
否 |
HY-104077A |
Remdesivir maleate |
Inhibitor |
/ |
否 |
HY-104077S1 |
Remdesivir-d4 |
Inhibitor |
/ |
否 |
HY-104077S2 |
Remdesivir impurity 9-d4 |
Inhibitor |
/ |
否 |
HY-10432R |
A 83-01 (Standard) |
Inhibitor |
/ |
否 |
HY-10451S2 |
Canagliflozin-d6 |
|
/ |
否 |
HY-10466S |
Daclatasvir-d6 |
Inhibitor |
/ |
否 |
HY-10466S2 |
Daclatasvir-d16 |
Inhibitor |
/ |
否 |
HY-105000S1 |
trans-Dihydro Tetrabenazine-d7 |
|
/ |
否 |
HY-105003 |
ST 1535 |
Antagonist |
/ |
否 |
HY-105035 |
Rodorubicin |
|
/ |
否 |
HY-105184 |
YM511 |
Inhibitor |
99.73% |
否 |
HY-105395 |
BCX-1898 |
Inhibitor |
/ |
否 |
HY-105521A |
Dexnafenodone hydrochloride |
Inhibitor |
/ |
否 |
HY-105545C |
Dexetimide hydrochloride |
Antagonist |
/ |
否 |
HY-10581AS |
Gatifloxacin-d3 hydrochloride |
Inhibitor |
/ |
否 |
HY-105919 |
Naroparcil |
Inhibitor |
/ |
否 |
HY-106158 |
T-1095 |
Inhibitor |
/ |
否 |
HY-106266B |
Chiglitazar sodium |
Agonist |
/ |
否 |
HY-106577A |
(-)-(S)-Cibenzoline |
Inhibitor |
/ |
否 |
HY-106597 |
Pirlimycin |
Inhibitor |
/ |
否 |
HY-106597A |
Pirlimycin hydrochloride |
Inhibitor |
/ |
否 |
HY-106685 |
Selenazofurin |
|
/ |
否 |
HY-106837 |
Israpafant |
Antagonist |
/ |
否 |
HY-106841A |
(S)-Draflazine |
Inhibitor |
/ |
否 |
HY-106933A |
Dabelotine methanesulfonate |
Activator |
/ |
否 |
HY-106959 |
Flurithromycin |
Inhibitor |
/ |
否 |
HY-107222 |
Lysionotin |
Inhibitor |
/ |
否 |
HY-107235 |
Saponin CP6 |
|
/ |
否 |
HY-107259 |
23S-Hydroxyl-11,15-dioxo-ganoderic acid DM |
|
/ |
否 |
HY-107409B |
(S,S)-GNE 5729 |
|
99.65% |
否 |
HY-107518 |
(R,S)-3,4-Dicarboxyphenylglycine |
Antagonist |
/ |
否 |
HY-107522B |
DL-TBOA ammonium |
Inhibitor |
/ |
否 |
HY-107608A |
5(S),12(S)-Leukotriene B4 |
|
/ |
否 |
HY-107608S |
Leukotriene B4-d4 |
|
/ |
否 |
HY-107661A |
S-(+)-Arundic Acid |
|
/ |
否 |
HY-107695 |
Remacemide hydrochloride |
Antagonist |
/ |
否 |
HY-108235C |
(R)-Lanicemine |
Antagonist |
/ |
否 |
HY-108258A |
PSN 375963 hydrochloride |
Agonist |
/ |
否 |
HY-108263A |
(S)-3-Hydroxy Midostaurin |
Inhibitor |
/ |
否 |
HY-108263S |
3-Hydroxy Midostaurin-d5 |
Inhibitor |
/ |
否 |
HY-108312 |
AC-VEID-CHO |
Inhibitor |
/ |
否 |
HY-108425A |
AMG8380 |
Antagonist |
/ |
否 |
HY-10844S1 |
Pretomanid-d5 |
Inhibitor |
/ |
否 |
HY-108492 |
TC-SP 14 |
Agonist |
/ |
否 |
HY-108501 |
(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 |
Agonist |
/ |
否 |
HY-108514 |
(±)-PPCC hemioxalate |
Modulator |
/ |
否 |
HY-108516 |
TC-E 5001 |
Inhibitor |
/ |
否 |
HY-108538 |
Ethacrynic acid D5 |
Inhibitor |
/ |
否 |
HY-108546 |
L-AP3 |
Antagonist |
/ |
否 |
HY-108553 |
Dihydroeponemycin |
|
/ |
否 |
HY-108560A |
15(S)-Fluprostenol |
Activator |
/ |
否 |
HY-108572 |
S26948 |
Agonist |
/ |
否 |
HY-108577A |
XE991 |
Inhibitor |
/ |
否 |
HY-108601 |
(S)-Ro 32-0432 free base |
Inhibitor |
/ |
否 |
HY-108609 |
YM-26734 |
Inhibitor |
/ |
否 |
HY-108614 |
GPi688 |
Inhibitor |
/ |
否 |
HY-108616 |
VU 0364739 hydrochloride |
Inhibitor |
/ |
否 |
HY-108648A |
2-MeSADP |
Agonist |
/ |
否 |
HY-108907 |
SR-1277 |
Inhibitor |
/ |
否 |
HY-108953 |
(S)-Quinolactacine A |
Inhibitor |
/ |
否 |
HY-108959 |
D-87503 |
Inhibitor |
/ |
否 |
HY-108960 |
PPADS |
Antagonist |
/ |
否 |
HY-109015S |
Tucidinostat-d4 |
Inhibitor |
/ |
否 |
HY-109022A |
(3R,5R,6S)-Atogepant |
Antagonist |
99.55% |
否 |
HY-109025AS |
Baloxavir-d5 |
Inhibitor |
/ |
否 |
HY-109036A |
(S)-Landipirdine |
|
/ |
否 |
HY-109053A |
Delgocitinib ethanolate |
Inhibitor |
/ |
否 |
HY-109086A |
Edicotinib hydrochloride |
Inhibitor |
/ |
否 |
HY-109125A |
Amcipatricin L-aspartate |
Inhibitor |
/ |
否 |
HY-109785A |
(R)-Gyramide A hydrochloride |
Inhibitor |
/ |
否 |
HY-10979 |
AN0128 |
Inhibitor |
98.04% |
否 |
HY-109854 |
(S)-Lisofylline |
|
99.89% |
否 |
HY-10999S |
Trametinib-d4 |
|
/ |
否 |
HY-10999S1 |
Trametinib-13C6 |
|
/ |
否 |
HY-10999S2 |
Trametinib-13C,d3 |
|
/ |
否 |
HY-110001 |
(S)-WAY 100135 dihydrochloride |
Antagonist |
/ |
否 |
HY-110022 |
GW1929 hydrochloride |
Agonist |
/ |
否 |
HY-110024A |
S-14506 |
Agonist |
/ |
否 |
HY-110046 |
CL-82198 hydrochloride |
Inhibitor |
/ |
否 |
HY-110134 |
S07662 |
Inhibitor |
/ |
否 |
HY-110137A |
Furamidine |
Inhibitor |
/ |
否 |
HY-11017AS |
(S)-Rivastigmine-d6 tartrate |
Inhibitor |
≥99.0% |
否 |
HY-110196 |
(S)-PFI-2 hydrochloride |
Inhibitor |
/ |
否 |
HY-110295 |
SPL-334 |
Inhibitor |
/ |
否 |
HY-11052A |
Trap-101 hydrochloride |
Antagonist |
/ |
否 |
HY-11063S |
Fingolimod-d4 |
|
98.97% |
否 |
HY-111067 |
(4S)-(+)-Ascochin |
Inhibitor |
/ |
否 |
HY-111136 |
BL-1020 mesylate |
|
/ |
否 |
HY-111164 |
CBS-3595 |
Inhibitor |
/ |
否 |
HY-111209 |
Pichromene |
Inhibitor |
/ |
否 |
HY-111239 |
GSK317354A |
Inhibitor |
/ |
否 |
HY-111274 |
Indomethacin farnesil |
Inhibitor |
/ |
否 |
HY-111283 |
AJ-76 |
Antagonist |
/ |
否 |
HY-111308 |
RTI-118 |
Inhibitor |
/ |
否 |
HY-111315 |
XEN103 |
Inhibitor |
/ |
否 |
HY-111592 |
S-(5′-Adenosyl)-L-cysteine |
|
/ |
否 |
HY-111615 |
J-2156 |
Agonist |
/ |
否 |
HY-111935 |
3,3'-Diethyl-9-methylthiacarbocyanine iodide |
Inhibitor |
/ |
否 |
HY-111957 |
Fenquinotrione |
|
/ |
否 |
HY-112006 |
(S)-ar-Curcumene |
|
/ |
否 |
HY-112078A |
(S,R,S,R)-AHPC-Me |
|
/ |
否 |
HY-112120 |
2-Amino-6-chloro-9-(3-deoxy-3-fluoro-beta-D-ribofuranosyl)-9H-purine |
|
/ |
否 |
HY-112280A |
Crozbaciclib fumarate |
Inhibitor |
99.37% |
否 |
HY-112289B |
(1R)-IDH889 |
|
/ |
否 |
HY-112304A |
(1R,2S)-NCD38 TFA |
Inhibitor |
/ |
否 |
HY-112336 |
Aloisine RP106 |
Inhibitor |
/ |
否 |
HY-112363 |
Aloisine A |
|
/ |
否 |
HY-112400 |
Bisindolylmaleimide V |
Inhibitor |
96.59% |
否 |
HY-112436A |
(3S,4R)-PF-6683324 |
Inhibitor |
/ |
否 |
HY-112477 |
Chk2-IN-1 |
Inhibitor |
/ |
否 |
HY-112666 |
Farnesyl thiosalicylic acid amide |
Inhibitor |
/ |
否 |
HY-112714A |
GSK3532795 oxalate |
Inhibitor |
/ |
否 |
HY-112714B |
GSK3532795 hydrochloride |
Inhibitor |
/ |
否 |
HY-112742 |
CP-195543 |
Antagonist |
/ |
否 |
HY-112796 |
Ethyl 2,3,4,6-tetra-O-benzyl-β-D-thiogalactopyranoside |
|
/ |
否 |
HY-113025A |
L-hydroxylysine dihydrochloride |
|
/ |
否 |
HY-113039R |
L-2-Hydroxyglutaric acid (Standard) |
Inhibitor |
/ |
否 |
HY-113071C |
(S)-Mevalonic acid |
|
/ |
否 |
HY-113084 |
L-Cysteine S-sulfate |
Agonist |
/ |
否 |
HY-113209A |
ent-8-Iso-15(S)-prostaglandin F2α |
|
/ |
否 |
HY-113322S |
(3S)-3-Hydroxy quinidine-vinyl-d3 |
|
/ |
否 |
HY-113336S |
15(S)-HETE-d8 |
|
/ |
否 |
HY-113443 |
12(S)-HPETE |
Activator |
/ |
否 |
HY-113519 |
14R(15S)-EET |
|
/ |
否 |
HY-113533 |
Resolvin D4 |
Inhibitor |
/ |
否 |
HY-113533A |
17(R)-Resolvin D4 |
Inhibitor |
/ |
否 |
HY-113616 |
VU0364572 |
Agonist |
/ |
否 |
HY-113739 |
Desmethylcitalopram hydrochloride |
Inhibitor |
/ |
否 |
HY-113739A |
(S)-Desmethylcitalopram |
Inhibitor |
/ |
否 |
HY-113776 |
15(S)-HETRE |
Inhibitor |
/ |
否 |
HY-113831 |
CLK1/2-IN-3 |
Inhibitor |
/ |
否 |
HY-113903 |
(+)-Isopulegol |
Inhibitor |
/ |
否 |
HY-113943 |
9(S)-HETE |
|
/ |
否 |
HY-113943S |
9(S)-HETE-d8 |
|
/ |
否 |
HY-113986B |
(S)-Dexfadrostat |
Inhibitor |
/ |
否 |
HY-114061 |
(R)-FTY 720P |
Inhibitor |
/ |
否 |
HY-114080A |
Patamostat mesylate |
Inhibitor |
/ |
否 |
HY-114080B |
Patamostat hydrochloride |
Inhibitor |
/ |
否 |
HY-114091A |
PF-00356231 |
Inhibitor |
/ |
否 |
HY-114203 |
Eckol |
Inhibitor |
/ |
否 |
HY-114461B |
(3S,17S)-FD-895 |
|
/ |
否 |
HY-114552 |
(S)-Dabelotine |
|
/ |
否 |
HY-114585A |
Sperabillin A dihydrochloride |
Inhibitor |
/ |
否 |
HY-114618 |
S33084 |
Antagonist |
/ |
否 |
HY-114668A |
Camptothecin-20(S)-O-propionate hydrate |
Inhibitor |
/ |
否 |
HY-114678 |
LY302148 |
Agonist |
/ |
否 |
HY-114792 |
15-Methylprostaglandin E1 |
|
/ |
否 |
HY-114800 |
Soporidine |
|
/ |
否 |
HY-114857 |
Clofencet |
|
/ |
否 |
HY-114976 |
S-Allylmercapturic acid |
|
/ |
否 |
HY-114981 |
SRTCX1002 |
Activator |
/ |
否 |
HY-114983 |
Chimmitecan |
Inhibitor |
98.96% |
否 |
HY-115391 |
Boc-LRR-AMC |
|
/ |
否 |
HY-115421B |
11(S)-HEPE |
|
/ |
否 |
HY-115566 |
S1PL-IN-1 |
|
/ |
否 |
HY-115701 |
1-Stearoyl-2-15(S)-Hpete-Sn-Glycero-3-Pe |
Inducer |
/ |
否 |
HY-115722 |
(S)-(-)-MRJF22 |
|
/ |
否 |
HY-115734 |
Phenylpyropene C |
Inhibitor |
/ |
否 |
HY-115739 |
RTIL 13 |
Inhibitor |
/ |
否 |
HY-115754 |
S-(N-PhenethylthiocarbaMoyl)-L-cysteine |
Inhibitor |
/ |
否 |
HY-115822 |
α-Fluoromethylhistidine dihydrochloride |
Inhibitor |
/ |
否 |
HY-115824 |
7ETMC |
Inhibitor |
/ |
否 |
HY-115826 |
AB-163 |
|
/ |
否 |
HY-115913 |
PDE4-IN-6 |
Inhibitor |
/ |
否 |
HY-115932 |
Aurora kinase-IN-1 |
Inhibitor |
/ |
否 |
HY-115947 |
Anticancer agent 33 |
|
/ |
否 |
HY-115959 |
Anticancer agent 34 |
Inhibitor |
/ |
否 |
HY-115960 |
Anticancer agent 35 |
|
/ |
否 |
HY-115961 |
Anticancer agent 36 |
Inhibitor |
/ |
否 |
HY-115990 |
Topoisomerase IV inhibitor 1 |
Inhibitor |
/ |
否 |
HY-115991 |
Topoisomerase IV inhibitor 2 |
Inhibitor |
/ |
否 |
HY-115993 |
CDK4/6-IN-10 |
|
/ |
否 |
HY-116050 |
17(S)-HETE |
|
/ |
否 |
HY-116050A |
17(R)-HETE |
|
/ |
否 |
HY-116088 |
W123 |
Antagonist |
/ |
否 |
HY-116121 |
S-Nitrosohomocysteine |
|
/ |
否 |
HY-116124 |
17(S)-HpDHA |
|
/ |
否 |
HY-116152A |
(S)-Cipepofol |
|
/ |
否 |
HY-116161 |
Bimatoprost isopropyl ester |
|
/ |
否 |
HY-116196 |
17-HETE |
|
/ |
否 |
HY-116214R |
Cyprodinil (Standard) |
|
/ |
否 |
HY-116214S |
Cyprodinil-d5 |
|
/ |
否 |
HY-116214S1 |
Cyprodinil-13C6 |
|
/ |
否 |
HY-116227 |
(2S,3R)-LP99 |
Inhibitor |
/ |
否 |
HY-116246 |
5(S)-HETE lactone |
|
/ |
否 |
HY-116290A |
Zaragozic acid A trisodium |
|
/ |
否 |
HY-116429A |
7(S)-Maresin 1 |
|
/ |
否 |
HY-116431 |
I-BOP |
Agonist |
/ |
否 |
HY-116444 |
16(S)-HETE |
Activator |
/ |
否 |
HY-116463A |
(2R,3S)-E1R |
Agonist |
98.84% |
否 |
HY-116463B |
(2S,3S)-E1R |
Agonist |
98.24% |
否 |
HY-116480 |
LY593093 |
Agonist |
/ |
否 |
HY-116494A |
(6R)-ML753286 |
Inhibitor |
≥98.0% |
否 |
HY-116528 |
GCA-186 |
Inhibitor |
/ |
否 |
HY-116586A |
(Rac)-AF710B |
Agonist |
/ |
否 |
HY-116604 |
RLX |
Inhibitor |
/ |
否 |
HY-116615 |
Methyl 2-hydroxytetracosanoate |
|
/ |
否 |
HY-116843 |
(15S)-15-Methylprostaglandin E2 |
Agonist |
/ |
否 |
HY-116930 |
S-20928 |
Antagonist |
/ |
否 |
HY-117058 |
LY243246 |
|
/ |
否 |
HY-117085 |
Lobaric acid |
Inhibitor |
/ |
否 |
HY-117162 |
S 1432 |
|
/ |
否 |
HY-117175 |
Pandamarilactonine A |
Inhibitor |
/ |
否 |
HY-117199 |
MCPA-thioethyl |
|
/ |
否 |
HY-117213 |
Ex26 |
Antagonist |
99.0% |
否 |
HY-117386S |
Methoxyfenozide-d9 |
|
/ |
否 |
HY-117488 |
(S)-Grepafloxacin |
Control |
/ |
否 |
HY-117526 |
(-)-Mesembrine |
|
/ |
否 |
HY-117682 |
L-(+)-threo-Chloramphenicol |
|
/ |
否 |
HY-117712 |
LG 6-101 |
|
/ |
否 |
HY-117722 |
JW 618 |
Inhibitor |
/ |
否 |
HY-117725 |
S-2720 |
Inhibitor |
/ |
否 |
HY-117736 |
Ro 09-1428 |
Inhibitor |
/ |
否 |
HY-117743S1 |
Eprosartan-d6 |
Antagonist |
/ |
否 |
HY-117947 |
(R)-OR-S1 |
Control |
/ |
否 |
HY-117957 |
BMS-932481 |
Modulator |
/ |
否 |
HY-117983 |
RU-505 |
Inhibitor |
/ |
否 |
HY-117991 |
DW10075 |
Inhibitor |
/ |
否 |
HY-118040 |
3-Oxo-C16:1 |
|
/ |
否 |
HY-118117 |
Rovatirelin |
|
/ |
否 |
HY-118250A |
GSK2245035 maleate |
|
/ |
否 |
HY-118512 |
Platencin |
Inhibitor |
/ |
否 |
HY-118557A |
Iferanserin hydrochloride |
Antagonist |
/ |
否 |
HY-118563 |
Farnesylthioacetic acid |
|
/ |
否 |
HY-118590A |
ICRF-196 |
|
/ |
否 |
HY-118665 |
L-736380 |
Antagonist |
/ |
否 |
HY-118672 |
HNHA |
Inhibitor |
99.76% |
否 |
HY-118723 |
BMH-22 |
Inhibitor |
/ |
否 |
HY-118761 |
5,6-Epoxyretinoic acid |
Agonist |
/ |
否 |
HY-118806 |
AC-42 |
Agonist |
/ |
否 |
HY-118828A |
(9S,13R)-12-Oxo phytodienoic acid |
|
≥99.0% |
否 |
HY-118916 |
FTI-2148 |
Inhibitor |
/ |
否 |
HY-118919 |
CYM5181 |
Agonist |
/ |
否 |
HY-118946A |
BPH-1358 free base |
Inhibitor |
/ |
否 |
HY-118946B |
BPH-1358 mesylate |
Inhibitor |
/ |
否 |
HY-119022 |
MAC-0547630 |
|
/ |
否 |
HY-119151 |
GS-9191 |
|
/ |
否 |
HY-119202 |
(S)-BMS-378806 |
|
/ |
否 |
HY-119221A |
AUY 954 hydrochloride |
Agonist |
/ |
否 |
HY-119232 |
GSK466317A |
Inhibitor |
/ |
否 |
HY-119245 |
Udifitimod |
Modulator |
/ |
否 |
HY-119352 |
S-2 Methanandamide |
Agonist |
/ |
否 |
HY-119397 |
KDM5-C49 |
Inhibitor |
/ |
否 |
HY-119398 |
Lanuginosine |
Inhibitor |
98.27% |
否 |
HY-119405 |
Niddamycin |
Inhibitor |
/ |
否 |
HY-119552 |
Acetylaszonalenin |
Inhibitor |
/ |
否 |
HY-119631 |
Nornidulin |
Inhibitor |
/ |
否 |
HY-119696S |
MTIC-d3 |
|
/ |
否 |
HY-119715 |
AG-012986 |
Inhibitor |
/ |
否 |
HY-119894 |
Althiomycin |
|
/ |
否 |
HY-119961 |
(+)-Mepivacaine |
Inhibitor |
99.72% |
否 |
HY-120035 |
DD1 |
|
99.40% |
否 |
HY-120039A |
(S)-MDL-101146 |
Inhibitor |
/ |
否 |
HY-120048 |
NBC19 |
Inhibitor |
/ |
否 |
HY-120109 |
13-HODE methyl ester |
|
/ |
否 |
HY-120206B |
Brasofensine sulfate |
Inhibitor |
/ |
否 |
HY-120214 |
TAS05567 |
Inhibitor |
/ |
否 |
HY-120255AS |
17(S)-HDHA-d5 |
|
/ |
否 |
HY-120288 |
AM4299B |
Inhibitor |
/ |
否 |
HY-120387 |
SMU-B |
Inhibitor |
/ |
否 |
HY-120468 |
GSK2263167 |
Agonist |
/ |
否 |
HY-120494 |
sEH inhibitor-1 |
Inhibitor |
99.62% |
否 |
HY-120576 |
ML169 |
Modulator |
/ |
否 |
HY-12057S1 |
Vemurafenib-d7 |
|
/ |
否 |
HY-120611 |
BMS-960 free base |
Agonist |
/ |
否 |
HY-120611A |
BMS-960 |
Agonist |
/ |
否 |
HY-120631A |
BMS-538305 hydrochloride |
Inhibitor |
/ |
否 |
HY-120659 |
Gly-Gly-AMC |
|
/ |
否 |
HY-120686 |
S-14671 |
Agonist |
/ |
否 |
HY-120774 |
GS-462808 |
Inhibitor |
/ |
否 |
HY-120794 |
SC-67655 |
|
/ |
否 |
HY-12083 |
PPY-A |
Inhibitor |
/ |
否 |
HY-120928 |
S 16474 |
Antagonist |
/ |
否 |
HY-120944 |
BAY-7598 |
Inhibitor |
/ |
否 |
HY-120950 |
S-tram,tram-Farnesylated cysteine methyl ester |
|
/ |
否 |
HY-120967A |
(2S)-OMPT |
|
/ |
否 |
HY-120973A |
(S)-Butaprost free acid |
|
/ |
否 |
HY-120986S |
(S)-Bromoenol lactone-d7 |
|
/ |
否 |
HY-121000 |
Albocycline |
Inhibitor |
/ |
否 |
HY-121068 |
Bisoxatin |
Inhibitor |
/ |
否 |
HY-121141 |
Adiphenine |
Inhibitor |
/ |
否 |
HY-121158 |
Butamifos |
|
/ |
否 |
HY-121161C |
(2R,3S)-Brassinazole |
Inhibitor |
99.83% |
否 |
HY-121178 |
Deoxyviolacein |
Inhibitor |
/ |
否 |
HY-121191 |
Bisnorcymserine |
Inhibitor |
/ |
否 |
HY-121268A |
Demeclocycline calcium |
Inhibitor |
/ |
否 |
HY-121309 |
Doxorubicinone |
|
/ |
否 |
HY-121309S |
Doxorubicinone-d3 |
|
/ |
否 |
HY-121328 |
Empenthrin |
Inhibitor |
/ |
否 |
HY-121348 |
Ficellomycin |
|
/ |
否 |
HY-121365 |
Forphenicinol |
Inhibitor |
/ |
否 |
HY-121519 |
GSK2332255B |
Antagonist |
/ |
否 |
HY-121549 |
S-NEPC |
|
/ |
否 |
HY-121550 |
ME3221 |
Antagonist |
/ |
否 |
HY-12159 |
MK-0668 |
Antagonist |
/ |
否 |
HY-121661 |
Antibacterial agent 201 |
Inhibitor |
/ |
否 |
HY-121692 |
(S)-Alprenolol |
Inhibitor |
/ |
否 |
HY-121765R |
Dacisteine (Standard) |
|
/ |
否 |
HY-121777 |
SFOM-0046 |
Inhibitor |
/ |
否 |
HY-121814 |
(S)-Acenocoumarol |
|
/ |
否 |
HY-121814A |
(R)-Acenocoumarol |
Inhibitor |
/ |
否 |
HY-121899 |
1-Oxo Ibuprofen |
|
/ |
否 |
HY-121987 |
15(S)-HEDE |
Inhibitor |
/ |
否 |
HY-122008 |
ORM-3819 |
Inhibitor |
/ |
否 |
HY-122010 |
NVP-AAD777 |
Inhibitor |
/ |
否 |
HY-122014 |
S 39625 |
Inhibitor |
/ |
否 |
HY-12201A |
TAK-901 hydrochloride |
Inhibitor |
/ |
否 |
HY-122080 |
Memoquin |
Inhibitor |
/ |
否 |
HY-122099 |
Riddelline |
Inhibitor |
/ |
否 |
HY-12210 |
(S)-BI-1001 |
Inhibitor |
/ |
否 |
HY-122123 |
S-6123 |
Inhibitor |
/ |
否 |
HY-122140 |
ACG548B |
Inhibitor |
99.72% |
否 |
HY-122209 |
DVR-01 |
Inhibitor |
/ |
否 |
HY-122294 |
Rociverine |
|
/ |
否 |
HY-122331 |
Norbormide |
Inhibitor |
98.91% |
否 |
HY-122350 |
Dactimicin sulfate |
|
/ |
否 |
HY-122595 |
EZH2-IN-1 |
Inhibitor |
/ |
否 |
HY-122783 |
Isogambogic acid |
|
/ |
否 |
HY-122825 |
SNIPER(ER)-110 |
Inhibitor |
/ |
否 |
HY-122857 |
PKCiota-IN-1 |
Inhibitor |
/ |
否 |
HY-122858 |
PKCiota-IN-2 |
Inhibitor |
/ |
否 |
HY-122938 |
Ceplignan |
|
/ |
否 |
HY-122957 |
Huperzine C |
Inhibitor |
/ |
否 |
HY-122980 |
Myxochelin A |
Inhibitor |
/ |
否 |
HY-123007S |
13(S)-HODE-d4 |
|
/ |
否 |
HY-123024 |
Cefatrizine |
|
/ |
否 |
HY-123112 |
Hoe 892 |
|
/ |
否 |
HY-123134 |
FIIN-4 |
Inhibitor |
/ |
否 |
HY-12316R |
20(S)-Hydroxycholesterol (Standard) |
Activator |
/ |
否 |
HY-123184 |
S 1924 |
Inhibitor |
/ |
否 |
HY-123230S |
Trifloxystrobin-d6 |
Inhibitor |
/ |
否 |
HY-123237 |
KRC-108 |
|
/ |
否 |
HY-123275C |
H-D-Phe-Pip-Arg-pNA dihydrochloride |
|
/ |
否 |
HY-123284 |
LY137150 |
|
/ |
否 |
HY-123347 |
TPU-0037C |
|
/ |
否 |
HY-123445 |
AZD7009 |
Inhibitor |
/ |
否 |
HY-123469 |
RS-0466 |
Inhibitor |
/ |
否 |
HY-123524 |
STAT3-IN-4 |
Inhibitor |
/ |
否 |
HY-123531 |
JNJ 10329670 |
Inhibitor |
/ |
否 |
HY-12355S |
Siponimod-d11 |
Modulator |
/ |
否 |
HY-123575 |
LY 245769 |
Inhibitor |
/ |
否 |
HY-123632 |
(3S,5S)-Atorvastatin sodium salt |
Inhibitor |
/ |
否 |
HY-123634 |
(S)-3'-Aminoblebbistatin |
Inhibitor |
/ |
否 |
HY-123849 |
SN32976 |
Inhibitor |
/ |
否 |
HY-123897 |
Chamaejasmenin C |
Inhibitor |
/ |
否 |
HY-124007 |
4-Iodo-SAHA |
Inhibitor |
/ |
否 |
HY-124110 |
TC299423 |
Agonist |
/ |
否 |
HY-124122 |
BPTQ |
|
/ |
否 |
HY-124138 |
Pikromycin |
Inhibitor |
/ |
否 |
HY-124150 |
BM567 |
Inhibitor |
/ |
否 |
HY-124153 |
GNE-431 |
Inhibitor |
/ |
否 |
HY-124199 |
Cephalochromin |
Inhibitor |
/ |
否 |
HY-124218 |
S 863390 |
|
/ |
否 |
HY-12421B |
BET-BAY 002 (S enantiomer) |
|
/ |
否 |
HY-12422C |
rel-(2S,3R)-Voruciclib |
Inhibitor |
/ |
否 |
HY-12422E |
rel-(2S,3R)-Voruciclib hydrochloride |
|
/ |
否 |
HY-124242 |
(S)-α-Methylbenzyl ricinoleamide |
|
/ |
否 |
HY-124281A |
9(S)-PAHSA |
Control |
/ |
否 |
HY-124300 |
JNJ-54166060 |
Antagonist |
/ |
否 |
HY-124300A |
(S)-JNJ-54166060 |
|
/ |
否 |
HY-124357 |
Seproxetine hydrochloride |
Inhibitor |
/ |
否 |
HY-124386 |
DBCO-NHCO-PEG4-amine |
|
/ |
否 |
HY-124456 |
Unguinol |
Inhibitor |
/ |
否 |
HY-12447 |
SMK-17 |
|
/ |
否 |
HY-124482 |
Mesembrenol |
|
/ |
否 |
HY-124576 |
ABD-1970 |
Inhibitor |
/ |
否 |
HY-124699 |
MMSET-IN-1 |
Inhibitor |
/ |
否 |
HY-124775 |
(S)-C33 |
Inhibitor |
99.46% |
否 |
HY-124779 |
(S)-Alaproclate |
Inhibitor |
/ |
否 |
HY-124779A |
(S)-Alaproclate hydrochloride |
Inhibitor |
/ |
否 |
HY-124827 |
Tec-IN-1 |
Inhibitor |
/ |
否 |
HY-124926 |
S23757 |
|
/ |
否 |
HY-125046 |
CYM50374 |
Antagonist |
/ |
否 |
HY-125051 |
SG3-179 |
Inhibitor |
/ |
否 |
HY-12515B |
(S)-Nicardipine |
|
99.25% |
否 |
HY-125172 |
PolyQ aggregation inhibitor C2-8 |
Inhibitor |
/ |
否 |
HY-125182 |
SMCypI C31 |
Inhibitor |
/ |
否 |
HY-125335 |
Oligomycin D |
|
/ |
否 |
HY-125409A |
(S,R)-Lysinoalanine |
|
/ |
否 |
HY-125424 |
AM8191 hydrochloride |
Inhibitor |
/ |
否 |
HY-125512 |
Saccharocarcin B |
|
/ |
否 |
HY-125540 |
Saussureamine C |
Inhibitor |
/ |
否 |
HY-12560D |
PNU-282987 S enantiomer free base |
|
99.58% |
否 |
HY-125612 |
Artonin E |
Inducer |
/ |
否 |
HY-125620 |
Rubiginone D2 |
Inhibitor |
/ |
否 |
HY-125727 |
Globosuxanthone A |
Inhibitor |
/ |
否 |
HY-125743 |
S-1 Methanandamide |
Agonist |
≥98.0% |
否 |
HY-12577 |
TNKS1/2-IN-1 |
Inhibitor |
/ |
否 |
HY-125858B |
(S,R,S)-MI-1061 |
Control |
/ |
否 |
HY-125861C |
Methyl cellulose(Viscosity:1500mPa.s) |
|
/ |
否 |
HY-125861H |
Methyl cellulose(Viscosity:25mPa.s) |
|
/ |
否 |
HY-12601 |
TNKS 22 |
Inhibitor |
/ |
否 |
HY-126028A |
(+)-Sotalol |
Inhibitor |
98.82% |
否 |
HY-126031 |
(R)-KT109 |
Inhibitor |
/ |
否 |
HY-126033 |
Sophoranol |
Inhibitor |
/ |
否 |
HY-126047 |
(S)-(-)-Anatabine |
|
/ |
否 |
HY-126047AR |
(R,S)-Anatabine (Standard) |
|
/ |
否 |
HY-126047AS |
(R,S)-Anatabine-d4 |
|
/ |
否 |
HY-126047B |
(R)-(+)-Anatabine |
|
/ |
否 |
HY-126057AS |
(S)-Praziquantel-d11 |
|
98.23% |
否 |
HY-126109 |
(±)-8-Prenylnaringenin |
|
/ |
否 |
HY-126115 |
15(S)-Latanoprost |
Inhibitor |
/ |
否 |
HY-126121 |
2-Hydroxy Ibuprofen |
Inhibitor |
/ |
否 |
HY-126123 |
NR2B-selective NMDA receptor antagonist 1 |
Inhibitor |
/ |
否 |
HY-126125 |
CHIR-98023 |
Inhibitor |
/ |
否 |
HY-126313 |
BnOH-NH-bis-(C2-S)-propane-O-isoprene ester |
|
/ |
否 |
HY-126414 |
Methylenedihydrotanshinquinone |
|
/ |
否 |
HY-126416 |
Methyl tanshinonate |
Inhibitor |
/ |
否 |
HY-126423 |
Isorhamnetin 3-glucuronide |
Inducer |
/ |
否 |
HY-126426 |
CBHcy |
Inhibitor |
/ |
否 |
HY-126564 |
Ebelactone A |
Inhibitor |
/ |
否 |
HY-126569 |
Efrotomycin |
Inhibitor |
/ |
否 |
HY-126618 |
Aspochalasin I |
Inhibitor |
/ |
否 |
HY-126619 |
Aspochalasin D |
|
/ |
否 |
HY-126699 |
Herbimycin C |
Inhibitor |
/ |
否 |
HY-126732 |
L-640876 |
Inhibitor |
/ |
否 |
HY-126785 |
Suc-AAP-Abu-pNA |
|
/ |
否 |
HY-126850 |
4-Epidoxycycline |
|
/ |
否 |
HY-126874 |
Tyropeptin A-4 |
Inhibitor |
/ |
否 |
HY-126972 |
RI(dl)-2 |
Inhibitor |
/ |
否 |
HY-127059 |
Clindamycin Sulfoxide |
|
/ |
否 |
HY-127146 |
Platensimycin |
Inhibitor |
/ |
否 |
HY-12783 |
SCH 50911 hydrochloride |
Antagonist |
/ |
否 |
HY-128029 |
Glycogen phosphorylase-IN-1 |
Inhibitor |
/ |
否 |
HY-128362 |
Ep300/CREBBP-IN-8 |
Inhibitor |
/ |
否 |
HY-128363 |
Ep300/CREBBP-IN-2 |
Inhibitor |
/ |
否 |
HY-128364 |
Ep300/CREBBP-IN-3 |
Inhibitor |
/ |
否 |
HY-128367 |
Ep300/CREBBP-IN-4 |
Inhibitor |
/ |
否 |
HY-128433 |
CK1-IN-3 |
Inhibitor |
99.00% |
否 |
HY-12847 |
CCT241161 |
|
/ |
否 |
HY-128680 |
c-Fms-IN-9 |
Inhibitor |
/ |
否 |
HY-128759 |
DYRKs-IN-2 |
Inhibitor |
/ |
否 |
HY-12880 |
HA-100 dihydrochloride |
Inhibitor |
/ |
否 |
HY-128836 |
(4R,5S)-Nutlin carboxylic acid |
|
/ |
否 |
HY-128888A |
(S,S)-GSK321 |
Inhibitor |
99.78% |
否 |
HY-128910 |
MC-VC(S)-PABQ-Tubulysin M |
Inhibitor |
/ |
否 |
HY-128912 |
Arborinine |
Inhibitor |
/ |
否 |
HY-129115 |
S1QEL1.1 |
Inhibitor |
/ |
否 |
HY-129152 |
Ganoderic acid T-N |
Inhibitor |
/ |
否 |
HY-129214 |
(2S,3R)-DEPMPO-Biotin |
|
/ |
否 |
HY-129231 |
Levomoprolol |
|
/ |
否 |
HY-129316 |
Dihydroaeruginoic Acid |
|
/ |
否 |
HY-129317 |
A457 |
Antagonist |
/ |
否 |
HY-129436 |
(S)-Bucindolol |
Inhibitor |
/ |
否 |
HY-129452 |
(S)-3'-Hydroxy blebbistatin |
Inhibitor |
/ |
否 |
HY-129454 |
TPU-0037A |
|
/ |
否 |
HY-129656 |
GLP-1 receptor agonist 3 |
Agonist |
/ |
否 |
HY-129701 |
MCL-1/BCL-2-IN-3 |
Inhibitor |
99.22% |
否 |
HY-129752 |
Piperafizine B |
|
/ |
否 |
HY-129852 |
5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride |
|
/ |
否 |
HY-129937 |
(S)-GNE-987 |
Inhibitor |
/ |
否 |
HY-129995 |
TSHR antagonist S37b |
Inhibitor |
99.06% |
否 |
HY-130050 |
Luzopeptin A |
Inhibitor |
/ |
否 |
HY-130060 |
12(S)-HETrE |
|
/ |
否 |
HY-13011S |
Alectinib-d8 |
Inhibitor |
/ |
否 |
HY-13011S1 |
Alectinib-d6 |
Inhibitor |
98.05% |
否 |
HY-130138 |
(5S,6S)-DiHETE |
|
/ |
否 |
HY-130138A |
(5S,6R)-DiHETE |
Activator |
/ |
否 |
HY-130138B |
(5S,6R)-DiHETEs |
Control |
/ |
否 |
HY-13016S1 |
Cabozantinib-d4 |
|
/ |
否 |
HY-130178 |
CL-385319 |
|
/ |
否 |
HY-13018B |
MRT67307 dihydrochloride |
Inhibitor |
/ |
否 |
HY-130205 |
Milacemide hydrochloride |
Inhibitor |
/ |
否 |
HY-130209 |
S-Acetyl-PEG8-OH |
|
/ |
否 |
HY-130281 |
Ianthelliformisamine B diTFA |
Inhibitor |
/ |
否 |
HY-130310A |
11(S)-HEDE |
|
/ |
否 |
HY-130310B |
(±)11-HEDE |
Inhibitor |
/ |
否 |
HY-130319 |
9(S)-HEPE |
|
/ |
否 |
HY-130319A |
9-HEPE |
Activator |
/ |
否 |
HY-130349 |
Emamectin B1a |
Activator |
/ |
否 |
HY-130357 |
15(S)-HETE Ethanolamide |
Agonist |
/ |
否 |
HY-13039 |
(2S,3R,4R)-2,3,5-Tris(benzyloxy)-4-hydroxypentanal |
|
/ |
否 |
HY-13047A |
rel-S-(+)-Mecamylamine hydrochloride |
Antagonist |
/ |
否 |
HY-13050A |
Sapitinib fumarate |
Inhibitor |
/ |
否 |
HY-130514 |
SMAPP1 |
Activator |
/ |
否 |
HY-130522 |
6β-Prostaglandin I1 |
|
/ |
否 |
HY-130607 |
IDO1-IN-2 |
Inhibitor |
/ |
否 |
HY-130654 |
(S,R,S)-AHPC-C2-PEG4-N3 |
|
/ |
否 |
HY-130675AS |
15(S)-HEPE-d5 |
|
/ |
否 |
HY-130696 |
(+)-U-50488 |
Agonist |
/ |
否 |
HY-130711C |
(S,R,S)-AHPC-C3-NH2 dihydrochloride |
|
/ |
否 |
HY-130723 |
AMPK activator 2 |
Activator |
/ |
否 |
HY-130794 |
ALK/ROS1-IN-1 |
Inhibitor |
/ |
否 |
HY-131023 |
Janelia Fluor® 549, Maleimide TFA |
|
/ |
否 |
HY-131024 |
Janelia Fluor® 549, Tetrazine |
|
/ |
否 |
HY-131025 |
Janelia Fluor® 585, SE |
|
/ |
否 |
HY-131168 |
(S,R,S)-AHPC-Boc-trans-3-aminocyclobutanol-Pip-CH2COOH |
|
99.31% |
否 |
HY-131194 |
JAK2/STAT3-IN-1 |
Inhibitor |
/ |
否 |
HY-131244 |
ALK-IN-9 |
Inhibitor |
/ |
否 |
HY-131252 |
Dihydro Donepezil |
Inhibitor |
/ |
否 |
HY-131254 |
(S)-O-Desmethyl Venlafaxine N-Oxide |
|
/ |
否 |
HY-131260 |
Ibuprofen Impurity K |
Inhibitor |
/ |
否 |
HY-131284 |
(S)-Dehydro Venlafaxine |
|
/ |
否 |
HY-131305 |
HBDDE |
|
98.03% |
否 |
HY-131390 |
S-Ethylglutathione |
|
/ |
否 |
HY-131481 |
Mnm5s2U |
|
/ |
否 |
HY-131923 |
DAPM |
Inhibitor |
/ |
否 |
HY-131942 |
sFTX-3.3 |
Antagonist |
/ |
否 |
HY-131944 |
S-Acetylglutathione |
|
/ |
否 |
HY-131995 |
O-Arachidonoyl glycidol |
Inhibitor |
/ |
否 |
HY-132093 |
Azido-PEG5-S-methyl ethanethioate |
|
/ |
否 |
HY-132103 |
NHS ester-PEG3-S-methyl ethanethioate |
|
/ |
否 |
HY-132281 |
16-Oxokahweol |
Inducer |
/ |
否 |
HY-132294A |
(1S,3R)-GNE-502 |
Inhibitor |
/ |
否 |
HY-13238S1 |
Dolutegravir-d3 |
Inhibitor |
99.64% |
否 |
HY-13238S2 |
Dolutegravir-d5 |
Inhibitor |
/ |
否 |
HY-13245A |
(s)-PF-4136309 |
Control |
98.93% |
否 |
HY-13245B |
(Rac)-PF-4136309 |
Antagonist |
≥98.0% |
否 |
HY-13272S3 |
Dacomitinib-d10 |
|
/ |
否 |
HY-132809A |
(S)-Baxdrostat |
Inhibitor |
98.84% |
否 |
HY-132828 |
Odatroltide |
Inhibitor |
/ |
否 |
HY-132912 |
Antifungal agent 15 |
Inhibitor |
/ |
否 |
HY-132913 |
Cyclopropenone probe 1 |
|
/ |
否 |
HY-132938 |
(S,R,S)-AHPC-Me-decanedioic acid |
Chemical |
/ |
否 |
HY-133036 |
APJ receptor agonist 1 |
Agonist |
/ |
否 |
HY-13317S1 |
Oseltamivir-d3-1 |
|
/ |
否 |
HY-13317S4 |
Oseltamivir-d3 hydrochloride |
|
/ |
否 |
HY-13338A |
(S)-Mabuterol |
Agonist |
/ |
否 |
HY-133473 |
S-acetyl-PEG6-Tos |
|
/ |
否 |
HY-133477 |
(S)-TCO-PEG3-maleimide |
|
/ |
否 |
HY-133535 |
PA Janelia Fluor® 646, SE |
|
/ |
否 |
HY-133537 |
Hygrolidin |
Inhibitor |
/ |
否 |
HY-133830 |
7α,24(S)-Dihydroxycholesterol |
|
/ |
否 |
HY-134090 |
9-Methylstreptimidone |
Inhibitor |
/ |
否 |
HY-134132 |
15(S)-HETE methyl ester |
|
/ |
否 |
HY-134221 |
S-Nitroso-N-acetylcysteine |
|
/ |
否 |
HY-134361 |
ATP-γ-S tetrasodium |
|
/ |
否 |
HY-13447 |
PF-429242 |
Inhibitor |
/ |
否 |
HY-134511 |
15(S)-HpEPE |
Inhibitor |
/ |
否 |
HY-134525 |
Ro 8-4304 |
Antagonist |
/ |
否 |
HY-134557 |
GS87 |
Inhibitor |
/ |
否 |
HY-134572 |
(2S,3S)-Pterosin C |
|
/ |
否 |
HY-134894A |
Glycerophosphorylethanolamine sodium |
Activator |
/ |
否 |
HY-134914 |
Fosmidomycin |
Inhibitor |
/ |
否 |
HY-134917 |
Aldi-2 |
Inhibitor |
/ |
否 |
HY-134996 |
N-Acetyl-2-carboxybenzenesulfonamide |
|
/ |
否 |
HY-13502AS |
Mitoxantrone-d8 dihydrochloride |
|
/ |
否 |
HY-135070 |
Ac-RLR-AMC |
|
/ |
否 |
HY-135070B |
Ac-RLR-AMC TFA |
|
/ |
否 |
HY-135107 |
(S)-Ademetionine |
|
/ |
否 |
HY-135133 |
S-Phenylsulfonylcysteine |
|
/ |
否 |
HY-135151 |
Difluoro atorvastatin |
|
/ |
否 |
HY-135256 |
Naphthol yellow S, 98% |
|
/ |
否 |
HY-135280 |
MRL-650 |
Inhibitor |
/ |
否 |
HY-135336AS |
(S)-Verapamil-d7 hydrochloride |
|
/ |
否 |
HY-135374 |
(3R,5S)-Atorvastatin sodium |
|
/ |
否 |
HY-135386 |
5β-Dutasteride |
|
/ |
否 |
HY-135478 |
LY393615 |
Inhibitor |
/ |
否 |
HY-135498 |
Ferrioxamine E |
Inhibitor |
/ |
否 |
HY-135511 |
Nor-Cerpegin |
Inhibitor |
/ |
否 |
HY-135564 |
RK-682 hemicalcium |
Inhibitor |
/ |
否 |
HY-135564A |
RK-682 |
Inhibitor |
≥99.0% |
否 |
HY-135564B |
(Rac)-RK-682 |
Inhibitor |
/ |
否 |
HY-135614 |
(+)-Lunacrine |
|
/ |
否 |
HY-135666 |
DHODH-IN-8 |
Inhibitor |
/ |
否 |
HY-135766 |
Colletodiol |
|
/ |
否 |
HY-135816 |
CK2/PIM1-IN-1 |
Inhibitor |
/ |
否 |
HY-135845 |
TP3011 |
Inhibitor |
/ |
否 |
HY-13593S |
Chlorambucil-d8 |
|
/ |
否 |
HY-13593S1 |
Chlorambucil-d8-1 |
|
/ |
否 |
HY-13595R |
Chrysophanol (Standard) |
Inhibitor |
/ |
否 |
HY-136008 |
(S,R,S)-AHPC-PEG1-NH2 |
|
/ |
否 |
HY-136124 |
Cetilistat impurity 1 |
|
/ |
否 |
HY-136163A |
(S,R,S)-AHPC-C2-NH2 |
|
/ |
否 |
HY-136186 |
(S,R,S)-AHPC-C7-amine |
|
/ |
否 |
HY-136186B |
(S,R,S)-AHPC-C7-amine hydrochloride |
|
/ |
否 |
HY-136187 |
(S,R,S)-AHPC-C5-NH2 |
|
/ |
否 |
HY-136187A |
(S,R,S)-AHPC-C5-NH2 dihydrochloride |
|
/ |
否 |
HY-136219 |
Protein kinase affinity probe 1 |
|
/ |
否 |
HY-13623C |
(1R,3S,4R)-ent-Entecavir |
Control |
/ |
否 |
HY-13623CS |
(1R,3S,4R)-ent-Entecavir-13C2,15N |
|
/ |
否 |
HY-13632S |
Exemestane-d2 |
Inhibitor |
/ |
否 |
HY-13632S1 |
Exemestane-13C3 |
Inhibitor |
/ |
否 |
HY-13632S2 |
Exemestane-d3 |
Inhibitor |
/ |
否 |
HY-136342 |
Antitumor agent-23 |
Inhibitor |
/ |
否 |
HY-136392 |
IKK-IN-3 |
Inhibitor |
/ |
否 |
HY-136393 |
IKK-IN-4 |
Inhibitor |
/ |
否 |
HY-136429 |
Ethylhydrocupreine |
Inhibitor |
/ |
否 |
HY-136577 |
RP101442 |
Agonist |
/ |
否 |
HY-136592 |
1-Hydroxy-ibuprofen |
Inhibitor |
/ |
否 |
HY-13662C |
(S)-Lansoprazole |
Inhibitor |
99.17% |
否 |
HY-136747 |
Nek2/Hec1-IN-1 |
|
/ |
否 |
HY-136813 |
Multitarget AD inhibitor-1 |
Inhibitor |
/ |
否 |
HY-13683S |
Mifepristone-d3 |
|
97.51% |
否 |
HY-13683S1 |
Mifepristone-13C,d3 |
|
/ |
否 |
HY-136841 |
SLM6 |
Inhibitor |
/ |
否 |
HY-13716S |
Noscapine-13C,d3 |
|
/ |
否 |
HY-137208 |
Chondroitin disaccharide Δdi-0S sodium |
|
/ |
否 |
HY-137231A |
(S)-UFR2709 |
Antagonist |
/ |
否 |
HY-137286 |
Z-Leu-Leu-Glu-βNA |
|
/ |
否 |
HY-137307 |
Cholest-5-ene-3ß,22(S)-diol |
|
/ |
否 |
HY-137307S |
Cholest-5-ene-3ß,22(S)-diol-d7 |
|
/ |
否 |
HY-137330 |
S-(2,4-Dinitrophenyl)glutathione |
|
/ |
否 |
HY-137390A |
(3S,5R)-Fluvastatin potassium |
|
/ |
否 |
HY-137391 |
2-Bromoestradiol |
Inhibitor |
/ |
否 |
HY-13749C |
(S)-Sitagliptin phosphate |
Inhibitor |
/ |
否 |
HY-137802 |
SAHO2 |
|
/ |
否 |
HY-13788A |
LY 344864 S-enantiomer |
|
≥98.0% |
否 |
HY-137936 |
Terrecyclic Acid |
|
/ |
否 |
HY-138061 |
DENV-IN-2 |
Inhibitor |
/ |
否 |
HY-138098 |
Sartorypyrone B |
|
/ |
否 |
HY-138148 |
13(S)-HPOTrE(γ) |
|
/ |
否 |
HY-138185 |
Collismycin A |
Inhibitor |
/ |
否 |
HY-138257 |
(S)-Indeloxazine benzenesulfonate |
Inhibitor |
/ |
否 |
HY-13832S3 |
cis-Atovaquone-d4 |
Inhibitor |
/ |
否 |
HY-13838A |
PLX647 dihydrochloride |
Inhibitor |
/ |
否 |
HY-138454 |
MEG hemisulfate |
Inhibitor |
/ |
否 |
HY-138493 |
F-PEG2-S-Boc |
|
/ |
否 |
HY-138497 |
F-PEG2-S-COOH |
|
/ |
否 |
HY-138506 |
DBCO-S-S-acid |
|
/ |
否 |
HY-138553A |
(S,R,S)-AHPC-isobutyl acetate-methanesulfonothioate-Me-C10-NH2 TFA |
|
98.86% |
否 |
HY-138658 |
Janelia Fluor® 526, SE |
|
/ |
否 |
HY-138660 |
HM Janelia Fluor® 526, SE |
|
/ |
否 |
HY-138678B |
(S,R,R)-VH032 |
|
/ |
否 |
HY-138748 |
S-acetyl-PEG5-alcohol |
|
/ |
否 |
HY-138752 |
S-acetyl-PEG4-amine |
|
/ |
否 |
HY-138755 |
S-acetyl-PEG4-NHBoc |
|
/ |
否 |
HY-138758 |
S-acetyl-PEG4-Thiol |
|
/ |
否 |
HY-138830A |
(S,S)-TAK-418 |
Inhibitor |
/ |
否 |
HY-138861 |
(S,R,S)-AHPC-C1-NH2 |
|
/ |
否 |
HY-138861A |
(S,R,S)-AHPC-C1-NH2 hydrochloride |
|
98.08% |
否 |
HY-138905 |
S-15176 difumarate |
|
/ |
否 |
HY-13904S |
Flumatinib-d3 |
Inhibitor |
/ |
否 |
HY-139062 |
C6 Urea Ceramide |
|
/ |
否 |
HY-139067 |
25(S)-27-Hydroxy cholesterol |
Activator |
/ |
否 |
HY-139090 |
3-Oxobetulin acetate |
Inhibitor |
/ |
否 |
HY-139124 |
15(R)-15-Methyl Prostaglandin F2α |
Agonist |
/ |
否 |
HY-139134 |
S-2E |
Inhibitor |
/ |
否 |
HY-139137 |
N-Acetyl-S-geranylgeranyl-L-cysteine |
Inhibitor |
/ |
否 |
HY-139150 |
EZH2-IN-4 |
Inhibitor |
/ |
否 |
HY-139248 |
Paclitaxel octadecanedioate |
|
/ |
否 |
HY-139294 |
PROTAC BRD4 Degrader-15 |
Inhibitor |
/ |
否 |
HY-139386 |
15β-Travoprost |
Agonist |
/ |
否 |
HY-139402 |
MRTX849 acid |
Inhibitor |
99.84% |
否 |
HY-139403 |
MRTX849 ethoxypropanoic acid |
Antagonist |
/ |
否 |
HY-139466 |
PF-03622905 |
Inhibitor |
/ |
否 |
HY-139467 |
PF-04577806 |
Inhibitor |
/ |
否 |
HY-139474S1 |
N-Acetyl-S-(carbamoylethyl)-L-cysteine-d4 |
|
/ |
否 |
HY-139611B |
(S)-Navlimetostat |
Inhibitor |
97.07% |
否 |
HY-139727 |
S(-)-Bisoprolol |
|
/ |
否 |
HY-139727A |
S(-)-Bisoprolol fumarate |
|
/ |
否 |
HY-139730 |
c-ABL-IN-1 |
Inhibitor |
/ |
否 |
HY-139866 |
SARS-CoV-2-IN-9 |
Inhibitor |
/ |
否 |
HY-139884 |
EGFR-IN-18 |
Inhibitor |
/ |
否 |
HY-13991A |
(S)-CCG-1423 |
|
/ |
否 |
HY-139968S |
13,14-Dihydro-15(R,S)-hydroxy-16,16-difluoro Prostaglandin E1-d4 |
|
/ |
否 |
HY-139974 |
BChE-IN-2 |
|
/ |
否 |
HY-139993 |
HIF-PHD-IN-2 |
Inhibitor |
/ |
否 |
HY-139995 |
Spermine Prodrug-1 |
|
/ |
否 |
HY-140590 |
Azido-PEG3-S-PEG3-azide |
|
/ |
否 |
HY-140591 |
Azido-PEG3-S-PEG4-propargyl |
|
/ |
否 |
HY-140592 |
Azido-PEG3-S-PEG4-t-butyl ester |
|
/ |
否 |
HY-140594 |
m-PEG3-S-PEG4-propargyl |
|
/ |
否 |
HY-140595 |
m-PEG3-S-PEG1-C2-Boc |
|
/ |
否 |
HY-140596 |
m-PEG3-S-PEG3-Boc |
|
/ |
否 |
HY-140597 |
Propargyl-PEG4-S-PEG4-acid |
|
/ |
否 |
HY-140598 |
Propargyl-PEG4-S-PEG4-propargyl |
|
/ |
否 |
HY-140599 |
Propargyl-PEG4-S-PEG4-Boc |
|
/ |
否 |
HY-140859 |
S-Acetyl-PEG3-azide |
|
/ |
否 |
HY-141167B |
(S)-TCO-PEG4-NHS ester |
|
/ |
否 |
HY-141317 |
S-acetyl-PEG3-phosphonic acid ethyl ester |
|
/ |
否 |
HY-141340 |
S-acetyl-PEG3-alcohol |
|
/ |
否 |
HY-141345 |
S-acetyl-PEG2-Boc |
|
/ |
否 |
HY-141346 |
S-acetyl-PEG3-Boc |
|
/ |
否 |
HY-141347 |
S-acetyl-PEG4-Boc |
|
/ |
否 |
HY-141348 |
S-acetyl-PEG6-Boc |
|
/ |
否 |
HY-141349 |
S-Acetyl-PEG3-C2-acid |
|
/ |
否 |
HY-141465 |
3-Hydroxybutyryl-CoA |
|
/ |
否 |
HY-14147A |
(S)-Renzapride |
|
98.06% |
否 |
HY-14154 |
THRX-194556 |
Agonist |
/ |
否 |
HY-141648 |
Antibacterial agent 219 |
Inhibitor |
/ |
否 |
HY-141651 |
(S,R,S)-AHPC-C3-COOH |
|
/ |
否 |
HY-14165A |
(S)-Veliflapon |
Inhibitor |
99.44% |
否 |
HY-141685 |
3-Methylthienyl-carbonyl-JNJ-7706621 |
Inhibitor |
/ |
否 |
HY-141845 |
S1P2 antagonist 1 |
Antagonist |
/ |
否 |
HY-141848A |
(S,S)-BMS-984923 |
|
98.82% |
否 |
HY-14202 |
Lazabemide hydrochloride |
Inhibitor |
/ |
否 |
HY-142032 |
RBM10-8 |
Inhibitor |
/ |
否 |
HY-142139S |
(S,S)-Iso Valganciclovir-d8 hydrochloride |
|
/ |
否 |
HY-142295A |
GNF2133 hydrochloride |
Inhibitor |
/ |
否 |
HY-142517 |
EGFR-IN-25 |
Inhibitor |
/ |
否 |
HY-142519 |
EGFR-IN-27 |
Inhibitor |
/ |
否 |
HY-142547S |
S 421-d4 |
|
/ |
否 |
HY-14258AS1 |
Escitalopram-d4 oxalate |
Inhibitor |
/ |
否 |
HY-142674 |
BRD4-BD1/2-IN-1 |
Inhibitor |
/ |
否 |
HY-142675 |
BRD4-BD1/2-IN-2 |
Inhibitor |
/ |
否 |
HY-142679 |
EGFR-IN-22 |
Inhibitor |
/ |
否 |
HY-142680 |
EGFR-IN-23 |
Inhibitor |
/ |
否 |
HY-142695 |
Antibacterial synergist 1 |
|
/ |
否 |
HY-142735 |
KCa2 channel modulator 2 |
|
/ |
否 |
HY-142743 |
Y08175 |
Inhibitor |
/ |
否 |
HY-142843 |
RORγt/DHODH-IN-1 |
Inhibitor |
/ |
否 |
HY-142847 |
RORγt/DHODH-IN-3 |
Inhibitor |
/ |
否 |
HY-142921 |
FGFR-IN-2 |
Inhibitor |
/ |
否 |
HY-14294 |
Capravirine |
Inhibitor |
/ |
否 |
HY-142945 |
KRAS G12C inhibitor 43 |
Inhibitor |
/ |
否 |
HY-142946 |
KRAS G12C inhibitor 44 |
Inhibitor |
/ |
否 |
HY-142972 |
19(S)-HETE |
Agonist |
/ |
否 |
HY-142976 |
Tetranor-12(S)-HETE |
|
/ |
否 |
HY-14300AS |
Vilanterol-d4 trifenatate |
Agonist |
/ |
否 |
HY-14302S1 |
Salmeterol-d5 |
Agonist |
/ |
否 |
HY-143244 |
Monoamine Oxidase B inhibitor 1 |
Inhibitor |
/ |
否 |
HY-143245 |
Monoamine Oxidase B inhibitor 2 |
Inhibitor |
/ |
否 |
HY-143246 |
EGFR kinase inhibitor 1 |
|
/ |
否 |
HY-143257 |
CDK4/6-IN-7 |
Inhibitor |
/ |
否 |
HY-143263 |
FAAH/MAGL-IN-1 |
Inhibitor |
/ |
否 |
HY-143264 |
FAAH/MAGL-IN-2 |
Inhibitor |
/ |
否 |
HY-143273 |
DENV-IN-6 |
Inhibitor |
/ |
否 |
HY-143274 |
DENV-IN-5 |
Inhibitor |
/ |
否 |
HY-143276A |
(S,S,R)-AHPC-C6-NH2 hydrochloride |
|
97.20% |
否 |
HY-143287 |
NTPDase-IN-1 |
Inhibitor |
/ |
否 |
HY-143288 |
NTPDase-IN-2 |
Inhibitor |
/ |
否 |
HY-143292 |
Antibacterial agent 81 |
Inhibitor |
/ |
否 |
HY-143293 |
VEGFR-IN-3 |
|
/ |
否 |
HY-143301 |
Topoisomerase I inhibitor 4 |
Inhibitor |
/ |
否 |
HY-143302 |
Anticancer agent 31 |
Inducer |
/ |
否 |
HY-143306 |
IDH1 Inhibitor 5 |
Inhibitor |
/ |
否 |
HY-143312C |
(S)-V-0219 |
Modulator |
/ |
否 |
HY-143317 |
XY153 |
Inhibitor |
/ |
否 |
HY-143400 |
HSP70-IN-3 |
Inhibitor |
/ |
否 |
HY-143413 |
BuChE-IN-2 |
Inhibitor |
/ |
否 |
HY-143414 |
Metallo-β-lactamase-IN-6 |
Inhibitor |
/ |
否 |
HY-143415 |
Metallo-β-lactamase-IN-7 |
Inhibitor |
/ |
否 |
HY-143423A |
(S)-MALT1-IN-5 |
Inhibitor |
/ |
否 |
HY-143430 |
(S)-LY3177833 |
Inhibitor |
/ |
否 |
HY-143432A |
(S)-Cdc7-IN-18 |
Inhibitor |
/ |
否 |
HY-143438 |
2-PAT |
Inhibitor |
/ |
否 |
HY-143440 |
CBP/p300-IN-16 |
Inhibitor |
/ |
否 |
HY-143441 |
CBP/p300-IN-17 |
Inhibitor |
/ |
否 |
HY-143442 |
CBP/p300-IN-18 |
Inhibitor |
/ |
否 |
HY-143445 |
EGFR-IN-48 |
Inhibitor |
/ |
否 |
HY-143462 |
c-Met/HDAC-IN-2 |
|
/ |
否 |
HY-143464 |
BChE-IN-4 |
Inhibitor |
/ |
否 |
HY-143465 |
BChE-IN-5 |
Inhibitor |
/ |
否 |
HY-143469 |
NPP1-IN-1 |
Inhibitor |
/ |
否 |
HY-143557 |
Trk-IN-7 |
Inhibitor |
/ |
否 |
HY-143561 |
Trk-IN-8 |
Inhibitor |
/ |
否 |
HY-143583 |
ATX inhibitor 10 |
Inhibitor |
/ |
否 |
HY-143611 |
AKT-IN-8 |
Inhibitor |
/ |
否 |
HY-143721 |
SSAO inhibitor-2 |
Inhibitor |
/ |
否 |
HY-143723 |
SSAO inhibitor-3 |
Inhibitor |
/ |
否 |
HY-143796S |
(S)-Etodolac-d4 |
|
/ |
否 |
HY-143800S |
S (+) Tolperisone-d10 |
|
/ |
否 |
HY-143808S |
(S)-Stiripentol-d9 |
|
/ |
否 |
HY-143864 |
S1PR1 agonist 1 |
Agonist |
/ |
否 |
HY-143865 |
S1PR1 agonist 2 |
Agonist |
/ |
否 |
HY-143873 |
Bcl-2-IN-5 |
Inhibitor |
/ |
否 |
HY-143894 |
FLT3-IN-11 |
Inhibitor |
/ |
否 |
HY-143895 |
FLT3-IN-12 |
Inhibitor |
/ |
否 |
HY-14391 |
PSI-353661 |
Inhibitor |
/ |
否 |
HY-143921S |
Almorexant (αS,1S) isomer-13C,d3 |
|
/ |
否 |
HY-144029 |
RET-IN-13 |
Inhibitor |
/ |
否 |
HY-144032 |
Tyk2-IN-9 |
Inhibitor |
/ |
否 |
HY-144044 |
EGFR-IN-30 |
Inhibitor |
/ |
否 |
HY-144053 |
EGFR-IN-36 |
Inhibitor |
/ |
否 |
HY-144069 |
Pan-Trk-IN-3 |
|
/ |
否 |
HY-144074 |
LRRK2-IN-4 |
Inhibitor |
/ |
否 |
HY-144087 |
TYK2-IN-11 |
Inhibitor |
/ |
否 |
HY-144106 |
HCV-IN-33 |
Inhibitor |
/ |
否 |
HY-144109 |
HCV-IN-36 |
Inhibitor |
/ |
否 |
HY-144113 |
HIV-1 inhibitor-14 |
Inhibitor |
/ |
否 |
HY-144122 |
HIV-1 inhibitor-15 |
Inhibitor |
/ |
否 |
HY-144123 |
HIV-1 inhibitor-16 |
Inhibitor |
/ |
否 |
HY-144126 |
S1P1 agonist 5 |
Agonist |
/ |
否 |
HY-144131 |
RET-IN-11 |
|
/ |
否 |
HY-144153S |
S-(1,2-Dichlorovinyl)glutathione-13C2,15N |
|
/ |
否 |
HY-144170 |
RET-IN-14 |
Inhibitor |
/ |
否 |
HY-14417B |
VU0155041 sodium |
Agonist |
/ |
否 |
HY-144210 |
SOS1-IN-6 |
Inhibitor |
/ |
否 |
HY-144211 |
SOS1-IN-7 |
Inhibitor |
/ |
否 |
HY-144216S |
(S)-Cetirizine-d4 dihydrochloride |
|
/ |
否 |
HY-144249S |
(S)-Pantoprazole-d6 |
|
/ |
否 |
HY-144264 |
hCAII-IN-6 |
Inhibitor |
/ |
否 |
HY-144269 |
SHR902275 |
Inhibitor |
/ |
否 |
HY-144270 |
Glucosylceramide synthase-IN-3 |
|
/ |
否 |
HY-144271 |
RAF-IN-1 |
Inhibitor |
/ |
否 |
HY-144283 |
BLK-IN-1 |
Inhibitor |
/ |
否 |
HY-144293 |
HDAC-IN-31 |
|
/ |
否 |
HY-144294 |
Purine phosphoribosyltransferase-IN-1 |
Inhibitor |
/ |
否 |
HY-144301 |
AAK1-IN-2 |
|
/ |
否 |
HY-144301A |
AAK1-IN-2 TFA |
|
/ |
否 |
HY-144307 |
Aurora A/PKC-IN-1 |
Inhibitor |
/ |
否 |
HY-144311 |
OXPHOS-IN-1 |
Inhibitor |
/ |
否 |
HY-144332 |
PHD2/HDACs-IN-1 |
Inhibitor |
/ |
否 |
HY-144338 |
PARP1/BRD4-IN-1 |
Inhibitor |
/ |
否 |
HY-144369 |
Proteasome-IN-4 |
Inhibitor |
/ |
否 |
HY-144387 |
Antibacterial agent 71 |
Inhibitor |
/ |
否 |
HY-144388 |
ChE/Aβ1-42-IN-1 |
Inhibitor |
/ |
否 |
HY-144406S |
N-Acetyl-S-(3-hydroxypropyl)cysteine-d3 dicyclohexylammonium |
|
/ |
否 |
HY-144446 |
BuChE-IN-1 |
Inhibitor |
/ |
否 |
HY-144449 |
mTOR/HDAC6-IN-1 |
|
/ |
否 |
HY-144497 |
HE-S2 |
|
/ |
否 |
HY-144614 |
JH-XVII-10 |
|
/ |
否 |
HY-144639 |
Carbonic anhydrase inhibitor 5 |
Inhibitor |
/ |
否 |
HY-144654 |
HDAC/Top-IN-1 |
Inhibitor |
/ |
否 |
HY-144657 |
(4S)-PROTAC SOS1 degrader-1 |
Inhibitor |
/ |
否 |
HY-144657A |
(4S)-PROTAC SOS1 degrader-1 diTFA |
Inhibitor |
98.09% |
否 |
HY-144693 |
MEK/PI3K-IN-2 |
Inhibitor |
/ |
否 |
HY-144705 |
GAT564 |
Modulator |
/ |
否 |
HY-144724 |
HSP90-IN-10 |
Inhibitor |
/ |
否 |
HY-144728 |
MraY-IN-3 hydrochloride |
Inhibitor |
/ |
否 |
HY-144763 |
XPO1-IN-1 |
Inducer |
/ |
否 |
HY-144772 |
SARS-CoV-2-IN-15 |
Inhibitor |
/ |
否 |
HY-144775 |
AChE-IN-10 |
Inhibitor |
/ |
否 |
HY-144777 |
FLT3-IN-14 |
|
/ |
否 |
HY-144790 |
AChE-IN-12 |
Inhibitor |
/ |
否 |
HY-144794 |
EGFR-IN-46 |
|
/ |
否 |
HY-144808 |
Anticancer agent 40 |
Inhibitor |
/ |
否 |
HY-144811 |
CDK2-IN-9 |
|
/ |
否 |
HY-144824 |
Monoamine oxidase/Aromatase-IN-1 |
Inhibitor |
/ |
否 |
HY-144827 |
AM8936 |
Agonist |
/ |
否 |
HY-144967 |
SOS1-IN-13 |
Inhibitor |
/ |
否 |
HY-145023 |
RET-IN-5 |
Inhibitor |
/ |
否 |
HY-145029 |
SYK/JAK-IN-1 |
Inhibitor |
/ |
否 |
HY-145053A |
(5S,8R)-HBV-IN-10 |
Inhibitor |
/ |
否 |
HY-145147A |
AAA-10 formic |
Inhibitor |
/ |
否 |
HY-145177 |
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc |
|
/ |
否 |
HY-145196 |
RTICBM-189 |
Modulator |
99.73% |
否 |
HY-145244 |
APN/AKT-IN-1 |
Inhibitor |
/ |
否 |
HY-145247 |
Biotin-PEG7-C2-S-Vidarabine |
Inhibitor |
/ |
否 |
HY-145248 |
Biotin-PEG7-C2-NH-Vidarabine-S-CH3 |
Inhibitor |
/ |
否 |
HY-145265 |
Antimicrobial photosensitizer-1 |
|
/ |
否 |
HY-145266 |
OM-1700 |
Inhibitor |
/ |
否 |
HY-145273 |
EB-0150 |
Inhibitor |
/ |
否 |
HY-145274 |
EB-0156 |
Inhibitor |
/ |
否 |
HY-145275 |
EB-0176 |
Inhibitor |
/ |
否 |
HY-145287 |
S-MGB-234 |
|
/ |
否 |
HY-145362 |
S1P1 agonist 4 |
Modulator |
/ |
否 |
HY-145389 |
SZ-015268 |
Inhibitor |
/ |
否 |
HY-145408 |
CDK7/9-IN-1 |
Inhibitor |
/ |
否 |
HY-145431 |
(S)-GSK1379725A |
Inhibitor |
/ |
否 |
HY-145438 |
Antitumor agent-38 |
|
/ |
否 |
HY-145473 |
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE |
|
/ |
否 |
HY-145476 |
N-Nitrosoanatabine |
|
/ |
否 |
HY-145519 |
Mu-6S-Palm-β-Glc |
|
/ |
否 |
HY-14551B |
(S)-Osanetant |
Antagonist |
99.25% |
否 |
HY-145543 |
9(S)10(S)13(S)-TriHOME |
|
/ |
否 |
HY-145670 |
cis,trans-Germacrone |
Inhibitor |
/ |
否 |
HY-145687 |
HDAC-IN-32 |
Inhibitor |
/ |
否 |
HY-145688 |
HDAC-IN-33 |
Inhibitor |
/ |
否 |
HY-145693 |
CDK5-IN-2 |
Inhibitor |
/ |
否 |
HY-145708 |
Dual AChE-MAO B-IN-2 |
Inhibitor |
/ |
否 |
HY-145749 |
PARPYnD |
Inhibitor |
/ |
否 |
HY-145769 |
N2S2-CBMBC |
|
/ |
否 |
HY-145835A |
(S)-PERK-IN-5 |
Inhibitor |
/ |
否 |
HY-145836 |
FGFR4-IN-8 |
Inhibitor |
/ |
否 |
HY-145842 |
Encephalitic alphavirus-IN-1 |
Inhibitor |
/ |
否 |
HY-145845 |
HDAC1/MAO-B-IN-1 |
Inhibitor |
/ |
否 |
HY-145851 |
Top/HDAC-IN-1 |
|
/ |
否 |
HY-145867 |
EGFR-IN-45 |
|
/ |
否 |
HY-145885 |
TLR7/8 agonist 6 |
Agonist |
/ |
否 |
HY-145886 |
TLR7/8 antagonist 1 |
Antagonist |
/ |
否 |
HY-145888 |
Antioxidant agent-2 |
Inhibitor |
/ |
否 |
HY-145889 |
LC kinetic stabilizer-1 |
|
/ |
否 |
HY-145891 |
B10-S |
|
/ |
否 |
HY-145900 |
S100A2-p53-IN-1 |
Inhibitor |
/ |
否 |
HY-145902 |
PDGFRα/FLT3-ITD-IN-1 |
Inhibitor |
/ |
否 |
HY-145903 |
PDGFRα/FLT3-ITD-IN-2 |
Inhibitor |
/ |
否 |
HY-145904 |
PDGFRα/FLT3-ITD-IN-3 |
Inhibitor |
/ |
否 |
HY-145905 |
D4R antagonist-1 |
Antagonist |
/ |
否 |
HY-145906 |
D4R antagonis-2 |
Antagonist |
/ |
否 |
HY-145925C |
(S,R)-CFT8634 |
Inhibitor |
/ |
否 |
HY-145949 |
Remdesivir de(ethylbutyl 2-aminopropanoate) |
|
/ |
否 |
HY-14595R |
Biochanin A (Standard) |
Inhibitor |
/ |
否 |
HY-146000 |
Influenza virus-IN-3 |
Inhibitor |
/ |
否 |
HY-146001 |
Influenza virus-IN-4 |
Inhibitor |
/ |
否 |
HY-146015 |
HIV-1 inhibitor-21 |
Inhibitor |
/ |
否 |
HY-146017 |
HIV-1 inhibitor-22 |
Inhibitor |
/ |
否 |
HY-146018 |
HIV-1 inhibitor-23 |
Inhibitor |
/ |
否 |
HY-146019 |
HIV-1 inhibitor-24 |
Inhibitor |
/ |
否 |
HY-146035 |
AChE-IN-14 |
Inhibitor |
/ |
否 |
HY-146038 |
Antitumor agent-55 |
|
/ |
否 |
HY-146039 |
AChE-IN-15 |
Inhibitor |
/ |
否 |
HY-146041 |
Antiparasitic agent-2 |
Inhibitor |
/ |
否 |
HY-146042 |
Antiparasitic agent-4 |
Inhibitor |
/ |
否 |
HY-146049 |
Antitrypanosomal agent 4 |
Inhibitor |
/ |
否 |
HY-14605S |
Rasagiline-13C3 mesylate |
|
/ |
否 |
HY-146061 |
KRAS G12C inhibitor 48 |
Inhibitor |
/ |
否 |
HY-146068 |
AEP-IN-1 |
|
/ |
否 |
HY-146071 |
Antitrypanosomal agent 5 |
Inhibitor |
/ |
否 |
HY-146080 |
Antitumor agent-61 |
Activator |
/ |
否 |
HY-146082 |
(Z)-α-Cyanostilbene |
|
/ |
否 |
HY-146098 |
Antibacterial agent 105 |
Inhibitor |
/ |
否 |
HY-146103 |
Antiproliferative agent-7 |
Inducer |
/ |
否 |
HY-146105 |
Anticancer agent 65 |
|
/ |
否 |
HY-146133 |
LA-Bac8c |
Inhibitor |
/ |
否 |
HY-146137 |
Transthyretin-IN-1 |
|
/ |
否 |
HY-146151 |
γ-Secretase modulator 12 |
|
/ |
否 |
HY-146155 |
TRPC4/5-IN-1 |
Inhibitor |
/ |
否 |
HY-146158 |
Fudapirine |
Inhibitor |
/ |
否 |
HY-146159 |
PI3K/HDAC-IN-2 |
Inhibitor |
/ |
否 |
HY-146160 |
PARP-1/HDAC-IN-1 |
Inhibitor |
/ |
否 |
HY-146165 |
Metallo-β-lactamase-IN-8 |
Inhibitor |
/ |
否 |
HY-146166 |
PT4 |
|
/ |
否 |
HY-146169 |
Antitumor agent-68 |
Inhibitor |
/ |
否 |
HY-146172 |
Antioxidant agent-3 |
Activator |
/ |
否 |
HY-146200 |
PI3K/mTOR Inhibitor-8 |
Inhibitor |
/ |
否 |
HY-146201 |
PDE4B/7A-IN-1 |
|
/ |
否 |
HY-146226 |
Viral 2C protein inhibitor 1 |
Inhibitor |
/ |
否 |
HY-146274 |
c-Met-IN-10 |
|
/ |
否 |
HY-146277 |
CBP/p300-IN-19 |
Inhibitor |
/ |
否 |
HY-146294 |
COX-2/5-LOX-IN-1 |
Inhibitor |
/ |
否 |
HY-146295 |
COX-2/5-LOX-IN-2 |
|
/ |
否 |
HY-146315 |
AChE/BChE-IN-6 |
Inhibitor |
/ |
否 |
HY-146337 |
Dyrk1A/B-IN-1 |
Inhibitor |
/ |
否 |
HY-146338 |
RPR103611 |
Inhibitor |
/ |
否 |
HY-146339 |
HIV-1 inhibitor-27 |
Inhibitor |
/ |
否 |
HY-146347 |
MAO-B-IN-10 |
Inhibitor |
/ |
否 |
HY-146365 |
HIV-1 inhibitor-30 |
|
/ |
否 |
HY-146380 |
S1427 |
Inhibitor |
/ |
否 |
HY-146400 |
Antibacterial agent 97 |
Inhibitor |
/ |
否 |
HY-146403 |
Antibacterial agent 98 |
Inhibitor |
/ |
否 |
HY-146405 |
nAChR antagonist 1 |
Antagonist |
/ |
否 |
HY-146429 |
NaPi2b-IN-3 |
Inhibitor |
/ |
否 |
HY-146443 |
BRAF V600E/CRAF-IN-2 |
Inhibitor |
/ |
否 |
HY-146447 |
PXYC13 |
Inhibitor |
/ |
否 |
HY-146448 |
PXYD3 |
Inhibitor |
/ |
否 |
HY-146449 |
PXYD4 |
Inhibitor |
/ |
否 |
HY-146450 |
PXYC2 |
Inhibitor |
/ |
否 |
HY-146451 |
PXYC12 |
Inhibitor |
/ |
否 |
HY-146452 |
Anticancer agent 57 |
Inducer |
/ |
否 |
HY-146453 |
TGR5 Receptor Agonist 3 |
Agonist |
/ |
否 |
HY-146454 |
Antiproliferative agent-6 |
|
/ |
否 |
HY-146458 |
Antibacterial agent 102 |
Inhibitor |
/ |
否 |
HY-146461 |
Anticancer agent 58 |
|
/ |
否 |
HY-146475 |
KRAS inhibitor-17 |
Inhibitor |
/ |
否 |
HY-146476 |
KRAS inhibitor-18 |
Inhibitor |
/ |
否 |
HY-146478 |
A1/A3 AR antagonist 1 |
Antagonist |
/ |
否 |
HY-146483 |
Anti-Aβ agent 1A |
Inhibitor |
/ |
否 |
HY-146491 |
VEGFR-2/BRAF-IN-1 |
|
/ |
否 |
HY-14649S5 |
Retinoic acid-d3 |
Agonist |
/ |
否 |
HY-146503 |
Antibacterial agent 86 |
|
/ |
否 |
HY-146527 |
c-ABL-IN-2 |
Inhibitor |
/ |
否 |
HY-146528 |
c-ABL-IN-3 |
Inhibitor |
/ |
否 |
HY-146530 |
c-ABL-IN-4 |
Inhibitor |
/ |
否 |
HY-146533 |
KRAS inhibitor-12 |
Inhibitor |
/ |
否 |
HY-146537 |
KRAS G12C inhibitor 47 |
Inhibitor |
/ |
否 |
HY-146543 |
KRAS inhibitor-13 |
Inhibitor |
/ |
否 |
HY-146545 |
KRAS inhibitor-15 |
Inhibitor |
/ |
否 |
HY-146552 |
PDHK-IN-4 |
Inhibitor |
/ |
否 |
HY-146554 |
PDHK-IN-5 |
Inhibitor |
/ |
否 |
HY-146561 |
S-HP210 |
Modulator |
98.12% |
否 |
HY-146578 |
Keap1-Nrf2-IN-8 |
Inhibitor |
/ |
否 |
HY-146586 |
Haspin-IN-1 |
Inhibitor |
/ |
否 |
HY-146587 |
Haspin-IN-2 |
Inhibitor |
/ |
否 |
HY-146591 |
Antibacterial agent 87 |
Inhibitor |
/ |
否 |
HY-146593 |
Antibacterial agent 88 |
Inhibitor |
/ |
否 |
HY-14660S |
Dabrafenib-d9 |
Inhibitor |
/ |
否 |
HY-146619 |
RAGE/SERT-IN-1 |
Inhibitor |
/ |
否 |
HY-14664CS |
(3S,5R)-Fluvastatin-d6 sodium |
Inhibitor |
≥98.0% |
否 |
HY-14664DS |
(3S,5R)-Fluvastatin-d6 |
Inducer |
/ |
否 |
HY-146656S |
S-Sulfo-DL-cysteine-2,3,3-d3 |
|
/ |
否 |
HY-146659S |
S-Phenyl-DL-cysteine-3,3-d2 |
|
/ |
否 |
HY-146661 |
Aldose reductase-IN-4 |
Inhibitor |
/ |
否 |
HY-146669 |
BChE-IN-6 |
Inhibitor |
/ |
否 |
HY-146671 |
ITK inhibitor 5 |
Inhibitor |
/ |
否 |
HY-146673 |
IDO1/TDO-IN-2 |
Inhibitor |
/ |
否 |
HY-146675 |
COX/5-LOX-IN-1 |
|
/ |
否 |
HY-146691 |
hMAO-B-IN-2 |
Inhibitor |
/ |
否 |
HY-146710 |
RET-IN-16 |
Inhibitor |
/ |
否 |
HY-146716S |
N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine-d3 dicyclohexylamine |
|
/ |
否 |
HY-146717S |
N-Acetyl-S-(3-hydroxypropyl)-L-cysteine-d6 dicyclohexylamine |
|
/ |
否 |
HY-146735 |
MNK1/2-IN-6 |
|
/ |
否 |
HY-146746 |
HIV-1 inhibitor-19 |
Inhibitor |
/ |
否 |
HY-146750 |
HDAC-IN-37 |
|
/ |
否 |
HY-146755 |
TIY-7 |
Inhibitor |
/ |
否 |
HY-146759 |
ZM514 |
Inhibitor |
/ |
否 |
HY-146762 |
MAO-B-IN-7 |
Inhibitor |
/ |
否 |
HY-146768S |
24(R/S),25-Epoxycholesterol-d6 |
|
/ |
否 |
HY-146769 |
Antimalarial agent 11 |
Inhibitor |
/ |
否 |
HY-146780 |
TGFβRI-IN-4 |
Inhibitor |
/ |
否 |
HY-146782 |
EGFR-IN-49 |
Inhibitor |
/ |
否 |
HY-146784S |
7α,24(R/S)-Dihydroxycholesterol-d7 |
|
/ |
否 |
HY-146786 |
ZMF-10 |
|
/ |
否 |
HY-146787S |
7α,24(R/S)-Dihydroxycholestenone-d7 |
|
/ |
否 |
HY-146789 |
PI3Kδ/γ-IN-2 |
Inhibitor |
/ |
否 |
HY-146807 |
Type II TRK inhibitor 1 |
Inhibitor |
/ |
否 |
HY-146815 |
CP19 |
|
/ |
否 |
HY-146883 |
As-358 |
Inhibitor |
/ |
否 |
HY-146883A |
As-358 hydrochloride |
Inhibitor |
/ |
否 |
HY-146886 |
FLT3-IN-15 |
Inhibitor |
/ |
否 |
HY-146905S |
CER6-2’S-d9 |
|
/ |
否 |
HY-146937S |
CER11-2’S-d9 |
|
/ |
否 |
HY-146940S |
CER7-2’S,6R-d9 |
|
/ |
否 |
HY-146942S |
CER5-2’S-d9 |
|
/ |
否 |
HY-146977 |
LDHA/PDKs-IN-1 |
Inhibitor |
/ |
否 |
HY-146978 |
LDHA/PDKs-IN-2 |
Inhibitor |
/ |
否 |
HY-147015 |
HOE961 |
Inhibitor |
/ |
否 |
HY-147038 |
AMPK activator 8 |
Activator |
/ |
否 |
HY-147041A |
(2S)-Selvigaltin |
Inhibitor |
/ |
否 |
HY-147065 |
γ-L-Glutamyl-S-allyl-L-cysteine |
|
/ |
否 |
HY-147192 |
(S,R,S)-AHPC-O-PEG1-propargyl |
|
/ |
否 |
HY-147255A |
(S)-Canocapavir |
Control |
/ |
否 |
HY-147285 |
PI3K/mTOR Inhibitor-9 |
Inhibitor |
/ |
否 |
HY-147304 |
BPH-1086 |
Inhibitor |
/ |
否 |
HY-147321 |
3'-DMTr-dG(iBu) |
|
/ |
否 |
HY-147333 |
Trimipramine N-oxide |
|
/ |
否 |
HY-147352 |
NMDA receptor potentiator-1 |
Modulator |
/ |
否 |
HY-147358C |
(1R,4S)-Yimitasvir diphosphate |
Inhibitor |
/ |
否 |
HY-147371 |
Quinoprazine |
Inhibitor |
/ |
否 |
HY-14741 |
Epetirimod |
Inhibitor |
/ |
否 |
HY-147518 |
p38-α MAPK-IN-5 |
Inhibitor |
/ |
否 |
HY-147522 |
ADG-2e |
Inhibitor |
/ |
否 |
HY-147531 |
Antibacterial agent 106 |
Inhibitor |
/ |
否 |
HY-147552 |
HIV-1 inhibitor-35 |
Inhibitor |
/ |
否 |
HY-147580 |
BTK-IN-10 |
Inhibitor |
/ |
否 |
HY-147582 |
BTK-IN-12 |
Inhibitor |
/ |
否 |
HY-147608 |
CSF1R-IN-7 |
Inhibitor |
/ |
否 |
HY-147644 |
α-Synuclein inhibitor 3 |
Inhibitor |
/ |
否 |
HY-147691 |
MPO-IN-5 |
Inhibitor |
/ |
否 |
HY-147698 |
ZLHQ-5f |
|
/ |
否 |
HY-147703 |
Aurora kinase inhibitor-9 |
Inhibitor |
/ |
否 |
HY-147708 |
T-Type calcium channel inhibitor 2 |
Inhibitor |
/ |
否 |
HY-147711 |
α-Amylase/α-Glucosidase-IN-1 |
|
/ |
否 |
HY-147713 |
FGFR3-IN-1 |
Inhibitor |
/ |
否 |
HY-147714 |
FGFR3-IN-2 |
Inhibitor |
/ |
否 |
HY-147715 |
FGFR3-IN-3 |
Inhibitor |
/ |
否 |
HY-147716 |
CDK8-IN-6 |
Inhibitor |
/ |
否 |
HY-147717 |
CDK8-IN-7 |
Inhibitor |
/ |
否 |
HY-147722 |
hCAIX-IN-8 |
Inhibitor |
/ |
否 |
HY-147725 |
Microtubule inhibitor 4 |
Inhibitor |
/ |
否 |
HY-147727 |
Microtubule inhibitor 6 |
Inhibitor |
/ |
否 |
HY-147784 |
HZ-A-005 |
Inhibitor |
/ |
否 |
HY-147796 |
EGFR/HER2/CDK9-IN-1 |
Inhibitor |
/ |
否 |
HY-147797 |
EGFR/HER2/CDK9-IN-2 |
Inhibitor |
/ |
否 |
HY-147798 |
EGFR/HER2/CDK9-IN-3 |
Inhibitor |
/ |
否 |
HY-147802 |
EGFR-IN-59 |
|
/ |
否 |
HY-147813 |
HIF-1α-IN-3 |
Inhibitor |
/ |
否 |
HY-147818 |
DNA Gyrase-IN-2 |
Inhibitor |
/ |
否 |
HY-147819 |
DNA Gyrase-IN-3 |
Inhibitor |
/ |
否 |
HY-147825 |
EGFR/BRAFV600E-IN-1 |
|
/ |
否 |
HY-147826 |
EGFR-IN-60 |
|
/ |
否 |
HY-147827 |
hCAIX-IN-10 |
Inhibitor |
/ |
否 |
HY-147828 |
hCAIX-IN-11 |
Inhibitor |
/ |
否 |
HY-14784 |
Bederocin |
Inhibitor |
/ |
否 |
HY-147844 |
F8-S43-S3 |
Inhibitor |
/ |
否 |
HY-147845 |
F8-S40 |
Inhibitor |
/ |
否 |
HY-147846 |
AChE/PDE4-IN-1 |
Inhibitor |
/ |
否 |
HY-147849 |
JMI-105 |
Inhibitor |
/ |
否 |
HY-147850 |
JMI-346 |
Inhibitor |
/ |
否 |
HY-147860 |
EGFR-IN-61 |
Inhibitor |
/ |
否 |
HY-147862 |
EGFR-IN-62 |
|
/ |
否 |
HY-147863 |
HBV-IN-24 |
Inhibitor |
/ |
否 |
HY-147881 |
Anti-Influenza agent 3 |
Inhibitor |
/ |
否 |
HY-147913 |
PI3K/Akt/mTOR-IN-3 |
|
/ |
否 |
HY-147930 |
ACC1/2-IN-1 |
Inhibitor |
/ |
否 |
HY-147937 |
AKT-IN-13 |
Inhibitor |
/ |
否 |
HY-147939 |
AChE/BuChE-IN-3 |
Inhibitor |
/ |
否 |
HY-14794 |
Dextromilnacipran |
Inhibitor |
99.90% |
否 |
HY-147953 |
MAO-B-IN-13 |
Inhibitor |
/ |
否 |
HY-147954 |
α-Glycosidase-IN-1 |
Inhibitor |
/ |
否 |
HY-147955 |
hCAI/II-IN-5 |
Inhibitor |
/ |
否 |
HY-147957 |
Antibacterial agent 112 |
Inhibitor |
/ |
否 |
HY-147958 |
Antibacterial agent 113 |
Inhibitor |
/ |
否 |
HY-147959 |
Antibacterial agent 114 |
Inhibitor |
/ |
否 |
HY-147976 |
Glucocerebrosidase-IN-1 |
Inhibitor |
/ |
否 |
HY-147976A |
Glucocerebrosidase-IN-1 hydrochloride |
Inhibitor |
/ |
否 |
HY-14806S1 |
Teneligliptin-d4 |
Inhibitor |
/ |
否 |
HY-14810 |
Atigliflozin |
|
/ |
否 |
HY-148152 |
PSMA I&S |
|
/ |
否 |
HY-148208 |
S-(p-Nitrobenzyl)glutathione |
|
/ |
否 |
HY-148218 |
N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine |
|
/ |
否 |
HY-148246 |
MU1700 |
Inhibitor |
/ |
否 |
HY-148252 |
ADRA1D receptor antagonist 1 free base |
Antagonist |
/ |
否 |
HY-148279 |
c-Met-IN-15 |
Inhibitor |
98.50% |
否 |
HY-148292 |
C16-Sphingosine-1-phosphate |
|
/ |
否 |
HY-148309 |
Anti-Influenza agent 4 |
Inhibitor |
/ |
否 |
HY-148361 |
Fluorogen binding modulator-1 |
|
/ |
否 |
HY-148367A |
(1s,4s)-Menin-MLL inhibitor-23 |
Inhibitor |
/ |
否 |
HY-148396 |
UCK2 Inhibitor-3 |
|
/ |
否 |
HY-148406 |
(S,R,S)-AHPC-C10-NHBoc |
|
98.32% |
否 |
HY-14852S |
Tafamidis-d3 |
|
/ |
否 |
HY-148572 |
NAMPT/IDO1-IN-1 |
Inhibitor |
/ |
否 |
HY-148585 |
BTK-IN-22 |
Inhibitor |
/ |
否 |
HY-148594 |
BTK-IN-23 |
Inhibitor |
/ |
否 |
HY-148597 |
FGFR-IN-10 |
Inhibitor |
/ |
否 |
HY-148668A |
MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan |
Inhibitor |
95.11% |
否 |
HY-148669B |
(S)-Bleximenib oxalate |
Inhibitor |
98.37% |
否 |
HY-148696B |
Gly-(S)-Cyclopropane-Exatecan |
|
/ |
否 |
HY-148709 |
ARTD10/PARP10-IN-1 |
Inhibitor |
/ |
否 |
HY-148710 |
ARTD10/PARP10-IN-2 |
Inhibitor |
/ |
否 |
HY-148807B |
(S)-Zavondemstat |
Control |
97.51% |
否 |
HY-148862 |
Cavα2δ1&NET-IN-1 |
Inhibitor |
/ |
否 |
HY-149004A |
SLF1081851 TFA |
Inhibitor |
/ |
否 |
HY-149004B |
SLF1081851 hydrochloride |
|
/ |
否 |
HY-149016 |
Tubulin polymerization-IN-25 |
Inhibitor |
/ |
否 |
HY-149022 |
HSV-1/HSV-2-IN-1 |
Inhibitor |
/ |
否 |
HY-149029 |
TH-6 |
|
95.00% |
否 |
HY-149034 |
Influenza A virus-IN-8 |
Inhibitor |
/ |
否 |
HY-149053A |
(S)-OY-101 |
|
/ |
否 |
HY-149054 |
GSK-3β inhibitor 13 |
Inhibitor |
/ |
否 |
HY-149066 |
Diaporthein B |
Inhibitor |
/ |
否 |
HY-149079 |
Antiparasitic agent-15 |
|
/ |
否 |
HY-149080 |
Antiparasitic agent-16 |
|
/ |
否 |
HY-149087 |
MR2938 |
Inhibitor |
/ |
否 |
HY-149088 |
Neuraminidase-IN-16 |
Inhibitor |
/ |
否 |
HY-149105 |
FSH receptor antagonist 1 |
Antagonist |
/ |
否 |
HY-149154 |
(4S,5S,6S,12aS)-Oxytetracycline |
|
/ |
否 |
HY-149206 |
HPK1-IN-33 |
Inhibitor |
/ |
否 |
HY-149210 |
S1PR1 Radioligand 1 |
|
/ |
否 |
HY-149211 |
AChE/BChE-IN-12 |
Inhibitor |
/ |
否 |
HY-149218 |
THR-β agonist 6 |
Agonist |
/ |
否 |
HY-149221 |
Apoptosis inducer 11 |
Inducer |
/ |
否 |
HY-149245 |
Keap1-Nrf2-IN-15 |
Inhibitor |
/ |
否 |
HY-149251 |
DENV-IN-10 |
Inhibitor |
/ |
否 |
HY-149254 |
PTP1B/AKR1B1-IN-1 |
Inhibitor |
/ |
否 |
HY-149255 |
PTP1B/AKR1B1-IN-2 |
Inhibitor |
/ |
否 |
HY-149256 |
PLpro/RBD-IN-1 |
Inhibitor |
/ |
否 |
HY-14926A |
Levonadifloxacin (arginine) hydrate |
Inhibitor |
/ |
否 |
HY-149271 |
Anti-MRSA agent 7 |
Inhibitor |
/ |
否 |
HY-149272 |
tau/Aβ40 aggregation-IN-1 |
Inhibitor |
/ |
否 |
HY-149279 |
JNK3 inhibitor-7 |
Inhibitor |
/ |
否 |
HY-149280 |
JNK3 inhibitor-8 |
Inhibitor |
/ |
否 |
HY-149288 |
hAChE/hBACE-1-IN-2 |
Inhibitor |
/ |
否 |
HY-149296 |
JAK1-IN-12 |
Inhibitor |
/ |
否 |
HY-149300 |
SB-1436 |
Inhibitor |
/ |
否 |
HY-149304 |
SARS-CoV-2-IN-40 |
Inhibitor |
/ |
否 |
HY-149305 |
PptT-IN-4 |
Inhibitor |
/ |
否 |
HY-149333 |
BO-1 |
Inhibitor |
/ |
否 |
HY-149340 |
PD07 |
Inhibitor |
/ |
否 |
HY-149354 |
Aurora kinase-IN-4 |
Inhibitor |
/ |
否 |
HY-149368 |
SARS-CoV-2-IN-51 |
Inhibitor |
/ |
否 |
HY-149390 |
TrxR1-IN-1 |
Inhibitor |
/ |
否 |
HY-149401 |
EGFR-IN-82 |
Inhibitor |
/ |
否 |
HY-149407 |
Multi-kinase-IN-4 |
|
/ |
否 |
HY-14940A |
(S)-Volinanserin |
Antagonist |
/ |
否 |
HY-149418 |
BChE/HDAC6-IN-2 |
Inhibitor |
/ |
否 |
HY-149419 |
GST-IN-1 |
Inhibitor |
/ |
否 |
HY-149421 |
BRD7-IN-3 |
Inhibitor |
/ |
否 |
HY-149427 |
PI3Kα-IN-12 |
Inhibitor |
/ |
否 |
HY-149471 |
hTYR/AbTYR-IN-1 |
Inhibitor |
99.06% |
否 |
HY-149483 |
CVN417 |
Antagonist |
/ |
否 |
HY-149484 |
AChE/BChE-IN-15 |
Inhibitor |
/ |
否 |
HY-149487 |
FGFR1 inhibitor-8 |
Inhibitor |
/ |
否 |
HY-149488 |
FGFR1 inhibitor-9 |
Inhibitor |
/ |
否 |
HY-149493 |
IHMT-PI3K-455 |
Inhibitor |
/ |
否 |
HY-149497 |
HDAC6-IN-19 |
Inhibitor |
/ |
否 |
HY-149509 |
α-Synuclein inhibitor 9 |
Inhibitor |
/ |
否 |
HY-149510 |
MET/PDGFRA-IN-1 |
|
/ |
否 |
HY-149511 |
MET/PDGFRA-IN-2 |
|
/ |
否 |
HY-149514 |
BC-05 |
|
/ |
否 |
HY-149519 |
BRD4 Inhibitor-28 |
Inhibitor |
/ |
否 |
HY-149522 |
WK499 |
|
/ |
否 |
HY-149536 |
TWIK-1/TREK-1-IN-1 |
Inhibitor |
/ |
否 |
HY-149537 |
TWIK-1/TREK-1-IN-2 |
Inhibitor |
/ |
否 |
HY-149538 |
TWIK-1/TREK-1-IN-3 |
Inhibitor |
99.61% |
否 |
HY-149540 |
CTL-06 |
Inhibitor |
/ |
否 |
HY-149541 |
CTL-12 |
Inhibitor |
/ |
否 |
HY-149542 |
GSK-3β inhibitor 15 |
|
/ |
否 |
HY-149557 |
α-Amylase/α-Glucosidase-IN-5 |
Inhibitor |
/ |
否 |
HY-149630 |
VEGFR2/HDAC1-IN-1 |
|
/ |
否 |
HY-149633 |
EGFR/HER2/DHFR-IN-3 |
|
/ |
否 |
HY-149634 |
PI3Kδ-IN-17 |
Inhibitor |
/ |
否 |
HY-149635 |
HIF-1α-IN-6 |
Inhibitor |
/ |
否 |
HY-149654 |
FAAH/cPLA2α-IN-1 |
Inhibitor |
/ |
否 |
HY-149661 |
PDE5-IN-11 |
Inhibitor |
/ |
否 |
HY-149674 |
VEGFR-2/c-Met-IN-1 |
Inhibitor |
/ |
否 |
HY-149695 |
EGFR-IN-91 |
Inhibitor |
/ |
否 |
HY-149729 |
ICMT-IN-53 |
Inhibitor |
/ |
否 |
HY-149730 |
ICMT-IN-54 |
Inhibitor |
/ |
否 |
HY-149731 |
M1/M2/M4 muscarinic agonist 2 |
Agonist |
/ |
否 |
HY-149732 |
M1/M4 muscarinic agonist 3 |
Agonist |
/ |
否 |
HY-149733 |
M1/M2/M4 muscarinic agonist 3 |
Agonist |
/ |
否 |
HY-149760 |
PVD-06 |
Inhibitor |
/ |
否 |
HY-149767 |
CMX990 |
Inhibitor |
/ |
否 |
HY-14977 |
CS-0777-P |
Agonist |
/ |
否 |
HY-149770 |
CYP4A11/CYP4F2-IN-2 |
Inhibitor |
/ |
否 |
HY-14979 |
ML786 |
Inhibitor |
/ |
否 |
HY-14979A |
ML786 dihydrochloride |
Inhibitor |
/ |
否 |
HY-149803 |
S1R agonist 1 |
Agonist |
≥98.0% |
否 |
HY-149804A |
S1R agonist 2 hydrochloride |
Agonist |
≥98.0% |
否 |
HY-149837 |
PRO-F |
|
/ |
否 |
HY-149844 |
S-F24 |
Inhibitor |
/ |
否 |
HY-149849 |
TS-IN-2 |
Inhibitor |
/ |
否 |
HY-149853 |
AD186 |
Agonist |
/ |
否 |
HY-149854 |
AB21 |
Antagonist |
/ |
否 |
HY-149854A |
AB21 oxalate |
Antagonist |
/ |
否 |
HY-149855 |
AB10 |
Antagonist |
/ |
否 |
HY-149861 |
Mip-IN-1 |
Inhibitor |
/ |
否 |
HY-149912 |
CZS-241 |
|
/ |
否 |
HY-149919 |
Antimalarial agent 23 |
Inhibitor |
/ |
否 |
HY-149926 |
Cathepsin Inhibitor 3 |
|
/ |
否 |
HY-149928 |
NNRT-IN-1 |
Inhibitor |
/ |
否 |
HY-149930 |
YL5084 |
|
/ |
否 |
HY-149936 |
HIV-1 protease-IN-8 |
Inhibitor |
/ |
否 |
HY-149946 |
HDAC-IN-57 |
|
/ |
否 |
HY-149960 |
Antiparasitic agent-17 |
Inhibitor |
/ |
否 |
HY-149962 |
PROTAC CDK9 degrader-5 |
Inhibitor |
/ |
否 |
HY-149963 |
PROTAC CDK9 degrader-6 |
Inhibitor |
/ |
否 |
HY-149971 |
XJ02862-S2 |
Agonist |
/ |
否 |
HY-149995 |
Pim-1 kinase inhibitor 5 |
Inhibitor |
/ |
否 |
HY-150021 |
GRK5-IN-3 |
Inhibitor |
/ |
否 |
HY-150045 |
TP0480066 |
Inhibitor |
/ |
否 |
HY-150072A |
(2S,4R)-DS89002333 |
Control |
/ |
否 |
HY-150073 |
DS01080522 |
Inhibitor |
/ |
否 |
HY-15008 |
L-368,899 |
Antagonist |
/ |
否 |
HY-150087 |
Ctrl-CF4-S2 |
|
/ |
否 |
HY-150092 |
8(S),9(R)-EET |
|
/ |
否 |
HY-150092S |
(2S,3R)-8(9)-EET-d11 |
|
/ |
否 |
HY-15026 |
ATB 429 |
|
/ |
否 |
HY-15028A |
(S)-Otenaproxesul |
|
/ |
否 |
HY-15029S2 |
(±)-Naproxen-13C,d3 |
|
/ |
否 |
HY-15033 |
ATB-343 |
|
/ |
否 |
HY-150331 |
DNA ligase-IN-2 |
Inhibitor |
/ |
否 |
HY-15037S |
Diclofenac-13C6 sodium heminonahydrate |
|
/ |
否 |
HY-15037S2 |
Diclofenac-13C6 sodium |
|
/ |
否 |
HY-150537 |
AChE/GSK-3β-IN-1 |
Inhibitor |
/ |
否 |
HY-15056 |
AMG 9090 |
Agonist |
/ |
否 |
HY-150561 |
Trk-IN-20 |
Inhibitor |
/ |
否 |
HY-150563 |
Neuroinflammatory-IN-2 |
Inhibitor |
/ |
否 |
HY-150569 |
BCR-ABL-IN-6 |
Inhibitor |
/ |
否 |
HY-150585 |
BuChE-IN-5 |
Inhibitor |
/ |
否 |
HY-150590 |
20S Proteasome-IN-2 |
Inhibitor |
/ |
否 |
HY-150591 |
20S Proteasome-IN-3 |
Inhibitor |
/ |
否 |
HY-150601 |
Estrogen receptor-IN-1 |
Inhibitor |
99.87% |
否 |
HY-150638 |
PI3Kδ/γ-IN-3 |
|
/ |
否 |
HY-150646 |
S07-2009 |
Inhibitor |
/ |
否 |
HY-150648 |
S07-2008 |
Inhibitor |
/ |
否 |
HY-150649 |
S07-2005 (racemic) |
Inhibitor |
/ |
否 |
HY-150650 |
S07-2001 |
Inhibitor |
/ |
否 |
HY-150655 |
Hsp90-IN-15 |
Inhibitor |
/ |
否 |
HY-150692 |
Estrogen receptor α antagonist 1 |
Antagonist |
/ |
否 |
HY-150699 |
TXA6101 |
Inhibitor |
/ |
否 |
HY-150702 |
MAGLi 432 |
Inhibitor |
/ |
否 |
HY-150774 |
HDAC6/HSP90-IN-2 |
|
/ |
否 |
HY-150791 |
FLDP-5 |
|
/ |
否 |
HY-150849S |
(RS)-S-Adenosyl-L-methionine-d3 (S-methyl-d3) Tri(p-toluenesulfonate) Salt |
|
/ |
否 |
HY-150885 |
BTK ligand 1 |
Degrader |
/ |
否 |
HY-150905 |
EGFR ligand-2 |
Inhibitor |
/ |
否 |
HY-150954S |
L-Methionine-d3 (S-methyl-d3) Methyl-d3-sulfonium Chloride |
|
/ |
否 |
HY-150963 |
Renin inhibitor-1 |
Inhibitor |
/ |
否 |
HY-150968 |
Antiproliferative agent-11 |
Inducer |
/ |
否 |
HY-151069 |
TMX-2039 |
Inhibitor |
/ |
否 |
HY-151094 |
FTEAA |
Inhibitor |
/ |
否 |
HY-151146 |
(1R,3S)-THCCA-Asn |
Inhibitor |
/ |
否 |
HY-151148 |
Trypanothione synthetase-IN-1 |
|
/ |
否 |
HY-151152 |
AChE-IN-24 |
Inhibitor |
/ |
否 |
HY-151154 |
EGFR/HER2/DHFR-IN-1 |
Inhibitor |
/ |
否 |
HY-151156 |
EGFR/HER2-IN-6 |
|
/ |
否 |
HY-151158 |
EGFR/HER2-IN-7 |
Inhibitor |
/ |
否 |
HY-151161 |
EGFR/HER2-IN-8 |
Inhibitor |
/ |
否 |
HY-151171 |
MDM2/4-p53-IN-3 |
Inhibitor |
/ |
否 |
HY-151174 |
PDE4-IN-12 |
Inhibitor |
/ |
否 |
HY-151183S |
N-Acetyl-S-phenyl-DL-cysteine-3,3-d2 |
|
/ |
否 |
HY-151190 |
cis-4-Br-2,5-F2-PCPA |
Inhibitor |
/ |
否 |
HY-151195 |
20S Proteasome-IN-4 |
Inhibitor |
/ |
否 |
HY-151209 |
MAO-B-IN-15 |
Inhibitor |
/ |
否 |
HY-151210 |
MAO-B-IN-17 |
Inhibitor |
≥99.0% |
否 |
HY-151211 |
BTK-IN-16 |
Inhibitor |
/ |
否 |
HY-151215S |
S-Sulfo-DL-cysteine-2,3,3-d3-1 |
|
/ |
否 |
HY-151229 |
S-Methyl-N,N-diethylthiolcarbamate |
Inhibitor |
/ |
否 |
HY-151233 |
ALK5-IN-10 |
Inhibitor |
/ |
否 |
HY-151248 |
HDAC2-IN-1 |
Inhibitor |
/ |
否 |
HY-151256 |
JAK-2/3-IN-2 |
Inhibitor |
/ |
否 |
HY-151265 |
MMT5-14 |
Inhibitor |
/ |
否 |
HY-151269 |
SARS-CoV-2-IN-26 |
Inhibitor |
/ |
否 |
HY-151269A |
SARS-CoV-2-IN-23 disodium |
Inhibitor |
/ |
否 |
HY-151271 |
SARS-CoV-2-IN-27 |
Inhibitor |
/ |
否 |
HY-151271A |
SARS-CoV-2-IN-27 disodium |
Inhibitor |
/ |
否 |
HY-151274 |
SARS-CoV-2-IN-28 |
Inhibitor |
/ |
否 |
HY-151274A |
SARS-CoV-2-IN-28 disodium |
Inhibitor |
/ |
否 |
HY-151276 |
SARS-CoV-2-IN-29 |
Inhibitor |
/ |
否 |
HY-151276A |
SARS-CoV-2-IN-29 disodium |
Inhibitor |
/ |
否 |
HY-151278 |
SARS-CoV-2-IN-30 |
Inhibitor |
/ |
否 |
HY-151278A |
SARS-CoV-2-IN-30 disodium |
Inhibitor |
/ |
否 |
HY-151279 |
ALK5-IN-30 |
Inhibitor |
/ |
否 |
HY-151285 |
JAK-2/3-IN-3 |
|
/ |
否 |
HY-151292 |
Antitumor agent-74 |
Inhibitor |
/ |
否 |
HY-151335 |
KU-177 |
Inhibitor |
/ |
否 |
HY-151348 |
BACE1-IN-11 |
Inhibitor |
/ |
否 |
HY-151358 |
SENP2-IN-1 |
Inhibitor |
/ |
否 |
HY-151370 |
AChE-IN-26 |
|
99.73% |
否 |
HY-151386 |
BChE-IN-13 |
Inhibitor |
/ |
否 |
HY-151389 |
BChE-IN-14 |
|
/ |
否 |
HY-151390 |
hMAO-B/MB-COMT-IN-2 |
Inhibitor |
/ |
否 |
HY-151405 |
Z164597606 |
Inhibitor |
/ |
否 |
HY-151408 |
CDK1-IN-4 |
Inhibitor |
/ |
否 |
HY-151443 |
HDAC-IN-47 |
Inhibitor |
/ |
否 |
HY-15144B |
(S)-Trichostatin A |
Inhibitor |
/ |
否 |
HY-151458 |
VEGFR-2/DHFR-IN-1 |
Inhibitor |
/ |
否 |
HY-151459 |
VEGFR-2/DHFR-IN-2 |
Inhibitor |
/ |
否 |
HY-15148S1 |
Tipranavir-d7 |
Inhibitor |
/ |
否 |
HY-151536 |
meso-Benzothiazole-BODIPY 505/515 |
|
/ |
否 |
HY-151562 |
AChE/BuChE/MAO-B-IN-1 |
Inhibitor |
/ |
否 |
HY-151574 |
PfGSK3/PfPK6-IN-1 |
Inhibitor |
/ |
否 |
HY-151581 |
HCVcc-IN-1 |
Inhibitor |
/ |
否 |
HY-151587 |
Anticancer agent 89 |
|
/ |
否 |
HY-151588 |
Anticancer agent 90 |
Inhibitor |
/ |
否 |
HY-151589 |
HCVcc-IN-2 |
Inhibitor |
/ |
否 |
HY-151592 |
Anticancer agent 91 |
|
/ |
否 |
HY-15160C |
TAK-960 monohydrochloride |
Inhibitor |
/ |
否 |
HY-151627 |
11β-HSD1-IN-11 |
Inhibitor |
/ |
否 |
HY-151630 |
hCAIX-IN-16 |
Inhibitor |
/ |
否 |
HY-151639 |
(2S,4R)-H-L-Pro(4-N3)-OH |
|
/ |
否 |
HY-151639A |
(2S,4R)-H-L-Pro(4-N3)-OH hydrochloride |
|
/ |
否 |
HY-151677 |
(2R,4S)-Boc-D-Pro(4-N3)-OH |
|
/ |
否 |
HY-151677A |
(2R,4S)-Boc-D-Pro(4-N3)-OH (DCHA) |
|
/ |
否 |
HY-151689 |
(2S,3R)-Fmoc-Abu(3-N3)-OH |
|
/ |
否 |
HY-151698A |
(S,E)-TCO-NHS Ester |
|
/ |
否 |
HY-151791 |
(S,R,S)-AHPC-C6-PEG3-butyl-N3 |
|
/ |
否 |
HY-151885 |
Dual AChE-MAO B-IN-3 |
Inhibitor |
/ |
否 |
HY-151897 |
HDAC-IN-49 |
Inhibitor |
/ |
否 |
HY-151898 |
CDK4/6-IN-14 |
Inhibitor |
/ |
否 |
HY-151899 |
A3AR modulator 1 |
Agonist |
/ |
否 |
HY-151900 |
SARS-CoV-2 Mpro-IN-4 |
Inhibitor |
/ |
否 |
HY-151901 |
SARS-CoV-2 Mpro-IN-5 |
Inhibitor |
/ |
否 |
HY-151903S |
FGFR2/3-IN-1 |
Inhibitor |
/ |
否 |
HY-151917 |
Enpp/Carbonic anhydrase-IN-2 |
Inhibitor |
99.76% |
否 |
HY-151928 |
JNK3 inhibitor-3 |
Inhibitor |
/ |
否 |
HY-151935 |
Antileishmanial agent-13 |
Inhibitor |
/ |
否 |
HY-151945 |
TRK II-IN-1 |
Inhibitor |
/ |
否 |
HY-151946 |
ALR2-IN-2 |
Inhibitor |
/ |
否 |
HY-151947 |
ALR2-IN-3 |
Inhibitor |
/ |
否 |
HY-151961 |
RSH-7 |
Inhibitor |
99.07% |
否 |
HY-151967 |
Anti-IAV agent 1 |
Inhibitor |
/ |
否 |
HY-151969 |
VEGFR-2-IN-30 |
Inhibitor |
/ |
否 |
HY-151972 |
BRD4 Inhibitor-25 |
Inhibitor |
/ |
否 |
HY-151984 |
CDK9-IN-22 |
Inhibitor |
/ |
否 |
HY-152019 |
EGFR/C797S-IN-1 |
Inhibitor |
/ |
否 |
HY-152076 |
Telomerase-IN-4 |
Inducer |
/ |
否 |
HY-152109 |
AChE/MAO-IN-1 |
Inhibitor |
/ |
否 |
HY-152110 |
AChE/MAO-IN-2 |
Inhibitor |
/ |
否 |
HY-152111 |
AChE/MAO-B-IN-3 |
Inhibitor |
/ |
否 |
HY-152112 |
AChE/BChE/MAO-B-IN-2 |
Inhibitor |
/ |
否 |
HY-152113 |
AChE/BChE/MAO-B-IN-3 |
Inhibitor |
/ |
否 |
HY-152114 |
AChE/BChE/MAO-B-IN-4 |
Inhibitor |
/ |
否 |
HY-152135 |
TJ08 |
Inducer |
/ |
否 |
HY-152141 |
hCAII-IN-9 |
Inhibitor |
/ |
否 |
HY-152157 |
HIV-1 inhibitor-52 |
Inhibitor |
/ |
否 |
HY-152160 |
HIV-1 inhibitor-50 |
Inhibitor |
/ |
否 |
HY-152161 |
HIV-1 inhibitor-51 |
Inhibitor |
/ |
否 |
HY-152199 |
AMPD2 inhibitor 2 |
Inhibitor |
/ |
否 |
HY-152204 |
Cathepsin L/S-IN-1 |
Inhibitor |
/ |
否 |
HY-152208 |
BPDA2 |
Inhibitor |
/ |
否 |
HY-152210 |
ASPER-29 |
Inhibitor |
/ |
否 |
HY-152225 |
MC2625 |
|
/ |
否 |
HY-152226 |
MC2590 |
|
/ |
否 |
HY-152297 |
(1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol |
|
/ |
否 |
HY-152305 |
(1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol |
|
/ |
否 |
HY-152532 |
2’-Deoxy-2’-fluoro-6-S-Methyl-6-thio-ara-guanosine |
|
/ |
否 |
HY-152552 |
α-Synuclein inhibitor 8 |
Inhibitor |
/ |
否 |
HY-152605 |
2’-Deoxy-2’-fluoro-6-S-methyl-6-thio-arabino-inosine |
|
/ |
否 |
HY-152657 |
N1-Methyl-N3-[(2S)-2-(t-butoxycarbonyl)amino-3-(t-butoxycarbonyl)] propylpseudouridine |
|
/ |
否 |
HY-152671 |
hMAO-B-IN-4 |
Inhibitor |
99.70% |
否 |
HY-15281 |
QL-IX-55 |
Inhibitor |
/ |
否 |
HY-153058 |
LRRK2-IN-8 |
Inhibitor |
/ |
否 |
HY-15315S |
Baricitinib-d5 |
Inhibitor |
/ |
否 |
HY-153189 |
TrkB-IN-1 |
Agonist |
/ |
否 |
HY-15319A |
(±)-AMG 487 |
Inhibitor |
/ |
否 |
HY-15321S1 |
Etoricoxib-13C,d3 |
Inhibitor |
/ |
否 |
HY-15321S2 |
Etoricoxib-d3 |
|
/ |
否 |
HY-153306A |
(S)-RLY-2608 |
Control |
/ |
否 |
HY-15344A |
(S,S)-Ketone monoester |
Control |
/ |
否 |
HY-153529 |
PI5P4Ks-IN-3 |
Inhibitor |
/ |
否 |
HY-153544 |
TLR7/8 agonist 9 |
Inhibitor |
/ |
否 |
HY-153576 |
Antibacterial agent 143 |
Inhibitor |
91.85% |
否 |
HY-153583 |
HDAC8-IN-4 |
Inhibitor |
/ |
否 |
HY-153608 |
JHDM-IN-1 |
Inhibitor |
97.60% |
否 |
HY-153610 |
ARC7 |
|
99.57% |
否 |
HY-153673 |
PROTAC IRAK4 degrader-8 |
|
/ |
否 |
HY-153702 |
JAK-IN-27 |
Inhibitor |
/ |
否 |
HY-153705 |
BTK-IN-25 |
Inhibitor |
/ |
否 |
HY-153744 |
JGK-068S |
Inhibitor |
/ |
否 |
HY-153951S |
BTK-IN-26 |
Inhibitor |
/ |
否 |
HY-153980 |
K-80001 |
Inhibitor |
/ |
否 |
HY-15449A |
(S)-Kaempferide |
Inhibitor |
/ |
否 |
HY-15455S |
Roflumilast-d4 |
Inhibitor |
/ |
否 |
HY-15455S2 |
Roflumilast-d3 |
Inhibitor |
/ |
否 |
HY-154571 |
2’,3’,5’-Tri-O-acetyl-6-S-methyl-6-thio-guanosine |
|
/ |
否 |
HY-154617 |
6-S-(2-Cyanoethyl)-2’-deoxy-5’-O-DMTr--6-thioguanosine 3’-CED phosphoramidite |
|
/ |
否 |
HY-154647 |
N3-(2S)-[2-(tert-Butoxycarbonyl)amino-3-(tert-butoxy carbonyl)]propyluridine |
|
/ |
否 |
HY-154662 |
2’-Deoxy-2’-fluoro-N3-(2S)-(2-amino-3-carbonyl] propyl-beta-D-arabinouridine |
|
/ |
否 |
HY-154724 |
2’-Deoxy-2’-fluoro-N3-(2S)-[2-(tert-butoxy-carbonyl)-amino-3-carbonyl]propyluridine |
|
/ |
否 |
HY-154726 |
2’-Deoxy-2’-fluoro- N3-(2S)-(2-amino-3-carbonyl)-propyluridine |
|
/ |
否 |
HY-154797 |
N,N-Dimethyldoxorubicin |
Control |
/ |
否 |
HY-154807 |
DQn-1 |
Inhibitor |
/ |
否 |
HY-154840A |
4-Thiouridine 5′-triphosphate tetrasodium |
Agonist |
/ |
否 |
HY-154842 |
S-Gem |
|
/ |
否 |
HY-154843 |
C-Gem |
Control |
/ |
否 |
HY-154855 |
HDAC-IN-56 |
Inhibitor |
/ |
否 |
HY-154860 |
PTD10 |
Degrader |
/ |
否 |
HY-154869 |
PD-1/PD-L1-IN-34 |
Inhibitor |
/ |
否 |
HY-154957 |
mTOR inhibitor-11 |
Inhibitor |
/ |
否 |
HY-154972 |
α-Amylase/α-Glucosidase-IN-3 |
Inhibitor |
/ |
否 |
HY-155010 |
Steroid sulfatase/17β-HSD1-IN-5 |
Inhibitor |
/ |
否 |
HY-155018 |
Anticancer agent 127 |
Inhibitor |
/ |
否 |
HY-155019 |
Anticancer agent 128 |
Inhibitor |
/ |
否 |
HY-155020 |
Antitumor agent-101 |
Inhibitor |
/ |
否 |
HY-155046 |
FGFR4-IN-14 |
Inhibitor |
/ |
否 |
HY-155051 |
Antiproliferative agent-25 |
|
/ |
否 |
HY-155054 |
Cysteine protease inhibitor-3 |
Inhibitor |
/ |
否 |
HY-155055 |
Antiproliferative agent-26 |
|
/ |
否 |
HY-155059 |
Antimycobacterial agent-6 |
Inhibitor |
/ |
否 |
HY-155064 |
TRAP1-IN-2 |
Inhibitor |
/ |
否 |
HY-155112 |
Antiproliferative agent-30 |
Inhibitor |
/ |
否 |
HY-155114 |
HIV-1 inhibitor-59 |
Inhibitor |
/ |
否 |
HY-155118 |
EGFR-IN-81 |
Inhibitor |
/ |
否 |
HY-155123 |
Antioxidant agent-13 |
Inhibitor |
/ |
否 |
HY-155127 |
Antiproliferative agent-33 |
Inhibitor |
/ |
否 |
HY-155129 |
Antiviral agent 36 |
Inhibitor |
/ |
否 |
HY-155154 |
PRMT4-IN-2 |
Inhibitor |
/ |
否 |
HY-155155 |
SARS-CoV-2-IN-57 |
Inhibitor |
/ |
否 |
HY-155160 |
COX-2/15-LOX-IN-3 |
Inhibitor |
/ |
否 |
HY-155161 |
COX-2/15-LOX-IN-4 |
Inhibitor |
/ |
否 |
HY-155177 |
CDK9-IN-27 |
Inhibitor |
/ |
否 |
HY-155180 |
FD2056 |
Inhibitor |
/ |
否 |
HY-155182 |
HDAC-IN-62 |
|
/ |
否 |
HY-155185 |
NMDA receptor antagonist 7 |
Antagonist |
/ |
否 |
HY-155186 |
SARS-CoV-2 3CLpro-IN-19 |
Inhibitor |
/ |
否 |
HY-155187 |
SARS-CoV-2 3CLpro-IN-20 |
Inhibitor |
97.09% |
否 |
HY-155196 |
ER degrader 6 |
Degrader |
/ |
否 |
HY-155197 |
ER degrader 7 |
|
/ |
否 |
HY-155201 |
YJ182 |
Inhibitor |
/ |
否 |
HY-155203 |
Anticancer agent 154 |
Inducer |
/ |
否 |
HY-155218 |
TMX-2172 |
Degrader |
/ |
否 |
HY-155227A |
ALK/EGFR-IN-2 |
Inhibitor |
/ |
否 |
HY-155227B |
ALK/EGFR-IN-3 |
Inhibitor |
/ |
否 |
HY-155231 |
Neutrophil elastase inhibitor 4 |
Inhibitor |
/ |
否 |
HY-155241 |
α-Amylase/α-Glucosidase-IN-4 |
Inhibitor |
/ |
否 |
HY-155280 |
SARS-CoV-2-IN-60 |
Inhibitor |
/ |
否 |
HY-155282 |
FASN-IN-6 |
Inhibitor |
/ |
否 |
HY-155286 |
(7S,8R,17S)-RCTR1 |
|
/ |
否 |
HY-155311 |
NKG2D-IN-1 |
Inhibitor |
/ |
否 |
HY-155312 |
NKG2D-IN-2 |
Inhibitor |
/ |
否 |
HY-155359 |
Tubulin polymerization-IN-55 |
Inhibitor |
98.84% |
否 |
HY-155368 |
BChE-IN-20 |
Inhibitor |
/ |
否 |
HY-155379 |
β-Herpesvirus protease-IN-1 |
Inhibitor |
/ |
否 |
HY-155416 |
M56-S2 iodide |
Inhibitor |
/ |
否 |
HY-155441 |
CDK2-IN-20 |
Inhibitor |
/ |
否 |
HY-155453 |
IB87 |
|
/ |
否 |
HY-155481 |
CB2 receptor antagonist 3 |
Chemical |
/ |
否 |
HY-155529 |
FD1024 |
Inhibitor |
/ |
否 |
HY-155536 |
Antimalarial agent 28 |
Inhibitor |
/ |
否 |
HY-155552 |
GSPT1 degrader-1 |
|
/ |
否 |
HY-155558 |
MptpB-IN-2 |
|
/ |
否 |
HY-15556A |
GSK269962A hydrochloride |
Inhibitor |
99.73% |
否 |
HY-155593 |
JNK-1-IN-2 |
Inhibitor |
/ |
否 |
HY-155602 |
CDK2-IN-18 |
Inhibitor |
/ |
否 |
HY-155609 |
VEGFR-2-IN-31 |
Inhibitor |
/ |
否 |
HY-155620 |
PD10 |
Inhibitor |
/ |
否 |
HY-155621 |
PD24 |
Inhibitor |
/ |
否 |
HY-155622 |
PD25 |
Inhibitor |
/ |
否 |
HY-155671 |
HDAC6-IN-18 |
Inhibitor |
/ |
否 |
HY-155685 |
SA-VA |
|
/ |
否 |
HY-155687 |
PDE5-IN-10 |
Inhibitor |
/ |
否 |
HY-155703 |
LW3 |
Inhibitor |
99.87% |
否 |
HY-155708 |
AChE/BChE-IN-13 |
Inhibitor |
/ |
否 |
HY-155715 |
G43 |
Inhibitor |
99.76% |
否 |
HY-155721 |
22-(4′-py)-JA |
Inhibitor |
/ |
否 |
HY-155726 |
Cy-FBP/SBPase-IN-1 |
|
/ |
否 |
HY-155727 |
Sirt1/2-IN-2 |
|
/ |
否 |
HY-155728 |
Sirt1/2-IN-3 |
|
/ |
否 |
HY-155729 |
Sirt1/2-IN-4 |
|
/ |
否 |
HY-155734 |
SARS-CoV-2-IN-55 |
|
/ |
否 |
HY-155759 |
HMGB1-IN-2 |
Inhibitor |
/ |
否 |
HY-155781 |
Anti-inflammatory agent 53 |
Inhibitor |
/ |
否 |
HY-155806 |
h-NTPDase-IN-2 |
Inhibitor |
/ |
否 |
HY-155809 |
BET-IN-17 |
|
/ |
否 |
HY-155822 |
TZ3O |
Inhibitor |
98.17% |
否 |
HY-155827 |
h-NTPDase-IN-3 |
Inhibitor |
/ |
否 |
HY-155828 |
h-NTPDase-IN-4 |
Inhibitor |
98.64% |
否 |
HY-155829 |
h-NTPDase-IN-5 |
Inhibitor |
/ |
否 |
HY-155902 |
Mal-PEG-OH (MW 5000) |
|
/ |
否 |
HY-155902A |
Mal-PEG-OH (MW 2000) |
|
/ |
否 |
HY-155902B |
Mal-PEG-OH (MW 1000) |
|
/ |
否 |
HY-15592AS |
Cabotegravir-d3 sodium |
|
/ |
否 |
HY-15592S2 |
Cabotegravir-d3-1 |
Inhibitor |
/ |
否 |
HY-155961 |
Antidiabetic agent 2 |
Inhibitor |
/ |
否 |
HY-155963 |
Tubulin polymerization-IN-48 |
Inhibitor |
/ |
否 |
HY-155965 |
VEGFR/PARP-IN-1 |
|
/ |
否 |
HY-155967 |
CB1R/AMPK modulator 1 |
|
/ |
否 |
HY-155975 |
PI3Kδ-IN-14 |
Inhibitor |
/ |
否 |
HY-155979 |
SARS-CoV-2 3CLpro-IN-16 |
Inhibitor |
/ |
否 |
HY-155980 |
SARS-CoV-2 3CLpro-IN-17 |
Inhibitor |
/ |
否 |
HY-155981 |
SARS-CoV-2 3CLpro-IN-18 |
Inhibitor |
/ |
否 |
HY-155996 |
FD2157 |
|
/ |
否 |
HY-156003 |
HDAC-IN-64 |
Inhibitor |
/ |
否 |
HY-156011 |
PSEN1-IN-1 |
Inhibitor |
/ |
否 |
HY-156012 |
PSEN1-IN-2 |
Inhibitor |
/ |
否 |
HY-156018 |
PI3Kα-IN-13 |
Inhibitor |
/ |
否 |
HY-156020 |
Glucocerebrosidase-IN-2 |
Inhibitor |
/ |
否 |
HY-15602S |
Ledipasvir-d6 |
Inhibitor |
≥99.0% |
否 |
HY-156065 |
S217879 |
Activator |
/ |
否 |
HY-156086 |
TRK-IN-24 |
Inhibitor |
/ |
否 |
HY-156097 |
Anticancer agent 158 |
Inhibitor |
/ |
否 |
HY-156098 |
c-Met-IN-19 |
Inhibitor |
/ |
否 |
HY-156113 |
RET-IN-25 |
Inhibitor |
/ |
否 |
HY-156114 |
EGFR/CDK2-IN-2 |
Inhibitor |
/ |
否 |
HY-156115 |
EGFR/CDK2-IN-3 |
Inhibitor |
/ |
否 |
HY-156116 |
EGFR/CDK2-IN-4 |
Inhibitor |
/ |
否 |
HY-156130 |
Menin-MLL inhibitor 29 |
Inhibitor |
/ |
否 |
HY-156167 |
LRRK2-IN-10 |
Inhibitor |
/ |
否 |
HY-156202 |
Geranylgeranoic acid |
|
/ |
否 |
HY-156292 |
IHMT-EZH2-426 |
Inhibitor |
/ |
否 |
HY-156298 |
PARP1-IN-16 |
|
/ |
否 |
HY-156334 |
FAK-IN-12 |
Inhibitor |
/ |
否 |
HY-156339 |
GABA receptor Antagonist 1 |
Antagonist |
/ |
否 |
HY-156348 |
MAO-B-IN-26 |
Inhibitor |
/ |
否 |
HY-156380 |
α-Amylase/α-Glucosidase-IN-6 |
Inhibitor |
/ |
否 |
HY-156405 |
FTO-IN-10 |
|
/ |
否 |
HY-156408 |
Spns2-IN-1 |
Inhibitor |
/ |
否 |
HY-156444 |
HDAC1/CDK7-IN-1 |
|
/ |
否 |
HY-156445 |
PI3K/mTOR Inhibitor-14 |
Inhibitor |
/ |
否 |
HY-156457 |
EGFR-IN-90 |
Inhibitor |
/ |
否 |
HY-156470 |
Multi-kinase-IN-6 |
|
/ |
否 |
HY-156521 |
αvβ1 integrin-IN-2 |
Inhibitor |
/ |
否 |
HY-156523 |
TNIK&MAP4K4-IN-1 |
|
/ |
否 |
HY-156526 |
PHD-IN-1 |
Inhibitor |
/ |
否 |
HY-156528 |
pan-KRAS-IN-4 |
Inhibitor |
/ |
否 |
HY-156533 |
5-HT2 agonist-1 |
Agonist |
/ |
否 |
HY-156533A |
5-HT2 agonist-1 free base |
Agonist |
/ |
否 |
HY-156534 |
5-HT2A&5-HT2C agonist-1 |
Agonist |
/ |
否 |
HY-156565 |
S1P1 agonist 6 |
Agonist |
/ |
否 |
HY-156565A |
S1P1 agonist 6 hemicalcium |
Agonist |
/ |
否 |
HY-156661 |
MurF-IN-1 |
Inhibitor |
≥98.0% |
否 |
HY-156696 |
S3226 |
Inhibitor |
/ |
否 |
HY-156762 |
Cbl-b-IN-6 |
Inhibitor |
/ |
否 |
HY-156763 |
Cbl-b-IN-7 |
Inhibitor |
/ |
否 |
HY-156764 |
Cbl-b-IN-8 |
Inhibitor |
/ |
否 |
HY-156765 |
Cbl-b-IN-9 |
Inhibitor |
/ |
否 |
HY-156766 |
Cbl-b-IN-10 |
Inhibitor |
/ |
否 |
HY-156767 |
Cbl-b-IN-11 |
Inhibitor |
/ |
否 |
HY-156796 |
Akt/ROCK-IN-1 |
|
/ |
否 |
HY-156878 |
Antiproliferative agent-39 |
|
/ |
否 |
HY-156879 |
Antiproliferative agent-40 |
|
/ |
否 |
HY-156912 |
Tyrosine kinase-IN-7 |
Inhibitor |
99.25% |
否 |
HY-156958 |
S-72 |
|
/ |
否 |
HY-157087 |
AChE/MAO-B-IN-4 |
Inhibitor |
/ |
否 |
HY-157089 |
AChE/MAO-B-IN-5 |
Inhibitor |
/ |
否 |
HY-157092A |
(S)-ICMT-IN-3 |
Inhibitor |
/ |
否 |
HY-157116 |
ICMT-IN-48 |
Inhibitor |
/ |
否 |
HY-157166 |
EGFR kinase inhibitor 2 |
Inhibitor |
/ |
否 |
HY-157192 |
Clothianidin-2-S-propanoic acid |
|
/ |
否 |
HY-15720B |
Glycyl H-1152 hydrochloride |
Inhibitor |
/ |
否 |
HY-157216 |
HDAC1 Degrader-1 |
Degrader |
/ |
否 |
HY-157217 |
Antitumor agent-99 |
Inhibitor |
/ |
否 |
HY-157249 |
Antiviral agent 43 |
Inhibitor |
/ |
否 |
HY-157287 |
(S)-Phe-A110/B319 |
|
/ |
否 |
HY-157298 |
anti-TNBC agent-4 |
Inducer |
/ |
否 |
HY-157323 |
HDAC6-IN-28 |
|
/ |
否 |
HY-157324 |
EGFR-IN-94 |
|
/ |
否 |
HY-157391 |
ALK/ROS1-IN-3 |
Inhibitor |
/ |
否 |
HY-157394 |
eeAChE/eqBuChE-IN-1 |
Inhibitor |
/ |
否 |
HY-157399 |
EGFR/HER2-IN-10 |
Inhibitor |
/ |
否 |
HY-157400 |
hMAO-B-IN-7 |
Inhibitor |
/ |
否 |
HY-157401 |
HDAC6-IN-29 |
|
/ |
否 |
HY-157419 |
FL77-24 |
Inducer |
/ |
否 |
HY-157432 |
EGFR-IN-97 |
|
/ |
否 |
HY-157437 |
AChE/BChE-IN-16 |
Inhibitor |
/ |
否 |
HY-15743A |
(R)-Birabresib |
|
99.94% |
否 |
HY-157441 |
AChE/Aβ-IN-4 |
Inhibitor |
/ |
否 |
HY-157452 |
(8S)-Methyl zearalenone |
Inhibitor |
/ |
否 |
HY-157490 |
PARP/HDAC-IN-1 |
Inhibitor |
/ |
否 |
HY-157527 |
hAChE-IN-7 |
Inhibitor |
/ |
否 |
HY-157558 |
KDRLKZ-1 |
|
/ |
否 |
HY-157564 |
Antitumor agent-135 |
Inducer |
/ |
否 |
HY-157588 |
(S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH |
Inducer |
/ |
否 |
HY-157590 |
E3 ligase Ligand-Linker Conjugate 32 |
|
/ |
否 |
HY-157593 |
E3 ligase Ligand-Linker Conjugate 35 |
|
/ |
否 |
HY-157596 |
E3 ligase Ligand-Linker Conjugate 40 |
|
/ |
否 |
HY-157597 |
E3 ligase Ligand-Linker Conjugate 42 |
|
/ |
否 |
HY-157598 |
E3 ligase Ligand-Linker Conjugate 46 |
|
/ |
否 |
HY-157634 |
E3 Ligase Ligand-linker Conjugate 91 |
|
/ |
否 |
HY-157690 |
19(S),20(R)-EDP |
|
/ |
否 |
HY-157690A |
19(R),20(S)-EDP |
|
/ |
否 |
HY-157740 |
XSJ-10 |
Inhibitor |
/ |
否 |
HY-157749 |
Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3 |
Inducer |
/ |
否 |
HY-157752 |
E3 Ligase Ligand-linker Conjugate 101 |
|
/ |
否 |
HY-157753 |
E3 Ligase Ligand-linker Conjugate 102 |
|
/ |
否 |
HY-157754 |
E3 Ligase Ligand-linker Conjugate 103 |
|
/ |
否 |
HY-157758 |
(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 |
Inducer |
/ |
否 |
HY-157759 |
(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH |
Inducer |
/ |
否 |
HY-157760 |
(S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH |
Inducer |
/ |
否 |
HY-157787 |
Ginkgolic acid 2-phosphate |
Agonist |
/ |
否 |
HY-157792 |
Antidepressant agent 6 |
Antagonist |
/ |
否 |
HY-157934 |
MAO-IN-4 |
Inhibitor |
/ |
否 |
HY-157936 |
GluN2B-NMDAR antagonist-2 |
Antagonist |
/ |
否 |
HY-157940 |
Methylsolfonyl 25(S)-Δ7-dafachronic acid |
Agonist |
/ |
否 |
HY-157981 |
AChE-IN-60 |
Inhibitor |
/ |
否 |
HY-158049 |
Anticancer agent 199 |
Inducer |
/ |
否 |
HY-158054 |
Antifungal agent 95 |
Inhibitor |
/ |
否 |
HY-158064 |
BTK-IN-36 |
Inhibitor |
/ |
否 |
HY-158076 |
S2/IAPinh |
Inhibitor |
/ |
否 |
HY-158126 |
G-quadruplex ligand 2 |
Inhibitor |
/ |
否 |
HY-158147 |
PI3Kδ-IN-20 |
Inhibitor |
/ |
否 |
HY-158150 |
20S Proteasome-IN-5 |
Inhibitor |
/ |
否 |
HY-158210 |
Wnt/β-catenin-IN-3 |
|
/ |
否 |
HY-158265 |
FLT3D835Y/F691L-IN-1 |
Inhibitor |
/ |
否 |
HY-158318 |
NUDT5/14 antagonist 1 |
Inhibitor |
/ |
否 |
HY-158365 |
LRRK2-IN-14 |
Inhibitor |
/ |
否 |
HY-158401 |
Antibiofilm agent-7 |
Inhibitor |
/ |
否 |
HY-158402 |
Anti-inflammatory agent 84 |
Inhibitor |
/ |
否 |
HY-158436 |
Antitumor agent-155 |
|
/ |
否 |
HY-158440 |
SARS-CoV-2 Mpro-IN-17 |
Inhibitor |
/ |
否 |
HY-158441 |
A2G2S1 glycan (G2S1), 2-AA labelled |
|
/ |
否 |
HY-158443 |
A2G2S1 glycan (G2S1), 2-AB labelled |
|
/ |
否 |
HY-158463 |
A2G2S2-KVANKT glycopeptide |
|
/ |
否 |
HY-158468 |
Sialylated Core 1 O-glycan (C1S(3)1), 2AB labelled |
|
/ |
否 |
HY-158472 |
Sialylated Core 1 O-glycan (C1S(3)1) |
|
/ |
否 |
HY-158474 |
A2G2S1 glycan (G2S1), APTS labelled |
|
/ |
否 |
HY-158475 |
A2G2S1 glycan (G2S1) |
|
/ |
否 |
HY-158476 |
FA2G2S1 glycan (G2FS1), procainamide labelled |
|
/ |
否 |
HY-158477 |
FA2G2S1 glycan (G2FS1) |
|
/ |
否 |
HY-158486 |
FA2G2S1 glycan (G2FS1), 2-AA labelled |
|
/ |
否 |
HY-158502 |
FA2G2S1 glycan (G2FS1), 2-AB labelled |
|
/ |
否 |
HY-158504 |
FA2G2S1 glycan (G2FS1), APTS labelled |
|
/ |
否 |
HY-158506 |
A2G2S2 glycan (G2S2) |
|
/ |
否 |
HY-158508 |
A2G2S2 glycan (G2S2), 2-AA labelled |
|
/ |
否 |
HY-158510 |
A2G2S2 glycan (G2S2), APTS labelled |
|
/ |
否 |
HY-158512 |
A2G2S2 glycan (G2S2), 2-AB labelled |
|
/ |
否 |
HY-158513 |
FA2G2S2 glycan (G2FS2) |
|
/ |
否 |
HY-158515 |
FA2G2S2 glycan (G2FS2), 2-AB labelled |
|
/ |
否 |
HY-158517 |
FA2G2S2 glycan (G2FS2), APTS labelled |
|
/ |
否 |
HY-158518 |
FA2G2S2 glycan (G2FS2), 2-AA labelled |
|
/ |
否 |
HY-158525 |
A3G3S3 glycan |
|
/ |
否 |
HY-158533 |
A3G3S3 glycan, 2-AA labelled |
|
/ |
否 |
HY-158535 |
A3G3S3 glycan, 2-AB labelled |
|
/ |
否 |
HY-158537 |
A3G3S3 glycan, procainamide labelled |
|
/ |
否 |
HY-158638 |
NBD-FTY720 phenoxy hydrochloride |
|
/ |
否 |
HY-158684 |
YX-02-030 |
Degrader |
/ |
否 |
HY-158685 |
RG7112D |
MDM2 Inhibitor |
/ |
否 |
HY-15882 |
GNE-783 |
|
/ |
否 |
HY-158978 |
Multitarget AD inhibitor-2 |
Inhibitor |
/ |
否 |
HY-159007 |
BD-AcAc2 |
|
/ |
否 |
HY-159116 |
AChE-IN-69 |
Inhibitor |
/ |
否 |
HY-159122 |
CA IX-IN-2 |
|
/ |
否 |
HY-159149 |
Antitumor agent-182 |
Inducer |
/ |
否 |
HY-159152 |
PQM-164 |
Inhibitor |
/ |
否 |
HY-159160 |
HBV-IN-46 |
Inhibitor |
/ |
否 |
HY-159171 |
sEH/HDAC6-IN-2 |
Inhibitor |
/ |
否 |
HY-159173 |
AChE-IN-71 |
Inhibitor |
/ |
否 |
HY-159176 |
Antitumor agent-183 |
Substrate |
/ |
否 |
HY-15923 |
MAOS |
|
99.98% |
否 |
HY-159449 |
PROTAC SMARCA2 degrader-5 |
Degrader |
/ |
否 |
HY-159451 |
PROTAC SMARCA2 degrader-7 |
Inhibitor |
/ |
否 |
HY-159452 |
PROTAC SMARCA2/4-degrader-1 |
|
/ |
否 |
HY-159453 |
PROTAC SMARCA2/4-degrader-2 |
|
/ |
否 |
HY-159455 |
PROTAC SMARCA2/4-degrader-4 |
Degrader |
/ |
否 |
HY-159456 |
PROTAC SMARCA2/4-degrader-5 |
Degrader |
/ |
否 |
HY-159458 |
PROTAC SMARCA2/4-degrader-7 |
|
/ |
否 |
HY-159459 |
PROTAC SMARCA2/4-degrader-32 |
|
/ |
否 |
HY-159460 |
PROTAC SMARCA2/4-degrader-8 |
Inhibitor |
/ |
否 |
HY-159461 |
PROTAC SMARCA2/4-degrader-9 |
Degrader |
/ |
否 |
HY-159487 |
(S,R,S)-AHPC-CO-spiro[3.3]heptane-Ph-CHO |
|
/ |
否 |
HY-159517 |
PI3K/Akt/mTOR-IN-5 |
|
/ |
否 |
HY-159537 |
(S,R,S)-AHPC-CO-bicyclo[2.2.2]octane-CHO |
|
/ |
否 |
HY-159547 |
Cyclopropane-(S,R,S)-AHPC |
|
/ |
否 |
HY-159548 |
Cyclopropane-(S,R,S)-AHPC-CO-cyclohexene-Bpin |
|
/ |
否 |
HY-159550 |
(S,R,S)-AHPC-CO-cyclohexene-Bpin |
|
/ |
否 |
HY-159553 |
Ac-NH-(S,R,S)-AHPC |
|
/ |
否 |
HY-159558 |
(S,R,S)-AHPC-CO-cyclohexane-C-Ph-pyrimidine-diazabicyclo |
|
/ |
否 |
HY-159584 |
LBG20304 |
Inhibitor |
/ |
否 |
HY-15958A |
(S,R,R)-VBY-825 |
|
98.01% |
否 |
HY-159593 |
Ac-NH-(S,R,S)-AHPC-CO-cyclohexane-pyrimidine-diazabicyclo |
|
/ |
否 |
HY-159594 |
Dimethylformamide-(S,R,S)-AHPC-CO-cyclohexane-pyrimidine-diazabicyclo |
|
/ |
否 |
HY-159608 |
PROTAC Cbl-b-IN-1 |
|
/ |
否 |
HY-159609 |
PROTAC GSPT1 degrader-1 |
|
/ |
否 |
HY-159610 |
PROTAC GSPT1 degrader-2 |
|
/ |
否 |
HY-159618 |
(3S)Lenalidomide-5-Pip-C-Pip-2C-Pip |
|
/ |
否 |
HY-159681 |
AASS-IN-1 |
|
/ |
否 |
HY-159767A |
(S)-DOTAGA.(SA.FAPi)2 |
|
/ |
否 |
HY-15977 |
(S)-P7C3-OMe |
|
/ |
否 |
HY-159943 |
ROS151 |
Inhibitor |
/ |
否 |
HY-159964 |
USP7-IN-16 |
Inhibitor |
/ |
否 |
HY-15997A |
(+)-U-50488 hydrochloride |
Agonist |
/ |
否 |
HY-159982 |
SH7s |
Inhibitor |
/ |
否 |
HY-160022 |
XIAP BIR2/BIR2-3 inhibitor-1 |
Inhibitor |
/ |
否 |
HY-160024 |
XIAP BIR2/BIR2-3 inhibitor-2 |
Inhibitor |
/ |
否 |
HY-160030 |
XIAP BIR2/BIR2-3 inhibitor-3 |
Inhibitor |
/ |
否 |
HY-160062 |
S2.2 aptamer sodium |
Chemical |
/ |
否 |
HY-160127 |
SerSA |
|
/ |
否 |
HY-160455 |
GSTP1-1 inhibitor 1 |
|
/ |
否 |
HY-160478 |
GNF-6 |
Inhibitor |
/ |
否 |
HY-160481 |
MG-1102 |
Inhibitor |
/ |
否 |
HY-160555 |
(S,R,S)-AHPC-CO-C9-NH2 |
|
/ |
否 |
HY-160555A |
(S,R,S)-AHPC-CO-C9-NH2 hydrochloride |
|
98.79% |
否 |
HY-160613 |
EGFR/HER2-IN-11 |
Inhibitor |
/ |
否 |
HY-160876 |
BC-1901S |
Activator |
/ |
否 |
HY-160945 |
NMT-IN-7 |
Inhibitor |
/ |
否 |
HY-161019 |
JAK1/TYK2-IN-4 |
Inhibitor |
/ |
否 |
HY-161032 |
IP6K2-IN-1 |
Inhibitor |
/ |
否 |
HY-161067 |
EGFR-IN-96 |
|
/ |
否 |
HY-161079 |
TDI-8304 |
Inhibitor |
/ |
否 |
HY-161125 |
(+)-JQ1-OH |
|
/ |
否 |
HY-161146 |
EGFR-IN-100 |
|
/ |
否 |
HY-161156 |
BChE-IN-26 |
Inhibitor |
/ |
否 |
HY-161170 |
Antimalarial agent 36 |
Inhibitor |
/ |
否 |
HY-161183 |
(S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc |
Inducer |
/ |
否 |
HY-161194 |
(S,R,S)-AHPC-acetyl-azetidine-PIP-boc |
|
/ |
否 |
HY-161207 |
(S,R,S)-AHPC-acetyl-Pip-O-azetidine-boc |
|
/ |
否 |
HY-161211 |
HSD17B13-IN-7 |
|
/ |
否 |
HY-161249 |
Vanin-1-IN-4 |
Inhibitor |
/ |
否 |
HY-161250 |
Pomalidomide-NH-PEG6-amide-C2-CPI-1612 |
|
/ |
否 |
HY-161269 |
EGFR-IN-101 |
Inhibitor |
/ |
否 |
HY-161282 |
hCAII-IN-10 |
Inhibitor |
/ |
否 |
HY-161284 |
MMP-9/10-IN-1 |
Inhibitor |
/ |
否 |
HY-161319 |
EGFR-IN-104 |
Inhibitor |
/ |
否 |
HY-161327 |
HBV-IN-44 |
Inhibitor |
/ |
否 |
HY-161331 |
S16–1029 |
Inhibitor |
/ |
否 |
HY-161332 |
Antitumor agent-143 |
|
/ |
否 |
HY-161334 |
CARM1-IN-4 |
|
/ |
否 |
HY-161350 |
ALK/HDAC-IN-1 |
Inhibitor |
/ |
否 |
HY-161371 |
VD5123 |
Inhibitor |
/ |
否 |
HY-161372 |
PARP1/c-Met-IN-1 |
|
/ |
否 |
HY-161429 |
Antidiabetic agent 5 |
Inhibitor |
/ |
否 |
HY-161441 |
SIK-IN-2 |
Inhibitor |
/ |
否 |
HY-161442 |
SIK-IN-3 |
Inhibitor |
/ |
否 |
HY-161445 |
(S,R,S)-AHPC-Me-piperazine-acetyl-PIP-AcOH |
|
/ |
否 |
HY-161502 |
DHX-SP |
|
/ |
否 |
HY-161539 |
KOR agonist 1 |
Agonist |
/ |
否 |
HY-161573A |
(7S)-BAY-593 |
Inhibitor |
99.61% |
否 |
HY-161577 |
BFC1103 |
|
/ |
否 |
HY-161596 |
SmCB1-IN-1 |
Inhibitor |
/ |
否 |
HY-161602 |
EGFR/HER2-IN-13 |
Inhibitor |
/ |
否 |
HY-161603 |
EGFR/HER2-IN-14 |
Inhibitor |
/ |
否 |
HY-161608 |
Myosin modulator 1 |
Modulator |
/ |
否 |
HY-161609 |
Myosin modulator 2 |
Modulator |
/ |
否 |
HY-161614 |
Tubulin inhibitor 44 |
Inhibitor |
/ |
否 |
HY-161628 |
Tapcin |
Inhibitor |
/ |
否 |
HY-161642 |
DENV-2/ZIKV-IN-1 |
Inhibitor |
/ |
否 |
HY-161643 |
S21-1011 |
|
/ |
否 |
HY-161654 |
PROTAC SOS1 degrader-10 |
Degrader |
/ |
否 |
HY-161665 |
BDZ-P7 |
Inhibitor |
/ |
否 |
HY-161667 |
GSK-3β/HDAC-IN-1 |
Inhibitor |
/ |
否 |
HY-161687 |
Cisplatin/Dasatinib prodrug-1 |
Inhibitor |
/ |
否 |
HY-161688 |
HDAC-IN-73 |
|
/ |
否 |
HY-161694 |
DNMT1-IN-3 |
Inhibitor |
/ |
否 |
HY-161707 |
MMP2-IN-4 |
Inhibitor |
/ |
否 |
HY-161708 |
PROTAC FLT3/CDKs degrader-1 |
Degrader |
/ |
否 |
HY-161721 |
Cathepsin Inhibitor 4 |
Inhibitor |
/ |
否 |
HY-161725 |
TFEB activator 3 |
Inhibitor |
/ |
否 |
HY-16172A |
(S)-DMAPT |
Inhibitor |
/ |
否 |
HY-161751 |
MJ34 |
Inhibitor |
/ |
否 |
HY-161772 |
(S)-Gebr32a |
Inhibitor |
/ |
否 |
HY-161780 |
Maleimide-PEG8-Val-Ala-PAB-SNS032 |
Inhibitor |
/ |
否 |
HY-161784 |
GABAA receptor modulator-5 |
Modulator |
/ |
否 |
HY-161785 |
EGFR-IN-117 |
Inhibitor |
/ |
否 |
HY-161789 |
PROTAC SARS-CoV-2 Mpro degrader-3 |
Inhibitor |
/ |
否 |
HY-161793 |
(S,R,S)-AHPC-NHCO-C-O-C5-N3 |
|
/ |
否 |
HY-161815 |
Anti-inflammatory agent 89 |
|
/ |
否 |
HY-161817 |
TGR5 agonist 5 |
Agonist |
/ |
否 |
HY-161825 |
Tubulin polymerization-IN-66 |
|
/ |
否 |
HY-161826 |
Antitumor agent-174 |
Inhibitor |
/ |
否 |
HY-161832 |
(S,R,S)-Me-AHPC-amide-C3-alkyne |
|
/ |
否 |
HY-161836 |
α2AR agonist 1 |
Agonist |
/ |
否 |
HY-161838 |
ICT10336 |
Inhibitor |
/ |
否 |
HY-161852 |
PI3K-IN-55 |
|
/ |
否 |
HY-161858 |
EpskA21 |
|
/ |
否 |
HY-161861 |
VEGFR-2/AKT-IN-1 |
Inhibitor |
/ |
否 |
HY-161863 |
Tubulin polymerization-IN-67 |
|
/ |
否 |
HY-161873 |
PW507 |
Antagonist |
/ |
否 |
HY-161885 |
SMARCA2-IN-6 |
Inhibitor |
/ |
否 |
HY-161891 |
EGFR/Akt-IN-1 |
Inhibitor |
/ |
否 |
HY-161923 |
EGFR-IN-120 |
|
/ |
否 |
HY-161925 |
sTGFBR3 antagonist 1 |
Antagonist |
/ |
否 |
HY-162006 |
Pim-1 kinase inhibitor 8 |
Inhibitor |
99.90% |
否 |
HY-162008 |
S1g-10 |
Inhibitor |
/ |
否 |
HY-162012 |
HC-258 |
|
/ |
否 |
HY-162032 |
FLT3-IN-25 |
Inhibitor |
/ |
否 |
HY-162036 |
α-Amylase/α-Glucosidase-IN-7 |
Inhibitor |
/ |
否 |
HY-162046 |
Anticancer agent 178 |
Inducer |
/ |
否 |
HY-162062 |
EGFR WT/T790M/L858R-IN-1 |
Inhibitor |
/ |
否 |
HY-162084 |
BKN-1 |
Inducer |
/ |
否 |
HY-162090 |
TRPC antagonist 1 |
Antagonist |
/ |
否 |
HY-162108 |
Antitumor agent-128 |
Inducer |
/ |
否 |
HY-162110A |
(S)-AM-9022 |
Control |
99.88% |
否 |
HY-162123 |
PPARα/δ agonist 2 |
Agonist |
/ |
否 |
HY-162148 |
HNPMI |
Inhibitor |
99.57% |
否 |
HY-162160 |
NR12S |
|
/ |
否 |
HY-162162 |
RXR agonist 1 |
Agonist |
/ |
否 |
HY-162167 |
COX-1-IN-1 |
Inhibitor |
/ |
否 |
HY-162169 |
α-Amylase/α-Glucosidase-IN-8 |
Inhibitor |
/ |
否 |
HY-162193 |
E3 Ligase Ligand-linker Conjugate 27 |
|
/ |
否 |
HY-162202 |
E3 Ligase Ligand-linker Conjugate 50 |
|
/ |
否 |
HY-162253 |
HIV-1 inhibitor-64 |
Inhibitor |
/ |
否 |
HY-162273 |
Antibacterial agent 189 |
Inhibitor |
/ |
否 |
HY-162279 |
Insecticidal agent 8 |
|
/ |
否 |
HY-162281 |
PROTAC SOS1 degrader-6 |
Degrader |
/ |
否 |
HY-162303 |
C175-0062 |
Inhibitor |
/ |
否 |
HY-162320 |
PPARγ agonist 12 |
Agonist |
/ |
否 |
HY-162332 |
EGFR-PK/JNK-2-IN-1 |
|
/ |
否 |
HY-162342 |
Topoisomerase I inhibitor 14 |
Inhibitor |
/ |
否 |
HY-162349 |
PARP7/HDACs-IN-1 |
Inhibitor |
/ |
否 |
HY-162358 |
DHFR-IN-17 |
Inhibitor |
/ |
否 |
HY-162367 |
FLT3/CHK1-IN-2 |
Inhibitor |
/ |
否 |
HY-162371 |
NRPSs-IN-1 |
|
/ |
否 |
HY-162380 |
Topoisomerase II inhibitor 18 |
Inhibitor |
/ |
否 |
HY-162401 |
AZ7976 |
Agonist |
/ |
否 |
HY-162403 |
Antiviral agent 53 |
|
/ |
否 |
HY-162404 |
Smad2/3-IN-2 |
Inhibitor |
/ |
否 |
HY-162405 |
Smad2/3-IN-1 |
Inhibitor |
/ |
否 |
HY-162406 |
UNC8969 |
|
/ |
否 |
HY-162407 |
I-As-1 |
Inhibitor |
/ |
否 |
HY-162411 |
E3 ligase Ligand 24 |
|
/ |
否 |
HY-162446 |
pan-KRAS-IN-13 |
Inhibitor |
/ |
否 |
HY-162447 |
P-gp inhibitor 22 |
|
/ |
否 |
HY-162451 |
Antibacterial agent 207 |
|
/ |
否 |
HY-162458 |
Antifungal agent 100 |
Inhibitor |
/ |
否 |
HY-162459 |
cGAS-IN-3 |
Inhibitor |
/ |
否 |
HY-162477 |
TS-24 |
|
98.96% |
否 |
HY-162490 |
TF-S14 |
Inhibitor |
/ |
否 |
HY-162573 |
Monoamine Oxidase B inhibitor 5 |
Inhibitor |
/ |
否 |
HY-162577 |
FGFR-IN-14 |
Inhibitor |
/ |
否 |
HY-162578 |
PPARα/γ agonist 4 |
Agonist |
/ |
否 |
HY-162583 |
PDE4-IN-17 |
Inhibitor |
/ |
否 |
HY-162621 |
BET-IN-25 |
Inhibitor |
/ |
否 |
HY-162629 |
LDHA-IN-7 |
Inhibitor |
/ |
否 |
HY-162634 |
α-Amylase/α-Glucosidase-IN-15 |
Inhibitor |
/ |
否 |
HY-162641 |
AF-45 |
Inhibitor |
/ |
否 |
HY-162643 |
Antitumor agent-169 |
Inhibitor |
/ |
否 |
HY-162655A |
SLF80821178 hydrochloride |
Inhibitor |
/ |
否 |
HY-162674 |
MERS-CoV-IN-2 |
Inhibitor |
/ |
否 |
HY-162681 |
eeAChE-IN-3 |
Inhibitor |
/ |
否 |
HY-162693 |
AChE-IN-68 |
Inhibitor |
/ |
否 |
HY-162698 |
JMF4073 |
Inhibitor |
/ |
否 |
HY-162699 |
LY2023-001 |
Inhibitor |
/ |
否 |
HY-162741 |
PROTAC SMARCA2/4-degrader-33 |
|
/ |
否 |
HY-162760 |
COMT-IN-1 |
Inhibitor |
/ |
否 |
HY-162766 |
Antitumor agent-184 |
Inducer |
/ |
否 |
HY-162775 |
TST1N-224 |
Inhibitor |
/ |
否 |
HY-162781 |
HDAC1/6-IN-2 |
Inhibitor |
/ |
否 |
HY-162788 |
EGFR-IN-121 |
Inhibitor |
/ |
否 |
HY-162791 |
(1s,4s)-C1-Piperidine-C1-cyclohexane-C1 |
|
/ |
否 |
HY-162801 |
Neuraminidase-IN-21 |
Inhibitor |
/ |
否 |
HY-162813 |
PROTAC SMARCA2/4-degrader-25 |
|
/ |
否 |
HY-162815 |
PROTAC SMARCA2/4-degrader-26 |
|
/ |
否 |
HY-162829 |
hURAT1 inhibitor 1 |
Inhibitor |
/ |
否 |
HY-162835 |
PROTAC SMARCA2/4-degrader-28 |
Degrader |
/ |
否 |
HY-162836 |
Rifamycin B |
Inhibitor |
/ |
否 |
HY-162845 |
TLR7/8 agonist 11 |
Agonist |
/ |
否 |
HY-162847 |
S24–14 |
|
/ |
否 |
HY-162852 |
OAF89 |
Chemical |
/ |
否 |
HY-162860 |
FO-4-15 |
|
/ |
否 |
HY-162881 |
DS06652923 |
Inhibitor |
/ |
否 |
HY-162891 |
EGFR-IN-123 |
Inhibitor |
/ |
否 |
HY-162898 |
Anti-virulence factor-IN-1 |
Inhibitor |
/ |
否 |
HY-162927 |
p53-MDM2-IN-6 |
|
/ |
否 |
HY-162934 |
TFCP2L1-IN-1 |
Inducer |
99.66% |
否 |
HY-162940 |
MerTK/Axl-IN-1 |
Inhibitor |
/ |
否 |
HY-162941 |
SGD-9501-TFA |
|
/ |
否 |
HY-162944 |
NA-Ir |
|
/ |
否 |
HY-162955 |
LSD1/HDAC-IN-1 |
Inhibitor |
/ |
否 |
HY-162962 |
IDO1/TDO-IN-7 |
Inhibitor |
/ |
否 |
HY-162964 |
EGFR-IN-126 |
Inhibitor |
/ |
否 |
HY-163062 |
Tubulin/NRP1-IN-1 |
|
/ |
否 |
HY-163091 |
EP4 receptor antagonist 5 |
Antagonist |
/ |
否 |
HY-163116 |
Anti-inflammatory agent 67 |
Inhibitor |
/ |
否 |
HY-163117 |
Anti-inflammatory agent 68 |
Inhibitor |
/ |
否 |
HY-163119 |
Pim-1 kinase inhibitor 9 |
Inhibitor |
/ |
否 |
HY-163150 |
5-HT6R antagonist 3 |
Antagonist |
/ |
否 |
HY-163153 |
Anticancer agent 184 |
Inducer |
/ |
否 |
HY-163175 |
BChE-IN-24 |
Inhibitor |
/ |
否 |
HY-163187 |
COX-2/LOX-IN-1 |
Inhibitor |
/ |
否 |
HY-163188 |
COX-2/LOX-IN-2 |
Inhibitor |
/ |
否 |
HY-163201 |
TMV-IN-7 |
Inhibitor |
/ |
否 |
HY-163202 |
MAGL-IN-13 |
Inhibitor |
/ |
否 |
HY-163207 |
sEH/HDAC6-IN-1 |
Inhibitor |
/ |
否 |
HY-163208 |
VH 032 amide-alkylC9-amine hydrochloride |
|
/ |
否 |
HY-163209 |
VH 032 amide-PEG6-amine hydrochloride |
|
/ |
否 |
HY-163214 |
(S)-PROTAC PTK6 ligand-1-(2S,4R)-O-CH2-O-hygric acid |
|
/ |
否 |
HY-163215 |
(S)-PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc |
|
/ |
否 |
HY-163216 |
PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc |
|
/ |
否 |
HY-163217 |
PROTAC PTK6 ligand-2,7-diazaspiro[3.5]nonane-Boc |
|
/ |
否 |
HY-163218 |
PROTAC PTK6 ligand-1-(2S,4R)-O-CH2-O-hygric acid |
|
/ |
否 |
HY-163220 |
(S,R,S)-AHPC-CO-CH2-O-CH2-piperidine-Boc |
|
/ |
否 |
HY-163221 |
(S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-N(Me)-Boc |
Inducer |
/ |
否 |
HY-163223 |
(S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc |
|
/ |
否 |
HY-163224 |
(S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc |
|
/ |
否 |
HY-163225 |
(S)-Thalidomide-piperazine-(1S,4r)-cyclohexane-NH-Boc |
Inducer |
/ |
否 |
HY-163226 |
(1R,5S)-Thalidomide-3,8-diazabicyclo[3.2.1]octane-(1R,4r)-cyclohexane-NH-Boc |
Inducer |
/ |
否 |
HY-163228 |
PROTAC PTK6 ligand-O-C2-O-piperidine-Boc |
|
/ |
否 |
HY-163230 |
(1R,5S)-Thalidomide-3,8-diazabicyclo[3.2.1]octane-Boc |
Inducer |
/ |
否 |
HY-163231 |
(S,R,S)-AHPC-CO-CH2-azetidine-piperazine-CH2-COOH |
|
/ |
否 |
HY-163273 |
FGFR4-IN-17 |
Inhibitor |
/ |
否 |
HY-163274 |
NOD1 antagonist-1 |
Antagonist |
/ |
否 |
HY-163278 |
Lck-IN-2 |
|
/ |
否 |
HY-163282 |
NB512 |
Inhibitor |
/ |
否 |
HY-163283 |
6′-Methyl paeonol |
Inhibitor |
/ |
否 |
HY-163288 |
EZH2/HSP90-IN-29 |
|
/ |
否 |
HY-163295 |
BTK degrader-1 |
Degrader |
/ |
否 |
HY-163332 |
MPO-IN-6 |
Inhibitor |
/ |
否 |
HY-163349 |
TUG-2099 |
Inhibitor |
/ |
否 |
HY-163380 |
CA/MAO-B-IN-1 |
Inhibitor |
98.34% |
否 |
HY-163382 |
Cbz-Gly-Pro-Ala-O-cinnamyl |
Inhibitor |
/ |
否 |
HY-163402 |
EGFR-IN-108 chloride |
|
/ |
否 |
HY-163434 |
PRMT5/EGFR-IN-1 |
Inhibitor |
/ |
否 |
HY-163437 |
Antitubercular agent-45 |
Inhibitor |
/ |
否 |
HY-163443 |
PPAR agonist 4 |
Agonist |
/ |
否 |
HY-163452 |
Squalene synthase-IN-2 |
Inhibitor |
/ |
否 |
HY-163486 |
Antituberculosis agent-10 |
Inhibitor |
/ |
否 |
HY-163502 |
PROTAC STAT3 degrader-3 |
Degrader |
/ |
否 |
HY-163514 |
hAChE-IN-8 |
Inhibitor |
/ |
否 |
HY-163515 |
Anticancer agent 207 |
Inhibitor |
/ |
否 |
HY-163569 |
FGFR4-IN-20 |
Inhibitor |
/ |
否 |
HY-163604 |
PDE4B/D-IN-1 |
Inhibitor |
/ |
否 |
HY-163605 |
PDE4B/D-IN-2 |
Inhibitor |
/ |
否 |
HY-163606 |
PDE4B/D-IN-3 |
Inhibitor |
/ |
否 |
HY-163613 |
NS163 |
Inhibitor |
/ |
否 |
HY-163632 |
EGFR-IN-112 |
Inhibitor |
/ |
否 |
HY-163655 |
Glutaminyl Cyclase Inhibitor 6 |
Inhibitor |
/ |
否 |
HY-163661 |
p53-MDM2-IN-5 |
|
/ |
否 |
HY-163679 |
PROTAC ERα Degrader-9 |
|
/ |
否 |
HY-163692 |
Tubulin polymerization-IN-64 |
|
/ |
否 |
HY-163695 |
NLRP3-IN-41 |
Inhibitor |
/ |
否 |
HY-163697 |
WEE1-IN-7 |
|
/ |
否 |
HY-163700 |
Fabl inhibitor 1 |
Inhibitor |
/ |
否 |
HY-163708 |
Antibacterial agent |
Inhibitor |
/ |
否 |
HY-163709 |
PROTAC FAK degrader 2 |
Degrader |
/ |
否 |
HY-163715 |
Antitumor agent-165 |
Inhibitor |
/ |
否 |
HY-163722 |
EGFR/DHFR-IN-1 |
Inhibitor |
/ |
否 |
HY-163735 |
BA6b9 |
Inhibitor |
/ |
否 |
HY-163762 |
Antibacterial agent 226 |
Inhibitor |
/ |
否 |
HY-163770 |
Anticancer agent 233 |
Inhibitor |
/ |
否 |
HY-163802 |
Nurr1 agonist 10 |
Agonist |
/ |
否 |
HY-163806 |
NT376 |
Inhibitor |
/ |
否 |
HY-163808 |
Anticancer agent 237 |
Inducer |
/ |
否 |
HY-163830 |
Pegasus |
Agonist |
/ |
否 |
HY-163834 |
HDAC6-IN-47 |
Inhibitor |
/ |
否 |
HY-163854 |
HSP70-IN-6 |
|
/ |
否 |
HY-163861 |
Tl45b |
Inhibitor |
/ |
否 |
HY-163869 |
PROTAC SMARCA2/4-degrader-16 |
|
/ |
否 |
HY-163875 |
PROTAC SMARCA2/4-degrader-22 |
|
/ |
否 |
HY-163876 |
PROTAC SMARCA2/4-degrader-23 |
|
/ |
否 |
HY-163890 |
Succinate dehydrogenase-IN-2 |
Inhibitor |
/ |
否 |
HY-163892 |
POLRMT-IN-1 |
Inhibitor |
/ |
否 |
HY-163904 |
(S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH |
|
/ |
否 |
HY-163913 |
SARS-CoV-IN-5 |
Inhibitor |
/ |
否 |
HY-163919 |
N,N-Dimethyl-idarubicin-trisaccharide |
|
/ |
否 |
HY-163930 |
(S,R,S)-AHPC-CO-cyclohexane-C2 |
|
/ |
否 |
HY-163932 |
(S,R,S)-AHPC-O-CF3 |
|
/ |
否 |
HY-163933 |
(S,R,S)-AHPC-CO-C-cyclohexane |
|
/ |
否 |
HY-163934 |
(S,R,S)-AHPC-phenylacetic acid |
|
/ |
否 |
HY-163935 |
(S,R,S)-AHPC-m-Tolylacetic acid |
|
/ |
否 |
HY-163936 |
(S,R,S)-AHPC-p-toluic acid |
|
/ |
否 |
HY-163937 |
(S,R,S)-AHPC-O-CF3
-CO-cyclohexane |
|
/ |
否 |
HY-163950 |
(S,R,S)-AHPC-O-CF3-CO-cyclohexene-Bpin |
|
/ |
否 |
HY-163951 |
(S,R,S)-AHPC-Ac |
|
/ |
否 |
HY-163952 |
(S,R,S)-AHPC-Ac-CO-cyclohexene-Bpin |
|
/ |
否 |
HY-163953 |
(S,R,S)-AHPC-Ala |
|
/ |
否 |
HY-163954 |
(S,R,S)-AHPC-Ala-CO-cyclohexene-Bpin |
|
/ |
否 |
HY-163961 |
(S)-Thalidomide-NH-cyclohexane-NH-Ph-NH2 |
|
/ |
否 |
HY-164105 |
S-Lactylglutathione |
|
/ |
否 |
HY-164349 |
WZ-2-033 |
Inhibitor |
/ |
否 |
HY-164392 |
TAS-121 |
|
/ |
否 |
HY-164397 |
XMU-MP-5 |
|
/ |
否 |
HY-164411 |
KRC-00715 |
Inhibitor |
/ |
否 |
HY-164490 |
LS-106 |
|
/ |
否 |
HY-164689 |
Cadmium pyrithione |
Inhibitor |
/ |
否 |
HY-164694 |
Emupertinib |
Inhibitor |
/ |
否 |
HY-164815 |
S 8849-1 free base |
|
/ |
否 |
HY-164829 |
Mal-C5-Gly-Gly-Phe-MMAE |
Inhibitor |
/ |
否 |
HY-164906 |
TMX-2138 |
Degrader |
/ |
否 |
HY-164911 |
VU0546110 |
Inhibitor |
/ |
否 |
HY-164924 |
ERD-12310A |
|
/ |
否 |
HY-164956 |
TB-9 |
Inhibitor |
/ |
否 |
HY-164978 |
KIF18A-IN-14 |
Inhibitor |
/ |
否 |
HY-164979 |
KIF18A-IN-15 |
Inhibitor |
/ |
否 |
HY-165030 |
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC |
|
/ |
否 |
HY-165097 |
1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC |
|
/ |
否 |
HY-165132 |
Floramultine |
Inhibitor |
/ |
否 |
HY-165668S |
Pitavastatin lactone-d4 |
|
/ |
否 |
HY-16622A |
GSK 1842799 TFA |
Modulator |
/ |
否 |
HY-16622B |
GSK 1842799 hydrochloride |
|
/ |
否 |
HY-167580 |
18:1 Hemi BMP (S,R) |
|
/ |
否 |
HY-167697 |
Antifungal agent 120 |
Inhibitor |
/ |
否 |
HY-16776A |
(2S,5S)-Censavudine |
|
98.12% |
否 |
HY-167841 |
Anti-MRSA agent 19 |
Inhibitor |
/ |
否 |
HY-167911 |
Cidofovir sodium |
|
/ |
否 |
HY-167939 |
(R)-Bambuterol |
|
/ |
否 |
HY-168019 |
(S,R,S)-AHPC-PEG2-C2-boc |
|
/ |
否 |
HY-168026 |
CEP1347-VHL-02 |
|
/ |
否 |
HY-168055 |
(S)-Deoxy-thalidomide |
|
/ |
否 |
HY-168076 |
(S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-CH2-Me-PIP-Boc |
|
/ |
否 |
HY-168082 |
Dot1L-IN-8 |
Inhibitor |
/ |
否 |
HY-168105 |
RET-IN-27 |
Inhibitor |
/ |
否 |
HY-168112 |
EGFR-IN-127 |
Inhibitor |
/ |
否 |
HY-168115 |
Multi-kinase inhibitor 4 |
Inhibitor |
/ |
否 |
HY-168152 |
SARS-CoV-2 3CLpro-IN-26 |
Inhibitor |
/ |
否 |
HY-168154 |
COMT-IN-2 |
Inhibitor |
/ |
否 |
HY-168180 |
WEE1-IN-11 |
Inhibitor |
/ |
否 |
HY-168235 |
(S,R,S)-AHPC-Me-amide-C9-acid |
Degrader |
/ |
否 |
HY-168286 |
FGFR-IN-16 |
Inhibitor |
/ |
否 |
HY-168308 |
(S)-Deoxy-thalidomide-Br |
|
/ |
否 |
HY-168310 |
(S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-C-Pip |
|
/ |
否 |
HY-168317 |
LNK2-S |
|
/ |
否 |
HY-168338 |
CB2 receptor agonist 8 |
|
/ |
否 |
HY-168339 |
Tyk2-IN-22 |
Inhibitor |
/ |
否 |
HY-168342 |
Anti-Trypanosoma cruzi agent-6 |
Inhibitor |
/ |
否 |
HY-168345 |
Ap4dT |
|
/ |
否 |
HY-168349 |
(S)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2 |
|
/ |
否 |
HY-168371 |
1-Palmitoyl-2-13(S)-HODE-sn-glycero-3-PC |
|
/ |
否 |
HY-168398 |
9(S),12(S),13(S)-TriHODE |
|
/ |
否 |
HY-168433 |
LSD1/EGFR-IN-1 |
Inhibitor |
/ |
否 |
HY-168435 |
VEGFR-2-IN-63 |
Inhibitor |
/ |
否 |
HY-168459 |
MAGL-IN-21 |
Inhibitor |
/ |
否 |
HY-168469 |
EGFR-IN-148 |
Inhibitor |
/ |
否 |
HY-168471 |
AAL-149 |
Inhibitor |
/ |
否 |
HY-168487 |
PROTAC WDR5 degrader 1 |
|
/ |
否 |
HY-168498 |
GJG057 |
Inhibitor |
/ |
否 |
HY-168512 |
BRAFV600E-IN-1 |
Inhibitor |
/ |
否 |
HY-168514 |
SOS1/EGFR-IN-2 |
Inhibitor |
/ |
否 |
HY-168540 |
PROTAC MPS1 degrader 1 |
Degrader |
/ |
否 |
HY-168543 |
PROTAC MPS1 degrader 2 |
Degrader |
/ |
否 |
HY-168558 |
PDE4B/D-IN-4 |
Inhibitor |
/ |
否 |
HY-168573 |
AZ99 |
Inhibitor |
/ |
否 |
HY-168591 |
CTSC-IN-1 |
Inhibitor |
/ |
否 |
HY-168622 |
AChE-IN-79 |
Inhibitor |
/ |
否 |
HY-168627 |
EGFR-IN-135 |
Inhibitor |
/ |
否 |
HY-168632 |
Topoisomerase I/II inhibitor 6 |
|
/ |
否 |
HY-168639 |
AMPK activator 15 |
Activator |
/ |
否 |
HY-168648 |
DNA Gyrase/DHFR-IN-1 |
Inhibitor |
/ |
否 |
HY-168694 |
E3 Ligase Ligand-linker Conjugate 147 |
|
/ |
否 |
HY-168712 |
FXIa-IN-15 |
Inhibitor |
/ |
否 |
HY-168714 |
Microtubule inhibitor 12 |
|
/ |
否 |
HY-168729 |
Antibacterial agent 256 |
Inhibitor |
/ |
否 |
HY-168853 |
Antibacterial agent 261 |
Inhibitor |
/ |
否 |
HY-168859 |
JNK3 inhibitor-9 |
Inhibitor |
/ |
否 |
HY-168878 |
EP652 |
Inhibitor |
/ |
否 |
HY-168884 |
AV457 |
Inhibitor |
/ |
否 |
HY-168902 |
Proteasome-IN-7 |
Inhibitor |
/ |
否 |
HY-168962 |
HDAC-IN-88 |
|
/ |
否 |
HY-168966 |
PDE2 inhibitor 6 |
|
/ |
否 |
HY-169014 |
HDAC-IN-77 |
|
/ |
否 |
HY-169043 |
(±)7(S),8(R)-EDT |
Control |
/ |
否 |
HY-169048 |
CDK2/4-IN-2 |
Inhibitor |
/ |
否 |
HY-169058 |
GSTP1-1 inhibitor 2 |
Inhibitor |
/ |
否 |
HY-16907 |
GSK-364735 |
Inhibitor |
/ |
否 |
HY-169075 |
CDK/HDAC-IN-4 |
|
/ |
否 |
HY-169080 |
ABCA1 inducer 1 |
Inducer |
/ |
否 |
HY-169095 |
(S,R,S)-AHPC-Me-CO-C9-NH2 |
|
/ |
否 |
HY-169105 |
DNA Gyrase-IN-12 |
Inhibitor |
/ |
否 |
HY-169109 |
DAPK1-IN-1 |
Inhibitor |
/ |
否 |
HY-169121 |
DA-143 |
Inhibitor |
/ |
否 |
HY-169134 |
PROTAC 20S proteasome subunit β5 degrader 1 |
Inducer |
/ |
否 |
HY-169135 |
PROTAC 20S proteasome subunit β5 degrader 2 |
Degrader |
/ |
否 |
HY-169144 |
Bortezomib analog |
|
/ |
否 |
HY-169158 |
Bortezomib analog 1 |
|
/ |
否 |
HY-169160 |
Anti-MRSA agent 18 |
Inhibitor |
/ |
否 |
HY-169172 |
Bfl-1-IN-5 |
|
/ |
否 |
HY-169176 |
LpxC-IN-15 |
Inhibitor |
/ |
否 |
HY-169177 |
JNK-1-IN-4 |
Inhibitor |
/ |
否 |
HY-169210 |
ECDD-S18 |
Inducer |
/ |
否 |
HY-169228 |
WS-11 |
Inhibitor |
/ |
否 |
HY-169298 |
Ferroptosis-IN-15 |
Inhibitor |
/ |
否 |
HY-169299 |
TOPOI/PARP-1-IN-2 |
|
/ |
否 |
HY-169306 |
IL-17A inhibitor 4 |
Inhibitor |
/ |
否 |
HY-169307 |
BTK-IN-38 |
Inhibitor |
/ |
否 |
HY-169308 |
EGFR-IN-132 |
Inhibitor |
/ |
否 |
HY-169309 |
EGFR-IN-133 |
Inhibitor |
/ |
否 |
HY-169311 |
KRAS inhibitor-37 |
Inhibitor |
/ |
否 |
HY-169331 |
H2S scavenger 1 (triflate) |
Inhibitor |
/ |
否 |
HY-169338 |
Antibacterial agent 253 |
Inhibitor |
/ |
否 |
HY-169372 |
(S,R,S)-AHPC-CO-C4-bromine |
|
/ |
否 |
HY-169378 |
CSI86 |
Degrader |
/ |
否 |
HY-169382 |
Melatonin-Tamoxifen Conjugate |
Inhibitor |
/ |
否 |
HY-169395 |
(S,R,S)-AHPC-CO-PEG-C2-iodine |
|
/ |
否 |
HY-169403 |
NW16 |
|
/ |
否 |
HY-169405 |
AAK1/HDACs-IN-1 |
Inhibitor |
/ |
否 |
HY-169408 |
EGFR-IN-137 |
|
/ |
否 |
HY-169413 |
AKT-IN-25 |
Inhibitor |
/ |
否 |
HY-169427 |
FRF-06-057 |
Inhibitor |
/ |
否 |
HY-169428 |
EGFR-IN-138 |
|
/ |
否 |
HY-169431 |
VEGFR-2/AKT-IN-2 |
|
/ |
否 |
HY-169445 |
(±)-Meclonazepam |
Control |
/ |
否 |
HY-16946 |
CP-610431 |
Inhibitor |
/ |
否 |
HY-169737 |
Inulobiose |
Inhibitor |
/ |
否 |
HY-169797 |
STAT3-IN-38 |
|
/ |
否 |
HY-169800 |
17S-FD-895 |
Inhibitor |
/ |
否 |
HY-169803 |
L-657926 |
|
/ |
否 |
HY-169831 |
HUP-55 |
Inhibitor |
/ |
否 |
HY-169928 |
WRN inhibitor 14 |
Inhibitor |
/ |
否 |
HY-169938 |
LSD1/HDAC-IN-2 |
|
/ |
否 |
HY-169939 |
1ACTA |
Inhibitor |
/ |
否 |
HY-169970 |
Me-(S,R,S)-AHPC-CO-CH2-Br |
|
/ |
否 |
HY-169984S |
Tyk2-IN-22-d3 |
Inhibitor |
/ |
否 |
HY-17021S |
Esomeprazole-d3 sodium |
Inhibitor |
/ |
否 |
HY-17021S1 |
Esomeprazole-d3 |
Inhibitor |
/ |
否 |
HY-17021S2 |
Esomeprazole-d3 potassium |
Inhibitor |
/ |
否 |
HY-17023S |
Esomeprazole-d6 sodium |
Inhibitor |
/ |
否 |
HY-170340 |
PROTAC ER Degrader-14 |
|
/ |
否 |
HY-170348 |
(S)-(S,R,S,R)-AHPC-Me-N3 |
|
/ |
否 |
HY-170377 |
ER degrader 10 |
|
/ |
否 |
HY-17038S2 |
Agomelatine-d3 |
|
≥98.0% |
否 |
HY-170398 |
ZG297 |
Inhibitor |
/ |
否 |
HY-170400 |
LNK4-S |
|
/ |
否 |
HY-170405 |
YB-3–17 |
Inhibitor |
/ |
否 |
HY-170418 |
ALK/ROS1-IN-5 |
|
/ |
否 |
HY-170438 |
EGFR-IN-139 |
|
/ |
否 |
HY-170440 |
ATV2301 |
Inhibitor |
/ |
否 |
HY-170446 |
MyD88-IN-2 |
Inhibitor |
/ |
否 |
HY-170482 |
Bouin's solution |
|
/ |
否 |
HY-170483 |
Antitumor agent-191 |
Inhibitor |
/ |
否 |
HY-170487 |
MAO-B-IN-38 |
Inhibitor |
/ |
否 |
HY-170494 |
AS-254s |
Inhibitor |
/ |
否 |
HY-170497 |
EGFR-IN-140 |
Inhibitor |
/ |
否 |
HY-170517 |
PKMYT1-IN-8 |
Inhibitor |
/ |
否 |
HY-170524 |
TDI-015051 |
Inhibitor |
/ |
否 |
HY-170544 |
RIPK1-IN-28 |
Inhibitor |
/ |
否 |
HY-170582 |
PTP1B-IN-29 |
Inhibitor |
/ |
否 |
HY-170615 |
Autophagy inducer 6 |
|
/ |
否 |
HY-170640 |
FLT3-IN-29 |
|
/ |
否 |
HY-170670 |
DQ661 |
Inhibitor |
/ |
否 |
HY-170823 |
PRC1-IN-1 |
Inhibitor |
/ |
否 |
HY-170828 |
SMD-1087 |
Degrader |
/ |
否 |
HY-170841 |
HDAC3/BRD4-IN-1 |
Inhibitor |
/ |
否 |
HY-170846 |
FGFRs-IN-1 |
Inhibitor |
/ |
否 |
HY-170869 |
PROTAC FGFR1 degrader-1 |
Degrader |
/ |
否 |
HY-170887 |
MAO-B-IN-39 |
|
/ |
否 |
HY-170895 |
Hsp90-IN-38 |
Inhibitor |
/ |
否 |
HY-170903 |
GABAA receptor modulator-3 |
Agonist |
/ |
否 |
HY-170906S |
MAT2A-IN-23 |
Inhibitor |
/ |
否 |
HY-170911 |
KIT/PDGFRA-IN-1 |
Inhibitor |
/ |
否 |
HY-170912 |
Topo I/II-IN-2 |
|
/ |
否 |
HY-170914 |
JPHM-2-167 |
Inhibitor |
/ |
否 |
HY-170919 |
FGFR2/3-IN-2 |
Inhibitor |
/ |
否 |
HY-170924 |
Tubulin polymerization-IN-76 |
|
/ |
否 |
HY-170927 |
JAK-IN-40 |
|
/ |
否 |
HY-170928 |
DA-0157 |
Inhibitor |
/ |
否 |
HY-170932 |
EGFR/COX-2-IN-1 |
|
/ |
否 |
HY-170938 |
AChE-IN-82 |
Inhibitor |
/ |
否 |
HY-170942 |
CDK9/PARP-IN-1 |
Inhibitor |
/ |
否 |
HY-170946 |
WR-S-462 |
Inhibitor |
/ |
否 |
HY-170955 |
HA-CD44 interaction inhibitor 3 |
Inhibitor |
/ |
否 |
HY-170958 |
Scr-IN-1 |
|
/ |
否 |
HY-170959 |
NYY-6a |
Inhibitor |
/ |
否 |
HY-170992 |
Autophagy agonist-1 |
|
/ |
否 |
HY-170995 |
PROTAC ROR1 degrader-1 |
|
/ |
否 |
HY-171132 |
PRMT3-IN-5 |
Inhibitor |
/ |
否 |
HY-171277 |
Casein kinase 1δ-IN-27 |
Inhibitor |
/ |
否 |
HY-171328 |
RG-15 |
Antagonist |
/ |
否 |
HY-172092 |
BG11 |
Inducer |
/ |
否 |
HY-172110 |
Apoptosis inducer 35 |
|
/ |
否 |
HY-172111 |
EGFR-IN-144 |
|
/ |
否 |
HY-172129 |
HDAC6-IN-52 |
Inhibitor |
/ |
否 |
HY-172140 |
Ebio3 |
Inhibitor |
/ |
否 |
HY-172143 |
ATUX-8385 |
Activator |
/ |
否 |
HY-172157 |
HDAC11-IN-2 |
|
/ |
否 |
HY-172159 |
FF2039 |
Inhibitor |
/ |
否 |
HY-172162 |
LC-04-045 |
|
/ |
否 |
HY-172171 |
GSK3β-IN-2 |
|
/ |
否 |
HY-172203 |
BI-1915 |
Inhibitor |
/ |
否 |
HY-172213 |
(3S,6R)-NML |
Antagonist |
/ |
否 |
HY-172217 |
DNMT1-IN-5 |
|
/ |
否 |
HY-172241 |
Tapencarium |
Inhibitor |
/ |
否 |
HY-172359 |
PROTAC HDAC6 degrader 4 |
Degrader |
/ |
否 |
HY-172363 |
Succinate dehydrogenase-IN-6 |
Inhibitor |
/ |
否 |
HY-172392 |
HSND80 |
Inhibitor |
/ |
否 |
HY-172396 |
PD-L1/VISTA-IN-2 |
Inhibitor |
/ |
否 |
HY-172423 |
Darlifarnib |
Inhibitor |
/ |
否 |
HY-172426 |
Dirozalkib |
Inhibitor |
/ |
否 |
HY-172430S |
Epaldeudomide |
Antagonist |
/ |
否 |
HY-173010 |
Me-(S,R,S)-AHPC-CO-C5-N3 |
|
/ |
否 |
HY-173034 |
PTP1B-IN-30 |
|
/ |
否 |
HY-173038 |
EGFR-IN-151 |
|
/ |
否 |
HY-173062 |
BRD4 Inhibitor-40 |
Inhibitor |
/ |
否 |
HY-173064 |
DS-103 |
Inhibitor |
/ |
否 |
HY-173093 |
Me-(S,R,S)-AHPC-CO-CH2-PEG4-O-CH2-COOH |
|
/ |
否 |
HY-17356G |
Fenofibrate (GMP) |
|
/ |
否 |
HY-17356S |
Fenofibrate-d6 |
|
99.70% |
否 |
HY-17356S1 |
Fenofibrate-d4 |
|
/ |
否 |
HY-17368S2 |
Rivastigmine-d3 hydrochloride |
Inhibitor |
/ |
否 |
HY-17372S |
Rofecoxib-d5 |
Inhibitor |
/ |
否 |
HY-17380S |
(S)-Timolol-d9 maleate |
Antagonist |
/ |
否 |
HY-17382S |
Metoclopramide-d3 |
Antagonist |
/ |
否 |
HY-17386S |
Rosiglitazone-d3 |
|
/ |
否 |
HY-17387S1 |
(-)-Huperzine A-d4 hydrochloride |
|
/ |
否 |
HY-17447AS |
(1S,2R)-Tranylcypromine-d5 hydrochloride |
|
/ |
否 |
HY-17453S |
Salmeterol-d3 xinafoate |
Agonist |
/ |
否 |
HY-17453S1 |
Salmeterol-13C6 xinafoate |
Agonist |
/ |
否 |
HY-17459S |
Clopidogrel-d3 hydrogen sulfate |
|
/ |
否 |
HY-17466A |
Sancycline hydrochloride |
|
/ |
否 |
HY-17504D |
(3S,5R)-Rosuvastatin |
|
/ |
否 |
HY-17586AS |
Dalbavancin-d6 |
|
/ |
否 |
HY-17618A |
Rac-Pemafibrate |
Agonist |
/ |
否 |
HY-18100 |
PRE-084 |
|
/ |
否 |
HY-18164 |
TASP0277308 |
Antagonist |
/ |
否 |
HY-18213 |
EGFR-IN-9 |
Inhibitor |
98.84% |
否 |
HY-18351A |
Indotecan hydrochloride |
Inhibitor |
/ |
否 |
HY-18507A |
AD57 hydrochloride |
Inhibitor |
/ |
否 |
HY-18621B |
(S)-OTS514 |
Control |
/ |
否 |
HY-18629A |
(E/Z)-SU9516 |
|
/ |
否 |
HY-18690S |
Enasidenib-d6 |
Inhibitor |
/ |
否 |
HY-18949 |
JI6 |
Inhibitor |
/ |
否 |
HY-18958A |
(S)-CCT245737 |
Inhibitor |
/ |
否 |
HY-19015 |
Probimane |
Inhibitor |
/ |
否 |
HY-19054 |
CGP-20376 |
Inhibitor |
/ |
否 |
HY-19325 |
SKI2852 |
Inhibitor |
98.33% |
否 |
HY-19433A |
(S)-ATPO |
|
/ |
否 |
HY-19434A |
cis-ACPD |
Agonist |
/ |
否 |
HY-19486 |
UR-1505 |
Inhibitor |
/ |
否 |
HY-19490A |
(S)-VQW-765 |
Agonist |
98.00% |
否 |
HY-19511A |
GSK2018682 hydrochloride |
Agonist |
/ |
否 |
HY-19528S1 |
SAH-13C5 |
|
/ |
否 |
HY-19570A |
NSC 15830 hydrochloride |
Inhibitor |
/ |
否 |
HY-19614 |
BMS-795311 |
Inhibitor |
/ |
否 |
HY-19717S |
DCVC-13C3,15N |
|
/ |
否 |
HY-19755 |
S-5751 |
Antagonist |
/ |
否 |
HY-19822S2 |
Elacestrant-d10 |
Degrader |
/ |
否 |
HY-19850 |
Exeporfinium chloride |
|
/ |
否 |
HY-19985A |
(3S,4S)-PF-06459988 |
|
99.85% |
否 |
HY-22385B |
(S)-Salsolidine |
Inhibitor |
/ |
否 |
HY-402309 |
IGF-1R modulator 1 |
Modulator |
/ |
否 |
HY-41631 |
Boc-Pyr-Oet |
|
≥98.0% |
否 |
HY-42938 |
(S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride |
|
/ |
否 |
HY-44630 |
VH 032 amide-alkylC6-acid |
|
/ |
否 |
HY-48394A |
Bis-S-C2-N(N-Me)-C2-OH dihydrochloride |
|
/ |
否 |
HY-50682A |
Azeliragon dihydrochloride |
Inhibitor |
/ |
否 |
HY-50687 |
(3S,4S)-Tivantinib |
Inhibitor |
98.71% |
否 |
HY-50767S1 |
Palbociclib-d4 hydrochloride |
Inhibitor |
/ |
否 |
HY-50856S2 |
Ruxolitinib-d9 |
|
/ |
否 |
HY-50878AS |
Crizotinib-d9 hydrochloride |
|
/ |
否 |
HY-50904S |
Nintedanib-d3 |
Inhibitor |
/ |
否 |
HY-50905S |
Dovitinib-d8 |
Inhibitor |
/ |
否 |
HY-50907S |
ABT-737-d8 |
|
99.11% |
否 |
HY-59140S1 |
(S)-2-Amino-3,3-dimethylbutanoic acid-18O, d2 |
|
/ |
否 |
HY-59140S2 |
(S)-2-Amino-3,3-dimethylbutanoic acid-d6 |
|
/ |
否 |
HY-70059A |
(Rac)-LY341495 |
Control |
97.73% |
否 |
HY-76996S1 |
(S)-5-Hydroxymethyl Tolterodine-d14 formate |
|
/ |
否 |
HY-77324S |
4-(Trifluoromethyl)aniline-d4 |
Inhibitor |
99.23% |
否 |
HY-78131AS |
(S)-(+)-Ibuprofen D3 |
Inhibitor |
98.87% |
否 |
HY-78131S1 |
Ibuprofen-13C,d3 |
|
/ |
否 |
HY-78327AS |
(S)-(+)-Modafinic acid-d5 |
Activator |
/ |
否 |
HY-78746A |
(3S,4R,5S)-rel-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-neopentylpyrrolidine-2-carboxylic acid |
|
96.90% |
否 |
HY-A0021AS |
(S,R)-Palonosetron-d3 hydrochloride |
|
/ |
否 |
HY-A0031S |
Bazedoxifene-d4 |
Modulator |
/ |
否 |
HY-A0031S2 |
Bazedoxifene-d4 acetate |
|
/ |
否 |
HY-A0052S |
(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 |
|
/ |
否 |
HY-A0104A |
HPMC (Type I,Viscosity:30mPa.s) |
|
/ |
否 |
HY-A0104E |
HPMC (Type II,Viscosity:100mPa.s) |
|
/ |
否 |
HY-A0104F |
HPMC (Type II,Viscosity:400mPa.s) |
|
/ |
否 |
HY-A0104G |
HPMC (Type II,Viscosity:4000mPa.s) |
|
/ |
否 |
HY-A0104H |
HPMC (Type II,Viscosity:15000mPa.s) |
|
/ |
否 |
HY-A0104I |
HPMC (Type II,Viscosity:100000mPa.s) |
|
/ |
否 |
HY-B0003AS |
(2S)-Gemcitabine-13C,15N2 hydrochloride |
|
/ |
否 |
HY-B0006BS |
(S)-Carvedilol-d4 |
Inhibitor |
/ |
否 |
HY-B0027R |
Valnemulin (hydrochloride) (Standard) |
Inhibitor |
/ |
否 |
HY-B0032AS |
Lurasidone-d8 |
|
/ |
否 |
HY-B0091S |
Adapalene-d3 |
|
/ |
否 |
HY-B0101S1 |
Fluconazole-13C2,15N |
Inhibitor |
/ |
否 |
HY-B0105BS |
(-)-Ketoconazole-d3 |
Inhibitor |
/ |
否 |
HY-B0106AS |
Etiracetam-d3 |
Agonist |
/ |
否 |
HY-B0161AS |
Duloxetine D3 hydrochloride |
Inhibitor |
/ |
否 |
HY-B0161AS1 |
Duloxetine-d7 hydrochloride |
Inhibitor |
/ |
否 |
HY-B0168BS |
Milnacipran-d5 ((1S-cis) hydrochloride) |
Inhibitor |
/ |
否 |
HY-B0196B |
(S)-Venlafaxine |
Inhibitor |
/ |
否 |
HY-B0199AS |
Mycophenolate Mofetil-d4 hydrochloride |
|
/ |
否 |
HY-B0220S1 |
Erythromycin-13C,d3 |
Inhibitor |
/ |
否 |
HY-B0220S2 |
Erythromycin-d3 |
|
≥95.0% |
否 |
HY-B0227S1 |
Ketoprofen-d4 |
|
≥98.0% |
否 |
HY-B0227S2 |
Ketoprofen-13C,d3 |
|
/ |
否 |
HY-B0239S3 |
Chloramphenicol-d4 |
Inhibitor |
/ |
否 |
HY-B0246S4 |
Carbamazepine-d4 |
|
/ |
否 |
HY-B0253S1 |
Piroxicam-d4 |
Inhibitor |
/ |
否 |
HY-B0261S1 |
Meloxicam-d3-1 |
|
≥98.0% |
否 |
HY-B0287S |
Clofibrate-d4 |
Agonist |
/ |
否 |
HY-B0311AS |
Carbidopa-d3 monohydrate |
Modulator |
≥98.0% |
否 |
HY-B0311D |
Carbidopa hydrochloride |
Modulator |
/ |
否 |
HY-B0311S1 |
Carbidopa-d3-1 |
Modulator |
/ |
否 |
HY-B0330S1 |
(S)-Ofloxacin-d3 |
Inhibitor |
≥98.0% |
否 |
HY-B0352AS |
(S)-Mirtazapine-d3 |
Antagonist |
≥99.0% |
否 |
HY-B0363S |
Nimesulide D5 |
Inhibitor |
/ |
否 |
HY-B0395DS |
(1R,2S,7R)-Sitafloxacin-d4 hydrochloride |
|
/ |
否 |
HY-B0442AS |
Vardenafil-d5 hydrochloride |
Inhibitor |
/ |
否 |
HY-B0462B |
(S)-Azelastine hydrochloride |
|
/ |
否 |
HY-B0471S2 |
(S)-Phenylephrine-d6 hydrochloride |
Agonist |
/ |
否 |
HY-B0479S1 |
Thiamphenicol-d3-1 |
|
/ |
否 |
HY-B0536A |
Clinafloxacin hydrochloride |
Inhibitor |
/ |
否 |
HY-B0551S |
Doxapram-d8 |
Inhibitor |
/ |
否 |
HY-B0574S |
Mefenamic acid D4 |
Inhibitor |
≥98.0% |
否 |
HY-B0574S1 |
Mefenamic Acid-d3 |
Inhibitor |
/ |
否 |
HY-B0574S2 |
Mefenamic acid-13C6 |
Inhibitor |
/ |
否 |
HY-B0602D |
(S)-(+)-O-Desmethyl Venlafaxine |
|
/ |
否 |
HY-B0602S1 |
(S)-(+)-O-Desmethyl Venlafaxine-d6 |
|
99.77% |
否 |
HY-B0612B |
(S)-Lercanidipine |
Inhibitor |
/ |
否 |
HY-B0612E |
(S)-Lercanidipine hydrochloride |
Inhibitor |
/ |
否 |
HY-B0612ES |
(S)-Lercanidipine-d3 hydrochloride |
|
/ |
否 |
HY-B0617B |
S-Adenosyl-L-methionine (1,4-butanedisulfonate) |
Inhibitor |
/ |
否 |
HY-B0619S1 |
Zaltoprofen-13C,d3 |
Inhibitor |
/ |
否 |
HY-B0623AS1 |
Ropinirole-d7 hydrochloride |
|
/ |
否 |
HY-B0623AS2 |
Ropinirole-d3 hydrochloride |
|
/ |
否 |
HY-B0637S1 |
Bezafibrate-d4 |
Agonist |
/ |
否 |
HY-B0792A |
CZC-54252 hydrochloride |
Inhibitor |
98.44% |
否 |
HY-B0793S1 |
AZ-5104-d2 |
Inhibitor |
/ |
否 |
HY-B0808S1 |
Oxaprozin-d5 |
Inhibitor |
/ |
否 |
HY-B0814S1 |
Levocetirizine-d4 |
|
/ |
否 |
HY-B0822S1 |
Fipronil-13C6 |
|
/ |
否 |
HY-B0827B |
(S)-Dinotefuran |
Inhibitor |
/ |
否 |
HY-B0843S |
Metalaxyl-13C6 |
Inhibitor |
/ |
否 |
HY-B0843S1 |
Metalaxyl-d6 |
Inhibitor |
/ |
否 |
HY-B0847S1 |
Propiconazole-d3 nitrate |
|
/ |
否 |
HY-B0852R |
Tebuconazole (Standard) |
|
/ |
否 |
HY-B0852S |
Tebuconazole-d9 |
Inhibitor |
/ |
否 |
HY-B0887B |
(-)-trans-Permethrin |
|
99.76% |
否 |
HY-B0905S |
Tilmicosin-d3 |
|
/ |
否 |
HY-B1059S |
Levosulpiride-d3 |
Antagonist |
99.79% |
否 |
HY-B1138S |
Fenbufen-d9 |
Inhibitor |
/ |
否 |
HY-B1190BS |
L-Cefadroxil-d4 trifluoroacetate |
|
/ |
否 |
HY-B1190S1 |
Cefadroxil-d4 trifluoroacetate |
Inhibitor |
/ |
否 |
HY-B1227S |
Carprofen-d3 |
Inhibitor |
/ |
否 |
HY-B1227S1 |
Carprofen-13C,d3 |
|
/ |
否 |
HY-B1334AS |
Perhexiline-d11 maleate |
Inhibitor |
/ |
否 |
HY-B1700B |
(S,S)-Mivacurium dichloride |
|
/ |
否 |
HY-B1804S |
Tricaprilin-13C3 |
|
/ |
否 |
HY-B1804S1 |
Tricaprilin-d50 |
|
/ |
否 |
HY-B1804S2 |
Tricaprilin-d15 |
|
/ |
否 |
HY-B1888AS |
Bromfenac-d4 sodium |
Inhibitor |
/ |
否 |
HY-B1895S |
Levodropropizine-d8 |
Inhibitor |
/ |
否 |
HY-B2031S |
Pyriproxyfen-d6 |
|
/ |
否 |
HY-B2031S1 |
Pyriproxyfen-d4 |
|
/ |
否 |
HY-B2144G |
Chitosan (≥80% deacetylated, High viscosity,>400mPa.s) |
|
/ |
否 |
HY-B2144J |
Chitosan (≥90% deacetylated,viscosity 650-700 mPa.s) |
Inhibitor |
/ |
否 |
HY-B2221B1 |
Hydroxyethyl cellulose, Viscosity(2%):150mPa.s |
|
/ |
否 |
HY-B2221B2 |
Hydroxyethyl cellulose, Viscosity(2%):40000mPa.s |
|
/ |
否 |
HY-B2221B3 |
Hydroxyethyl cellulose, Viscosity(2%):6000mPa.s |
|
/ |
否 |
HY-CE00001 |
(2R,3S)-3-Fluoro-2-methylhexadecanoyl-CoA |
|
/ |
否 |
HY-CE00065 |
(25S)-3-Oxocholest-4-en-26-oyl-CoA |
|
/ |
否 |
HY-CE00074 |
(25S)-3Alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA |
|
/ |
否 |
HY-CE00077 |
(25S)-3Beta-hydroxy-5-cholesten-26-oyl-CoA |
|
/ |
否 |
HY-CE00091A |
(1S)-(Methylenecyclopropyl)acetyl-CoA |
|
/ |
否 |
HY-CE00140 |
(2S)-2,6-Dimethylheptanoyl-CoA |
|
/ |
否 |
HY-CE00149 |
(2S)-2-Methylpentadecanoyl-CoA |
|
/ |
否 |
HY-CE00150 |
(2S)-2-Methyltetradecanoyl-CoA |
|
/ |
否 |
HY-CE00151 |
(2S)-Methylsuccinyl-CoA |
|
/ |
否 |
HY-CE00156 |
(2S)-Pristanoyl-CoA |
|
/ |
否 |
HY-CE00158 |
(2S)-Sulfonatepropionyl-CoA |
|
/ |
否 |
HY-CE00162 |
(2S,3R)-3-Fluoro-2-methylhexadecanoyl-CoA |
|
/ |
否 |
HY-CE00182 |
(2S)-2-Hydroxy-2-(propan-2-yl)butanedioyl-CoA |
|
/ |
否 |
HY-CE00184 |
(2S)-2-Hydroxyoctadecanoyl-CoA |
|
/ |
否 |
HY-CE00185 |
(2S)-Methylmalonyl-CoA |
|
/ |
否 |
HY-CE00186 |
(2S,6R,10R)-Trimethyl-hendecanoyl-CoA |
|
/ |
否 |
HY-CE00213 |
(2S,5S)-5-Carboxymethylproline-CoA |
|
/ |
否 |
HY-D0064 |
6,7-Dihydroxy-4-coumarinylacetic acid |
Inhibitor |
/ |
否 |
HY-D0307 |
Amaranth free acid |
|
/ |
否 |
HY-D0800 |
Mordant Blue 29 |
|
/ |
否 |
HY-D1056C2 |
Lipopolysaccharides, from S. enterica serotype minnesota |
Activator |
/ |
否 |
HY-D1056C3 |
Lipopolysaccharides, from S. enterica serotype typhimurium |
Activator |
/ |
否 |
HY-D1056C4 |
Lipopolysaccharides, from S. enterica serotype abortus equi |
Activator |
/ |
否 |
HY-D1400 |
HBTP-H2S chloride |
|
/ |
否 |
HY-D1486 |
4,4-Difluoro-8-(4'-iodophenyl)-1,7-bis-(1'-napthyl)-4-bora-3alpha,4alpha-diaza-s-indacene |
|
/ |
否 |
HY-D1497 |
Fluorescent Red Mega 480 |
|
/ |
否 |
HY-D1634A |
Bz-FVR-AMC TFA |
|
/ |
否 |
HY-D1637 |
5-Nitro BAPTA tetramethyl ester |
|
/ |
否 |
HY-D1708 |
RuBP-4S |
|
/ |
否 |
HY-D2190 |
Ag2S Oil phase (1200 nm) |
|
/ |
否 |
HY-D2191 |
Ag2S-COOH (1200 nm) |
|
/ |
否 |
HY-D2312 |
Mito-Rh-S |
|
/ |
否 |
HY-D2327 |
DPP-8/9 probe-1 |
Inhibitor |
/ |
否 |
HY-D2343 |
PB0822 |
|
/ |
否 |
HY-D2380 |
H2S probe 1 |
|
/ |
否 |
HY-E70043 |
Ganglioside sialidase (AuSialidase S) |
|
/ |
否 |
HY-E70078 |
Cystathionine β-synthase |
|
90.00% |
否 |
HY-E70081 |
mRNA Cap 2'-O-methyltransferase |
|
/ |
否 |
HY-E70209 |
EcoRI Methyltransferase |
|
/ |
否 |
HY-E70226 |
Cathepsin S, human |
|
/ |
否 |
HY-E70236 |
CoA-S-S-CoA |
|
/ |
否 |
HY-E70246 |
Nonanoyl-CoA |
|
/ |
否 |
HY-E70247 |
(S)-3-Hydroxyhexanoyl-CoA |
|
/ |
否 |
HY-E70248 |
S-(3-Hydroxydodecanoate)-CoA |
|
/ |
否 |
HY-E70249 |
3-Hydroxydecanoyl-CoA |
|
/ |
否 |
HY-E70303 |
Fucosyltransferase 6 |
|
/ |
否 |
HY-E70334 |
Carboxypeptidase Y, Baker's yeast (S. cerevisiae) |
|
/ |
否 |
HY-E70346 |
S-Adenosylmethionine synthetase |
|
/ |
否 |
HY-E70349 |
Betaine homocysteine S-methyltransferase |
|
/ |
否 |
HY-E70390 |
C1s Enzyme |
Antagonist |
/ |
否 |
HY-E70534 |
C1s Proenzyme |
|
/ |
否 |
HY-E70552 |
Human Protein S |
|
/ |
否 |
HY-G0025 |
Tetrabenazine Metabolite |
Inhibitor |
/ |
否 |
HY-I0392AS |
(S)-Cinacalcet-d3 hydrochloride |
|
/ |
否 |
HY-I0392S |
(S)-Cinacalcet-d3 |
|
/ |
否 |
HY-I0678S |
Regorafénib N-oxyde-d3 (M2) |
|
/ |
否 |
HY-I0678S1 |
Regorafénib N-oxyde (M2)-13C,d3 |
|
/ |
否 |
HY-N0043R |
Ginsenoside Rd (Standard) |
Inhibitor |
/ |
否 |
HY-N0060S1 |
Ferulic acid-13C3 |
Inhibitor |
/ |
否 |
HY-N0166R |
Gramine (Standard) |
|
/ |
否 |
HY-N0215S13 |
L-Phenylalanine-d1 |
Antagonist |
/ |
否 |
HY-N0215S9 |
L-Phenylalanine-13C9,15N,d8 |
Antagonist |
/ |
否 |
HY-N0224A |
Goitrin |
Inhibitor |
/ |
否 |
HY-N0252B |
Catharanthine Sulfate |
Inhibitor |
/ |
否 |
HY-N0376R |
Liquiritin (Standard) |
|
/ |
否 |
HY-N0455AS3 |
L-Arginine-1-13C hydrochloride |
Activator |
/ |
否 |
HY-N0455AS4 |
L-Arginine-13C6,15N4,d7 hydrochloride |
Activator |
/ |
否 |
HY-N0605R |
Ginsenoside Rh2 (Standard) |
|
/ |
否 |
HY-N0610AS2 |
Cinnamic acid-13C3 |
|
99.91% |
否 |
HY-N0650S12 |
L-Serine-d3,15n |
|
/ |
否 |
HY-N0650S3 |
L-Serine-13C3,15N,d3 |
|
/ |
否 |
HY-N0650S4 |
L-Serine-2-13C |
|
/ |
否 |
HY-N0650S7 |
L-Serine-d2 |
|
/ |
否 |
HY-N0707S |
(S)-Indoximod-d3 |
Inhibitor |
≥99.0% |
否 |
HY-N0725 |
Cucurbitacin S |
|
/ |
否 |
HY-N0804A |
Isonaringin |
Inhibitor |
/ |
否 |
HY-N0894B |
(3S,5S)-Octahydrocurcumin |
|
/ |
否 |
HY-N0904R |
Ginsenoside C-K (Standard) |
Inhibitor |
/ |
否 |
HY-N0924B |
(-)-Stylopine |
|
/ |
否 |
HY-N0948A |
(+)-Rhododendrol |
Inhibitor |
/ |
否 |
HY-N0961 |
(2S,3S)-(-)-Glucodistylin |
|
/ |
否 |
HY-N0985 |
1,4,5,6-Tetrahydroxy-7,8-diprenylxanthone |
|
/ |
否 |
HY-N0987 |
1,4,6-Trihydroxy-5-methoxy-7-prenylxanthone |
Inhibitor |
/ |
否 |
HY-N0998 |
1,7-Bis(4-hydroxyphenyl)-hepta-4E,6E-dien-3-one |
Inhibitor |
/ |
否 |
HY-N10061 |
(9S)-Macrocidin B |
Inhibitor |
/ |
否 |
HY-N10087A |
Angustifoline hydrochloride |
Inhibitor |
/ |
否 |
HY-N10130 |
Isouvaretin |
Inhibitor |
/ |
否 |
HY-N10268 |
3-Hydroxyterphenyllin |
|
/ |
否 |
HY-N10283 |
Neoechinulin C |
|
/ |
否 |
HY-N10307 |
Anserinone B |
Inhibitor |
/ |
否 |
HY-N10364 |
6β,7β-Epoxyasteriscunolide A |
|
/ |
否 |
HY-N1037 |
δ-Amyrenone |
|
98.50% |
否 |
HY-N10392 |
(S)-Erypoegin K |
Inducer |
/ |
否 |
HY-N10394 |
Metachromins X |
|
/ |
否 |
HY-N10429 |
Geissoschizoline |
Inhibitor |
/ |
否 |
HY-N10447 |
Kurzipene D |
Inducer |
/ |
否 |
HY-N10502 |
Colletofragarone A2 |
Inhibitor |
/ |
否 |
HY-N10541 |
Aplyronine B |
|
/ |
否 |
HY-N10542 |
Aplyronine C |
|
/ |
否 |
HY-N10572 |
Antibacterial synergist 2 |
Inhibitor |
/ |
否 |
HY-N10621 |
3,5-Dimethoxy-2,7-phenanthrenediol |
|
/ |
否 |
HY-N10664 |
Piperlactam S |
|
/ |
否 |
HY-N10677 |
S-30-Hydroxygambogic acid |
|
/ |
否 |
HY-N10678 |
R-30-Hydroxygambogic acid |
|
/ |
否 |
HY-N10701 |
AChE/BChE-IN-11 |
Inhibitor |
/ |
否 |
HY-N10764 |
Acetylexidonin |
|
/ |
否 |
HY-N10789 |
(2S)-4'-Hydroxy-7-methoxyflavan |
|
/ |
否 |
HY-N10817 |
(2S)-5-Methoxyflavan-7-ol |
|
/ |
否 |
HY-N1081A |
Viteralone |
|
/ |
否 |
HY-N10837 |
rel-3R-Methoxy-4S-furanogermacra-1E,10(15)-dien-6-one |
|
/ |
否 |
HY-N10850 |
Blepharotriol |
|
/ |
否 |
HY-N10856 |
2H-1-Benzopyran-2-one, 6-[(1R,2S)-2,3-dihydroxy-1-methoxy-3-methylbutyl]-7-methoxy- |
|
/ |
否 |
HY-N10876 |
8-epi-Chlorajapolide F |
|
/ |
否 |
HY-N10896 |
5,4'-Dihydroxy-7-methoxy-6-methylflavane |
|
/ |
否 |
HY-N10917 |
Xanthohumol I |
Inhibitor |
/ |
否 |
HY-N10922 |
(3S,4aS,10aS)-3-(Acetyloxy)-2,3,4,4a,10,10a-hexahydro-6-hydroxy-1,1,4a-trimethyl-7-(1-methylethyl)-9(1H)-phenanthrenone |
|
/ |
否 |
HY-N10950 |
Vanicoside E |
Inhibitor |
/ |
否 |
HY-N10986 |
(±)-Hydnocarpin |
|
/ |
否 |
HY-N10989 |
(20S)-Protopanaxadiol-3-one |
|
/ |
否 |
HY-N11064 |
Rebaudioside S |
|
/ |
否 |
HY-N11139 |
Solidagolactone II |
|
/ |
否 |
HY-N11469 |
Cyclobisdemethoxycurcumin |
|
/ |
否 |
HY-N11490 |
(25S)-12β-Hydroxyspirost-4-en-3-one |
|
/ |
否 |
HY-N11496 |
17(13→14)-Abeo-ent-3S*,13S*,16-trihydroxystrob-8(15)-ene |
|
/ |
否 |
HY-N1150S10 |
Thymidine-d14 |
Inhibitor |
/ |
否 |
HY-N1150S11 |
Thymidine-13C10 |
Inhibitor |
/ |
否 |
HY-N1150S2 |
Thymidine-13C |
|
/ |
否 |
HY-N1150S3 |
Thymidine-13C-1 |
|
/ |
否 |
HY-N1150S4 |
Thymidine-13C-2 |
|
/ |
否 |
HY-N1150S5 |
Thymidine-2′-13C |
|
/ |
否 |
HY-N1150S6 |
Thymidine-d2 |
|
/ |
否 |
HY-N11515 |
Saikosaponin S |
|
/ |
否 |
HY-N11519 |
Polyporusterone C |
|
/ |
否 |
HY-N11624 |
Axinelline A |
Inhibitor |
/ |
否 |
HY-N11636 |
Ganoderic acid S |
Inducer |
/ |
否 |
HY-N11641 |
Methyl ganoderate A acetonide |
Inhibitor |
/ |
否 |
HY-N11650 |
(22S,24E)-3β,22-Diacetoxylanosta-7,9(11),24-trien-26-oic acid |
Inhibitor |
/ |
否 |
HY-N11651 |
Peganumine A |
|
/ |
否 |
HY-N11664 |
Salvileucantholide |
|
/ |
否 |
HY-N11801 |
6,7-Dihydrosalviandulin E |
|
/ |
否 |
HY-N11802 |
Salvileucalin A |
|
/ |
否 |
HY-N11867A |
5(S)-5-Carboxystrictosidine |
|
/ |
否 |
HY-N11917 |
Schisantherin S |
|
/ |
否 |
HY-N11928 |
Changnanic acid |
|
/ |
否 |
HY-N11997 |
Feralolide |
Inhibitor |
/ |
否 |
HY-N12027 |
AChE/BChE-IN-14 |
Inhibitor |
/ |
否 |
HY-N12075 |
Dehydrodiscretamine chloride |
Inhibitor |
/ |
否 |
HY-N12096 |
Galbinic acid |
Inhibitor |
/ |
否 |
HY-N12102 |
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside |
Inhibitor |
/ |
否 |
HY-N12108 |
Forphenicine |
Inhibitor |
/ |
否 |
HY-N12135 |
15α-Hydroxy-20-oxo-6,7-seco-ent-kaur-16-en-1,7α(6,11α)-diolide |
|
/ |
否 |
HY-N12198 |
Mollicellin H |
|
/ |
否 |
HY-N12200 |
Mollicellin I |
|
/ |
否 |
HY-N12209 |
Neohelmanthicin A |
|
/ |
否 |
HY-N12255 |
COTC |
Inhibitor |
/ |
否 |
HY-N12411 |
(S)-O-Methylencecalinol |
Inhibitor |
/ |
否 |
HY-N12418 |
(20S)-18,19-Dehydrocamptothecin |
|
/ |
否 |
HY-N12428 |
17-Hydroxyjolkinolide A |
|
/ |
否 |
HY-N12437 |
Marsdenoside B |
|
/ |
否 |
HY-N12446 |
2'-O-Coumaroyl-(S)-aloesinol |
|
/ |
否 |
HY-N12466 |
3′-O-Demethyl-4′-N-demethyl-4′-N-acetyl-4′-epi-staurosporine |
Inhibitor |
/ |
否 |
HY-N1252 |
Scillascillin |
|
/ |
否 |
HY-N12521 |
(3β,24S)-3-Hydroxystigmast-5-en-7-one |
|
/ |
否 |
HY-N12537A |
(2R,3S)-PD-1/PD-L1-IN-38 |
|
/ |
否 |
HY-N12555 |
6,6′-Didemethyl-7-methyl dragonbloodin A2 |
|
/ |
否 |
HY-N12581 |
Kuwanon U |
Inhibitor |
/ |
否 |
HY-N12600 |
Thiolopyrrolone A |
Inhibitor |
/ |
否 |
HY-N12619 |
12R,13S-Dihydroxyfumitremorgin C |
Agonist |
/ |
否 |
HY-N12657 |
Retinestatin |
Inhibitor |
/ |
否 |
HY-N12821 |
visamminol-3'-O-glucoside |
|
/ |
否 |
HY-N12960 |
Artobiloxanthone |
|
/ |
否 |
HY-N13094 |
(7S,8S)-Threo-7,9,9′-trihydroxy-3,3′-dimethoxy-8-O-4′-neolignan-4-O-β-D-glucopyranoside |
|
/ |
否 |
HY-N1333 |
Rubioncolin C |
Inhibitor |
/ |
否 |
HY-N13380 |
6′‐O‐Galloylsalidroside |
|
/ |
否 |
HY-N1418 |
(S)-(-)-Tetrahydroberberine |
|
/ |
否 |
HY-N1418A |
(R)-(+)-Tetrahydroberberine |
|
/ |
否 |
HY-N1428S3 |
Citric acid-13C3 |
|
/ |
否 |
HY-N1459A |
(S)-Campesterol |
|
/ |
否 |
HY-N1459AS |
(S)-Campesterol-d6 |
|
/ |
否 |
HY-N15208 |
(3S,5S)-1-(4-Hydroxy-3-methoxyphenyl)-7-phenyl-3,5-heptanediol |
|
/ |
否 |
HY-N15252 |
Eutypenes I |
Inhibitor |
/ |
否 |
HY-N15301 |
Nocarnickelamides B |
Inhibitor |
/ |
否 |
HY-N1542 |
Prionitin |
|
/ |
否 |
HY-N1610 |
19(S)-Hydroxyconopharyngine |
|
/ |
否 |
HY-N1631 |
1-Hydroxyrutecarpine |
|
/ |
否 |
HY-N1654 |
2',3'-Dehydrosalannol |
Inhibitor |
/ |
否 |
HY-N1683 |
20(S),24(S)-Dihydroxydammar-25-en-3-one |
|
/ |
否 |
HY-N1768 |
(2S)-3',4',7-Trimethoxyflavan |
|
/ |
否 |
HY-N1841 |
Rocaglamide D |
|
/ |
否 |
HY-N2034 |
Dehydrodicentrine |
Inhibitor |
/ |
否 |
HY-N2037B |
(S)-Higenamine |
|
/ |
否 |
HY-N2166A |
Tomatine hydrochloride |
|
/ |
否 |
HY-N2511S |
Trimyristin--d15 |
Inhibitor |
/ |
否 |
HY-N2656 |
5,7,8-Trimethoxycoumarin |
Inhibitor |
/ |
否 |
HY-N2682 |
(7R,8S)-Dehydrodiconiferyl alcohol |
|
/ |
否 |
HY-N2703 |
6β-Hydroxyipolamiide |
Inhibitor |
/ |
否 |
HY-N2738 |
(2S)-7,4'-Dihydroxy-3'-prenylflavan |
|
/ |
否 |
HY-N2741 |
Vitexin B-1 |
Inhibitor |
/ |
否 |
HY-N2812 |
Epipodophyllotoxin acetate |
Inhibitor |
/ |
否 |
HY-N2886 |
Aporeine |
|
/ |
否 |
HY-N2898 |
Artanin |
Inhibitor |
/ |
否 |
HY-N2962 |
Broussonin C |
Inhibitor |
/ |
否 |
HY-N2980 |
Ocotillone |
Inhibitor |
/ |
否 |
HY-N3199 |
Neorauflavene |
Inhibitor |
/ |
否 |
HY-N3251 |
(S)-Moluccanin |
|
/ |
否 |
HY-N3389A |
(S)-Licoisoflavone A |
|
/ |
否 |
HY-N3413 |
Kushenol X |
Inhibitor |
≥97.0% |
否 |
HY-N3443 |
Jolkinol A |
|
/ |
否 |
HY-N3608 |
Coccinic acid |
|
/ |
否 |
HY-N3661 |
(24S)-Cycloartane-3β,24,25-triol |
Inhibitor |
/ |
否 |
HY-N3694 |
Deacetylnimbin |
|
/ |
否 |
HY-N3713 |
Dehydro-δ-tocopherol |
|
/ |
否 |
HY-N3745 |
(-)-(7R, 8S)-dihydrodehydrodiconiferyl alcohol |
|
/ |
否 |
HY-N3761 |
Dimethylmatairesinol |
|
/ |
否 |
HY-N3763 |
Di-O-methylcrenatin |
|
/ |
否 |
HY-N3837 |
Epitaraxerol |
|
/ |
否 |
HY-N3923 |
Ganoderic acid S1 |
|
/ |
否 |
HY-N3951 |
Glochidone |
|
/ |
否 |
HY-N4044 |
Hirsutanonol |
Inhibitor |
/ |
否 |
HY-N4048 |
Heudelotinone |
|
/ |
否 |
HY-N4061 |
Hedycoronen A |
Inhibitor |
/ |
否 |
HY-N4282 |
8-Hydroxy-7-methoxycoumarin |
|
/ |
否 |
HY-N4330 |
Rivulariapeptolides 1155 |
Inhibitor |
/ |
否 |
HY-N5051 |
25(S)-Ruscogenin-1-O-α-L-rhamnopyranosyl (1→2)-β-D-xylopyranoside |
Inhibitor |
/ |
否 |
HY-N5054 |
(R)-5,7-Dimethoxyflavanone |
Inhibitor |
≥99.0% |
否 |
HY-N5077B |
Sinapine hydroxide |
Inhibitor |
/ |
否 |
HY-N5109 |
Cheilanthifoline |
Inhibitor |
/ |
否 |
HY-N5152 |
(2′S)-4′-O-β-D-apiofuranosyl-(1→6)-O-β-D-glucopyranosylvisamminol |
|
/ |
否 |
HY-N6680 |
Virginiamycin S1 |
Inhibitor |
/ |
否 |
HY-N6770 |
Curvularin |
Inhibitor |
/ |
否 |
HY-N6916 |
Siraitic Acid B |
|
/ |
否 |
HY-N6917 |
Siraitic Acid A |
|
/ |
否 |
HY-N7161 |
3-O-(2'E,4'E-Decadienoyl)-ingenol |
|
/ |
否 |
HY-N7267 |
31-Norlanostenol |
|
/ |
否 |
HY-N7268 |
Solanidiene |
|
/ |
否 |
HY-N7382 |
Laburnetin |
Inhibitor |
/ |
否 |
HY-N7552 |
Isodaphnoretin B |
|
/ |
否 |
HY-N7599 |
Chrysophanol triglucoside |
Inhibitor |
/ |
否 |
HY-N7606 |
(Rac)-β-Chamigrenic acid |
|
/ |
否 |
HY-N7634 |
Tectol |
Inhibitor |
98.32% |
否 |
HY-N7776 |
7-Xylosyl-10-Deacetyltaxol B |
|
/ |
否 |
HY-N7777 |
7-Xylosyl-10-Deacetyltaxol C |
|
/ |
否 |
HY-N7801 |
(±)5-HEPE |
|
/ |
否 |
HY-N8092 |
Kushenol B |
Inhibitor |
/ |
否 |
HY-N8158 |
Gomisin S |
|
/ |
否 |
HY-N8168 |
LPRP-Et-97543 |
Inhibitor |
/ |
否 |
HY-N8186 |
(3R)-7,4’-Dihydrohomoisoflavanone |
Inhibitor |
/ |
否 |
HY-N8256 |
(–)-Mycousnine |
Inhibitor |
/ |
否 |
HY-N8295 |
Leucomycin A13 |
|
/ |
否 |
HY-N8387 |
Neogrifolin |
Inhibitor |
/ |
否 |
HY-N8414 |
Dehydrogeijerin |
Inhibitor |
/ |
否 |
HY-N8453 |
Macranthoin G |
Inhibitor |
/ |
否 |
HY-N8462 |
6-O-Nicotinoylscutebarbatine G |
|
/ |
否 |
HY-N8480 |
Atractylochromene |
Inhibitor |
/ |
否 |
HY-N8488 |
Anhydro-6-epiophiobolin A |
|
/ |
否 |
HY-N8488A |
Anhydroophiobolin A |
|
/ |
否 |
HY-N8499 |
Sporothriolide |
Inhibitor |
/ |
否 |
HY-N8501 |
Emestrin |
Inhibitor |
/ |
否 |
HY-N8502 |
Urdamycin A |
|
/ |
否 |
HY-N8512 |
Asperfuran |
|
/ |
否 |
HY-N8532 |
(1’S)-Dehydropestalotin |
|
/ |
否 |
HY-N8723S |
(1′S,2′S)-Nicotine-1'-oxide-d3 |
|
/ |
否 |
HY-N8754 |
(7S)-Dalbergiphenol |
|
/ |
否 |
HY-N8900 |
Vernolide B |
|
/ |
否 |
HY-N8942 |
(S)-17-Hydroxy-18,20-ene-neogrifolin |
|
/ |
否 |
HY-N9022 |
(S)-1-(4-Hydroxy-2,2-dimethylchroman-6-yl)ethanone |
|
/ |
否 |
HY-N9061 |
Withanolide S |
|
/ |
否 |
HY-N9172 |
Eupaglehnin C |
|
/ |
否 |
HY-N9475 |
Betulonaldehyde |
Inhibitor |
/ |
否 |
HY-N9530 |
1-Methyl-2-[(4Z,7Z)-4,7-tridecadienyl]-4(1H)-quinolone |
Inhibitor |
/ |
否 |
HY-N9532 |
Isobyakangelicol |
|
/ |
否 |
HY-N9583 |
(S)-4-Methoxydalbergione |
|
/ |
否 |
HY-N9735 |
8-Hydroxy-9,10-diisobutyryloxythymol |
Inhibitor |
/ |
否 |
HY-N9746 |
(R)-4-Methoxydalbergione |
Inhibitor |
/ |
否 |
HY-NP134 |
Flagellin from S. typhimurium |
Agonist |
/ |
否 |
HY-NP143 |
Nerve Growth Factor 2.5S,murine submaxillary gland |
|
/ |
否 |
HY-NP144 |
Nerve Growth Factor 7S,murine submaxillary gland |
|
/ |
否 |
HY-P0018C |
Pepstatin acetate |
Inhibitor |
/ |
否 |
HY-P0135 |
Penta lysine |
Inhibitor |
/ |
否 |
HY-P0141 |
Akt/SKG Substrate Peptide |
|
/ |
否 |
HY-P0141A |
Akt/SKG Substrate Peptide TFA |
|
/ |
否 |
HY-P0162 |
HCV-IN-4 |
Inhibitor |
/ |
否 |
HY-P0184 |
Camstatin |
Inhibitor |
/ |
否 |
HY-P0184A |
Camstatin TFA |
Inhibitor |
/ |
否 |
HY-P0221A |
PACAP (1-38), human, ovine, rat TFA |
|
/ |
否 |
HY-P0252B |
α-MSH free acid |
Agonist |
/ |
否 |
HY-P10042 |
S6K Substrate |
Substrate |
/ |
否 |
HY-P10061 |
Cathepsin K inhibitor 4 |
Inhibitor |
/ |
否 |
HY-P10224 |
G7-18NATE |
|
/ |
否 |
HY-P10228 |
S-Thanatin |
Inhibitor |
/ |
否 |
HY-P10247 |
Amyloid precursor C-terminal peptide |
|
/ |
否 |
HY-P10319 |
RI-STAD-2 |
Inhibitor |
/ |
否 |
HY-P10320 |
T3 Peptide |
Activator |
/ |
否 |
HY-P10364 |
Ubiquicidin(29-41) |
|
/ |
否 |
HY-P10378 |
GPR10 agonist 1 |
Agonist |
/ |
否 |
HY-P10386 |
155H1 |
Inhibitor |
/ |
否 |
HY-P10563 |
Noraramtide |
|
/ |
否 |
HY-P10570 |
[Nle20] H4 peptide (16−23) |
Inhibitor |
/ |
否 |
HY-P10578 |
SEN 304 |
Inhibitor |
/ |
否 |
HY-P10596 |
Lasioglossin-III |
Inhibitor |
/ |
否 |
HY-P1060 |
LPYFD-NH2 |
|
/ |
否 |
HY-P10606 |
CK1tide |
|
/ |
否 |
HY-P10609 |
Btk substrate peptide |
|
/ |
否 |
HY-P1060A |
LPYFD-NH2 TFA |
|
/ |
否 |
HY-P10622 |
SHLP-3 |
Inhibitor |
/ |
否 |
HY-P10625 |
SHLP-6 |
|
/ |
否 |
HY-P10630 |
Pep63 |
Inhibitor |
/ |
否 |
HY-P10652 |
hsBCL9CT-24 |
Inhibitor |
/ |
否 |
HY-P10681 |
Crabrolin |
Inhibitor |
/ |
否 |
HY-P10694 |
IDR-HH2 |
Inhibitor |
/ |
否 |
HY-P10695 |
Bac8c |
Inhibitor |
/ |
否 |
HY-P1080 |
ω-Agatoxin IVA |
Inhibitor |
/ |
否 |
HY-P10819 |
S9-CMC1 TFA |
|
/ |
否 |
HY-P10827 |
PIC1 PA |
Inhibitor |
/ |
否 |
HY-P10855 |
S1b3inL1 |
Inhibitor |
/ |
否 |
HY-P10872 |
P315V3 |
Inhibitor |
/ |
否 |
HY-P1112 |
Sarafotoxin S6a |
Agonist |
/ |
否 |
HY-P1112A |
Sarafotoxin S6a TFA |
Agonist |
/ |
否 |
HY-P1115 |
AKTide-2T |
Inhibitor |
/ |
否 |
HY-P1115A |
AKTide-2T TFA |
Inhibitor |
/ |
否 |
HY-P1117A |
MMK1 TFA |
|
/ |
否 |
HY-P1217A |
[D-Trp8]-γ-MSH TFA |
Agonist |
/ |
否 |
HY-P1218 |
Phrixotoxin 3 |
Inhibitor |
/ |
否 |
HY-P1218A |
Phrixotoxin 3 TFA |
Inhibitor |
/ |
否 |
HY-P1220 |
Huwentoxin-IV |
Inhibitor |
/ |
否 |
HY-P1258A |
PSI TFA |
Inhibitor |
/ |
否 |
HY-P1267 |
α-Conotoxin PnIA |
Antagonist |
/ |
否 |
HY-P1268 |
α-Conotoxin PIA |
Antagonist |
/ |
否 |
HY-P1274 |
ShK-Dap22 |
Inhibitor |
/ |
否 |
HY-P1289 |
[Ala113]MBP(104-118) |
Inhibitor |
/ |
否 |
HY-P1289A |
[Ala107]MBP(104-118) |
Inhibitor |
/ |
否 |
HY-P1289B |
[Ala107]MBP(104-118) TFA |
Inhibitor |
/ |
否 |
HY-P1289C |
[Ala113]MBP(104-118) TFA |
Inhibitor |
/ |
否 |
HY-P1301 |
[Arg14,Lys15]Nociceptin |
Agonist |
/ |
否 |
HY-P1301A |
[Arg14,Lys15]Nociceptin TFA |
Agonist |
/ |
否 |
HY-P1318 |
Ac-RYYRIK-NH2 |
Agonist |
/ |
否 |
HY-P1318A |
Ac-RYYRIK-NH2 TFA |
Agonist |
/ |
否 |
HY-P1342A |
Prosaptide Tx14(A) TFA |
Activator |
/ |
否 |
HY-P1389A |
Neuropeptide S (human) TFA |
Agonist |
/ |
否 |
HY-P1423 |
BA 1 |
Agonist |
/ |
否 |
HY-P1437A |
Neuropeptide S(Mouse) TFA |
Agonist |
/ |
否 |
HY-P1438A |
Neuropeptide S(Rat) TFA |
Agonist |
/ |
否 |
HY-P1548B |
β-CGRP, human acetate |
|
/ |
否 |
HY-P1610 |
Asudemotide |
Inducer |
/ |
否 |
HY-P1916 |
FliC, Serotype a (427-441), S.paratyphi A |
|
/ |
否 |
HY-P1978 |
CysHHC10 |
Inhibitor |
/ |
否 |
HY-P1978A |
CysHHC10 TFA |
Inhibitor |
/ |
否 |
HY-P2020 |
Berninamycin A |
|
/ |
否 |
HY-P2200 |
Siamycin I |
Inhibitor |
/ |
否 |
HY-P2206 |
Zelkovamycin |
|
/ |
否 |
HY-P2265 |
SAH-SOS1A |
Inhibitor |
/ |
否 |
HY-P2413 |
Ac-PPPHPHARIK-NH2 |
Inhibitor |
/ |
否 |
HY-P2446 |
ORG 30276 |
Antagonist |
/ |
否 |
HY-P2562 |
β-Amyloid (1-38), mouse, rat |
|
/ |
否 |
HY-P2961 |
Glutathione S-transferase |
|
/ |
否 |
HY-P2996B |
Nitrate Reductase (NAD[P]H), Pichia Pastoris (recombinant) |
|
/ |
否 |
HY-P3054 |
S6 peptide |
|
/ |
否 |
HY-P3055 |
Dendrotoxin-I |
Inhibitor |
/ |
否 |
HY-P3078 |
Amphomycin |
Inhibitor |
/ |
否 |
HY-P3116 |
Thiocoraline |
Inhibitor |
/ |
否 |
HY-P3119 |
Desotamide |
|
/ |
否 |
HY-P3258 |
SP-10 |
|
/ |
否 |
HY-P3316 |
OSK-1 |
Inhibitor |
/ |
否 |
HY-P3328 |
MDP1 |
Inhibitor |
/ |
否 |
HY-P3346 |
NH2-c[X-R-L-S-X]-K-G-P-(D-1Nal) |
Agonist |
/ |
否 |
HY-P3347 |
NH2-c[X-R-L-S-X]-K-G-P-(D-2Nal) |
Agonist |
/ |
否 |
HY-P3348 |
c[Arg-Arg-Arg-Arg-Dip-Dip-Dip] |
Inhibitor |
/ |
否 |
HY-P3349 |
c[Arg-Arg-Arg-Arg-Nal-Nal-Nal] |
Inhibitor |
/ |
否 |
HY-P3424 |
NH2-AKK-COOH |
Inhibitor |
/ |
否 |
HY-P3433 |
Sarafotoxin S6b |
Agonist |
/ |
否 |
HY-P3563 |
[Lys4] Sarafotoxin S6c |
Agonist |
/ |
否 |
HY-P3565 |
Sarafotoxin S6d |
|
/ |
否 |
HY-P3570 |
Adipokinetic hormone II (Locusta migratoria) |
Inducer |
/ |
否 |
HY-P3572 |
Adipokinetic hormone I (Locusta migratoria) |
Inducer |
/ |
否 |
HY-P3654 |
α-Conotoxin S IA |
Antagonist |
/ |
否 |
HY-P3781 |
(Met(O)35)-Amyloid β-Protein (1-42) |
|
/ |
否 |
HY-P3814 |
S6 Kinase Substrate Peptide 32 |
|
/ |
否 |
HY-P3908 |
FITC-β-Ala-Amyloid β-Protein (1-42) (ammonium) |
|
/ |
否 |
HY-P4021 |
Mca-KKEDVV-Abu-CS-Abu-S-(NO2)F-KK-NH2 |
|
/ |
否 |
HY-P4038 |
Hepatitis C Virus S5A/5B |
|
/ |
否 |
HY-P4043 |
Hepatitis b virus pre-s region (120-145) |
Inhibitor |
/ |
否 |
HY-P4204 |
Ranalexin |
Inhibitor |
/ |
否 |
HY-P4281 |
Ovotransferrin (328-332) |
Inhibitor |
/ |
否 |
HY-P4390 |
Z-Leu-Leu-Arg-AMC |
|
/ |
否 |
HY-P4521 |
Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt |
|
/ |
否 |
HY-P4532 |
Ac-Leu-Val-Lys-Aldehyde |
Inhibitor |
/ |
否 |
HY-P4773 |
HSV-1 Protease substrate |
|
/ |
否 |
HY-P4820 |
SYNV-cyclo(CGGYF) |
Inhibitor |
/ |
否 |
HY-P4905 |
Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH2 |
Inhibitor |
/ |
否 |
HY-P4979 |
Cdc25A (80-93) (human) |
|
/ |
否 |
HY-P5016 |
CRAMP-18 (mouse) |
Inhibitor |
/ |
否 |
HY-P5084 |
Neuromedin S (human) |
|
/ |
否 |
HY-P5122 |
Z-LEED-FMK |
Inhibitor |
/ |
否 |
HY-P5147 |
α-Conotoxin GID |
Antagonist |
/ |
否 |
HY-P5148 |
α-Conotoxin BuIA |
Antagonist |
/ |
否 |
HY-P5164 |
GrTx1 |
Inhibitor |
/ |
否 |
HY-P5184 |
Hainantoxin-IV |
Antagonist |
/ |
否 |
HY-P5370 |
Scrambled β-amyloid (1-40) |
|
/ |
否 |
HY-P5377 |
Abz-HPGGPQ-EDDnp |
|
/ |
否 |
HY-P5378 |
Ac-KQKLR-AMC |
|
/ |
否 |
HY-P5439 |
Epsilon-V1-2, Cys-conjugated |
Inhibitor |
/ |
否 |
HY-P5449 |
p70 S6 Kinase substrate |
|
/ |
否 |
HY-P5467 |
S6(229-239), Amide, biotinalyted |
Substrate |
/ |
否 |
HY-P5560 |
PP13 |
Inhibitor |
/ |
否 |
HY-P5561 |
Aurein 2.2 |
Inhibitor |
/ |
否 |
HY-P5562 |
PP102 |
Inhibitor |
/ |
否 |
HY-P5563 |
PP113 |
Inhibitor |
/ |
否 |
HY-P5565 |
RP-1 |
Inhibitor |
/ |
否 |
HY-P5573 |
Aurein 2.6 |
Inhibitor |
/ |
否 |
HY-P5574 |
Aurein 3.1 |
Inhibitor |
/ |
否 |
HY-P5580 |
Dermaseptin-B3 |
Inhibitor |
/ |
否 |
HY-P5613 |
XT-1 |
Inhibitor |
/ |
否 |
HY-P5621 |
Maximin 63 |
Inhibitor |
/ |
否 |
HY-P5625 |
ROAD-1 |
Inhibitor |
/ |
否 |
HY-P5626 |
Seabream hepcidin |
Inhibitor |
/ |
否 |
HY-P5629 |
MCF |
Inhibitor |
/ |
否 |
HY-P5632 |
Bovine tracheal antimicrobial peptide |
Inhibitor |
/ |
否 |
HY-P5664 |
Maximin S4 |
Inhibitor |
/ |
否 |
HY-P5682 |
Maximin 41 |
Inhibitor |
/ |
否 |
HY-P5683 |
Maximin 45 |
Inhibitor |
/ |
否 |
HY-P5684 |
Maximin H39 |
Inhibitor |
/ |
否 |
HY-P5685 |
Maximin 49 |
Inhibitor |
/ |
否 |
HY-P5686 |
Maximin 78 |
Inhibitor |
/ |
否 |
HY-P5687 |
Im5 |
Inhibitor |
/ |
否 |
HY-P5688 |
Maximin 68 |
Inhibitor |
/ |
否 |
HY-P5689 |
Maximin 42 |
Inhibitor |
/ |
否 |
HY-P5690 |
Distinctin |
Inhibitor |
/ |
否 |
HY-P5692 |
Maximin 77 |
Inhibitor |
/ |
否 |
HY-P5695 |
GP-2B |
Inhibitor |
/ |
否 |
HY-P5697 |
Tilapia piscidin 3 |
Inhibitor |
/ |
否 |
HY-P5706 |
HG2 |
Inhibitor |
/ |
否 |
HY-P5709 |
HG4 |
Inhibitor |
/ |
否 |
HY-P5723 |
Api137 |
Inhibitor |
/ |
否 |
HY-P5737 |
ASP-1 |
Inhibitor |
/ |
否 |
HY-P5746 |
Suicin 65 |
|
/ |
否 |
HY-P5790 |
μ-TRTX-Hd1a |
Inhibitor |
/ |
否 |
HY-P5795 |
GsAF-I |
Inhibitor |
/ |
否 |
HY-P5810 |
Ceratotoxin-2 |
Inhibitor |
/ |
否 |
HY-P5823 |
Azemiopsin |
Inhibitor |
/ |
否 |
HY-P5836 |
Citrullinated LL-37 1cit |
Inhibitor |
/ |
否 |
HY-P5846 |
Muscarinic toxin 3 |
Antagonist |
/ |
否 |
HY-P5850 |
α-Conotoxin Bt1.8 |
Inhibitor |
/ |
否 |
HY-P5865 |
Tap1a |
Inhibitor |
/ |
否 |
HY-P5868 |
mHuwentoxin-IV |
Inhibitor |
/ |
否 |
HY-P5900 |
m3-Huwentoxin IV |
Inhibitor |
/ |
否 |
HY-P5925 |
Ssm spooky toxin |
Inhibitor |
/ |
否 |
HY-P5940 |
β-Amyloid precursor protein (96-110), cyclized (human) |
|
/ |
否 |
HY-P5967 |
Acetly-β Amyloid(15-20), Amide |
|
/ |
否 |
HY-P6177 |
SGP8 |
Inhibitor |
/ |
否 |
HY-R01697 |
hsa-miR-548s mimic |
|
/ |
否 |
HY-R01697A |
hsa-miR-548s agomir |
|
/ |
否 |
HY-RI01697 |
hsa-miR-548s inhibitor |
|
/ |
否 |
HY-RI01697A |
hsa-miR-548s antagomir |
|
/ |
否 |
HY-RS00545 |
AKT1S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS00781 |
AP1S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS00782 |
AP1S2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS00783 |
AP1S3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS00788 |
AP2S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS00794 |
AP3S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS00795 |
AP3S2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS00799 |
AP4S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS01523 |
BLOC1S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS01524 |
BLOC1S2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS01525 |
BLOC1S6 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS01737 |
C1S Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS01800 |
CACNA1S Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS03242 |
CSN1S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS03467 |
CYP2S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS04254 |
EIF2S1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS04255 |
EIF2S2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS04256 |
EIF2S3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS05187 |
G0S2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS07882 |
LTC4S Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS07904 |
LY6S Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS08031 |
MAP1S Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12371 |
S100A1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12372 |
S100A10 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12373 |
S100A11 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12374 |
S100A12 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12375 |
S100A13 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12376 |
S100A14 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12377 |
S100A16 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12378 |
S100A2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12379 |
S100A3 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12380 |
S100A4 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12381 |
S100A5 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12383 |
S100A7 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12384 |
S100A7A Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12385 |
S100A8 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12386 |
S100A9 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12387 |
S100B Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12388 |
S100G Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12389 |
S100P Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12390 |
S100Z Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12391 |
S1PR1 Human Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12392 |
S1pr1 Mouse Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12393 |
S1pr1 Rat Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12395 |
S1pr2 Mouse Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12396 |
S1pr2 Rat Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12397 |
S1PR3 Human Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12398 |
S1pr3 Mouse Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12399 |
S1pr3 Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12400 |
S1PR4 Human Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12401 |
S1pr4 Mouse Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12402 |
S1pr4 Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-RS12404 |
S1pr5 Mouse Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS12405 |
S1pr5 Rat Pre-designed siRNA Set A |
|
/ |
否 |
HY-RS15361 |
UBE2S Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
HY-U00079B |
(S)-Vamicamide |
Antagonist |
/ |
否 |
HY-U00199A |
(S)-Norzopiclone |
|
/ |
否 |
HY-U00460B |
3,6-DMAD dihydrochloride |
Inhibitor |
/ |
否 |
HY-W003499 |
(S)-3-Benzyloxycarbonylamino-2-(Boc-amino)propionic acid |
|
≥95.0% |
否 |
HY-W003576 |
ACHE-IN-38 hydrochloride |
Inhibitor |
99.86% |
否 |
HY-W004153 |
S-(Acetamidomethyl)-N-(tert-butoxycarbonyl)-L-cysteine |
|
98.18% |
否 |
HY-W008599 |
(S)-2-Amino-3-methyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)butanamide 2,2,2-trifluoroacetate |
|
/ |
否 |
HY-W008621S |
Oleic acid-13C potassium |
|
/ |
否 |
HY-W008667 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid hydrate |
|
99.49% |
否 |
HY-W009078 |
4-S-β-D-Glucopyranosyl-4-thio-D-glucose |
|
/ |
否 |
HY-W009343 |
(S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoic acid |
|
99.62% |
否 |
HY-W009477 |
(S)-6-Amino-2-((S)-2-aminopropanamido)hexanoic acid hydrochloride |
|
/ |
否 |
HY-W009682 |
S-(Acetamidomethyl)-L-cysteine hydrochloride |
|
/ |
否 |
HY-W009775 |
(S)-2-((S)-2-Amino-3-methylbutanamido)-3-hydroxypropanoic acid |
|
/ |
否 |
HY-W009911 |
(S)-3-(4-Hydroxyphenyl)-2-(methylamino)propanoic acid |
|
/ |
否 |
HY-W010143S |
(R,S)-Norcotinine-d4 |
|
/ |
否 |
HY-W010255S |
Phenylglyoxylic acid-d5 |
|
/ |
否 |
HY-W010835 |
Boc-D-Cys(Trt)-OH |
|
/ |
否 |
HY-W010913 |
(S)-2-((tert-Butoxycarbonyl)amino)-5-(3-tosylguanidino)pentanoic acid |
|
/ |
否 |
HY-W011004 |
(S)-4-Amino-5-(((S)-1-(((S)-1-carboxy-2-phenylethyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid |
|
/ |
否 |
HY-W011049 |
(S)-6-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoic acid |
|
≥98.0% |
否 |
HY-W011090S |
((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 sodium |
|
/ |
否 |
HY-W011109 |
CKI-7 |
Inhibitor |
/ |
否 |
HY-W011116 |
(S)-2-((S)-2-((S)-2-Amino-4-methylpentanamido)-4-methylpentanamido)-4-methylpentanoic acid |
|
/ |
否 |
HY-W011137 |
(S)-4-Nitrophenyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate |
|
/ |
否 |
HY-W011203 |
(S)-2-(5-Amino-2-(((benzyloxy)carbonyl)amino)-5-oxopentanamido)acetic acid |
|
≥98.0% |
否 |
HY-W011223 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid |
|
97.64% |
否 |
HY-W011241 |
Cinchonine hydrochloride |
|
/ |
否 |
HY-W011337 |
(S)-2-((R)-2-Amino-4-methylpentanamido)-3-(4-hydroxyphenyl)propanoic acid hydrate |
|
/ |
否 |
HY-W011338S |
Benzyl butyl phthalate-d4 |
|
/ |
否 |
HY-W011567 |
(S)-2-(((Benzyloxy)carbonyl)(methyl)amino)-4-methylpentanoic acid |
|
/ |
否 |
HY-W011652 |
(S)-2-((tert-Butoxycarbonyl)amino)-3-(thiophen-2-yl)propanoic acid |
|
≥95.0% |
否 |
HY-W012003 |
(S)-2-(2-(2-Amino-4-methylpentanamido)acetamido)acetic acid |
|
/ |
否 |
HY-W012126R |
2,6-Dichlorodiphenylamine (Standard) |
Inhibitor |
/ |
否 |
HY-W012214 |
(S)-2-Amino-3-(2-(trifluoromethyl)phenyl)propanoic acid |
|
99.36% |
否 |
HY-W012864S |
(2S,3R)-2,3,4-Trihydroxybutanal-13C |
|
/ |
否 |
HY-W012864S1 |
(2S,3R)-2,3,4-Trihydroxybutanal-13C-1 |
|
/ |
否 |
HY-W012864S2 |
(2S,3R)-2,3,4-Trihydroxybutanal-13C-2 |
|
99.4% |
否 |
HY-W013166 |
MTSEA-biotin |
|
/ |
否 |
HY-W013201 |
(S)-1-((S)-2-Amino-4-methylpentanoyl)pyrrolidine-2-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:1) |
|
/ |
否 |
HY-W013864 |
(S)-2-(Benzylamino)-3-(4-hydroxyphenyl)propanoic acid |
|
/ |
否 |
HY-W013870 |
(S)-2-(2-(2-Aminoacetamido)acetamido)-3-(1H-imidazol-4-yl)propanoic acid |
|
/ |
否 |
HY-W014076 |
(2S,3R)-2-((S)-2-Amino-3-methylbutanamido)-3-hydroxybutanoic acid |
|
/ |
否 |
HY-W014238 |
S-tert-Butyl-L-cysteine hydrochloride |
|
≥98.0% |
否 |
HY-W014303 |
(S)-2-(2-Aminoacetamido)-3-(1H-imidazol-4-yl)propanoic acid |
|
/ |
否 |
HY-W014304 |
(S)-2-(2-Amino-3-(1H-imidazol-4-yl)propanamido)acetic acid |
|
/ |
否 |
HY-W014663S |
(S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxypropanoic acid-d3 |
|
/ |
否 |
HY-W014913 |
(S)-3-Amino-1-chloro-5-methylhexan-2-one hydrochloride |
|
/ |
否 |
HY-W014928 |
Anabasine hydrochloride |
Agonist |
/ |
否 |
HY-W015366 |
(S)-3-Amino-2-oxo-azepane hydrochloride |
|
/ |
否 |
HY-W015875 |
(2S,3S)-2-amino-3-methylpentan-1-ol |
|
99.88% |
否 |
HY-W016087 |
Monoethyl pimelate |
|
/ |
否 |
HY-W016099 |
3-Methyl-2-quinoxalinecarboxylic acid |
|
/ |
否 |
HY-W016319 |
(S)-2-aminopentanedioic acid hydrochloride |
|
/ |
否 |
HY-W016363 |
(S)-2-amino-3-guanidinopropanoic acid hydrochloride |
|
/ |
否 |
HY-W016644 |
(S)-1-Benzylpyrrolidin-3-ol |
|
99.64% |
否 |
HY-W017255 |
(S)-3-Thienylglycine |
|
/ |
否 |
HY-W017256 |
(S)-2-Amino-2-(thiophen-2-yl)acetic acid |
|
/ |
否 |
HY-W017413 |
(S)-Pyrrolidine-2-carboxamide hydrochloride |
|
/ |
否 |
HY-W017610 |
(R)-1-Phenyl-2-propanol |
|
/ |
否 |
HY-W019816S |
S-Ethyl dipropylthiocarbamate-d14 |
|
/ |
否 |
HY-W020576 |
Rivastigmine metabolite |
Inhibitor |
99.01% |
否 |
HY-W022138 |
N-Tert-Butoxycarbonyl-(4S)-4-Methoxymethyl-L-proline |
|
≥95.0% |
否 |
HY-W022796 |
(S)-2-Amino-3-(benzo[b]thiophen-3-yl)propanoic acid |
|
/ |
否 |
HY-W040233R |
L-Lactic acid (sodium) (Standard) |
Inhibitor |
/ |
否 |
HY-W040233S |
L-Lactic acid-d3 sodium |
|
/ |
否 |
HY-W040233S1 |
L-Lactic acid-2-d1 sodium |
|
/ |
否 |
HY-W040240S |
(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C |
|
/ |
否 |
HY-W040240S1 |
(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-1 |
|
/ |
否 |
HY-W040240S2 |
(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 |
|
/ |
否 |
HY-W040288A |
L-Threose (solution),0.5M |
|
/ |
否 |
HY-W040430A |
(S)-Nornicotine hydrochloride |
|
/ |
否 |
HY-W040441 |
(S)-Methyl 2-amino-3-(3-hydroxyphenyl)propanoate hydrochloride |
|
99.82% |
否 |
HY-W048245 |
(2R,3S,4R)-2-(Hydroxymethyl)tetrahydrothiophene-3,4-diol |
|
/ |
否 |
HY-W055872S1 |
Erythromycylamine-13C,d3 |
|
/ |
否 |
HY-W062695 |
(R)-Acalabrutinib |
Inhibitor |
/ |
否 |
HY-W062835A |
CGP77675 hydrate |
Inhibitor |
/ |
否 |
HY-W072274 |
(S)-Desoxy-D2PM hydrochloride |
|
/ |
否 |
HY-W087444A |
(S)-1-(4-Hydroxyphenyl)ethane-1,2-diol |
Inhibitor |
/ |
否 |
HY-W088413A |
DOTA-amide dihydrate |
|
/ |
否 |
HY-W088589S |
(S)-3-Aminopiperidine-2,6-dione-d1 hydrochloride |
|
/ |
否 |
HY-W096147 |
S-acetyl-PEG6 |
|
/ |
否 |
HY-W097106 |
(S)-3-N-Cbz-Amino-succinimide |
|
/ |
否 |
HY-W101367S |
N-Acetyl-S-benzyl-L-cysteine-d5 |
|
/ |
否 |
HY-W110242A |
(S)-CPP sodium |
|
/ |
否 |
HY-W121901 |
Naproxen glucuronide |
|
/ |
否 |
HY-W127359 |
(S)-1,2-Dilauroyl-sn-glycero-3-phosphocholine |
|
/ |
否 |
HY-W127584 |
S-(3)-Hydroxymyristic acid, methyl ester |
|
/ |
否 |
HY-W127793 |
EDTA-p-Bromoacetamido benzyl |
|
/ |
否 |
HY-W127798 |
[S-Methanethiosulfonylcysteaminyl]ethylenediamine-N,N,N',N'-tetraacetic acid |
|
/ |
否 |
HY-W127814 |
Ethylenediamine-N,N′-diglutaric acid |
|
/ |
否 |
HY-W127836 |
EDTA-(S)-1-(4-Aminoxyacetamidobenzyl) |
|
/ |
否 |
HY-W128037 |
(S)-N-(1-Amino-5-guanidino-1-oxopentan-2-yl)benzamide hydrochloride |
|
/ |
否 |
HY-W129448 |
N-Boc-S-benzyl-D-cysteine |
|
/ |
否 |
HY-W134546S |
Dicamba methyl ester-d6 |
|
/ |
否 |
HY-W141771 |
N-Acetyl-S-benzyl-D-cysteine |
|
/ |
否 |
HY-W141772S |
N-Acetyl-S-benzyl-2,3,4,5,6-d5-DL-cysteine |
|
/ |
否 |
HY-W141791 |
S-tert-Butylmercapto-L-cysteine |
|
/ |
否 |
HY-W142139 |
(S)-Boc-2-amino-5-azido-pentanoic acid dicyclohexylammonium |
|
/ |
否 |
HY-W142867 |
S-β-(4-Pyridylethyl)-L-cysteine |
|
/ |
否 |
HY-W145488 |
L-Altrose |
|
/ |
否 |
HY-W156412S |
(2S)-2-(Acetylamino)-N,4-dimethylpentanamide-d16 |
|
/ |
否 |
HY-W214058 |
Ac-2-Nal-OH |
|
/ |
否 |
HY-W230975 |
(E/Z)-Piperine |
Inhibitor |
/ |
否 |
HY-W242887S2 |
D-Gulose-13C |
|
/ |
否 |
HY-W242887S3 |
D-Gulose-1-13C |
|
/ |
否 |
HY-W243018S |
1,2:5,6-Di-O-isopropylidene-a-D-glucofuranose-1,2,3,4,5,6-13C6 |
|
/ |
否 |
HY-W278582 |
Topoisomerase II inhibitor 14 |
|
99.68% |
否 |
HY-W294889 |
OUL245 |
Inhibitor |
/ |
否 |
HY-W309130 |
(S)-Tolterodine |
Inhibitor |
/ |
否 |
HY-W322573 |
(R)-Ketoprofen |
Inhibitor |
/ |
否 |
HY-W334680 |
9-β-D-[2'-Fluoro-2'-deoxy-arabinofuranosyl]-guanin |
|
/ |
否 |
HY-W334800S |
(2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2 |
|
/ |
否 |
HY-W334800S1 |
(2S,6S)-2,6-Diaminoheptanedioic acid-15N2 |
|
/ |
否 |
HY-W334800S2 |
(2S,6S)-2,6-Diaminoheptanedioic acid-13C7 |
|
/ |
否 |
HY-W339645 |
Naproxen ethyl ester |
Inhibitor |
/ |
否 |
HY-W354252 |
2-Amino-9-β-D-ribofuranosylpurine |
|
/ |
否 |
HY-W354851 |
Pisiferic acid |
Inhibitor |
/ |
否 |
HY-W357137 |
L-Threonolactone |
|
/ |
否 |
HY-W371164 |
C1s-IN-1 |
Inhibitor |
/ |
否 |
HY-W377455 |
2',5-Difluoro-2'-deoxy-1-arabinosyluracil |
|
/ |
否 |
HY-W392857 |
(S)-NH2-Pyridine-piperazine(Me)-Boc |
|
/ |
否 |
HY-W394432 |
9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine |
|
/ |
否 |
HY-W399940 |
Actiphenol |
Inhibitor |
/ |
否 |
HY-W403075 |
N-(3-Methoxybenzyl)stearamide |
Inhibitor |
/ |
否 |
HY-W423489 |
SARS-CoV-2-IN-76 |
Inhibitor |
/ |
否 |
HY-W440986S |
Distearoylphosphatidylserine-d70 sodium |
|
/ |
否 |
HY-W471938 |
Antiproliferative agent-35 |
|
/ |
否 |
HY-W554799 |
S-Benzyl-L-cysteine ethyl ester hydrochloride |
|
/ |
否 |
HY-W560593 |
S-Benzyl-L-cysteine 7-amido-4-methylcoumarin |
|
/ |
否 |
HY-W585815S |
(S)-1-Chloro-3-(hexadecyloxy)propan-2-ol-d5 |
|
/ |
否 |
HY-W587506 |
Biotin-d-sulfoxide |
|
/ |
否 |
HY-W587731S |
N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine-d7 |
|
/ |
否 |
HY-W587768 |
Metoxadiazone |
|
/ |
否 |
HY-W590670 |
C20-Dihydroceramide |
|
/ |
否 |
HY-W654314 |
S-Phenyl-d5-mercapturic Acid |
|
/ |
否 |
HY-W670564A |
(4S)-10-Nor-calamenen-10-one |
Inhibitor |
/ |
否 |
HY-W683760 |
N-Nitrosonornicotine |
|
/ |
否 |
HY-W686216 |
VK-28 |
|
97.17% |
否 |
HY-W698574 |
Dansylamidoethyl mercaptan |
|
/ |
否 |
HY-W699196 |
(4R,4S)-Benzyl-4-deoxy-4-C-nitromethyl-β-D-arabinopyranoside |
|
/ |
否 |
HY-W699238 |
S-(-)-Aminoglutethimide D-tartrate |
|
/ |
否 |
HY-W701470 |
W140 hydrobromide |
Antagonist |
/ |
否 |
HY-W705106 |
(-)-Coclaurine hydrochloride |
Antagonist |
/ |
否 |
HY-W747548 |
12(S)-HEPE |
Inhibitor |
/ |
否 |
HY-W747572 |
(+)-Perillyl alcohol |
Inhibitor |
/ |
否 |
HY-W753820A |
Boc-LRR-AMC TFA |
|
/ |
否 |
HY-W756041 |
rel-(1S,2S)-Dihydro bupropion-d9 hydrochloride |
|
/ |
否 |
HY-W762015 |
1,2,3,6,7,8-Hexachlorodibenzofuran |
Inducer |
/ |
否 |
HY-W762018 |
2,3,4,6,7,8-Hexachlorodibenzofuran |
Inducer |
/ |
否 |
HY-W766569 |
N-Acetyl S-(1,2-dichlorovinyl)-L-cysteine-13C,d3 |
|
/ |
否 |
HY-W776851 |
S-[2-(Iodo-4-azidosalicylamido)ethylthio]-2-thiopyridine |
|
/ |
否 |
HY-W780790 |
(Z,Z)-3,13-Octadecadienyl acetate |
|
/ |
否 |
HY-W781265 |
BE 24566B |
|
/ |
否 |
HY-W796158 |
Z-DEVD-CMK |
Inhibitor |
/ |
否 |
HY-W797329 |
(3S)Lenalidomide-5-Br |
|
/ |
否 |
HY-W846144 |
ETP-45835 |
Inhibitor |
/ |
否 |
HY-W956235 |
(S,R,S)-AHPC-CO-C-piperazine |
|
/ |
否 |
HY-W981453 |
1,3-o-(S)-Benzylidene-D-arabitol |
|
/ |
否 |
HY-Y0007 |
N-[(Benzyloxy)carbonyl]-L-alanine |
|
≥98.0% |
否 |
HY-Y0017S |
L-Norleucine-d9 |
Inhibitor |
/ |
否 |
HY-Y0152A |
Cinchonine monohydrochloride hydrate |
|
/ |
否 |
HY-Y0219A |
1,2,4-Triazole sodium |
|
≥95.0% |
否 |
HY-Y0219S |
1,2,4-Triazole-13C2,15N3 |
|
/ |
否 |
HY-Y0219S1 |
1,2,4-Triazole-d3 |
|
/ |
否 |
HY-Y0313S1 |
p-Hydroxybenzaldehyde-13C |
Antagonist |
/ |
否 |
HY-Y0313S2 |
p-Hydroxybenzaldehyde-d5 |
|
/ |
否 |
HY-Y0337S7 |
L-Cysteine-d3,15N |
|
/ |
否 |
HY-Y0366R |
Lauric acid (Standard) |
Inhibitor |
/ |
否 |
HY-Y0366S4 |
Lauric acid-13C-1 |
Inhibitor |
/ |
否 |
HY-Y0366S5 |
Lauric acid-d5 |
Inhibitor |
/ |
否 |
HY-Y0703E |
Sodium carboxymethyl cellulose (Viscosity:2500-6000mpa.s) |
|
/ |
否 |
HY-Y0837S |
L-Alaninol-d3 |
|
/ |
否 |
HY-Y1069S3 |
(S)-Malic acid-13C4 |
|
/ |
否 |
HY-Y1108 |
(S,S)-TsDPEN |
|
99.46% |
否 |
HY-Y1760 |
tert-Butyl bromoacetate |
|
/ |
否 |
HY-Z1430S |
(3R,4S)-Paroxetine-d4 hydrochloride |
|
/ |
否 |
HY-Z1917S |
(S)-1-(6-amino-9H-purin-9-yl)propan-2-ol-d6 |
|
/ |
否 |
HY-Z4561S |
Bortezomib trimer-d15 |
|
/ |
否 |
HY-Z5058S |
(3R,5S)-Fluvastatin-d7 sodium |
|
/ |
否 |
HY-100228 |
SKF 89976A |
Inhibitor |
/ |
否 |
HY-100349A |
cis-SU4312 |
Inhibitor |
/ |
否 |
HY-100442S |
Paquinimod-d5 |
Inhibitor |
/ |
否 |
HY-100449A |
(S)-AL-8810 |
Antagonist |
/ |
否 |
HY-100603A |
(S)-GSK-F1 |
Inhibitor |
/ |
否 |
HY-100840 |
(S)-4C3HPG |
|
/ |
否 |
HY-100841A |
(S)-3-Hydroxyphenylglycine |
Agonist |
/ |
否 |
HY-100961 |
NPC 200 |
Antagonist |
/ |
否 |
HY-101048 |
Synthalin A sulfate |
Inhibitor |
/ |
否 |
HY-101304 |
S-Isopropylisothiourea hydrobromide |
Inhibitor |
≥98.0% |
否 |
HY-101377B |
S(-)-8-OH-DPAT hydrobromide |
Agonist |
/ |
否 |
HY-101479S |
Iclaprim-d6 |
Inhibitor |
/ |
否 |
HY-101549A |
MRX-2843 hydrochloride |
Inhibitor |
/ |
否 |
HY-10158AR |
Bosutinib (hydrate) (Standard) |
Inhibitor |
/ |
否 |
HY-101598 |
PD-159020 |
Antagonist |
/ |
否 |
HY-101619 |
Abaperidone |
Antagonist |
/ |
否 |
HY-101619A |
Abaperidone hydrochloride |
Antagonist |
/ |
否 |
HY-101698 |
Alniditan |
Agonist |
/ |
否 |
HY-101775 |
9-Hydroxyellipticin |
Inhibitor |
/ |
否 |
HY-101817 |
Spirendolol |
Antagonist |
/ |
否 |
HY-10181S1 |
Dasatinib-d4 |
|
/ |
否 |
HY-101967 |
GSK299423 |
Inhibitor |
/ |
否 |
HY-101977B |
(3aR)-Selitrectinib |
Inhibitor |
/ |
否 |
HY-10201S4 |
Sorafenib-d3 tosylate |
Inhibitor |
/ |
否 |
HY-10202B |
Tandutinib sulfate |
|
/ |
否 |
HY-10208S2 |
Pazopanib-d3 |
|
/ |
否 |
HY-10255AS1 |
Sunitinib-d4 |
|
/ |
否 |
HY-103045A |
CMPD101 hydrochloride |
Inhibitor |
/ |
否 |
HY-10341D |
Fasudil mesylate |
|
/ |
否 |
HY-103443A |
HKI-357 dimaleate |
Inhibitor |
/ |
否 |
HY-103467 |
NPE-caged-HPTS sodium |
|
/ |
否 |
HY-103641AS1 |
(2R)-Octyl-α-hydroxyglutarate-d17 |
|
/ |
否 |
HY-10399B |
(S)-Ladostigil |
Inhibitor |
/ |
否 |
HY-104020B |
Philanthotoxin 74 diTFA |
Antagonist |
/ |
否 |
HY-10405S |
Pamapimod-d4 |
Inhibitor |
/ |
否 |
HY-10466S1 |
Daclatasvir-13C2,d6 |
Inhibitor |
/ |
否 |
HY-105109B |
(S)-Cilansetron |
Control |
/ |
否 |
HY-10549 |
PI3Kγ inhibitor 1 |
Inhibitor |
/ |
否 |
HY-105751 |
Kalafungin |
Inhibitor |
/ |
否 |
HY-105815 |
Chlornaphazine |
|
/ |
否 |
HY-106306 |
Laprafylline |
Inhibitor |
/ |
否 |
HY-10635A |
(S)-ABT-102 |
Antagonist |
/ |
否 |
HY-106412 |
Stacofylline |
Inhibitor |
/ |
否 |
HY-106514 |
Prifelone |
Inhibitor |
/ |
否 |
HY-106515 |
Tebuquine |
Inhibitor |
/ |
否 |
HY-106577AS |
(-)-(S)-Cibenzoline-d4 |
Inhibitor |
/ |
否 |
HY-106897 |
BF389 |
Inhibitor |
/ |
否 |
HY-106964A |
(Rac)-S 16924 |
Agonist |
/ |
否 |
HY-107004 |
Amotosalen |
Inhibitor |
/ |
否 |
HY-107632G |
GYY4137 (GMP) |
|
/ |
否 |
HY-107676A |
SIB-1553A free base |
Agonist |
/ |
否 |
HY-108257 |
Atorvastatin sodium |
|
/ |
否 |
HY-109037S |
Mavacamten-d6 |
Modulator |
/ |
否 |
HY-109037S2 |
Mavacamten-d1 |
Modulator |
/ |
否 |
HY-109089S |
Epeleuton-d5 |
|
/ |
否 |
HY-10977S |
Tivozanib-d6 |
Inhibitor |
/ |
否 |
HY-10984A |
(S)-Pomalidomide |
|
/ |
否 |
HY-110045 |
ZM-306416 hydrochloride |
Inhibitor |
/ |
否 |
HY-11010A |
AS601245 TFA |
Inhibitor |
/ |
否 |
HY-110133A |
JTE-607 free base |
Inhibitor |
/ |
否 |
HY-110314 |
CYM50358 hydrochloride |
Antagonist |
/ |
否 |
HY-11071 |
MK-0952 sodium |
Inhibitor |
/ |
否 |
HY-111156 |
NW-1172 free base |
Inhibitor |
/ |
否 |
HY-111210 |
Pridopidine hydrochloride |
Antagonist |
/ |
否 |
HY-111273 |
AR244555 |
Antagonist |
/ |
否 |
HY-112403 |
(S)-Roscovitine |
Inhibitor |
/ |
否 |
HY-112461 |
NF449 |
Antagonist |
/ |
否 |
HY-112547 |
CRT5 |
Inhibitor |
/ |
否 |
HY-112680 |
Carboxypyridostatin |
|
/ |
否 |
HY-113257 |
Dopamine 4-sulfate |
|
/ |
否 |
HY-113453A |
11-S-Hydroxyeicosatetraenoic acid |
|
/ |
否 |
HY-113455S1 |
9(S)-HODE-13C18 |
Inducer |
/ |
否 |
HY-113475A |
8(S),15(S)-DiHETE |
|
/ |
否 |
HY-113486S |
(S)-Lathosterol-d4 |
|
99.70% |
否 |
HY-113510 |
9(S)-HOTrE |
|
/ |
否 |
HY-113513 |
5-HEPE |
|
/ |
否 |
HY-113572 |
PX-866-17OH |
Inhibitor |
/ |
否 |
HY-113602 |
Paldimycin B |
Inhibitor |
/ |
否 |
HY-113687 |
T145 |
Inhibitor |
/ |
否 |
HY-113739S1 |
Desmethylcitalopram-d4 hydrochloride |
Inhibitor |
/ |
否 |
HY-113824 |
RID-F |
Inhibitor |
/ |
否 |
HY-113846A |
CMP-5 dihydrochloride |
Inhibitor |
/ |
否 |
HY-113884 |
(R)-Coriolic acid |
|
/ |
否 |
HY-113908 |
(1S,3S)-3-Aminomethyl-cyclopentanol |
|
/ |
否 |
HY-113913 |
12(S)-HPEPE |
Inhibitor |
/ |
否 |
HY-113967 |
PF-04859989 |
Inhibitor |
/ |
否 |
HY-114234A |
TAK-070 Free base |
Inhibitor |
/ |
否 |
HY-114622 |
AFN-1252 tosylate |
Inhibitor |
/ |
否 |
HY-114976S |
N-Acetyl-S-allyl-L-cysteine-d3 |
|
/ |
否 |
HY-115407 |
Cochliodone A |
Inhibitor |
/ |
否 |
HY-115849 |
Nrf2-Activator-12G |
Activator |
99.61% |
否 |
HY-116065 |
CUMI-101 |
Agonist |
/ |
否 |
HY-116143 |
MAGL-IN-12 |
Inhibitor |
/ |
否 |
HY-116231 |
(S)-Gyramide A |
Inhibitor |
/ |
否 |
HY-116252 |
(±)-trans-Lamivudine |
Inhibitor |
/ |
否 |
HY-116259 |
PT-S58 |
Antagonist |
/ |
否 |
HY-116486 |
Aureusimine B |
Inhibitor |
/ |
否 |
HY-116567A |
(S)-OPC-51803 |
|
/ |
否 |
HY-116726 |
Crambene |
|
/ |
否 |
HY-116904 |
Anticancer agent 253 |
|
/ |
否 |
HY-116920B |
(S)-Alyssin |
Activator |
/ |
否 |
HY-116974 |
ent-Thiamphenicol |
|
/ |
否 |
HY-117044 |
12(R)-HEPE |
|
/ |
否 |
HY-117044A |
(±)12-HEPE |
Inhibitor |
/ |
否 |
HY-117146 |
Indoxacarb |
|
/ |
否 |
HY-117440 |
4'-Methoxy-S-trityl-L-cysteinol |
Inhibitor |
/ |
否 |
HY-117441 |
5(S)-HPEPE |
|
/ |
否 |
HY-117636 |
(Rac)-L-659989 |
Antagonist |
/ |
否 |
HY-117885 |
PF-5177624 |
Inhibitor |
/ |
否 |
HY-118098 |
LY3202626 |
Inhibitor |
/ |
否 |
HY-118238 |
Remeglurant |
Antagonist |
/ |
否 |
HY-118285 |
Ro4491533 |
Inhibitor |
/ |
否 |
HY-118329 |
S 135 |
|
/ |
否 |
HY-118332 |
19(R)-HETE |
|
/ |
否 |
HY-118514 |
CAY10514 |
Inhibitor |
/ |
否 |
HY-118670 |
16(S)-Iloprost |
Control |
/ |
否 |
HY-118736 |
Ganodermic acid S |
|
/ |
否 |
HY-118806A |
AC-42 hydrochloride |
Agonist |
/ |
否 |
HY-118828AS |
(9S,13R)-12-Oxo phytodienoic acid-d5 |
|
/ |
否 |
HY-118843 |
Lombazole |
|
/ |
否 |
HY-118959 |
S2160 |
|
/ |
否 |
HY-119030 |
Rubradirin |
Inhibitor |
/ |
否 |
HY-119219 |
Detoxin C1 |
Inhibitor |
/ |
否 |
HY-119221 |
AUY954 |
Agonist |
/ |
否 |
HY-119333 |
NNC 11-1607 |
Agonist |
/ |
否 |
HY-119335 |
Cyphenothrin |
|
/ |
否 |
HY-119442 |
Quininib |
Antagonist |
/ |
否 |
HY-119682 |
Bax agonist 1 |
|
/ |
否 |
HY-119813 |
(S,S)-Sinogliatin |
Activator |
/ |
否 |
HY-119832B |
(S)-Setastine |
Antagonist |
99.72% |
否 |
HY-120002 |
Proclonol |
Inhibitor |
/ |
否 |
HY-120206A |
Brasofensine maleate |
Inhibitor |
/ |
否 |
HY-120255A |
17(S)-HDHA |
Activator |
/ |
否 |
HY-120268 |
SLM6031434 |
Inhibitor |
/ |
否 |
HY-12057S |
Vemurafenib-d5 |
|
/ |
否 |
HY-120633A |
BMS-986104 hydrochloride |
Agonist |
/ |
否 |
HY-120636 |
P2Y1 antagonist 1 |
Antagonist |
/ |
否 |
HY-120661 |
T-1840383 |
Inhibitor |
/ |
否 |
HY-120939 |
S14063 |
Antagonist |
/ |
否 |
HY-120982 |
(+)-15-epi Cloprostenol |
|
/ |
否 |
HY-121120 |
Isosulfazecin |
|
/ |
否 |
HY-121197 |
Balanol |
Inhibitor |
/ |
否 |
HY-121203S4 |
Citalopram-d3 hydrochloride |
Inhibitor |
/ |
否 |
HY-121474 |
Dactimicin |
Inhibitor |
/ |
否 |
HY-121538S |
CUDA-d11 |
|
/ |
否 |
HY-12159A |
MK-0668 mesylate |
Antagonist |
/ |
否 |
HY-121613 |
Resistoflavine |
|
/ |
否 |
HY-121692A |
(S)-Alprenolol L-tartrate |
Antagonist |
/ |
否 |
HY-121893 |
p53-MDM2-IN-3 |
Inhibitor |
/ |
否 |
HY-121998 |
Binucleine 2 |
Inhibitor |
/ |
否 |
HY-122106 |
RS-104966 |
Inhibitor |
/ |
否 |
HY-122177 |
MK181 |
Inhibitor |
/ |
否 |
HY-122189 |
Akuammine |
|
/ |
否 |
HY-122259 |
AMPte-Glu-γ-Glu |
Inhibitor |
/ |
否 |
HY-122260 |
S-25932 |
Inhibitor |
/ |
否 |
HY-122327 |
Nodusmicin |
Inhibitor |
/ |
否 |
HY-122522 |
2-Methylcardol triene |
|
/ |
否 |
HY-122523 |
Tetromycin A |
|
/ |
否 |
HY-123016 |
9(S)-HODE cholesteryl ester |
|
/ |
否 |
HY-123033D |
Nicotinamide riboside (triflate) |
Activator |
/ |
否 |
HY-123045 |
PNU-292137 |
Inhibitor |
/ |
否 |
HY-123216 |
Cefmatilen |
Inhibitor |
/ |
否 |
HY-123220 |
S 1592 |
|
/ |
否 |
HY-123260 |
S12340 |
Inhibitor |
/ |
否 |
HY-123331 |
S 82-5455 |
|
/ |
否 |
HY-123440 |
S3608 |
Agonist |
/ |
否 |
HY-123615 |
SPD-2 |
|
/ |
否 |
HY-124093 |
8-Deazahomofolic acid |
Inhibitor |
/ |
否 |
HY-124469 |
UM-C162 |
Inhibitor |
/ |
否 |
HY-124626 |
(R)-(+)-Mequitazine |
Inhibitor |
/ |
否 |
HY-124894 |
(+)-Benalaxyl |
Inhibitor |
/ |
否 |
HY-12491 |
PIK-C98 |
|
/ |
否 |
HY-125064 |
AP22408 |
Inhibitor |
/ |
否 |
HY-125152 |
Candicidin D |
Inhibitor |
/ |
否 |
HY-125416 |
Streptothricin F |
Inhibitor |
/ |
否 |
HY-125569 |
Leucomycin A5 |
Inhibitor |
/ |
否 |
HY-125602 |
MNI-444 |
|
/ |
否 |
HY-12560C |
(S)-PNU-282987 hydrochloride |
|
/ |
否 |
HY-126031A |
(S)-KT109 |
|
/ |
否 |
HY-12616 |
ACT-209905 |
Agonist |
/ |
否 |
HY-126170 |
Valanimycin |
Inhibitor |
/ |
否 |
HY-126407 |
Secologanin dimethyl acetal |
Inhibitor |
/ |
否 |
HY-12659B |
LX7101 monohydrochloride |
Inhibitor |
/ |
否 |
HY-126735 |
Saquayamycin D |
Inhibitor |
/ |
否 |
HY-128222 |
Selenosemicarbazide |
Inhibitor |
/ |
否 |
HY-12855 |
Lys01 |
Inhibitor |
/ |
否 |
HY-128732 |
rel-(2R,3S)-2,3-Dihydroxysuccinic acid hydrate |
|
/ |
否 |
HY-129037 |
BCRP-IN-1 |
Inhibitor |
/ |
否 |
HY-129300S |
Prosulfocarb-d7 |
|
/ |
否 |
HY-129306 |
Gilvocarcin M |
Inhibitor |
/ |
否 |
HY-129469 |
Saframycin S |
|
/ |
否 |
HY-129485 |
CM304 |
Antagonist |
/ |
否 |
HY-129624 |
Bisindolylmaleimide VIII |
|
/ |
否 |
HY-12965B |
(Z)-S49076 hydrochloride |
Inhibitor |
/ |
否 |
HY-129865 |
MET oxalate |
|
/ |
否 |
HY-129867 |
Z-Leu-Leu-Leu-AMC |
|
/ |
否 |
HY-129899 |
(±)-Equol 4'-sulfate sodium |
|
/ |
否 |
HY-130239S |
14(S)-HDHA-d5 |
|
/ |
否 |
HY-130285 |
10(S),17(S)-DiHDHA |
Modulator |
/ |
否 |
HY-130484 |
2,3-Dehydro-3,4-dihydro ivermectin |
Inhibitor |
/ |
否 |
HY-130743 |
Dieugenol |
|
/ |
否 |
HY-13100A |
(S)-PF 03716556 |
|
/ |
否 |
HY-131044 |
5-[(2-Nitrophenyl)methylene]-2,4-thiazolidinedione |
Inhibitor |
/ |
否 |
HY-131049 |
Antimicrobial agent-30 |
Inhibitor |
/ |
否 |
HY-131527 |
Wy-45494 hydrochloride |
Inhibitor |
/ |
否 |
HY-131549A |
bpV(bipy) hydrate |
Inhibitor |
/ |
否 |
HY-13213A |
AM211 sodium |
Antagonist |
/ |
否 |
HY-13287A |
SGI-1776 |
|
/ |
否 |
HY-133018A |
HCV-IN-7 hydrochloride |
Inhibitor |
/ |
否 |
HY-133199 |
Benastatin A |
Inhibitor |
/ |
否 |
HY-133718 |
Acarviosin |
|
/ |
否 |
HY-133885 |
S-(-)-7-Desmethyl-8-nitro blebbistatin |
|
/ |
否 |
HY-133965 |
Cinchonain IIa |
|
/ |
否 |
HY-134314 |
8-Nitro-cGMP |
Inducer |
/ |
否 |
HY-134556 |
2'-Hydroxyflavanone |
|
/ |
否 |
HY-134664 |
8α-(2-Methylacryloyloxy)-hirsutinolide-13-O-acetate |
Inhibitor |
/ |
否 |
HY-13496 |
JNJ-28312141 |
Inhibitor |
/ |
否 |
HY-134999 |
10-Hydroxywarfarin |
Inhibitor |
/ |
否 |
HY-135043 |
S-Aristeromycinyl-L-homocysteine |
Inhibitor |
/ |
否 |
HY-135073 |
PCMPA hydrochloride |
Control |
/ |
否 |
HY-135329S |
(1R,3S-)Solifenacin-d5 hydrochloride |
Antagonist |
/ |
否 |
HY-135383A |
(3S,5R)-Pitavastatin calcium |
Control |
/ |
否 |
HY-135478A |
LY393615 free base |
Inhibitor |
/ |
否 |
HY-135928 |
Biotin-C2-S-S-pyridine |
|
/ |
否 |
HY-136186A |
(S,R,S)-AHPC-C7-amine dihydrochloride |
|
/ |
否 |
HY-13632S5 |
Exemestane-13C,d2 |
Inhibitor |
/ |
否 |
HY-136570A |
GSK778 hydrochloride |
|
/ |
否 |
HY-136674 |
Aftin-5 |
Inducer |
/ |
否 |
HY-136756 |
CYP51-IN-6 |
Inhibitor |
/ |
否 |
HY-136757 |
CYP51-IN-7 |
Inhibitor |
/ |
否 |
HY-136758 |
CYP51-IN-8 |
Inhibitor |
/ |
否 |
HY-136763 |
CYP51-IN-13 |
Inhibitor |
/ |
否 |
HY-13683S2 |
Mifepristone-d6 |
|
/ |
否 |
HY-136885 |
(S,S)-TAPI-0 |
Inhibitor |
/ |
否 |
HY-136959 |
M133 |
Inhibitor |
/ |
否 |
HY-137025 |
(S)-NIFE |
|
/ |
否 |
HY-137038 |
N-a-Tosyl-L-lysinyl-chloromethylketone hydrochloride |
Inhibitor |
/ |
否 |
HY-137608 |
Uridine 5'-O-thiodiphosphate |
Agonist |
/ |
否 |
HY-137612 |
Sp-UTP-α-S |
Activator |
/ |
否 |
HY-137966A |
N-Desethyl Brinzolamide oxalate |
Inhibitor |
/ |
否 |
HY-138023 |
Leucomycin A4 |
Inhibitor |
/ |
否 |
HY-138089 |
17β-Hydroxy exemestane |
|
/ |
否 |
HY-138123 |
Fmoc-Glu(OtBu)-OSu |
|
/ |
否 |
HY-138164 |
Cafestol palmitate |
|
/ |
否 |
HY-138563A |
(2R,3R)-GSK973 |
Control |
/ |
否 |
HY-138815 |
(S)-N-(1H-Indole-3-acetyl)tryptophan |
Inhibitor |
/ |
否 |
HY-138815S |
(S)-N-(1H-Indole-3-acetyl)tryptophan-d4 |
|
/ |
否 |
HY-138906 |
25C-NBF hydrochloride |
Agonist |
/ |
否 |
HY-139071 |
Boc-D-Leu-Osu |
|
/ |
否 |
HY-139355 |
(S)-GS-621763 |
Control |
/ |
否 |
HY-139795 |
ZYJ-25e |
Inhibitor |
/ |
否 |
HY-139815 |
ZYJ-34c |
Inhibitor |
/ |
否 |
HY-140015A |
(S,E)-TCO2-PEG3-acid |
|
/ |
否 |
HY-141159B |
(S,E)-TCO2-PEG4-COOH |
|
/ |
否 |
HY-141161A |
(S,E)-TCO2-PEG8-acid |
|
/ |
否 |
HY-141166A |
(S,E)-TCO2-PEG3-NHS ester |
|
/ |
否 |
HY-141169A |
(S,E)-TCO2-PEG8-NHS ester |
|
/ |
否 |
HY-141178A |
(S)-TCO-PEG3-amine |
|
/ |
否 |
HY-14153S |
Tegaserod-d11 |
|
/ |
否 |
HY-14205 |
NW-1772 |
Inhibitor |
/ |
否 |
HY-142162A |
(S,R)-LSN3318839 |
Control |
/ |
否 |
HY-143276 |
(S,S,R)-AHPC-C6-NH2 |
|
/ |
否 |
HY-144355S |
N-Acetyl-S-propyl-L-cysteine-d7 |
|
98.1% |
否 |
HY-144362S |
N-Acetyl-S-(2,5-dimethylbenzene)-L-cysteine-d3 |
|
/ |
否 |
HY-144364S |
N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3 |
|
/ |
否 |
HY-144364S1 |
cis-N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine-d3 |
|
/ |
否 |
HY-144365S |
N-Acetyl-S-(2-hydroxypropyl)cysteine-d3 dicyclohexylammonium |
|
/ |
否 |
HY-144367S |
N-Acetyl-S-(2-hydroxy-3-propionamide)-L-cysteine-d3 dicyclohexylammonium |
|
/ |
否 |
HY-144403S |
S-(N-Methylcarbamoyl)glutathione-d3 |
|
/ |
否 |
HY-144407S |
N-Acetyl-S-(2-carboxyethyl)-L-cysteine-d3 |
|
/ |
否 |
HY-144408S |
N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine-d3 |
|
/ |
否 |
HY-144409S |
N-Acetyl-S-(2-cyanoethyl)-L-cysteine-d3 |
|
/ |
否 |
HY-144414S |
N-Acetyl-S-ethyl-L-cysteine-d5 |
|
/ |
否 |
HY-145287A |
S-MGB-234 TFA |
|
/ |
否 |
HY-145473S |
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11 |
|
/ |
否 |
HY-145477 |
8(R),11(S)-DiHODE |
|
/ |
否 |
HY-145511 |
10(S)-HOME |
|
/ |
否 |
HY-145521 |
5(S)-HETrE |
|
/ |
否 |
HY-145530 |
(S)-Hydroxychloroquine sulfate |
Control |
/ |
否 |
HY-14649S2 |
11-cis-Retinoic Acid-d5 |
Agonist |
/ |
否 |
HY-14649S6 |
Retinoic acid-d3-1 |
Agonist |
/ |
否 |
HY-146708S |
((2R,3S,4R,5R)-5-(2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-15N4 sodium |
|
/ |
否 |
HY-14780 |
Viquidacin |
Inhibitor |
/ |
否 |
HY-14782A |
Adoprazine hydrochloride |
|
/ |
否 |
HY-14794AS |
Levomilnacipran-d10 hydrochloride |
Inhibitor |
/ |
否 |
HY-148034 |
Plm IV inhibitor-1 |
Inhibitor |
/ |
否 |
HY-14855S |
Tedizolid-13C,d3 |
Inhibitor |
/ |
否 |
HY-148624 |
CHDI-00484077 |
Inhibitor |
/ |
否 |
HY-14879S2 |
Avibactam sodium salt-13C5 |
Inhibitor |
/ |
否 |
HY-14894S2 |
Pragliflozin-13C6 |
Inhibitor |
/ |
否 |
HY-149687 |
4-Ketobenzotriazine-CH2-S-(CH2)2-COOH |
|
/ |
否 |
HY-149688 |
4-Ketobenzotriazine-CH2-S-(CH2)5-COOH |
|
/ |
否 |
HY-149690 |
O-Phthalimide-C1-S-C1-acid |
|
/ |
否 |
HY-149691 |
O-Phthalimide-C1-S-C5-acid |
|
/ |
否 |
HY-149697 |
Insecticidal agent 6 |
Inhibitor |
/ |
否 |
HY-149715 |
R1-11 |
Inhibitor |
/ |
否 |
HY-149716 |
MEY-003 |
|
/ |
否 |
HY-149779 |
RyR2 stabilizer-1 |
Modulator |
/ |
否 |
HY-149854B |
AB21 hydrochloride |
Antagonist |
99.93% |
否 |
HY-15030S1 |
Naproxen-d3 |
|
/ |
否 |
HY-151150 |
Trypanothione synthetase-IN-2 |
|
/ |
否 |
HY-151734 |
(2R,3S)-Fmoc-Abu(3-N3)-OH |
|
/ |
否 |
HY-151760 |
(2R,4S)-H-D-Pro(4-N3)-OH |
|
/ |
否 |
HY-151760A |
(2R,4S)-H-D-Pro(4-N3)-OH hydrochloride |
|
/ |
否 |
HY-151762 |
(2R,4S)-Fmoc-D-Pro(4-N3)-OH |
|
/ |
否 |
HY-151814 |
(2S,4S)-Fmoc-L-Pro(4-NHPoc)-OH |
|
/ |
否 |
HY-151836 |
(2S,3R)-H-Abu(3-N3)-OH hydrochloride |
|
/ |
否 |
HY-151838 |
(2S,3S)-H-Abu(3-N3)-OH hydrochloride |
|
/ |
否 |
HY-151850 |
(2S,4R)-Fmoc-L-Pro(4-N3)-OH |
|
/ |
否 |
HY-151865 |
(2S,4S)-H-L-Pro(4-N3)-OH |
|
/ |
否 |
HY-151865A |
(2S,4S)-H-L-Pro(4-N3)-OH hydrochloride |
|
/ |
否 |
HY-152040S |
Tenuazonic acid-(acetyl-13C2) (mixture of diastereomers) in methanol |
|
/ |
否 |
HY-152105 |
Metallo-β-lactamase-IN-9 |
Inhibitor |
/ |
否 |
HY-152903S |
Sulfuric-34S acid disodium |
|
/ |
否 |
HY-153332 |
Tankyrase-IN-5 |
Inhibitor |
/ |
否 |
HY-153358A |
(S)-TNG260 |
|
98.84% |
否 |
HY-153697 |
FAK-IN-10 |
Inhibitor |
98.04% |
否 |
HY-15391A |
Lucitanib dihydrochloride |
Inhibitor |
/ |
否 |
HY-154924 |
Thio-NADP |
|
/ |
否 |
HY-155169 |
hLTA4H/hLTA4S-IN-1 |
|
/ |
否 |
HY-15543 |
CP-809101 |
Agonist |
/ |
否 |
HY-156333S |
S-(2-Furanylmethyl) methanethioate-d2 |
|
/ |
否 |
HY-156352S |
Ethyl (S)-2-hydroxy-3-methylbutyrate-d5 |
|
/ |
否 |
HY-156407 |
Adam-20-S |
Inhibitor |
/ |
否 |
HY-156416 |
LtaS-IN-2 |
Inhibitor |
/ |
否 |
HY-156711 |
Ternatumoside II |
Activator |
/ |
否 |
HY-157003 |
(S)-TCO-PEG2-NH2 |
|
/ |
否 |
HY-157006 |
(S)-TCO-PEG3-NH2 |
|
/ |
否 |
HY-157007 |
(S)-TCO-PEG7-NH2 |
|
/ |
否 |
HY-157008 |
(S)-TCO-PEG2-Maleimide |
|
/ |
否 |
HY-157025 |
Herbicidal agent 1 |
|
/ |
否 |
HY-157143 |
Antibacterial agent 164 |
Inhibitor |
/ |
否 |
HY-157165 |
Tubulin/PARP-IN-1 |
Inhibitor |
/ |
否 |
HY-157253 |
13(S)-HODE-biotin |
|
/ |
否 |
HY-157404 |
Pim-1/2 kinase inhibitor 2 |
Inhibitor |
/ |
否 |
HY-157571S |
N-6-[rel-(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinamine-Sonidegib-d8 |
|
/ |
否 |
HY-15769A |
WHI-P180 hydrochloride |
Inhibitor |
/ |
否 |
HY-157700 |
Hexadecenyl-2-hydroxy-sn-glycero-3-PC |
|
/ |
否 |
HY-15800 |
CZC-25146 hydrochloride |
Inhibitor |
/ |
否 |
HY-158117 |
[Cu2Cl2(4'-(4-Methoxy-1-naphthyl)-terpy)2](PF6)2 |
Inducer |
/ |
否 |
HY-158207S |
(+)-Nebivolol-d4 |
|
/ |
否 |
HY-158252S |
Tiagabine-d5 hydrochloride |
Inhibitor |
/ |
否 |
HY-158431 |
(S,R,S)-AHPC-Me-8-bromooctanoic acid |
|
/ |
否 |
HY-158783 |
SACLAC |
|
/ |
否 |
HY-159422 |
S-309309 |
Inhibitor |
/ |
否 |
HY-159540 |
(S,R,S)-AHPC-CO-Spiro-CHO |
|
/ |
否 |
HY-159543 |
(S,R,S)-AHPC-CO-Ph-Ph-CHO |
|
/ |
否 |
HY-159546 |
(S,R,S)-AHPC-Me-CO-cyclohexene-Bpin |
|
/ |
否 |
HY-159549 |
(S,R,S)-AHPC-CO-C-Cyclohexene-Bpin |
|
/ |
否 |
HY-159556 |
Dimethylformamide-(S,R,S)-AHPC |
|
/ |
否 |
HY-159603 |
S-WJM992 |
Inhibitor |
/ |
否 |
HY-159780 |
Amino-PEG4-(S,R,S)-AHPC-Me |
|
/ |
否 |
HY-159802 |
Tolamolol |
|
/ |
否 |
HY-159996 |
GRL093-22 |
Inhibitor |
/ |
否 |
HY-160240 |
HPI |
|
/ |
否 |
HY-160251 |
3-HC-Gluc |
|
/ |
否 |
HY-160260 |
EP300/CBP-IN-1 |
Inhibitor |
/ |
否 |
HY-160456 |
FABP4/5-IN-4 |
Inhibitor |
/ |
否 |
HY-160485 |
G-4'G-7S |
|
/ |
否 |
HY-160874 |
GST-FH.4 |
Inhibitor |
/ |
否 |
HY-160943 |
F594-1001 |
Inhibitor |
/ |
否 |
HY-160943A |
F594-1001 hydrochloride |
Inhibitor |
/ |
否 |
HY-161043 |
ECDD-S16 |
Inhibitor |
/ |
否 |
HY-161047 |
Antiviral agent 45 |
Inhibitor |
/ |
否 |
HY-161058 |
AChE-IN-49 |
Inhibitor |
/ |
否 |
HY-161094 |
Metallo-β-lactamase-IN-12 |
Inhibitor |
/ |
否 |
HY-161124 |
SrtA-IN-2 |
Inhibitor |
/ |
否 |
HY-161172 |
Antibacterial agent 178 |
Inhibitor |
/ |
否 |
HY-16122A |
CAL-130 |
Inhibitor |
/ |
否 |
HY-16123 |
Canfosfamide hydrochloride |
Chemical |
/ |
否 |
HY-161239 |
(S)-IB-96212 |
Inhibitor |
/ |
否 |
HY-161693 |
Telomeric G4s ligand 1 |
|
/ |
否 |
HY-161758 |
F0045(S) |
Inhibitor |
/ |
否 |
HY-161797 |
Antibacterial agent 227 |
Inhibitor |
/ |
否 |
HY-161803 |
Anti-MRSA agent 12 |
Inhibitor |
/ |
否 |
HY-161820 |
IAV-IN-3 |
Inhibitor |
/ |
否 |
HY-161827 |
Anti-MRSA agent 14 |
Inhibitor |
/ |
否 |
HY-161960 |
EP300/CBP ligand 2 |
|
/ |
否 |
HY-161961 |
Thalidomide-NH-C10-Boc |
|
/ |
否 |
HY-162015 |
LTA4H-IN-2 |
Inhibitor |
/ |
否 |
HY-162044 |
COX-1/2-IN-6 |
Inhibitor |
/ |
否 |
HY-162070 |
CCK antagonist 1 |
Antagonist |
99.96% |
否 |
HY-162102 |
DDR1-IN-8 |
Inhibitor |
/ |
否 |
HY-162559 |
SDH-IN-16 |
Inhibitor |
/ |
否 |
HY-162631 |
IDH1 Inhibitor 9 |
|
/ |
否 |
HY-162635 |
α-Amylase/α-Glucosidase-IN-14 |
Inhibitor |
/ |
否 |
HY-16273B |
L-778123 dihydrochloride |
Inhibitor |
/ |
否 |
HY-162761 |
COX-1/2-IN-9 |
Inhibitor |
/ |
否 |
HY-162862 |
JAK-IN-38 |
|
/ |
否 |
HY-162948 |
(S,R,S)-AHPC-PEG2-C5-N3 |
|
/ |
否 |
HY-163015 |
RNA polymerase-IN-1 |
Inhibitor |
/ |
否 |
HY-163016 |
RNA polymerase-IN-2 |
Inhibitor |
/ |
否 |
HY-163029 |
CTSL/B-IN-1 |
Inhibitor |
/ |
否 |
HY-163098 |
JJ-OX-007 |
|
/ |
否 |
HY-163103 |
(S)-Isomyosmine |
|
/ |
否 |
HY-163177 |
HIV-1 inhibitor-63 |
Inhibitor |
/ |
否 |
HY-163206 |
SARS-CoV-2-IN-77 |
Inhibitor |
/ |
否 |
HY-163529A |
(S)-HN0037 |
Inhibitor |
98.42% |
否 |
HY-164043 |
(S,R,S)-AHPC(Me)-amido-C2-acid |
|
/ |
否 |
HY-164384 |
DFX117 |
|
/ |
否 |
HY-164393 |
ON044580 |
|
/ |
否 |
HY-16441 |
Tegafur-gimeracil-oteracil potassium |
|
/ |
否 |
HY-164427 |
SHP2-IN-31 |
Inhibitor |
/ |
否 |
HY-164510 |
N-Formyldemecolcine |
|
/ |
否 |
HY-164643 |
Antifungal agent 113 |
Inhibitor |
/ |
否 |
HY-164662 |
mTOR inhibitor-24 |
Inhibitor |
/ |
否 |
HY-164774 |
(4S)-GLP-1 receptor agonist 14 |
Modulator |
/ |
否 |
HY-164958 |
TB-11 |
Inhibitor |
/ |
否 |
HY-165005 |
14S(15R)-EET methyl ester |
Control |
/ |
否 |
HY-165031 |
C16 (2'(S)-Hydroxy) ceramide (d18:1/16:0) |
|
/ |
否 |
HY-165032 |
C24 (2'(S)-Hydroxy) ceramide (d18:1/24:0) |
|
/ |
否 |
HY-165034 |
C18 ((±)-2'-Hydroxy) ceramide (d18:1/18:0) |
|
/ |
否 |
HY-165088 |
15(S)-Acetate prostaglandin A2 methyl ester |
|
/ |
否 |
HY-165122 |
1,2-Dioleoyl-3(S)-trimethylammoniumpropane chloride |
|
/ |
否 |
HY-165125 |
(S)-VU0637120 |
Antagonist |
/ |
否 |
HY-165130 |
7(S),10(S)-DiHOME |
|
/ |
否 |
HY-165154 |
Cyclamidomycin |
Inhibitor |
/ |
否 |
HY-165447 |
(S,S)-Lysinoalanine |
|
/ |
否 |
HY-165655 |
17(S)-HDHA-d5 Ethyl ester |
|
/ |
否 |
HY-165656 |
15(S)-HETE-d8 ethyl ester |
|
/ |
否 |
HY-165663S |
1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC |
|
/ |
否 |
HY-165673S |
9(S)-Hexahydrocannabinol-d9 |
|
/ |
否 |
HY-165703S |
Prothioconazole-S-methyl-d3 |
|
/ |
否 |
HY-165706 |
11(S)-Hydroperoxy-7(Z),9(E),13(Z)-hexadecatrienoic acid |
|
/ |
否 |
HY-165716 |
11(S)-Hydroxy-7(Z),9(E),13(Z)-hexadecatrienoic acid |
|
/ |
否 |
HY-165768 |
(2S,3R)-2-Aminodocosane-1,3-diol |
|
/ |
否 |
HY-165804 |
(8(Z),11Z)-Methyl 13-(3-pentyloxiran-2-yl)trideca-8,11-dienoate |
|
/ |
否 |
HY-165875A |
13(S)-HODE Cholesteryl ester |
|
/ |
否 |
HY-165884 |
13(S)-Hydroxy-6(Z),9(Z),11(E)-octadecatrienoic acid |
|
/ |
否 |
HY-165891 |
13(S)-Hydroxy-9(Z),11(E)-octadecadiene-(2-biotinyl)hydrazide |
|
/ |
否 |
HY-165912 |
11(R),12(S),13(S)-Trihydroxy-9(Z)-octadecenoic acid |
|
/ |
否 |
HY-165918 |
Methyl 9(S),10(S)-epoxy-11(S)-hydroxy-12(Z)-octadecenoate |
|
/ |
否 |
HY-165922 |
Methyl 9(S),10(R)-epoxy-13(S)-hydroxy-11(E),15(Z)-octadecadienoate |
|
/ |
否 |
HY-165925 |
Methyl 9(S),10(R)-epoxy-13(S)-hydroxy-11(E)-octadecenoate |
|
/ |
否 |
HY-165928 |
12(S)-Bromo-13(S)-hydroxy-9(Z)-octadecenoic acid |
|
/ |
否 |
HY-165944 |
14(R),15(S)-Dihydroxy-5(Z),8(Z),10(E),12(E)-eicosatetraenoic acid |
|
/ |
否 |
HY-165948 |
14(S),15(S)-Dihydroxy-5(Z),8(Z),10(E),12(E)-eicosatetraenoic acid |
|
/ |
否 |
HY-165975 |
(2S)-3-Keto sphinganine (d6:0) (hydrochloride) |
|
/ |
否 |
HY-165985 |
(2S)-3-Keto sphinganine (d8:0) hydrochloride |
|
/ |
否 |
HY-166000 |
Methyl (9R,10S)-9,10-dihydroxyoctadecanoate |
|
/ |
否 |
HY-166001 |
Methyl 10(R),11(R)-epoxy-9(S)-hydroxy-12(Z)-octadece |
|
/ |
否 |
HY-166001A |
Methyl 10(S),11(S)-epoxy-9(S)-hydroxy-12(Z)-octadecenoate |
|
/ |
否 |
HY-166008 |
Methyl 10(S),11(S)-epoxy-9(S)-hydroxy-12(Z),15(Z)-octadecadienoate |
|
/ |
否 |
HY-166010 |
15(S)-Hydroperoxy-11(Z),13(E)-eicosadienoic acid |
|
/ |
否 |
HY-166021 |
Methyl 11(R),12(R)-epoxy-13(S)-hydroxy-9(Z)-octadecen |
|
/ |
否 |
HY-166024 |
18(S)-Methyleicosanoic acid |
|
/ |
否 |
HY-166048 |
Methyl 11(R),12(S),13(S)-trihydroxy-12(Z)-octadecenoate |
|
/ |
否 |
HY-166064 |
Methyl 11(S),12(S)-epoxy-13(S)-hydroxy-9(Z),15(Z)-octadecadienoate |
|
/ |
否 |
HY-166093 |
Methyl 12(R),13(S)-epoxy-9(S)-hydroxy-10(E),15(Z)-octadecadienoate |
|
/ |
否 |
HY-166094 |
Methyl 12(S),13(S)-epoxy-11(S)-hydroxy-9(Z),15(Z)-octadecadienoate |
|
/ |
否 |
HY-166130 |
Methyl 3(R,S)-hydroxy-10(Z),13(Z),16(Z)-docosatrienoate |
|
/ |
否 |
HY-166134 |
Methyl 3(R,S)-hydroxy-11(Z),14(Z)-eicosadienoate |
|
/ |
否 |
HY-166139 |
Methyl 3(R,S)-hydroxy-13(Z),16(Z),19(Z)-docosatrienoate |
|
/ |
否 |
HY-166146 |
Methyl 3(R,S)-hydroxy-7(Z),10(Z),13(Z),16(Z)-docosatetraenoate |
|
/ |
否 |
HY-166150 |
Methyl 3(R,S)-hydroxy-7(Z),14(Z),13(Z),16(Z),19(Z)-docosapentaenoate |
|
/ |
否 |
HY-166159 |
Methyl 3(R,S)-hydroxy-8(Z),11(Z),14(Z)-eicosatrienoate |
|
/ |
否 |
HY-166188 |
Methyl 13(S)-hydroxy-14(S),15(S)-epoxy-5(Z),8(Z),11(Z)-eicosatrienoate |
|
/ |
否 |
HY-166189 |
9(S),10(S),11(R)-Trihydroxy-12(Z)-octadecenoic acid |
|
/ |
否 |
HY-166194 |
Methyl 14(S),15(S)-epoxy-11(R,S)-hydroxy-5(Z),8(Z),12(E)-eicosatrienoate |
|
/ |
否 |
HY-166195 |
9(S),10(S),13(S)-Trihydroxy-11(E),15(Z)-octadecadienoic acid |
|
/ |
否 |
HY-166196 |
9(S),12(S),13(S)-Trihydroxy-10(E),15(Z)-octadecadienoic acid |
|
/ |
否 |
HY-166207 |
9(S),10(S),11(R)-Trihydroxy-12(Z),15(Z)-octadecadienoic acid |
|
/ |
否 |
HY-166297 |
Butyryl coenzyme A lithium |
|
/ |
否 |
HY-16672 |
AVX 13616 |
Inhibitor |
/ |
否 |
HY-166887S |
Tiotropium bromide impurity-d3 |
|
/ |
否 |
HY-166898S |
trans Nonachlor-13C10 |
|
/ |
否 |
HY-166906S |
cis-Nonachlor-13C10 |
|
/ |
否 |
HY-16708 |
ZLN024 |
Activator |
/ |
否 |
HY-167168 |
(S)-Azelnidipine |
Antagonist |
/ |
否 |
HY-16737A |
(E/Z)-Elafibranor |
Agonist |
/ |
否 |
HY-167679 |
Scio-323 |
|
/ |
否 |
HY-16767S1 |
Doravirine-13C,d3 |
Inhibitor |
/ |
否 |
HY-167922 |
(R,R,S)-GAT107 |
|
/ |
否 |
HY-168069 |
DHFR-IN-20 |
Inhibitor |
/ |
否 |
HY-168250 |
trans-(S,R,S)-AHPC-Me-Amide-cyclohexane-pyrimidine-Cl |
|
/ |
否 |
HY-168272 |
(3S)Lenalidomide-piperazine-C-piperidine |
|
/ |
否 |
HY-168290 |
(S,R,S)-AHPC-Me-12-((4-Bromobutyl)amino)dodecanamide |
|
/ |
否 |
HY-168303 |
(S)-4-(1-(Pyrrolidin-3-ylmethyl)piperidin-4-yl)aniline |
|
/ |
否 |
HY-168364 |
1(R),2(S)-epoxy Cannabidiol |
Inhibitor |
/ |
否 |
HY-168378 |
D-Val-Leu-Lys-pNA |
|
/ |
否 |
HY-168382 |
5R(6S)-EET |
Agonist |
/ |
否 |
HY-168382A |
5S(6R)-EET |
Agonist |
/ |
否 |
HY-168523 |
S1647 |
Inhibitor |
/ |
否 |
HY-168529 |
NU074381b |
Inhibitor |
/ |
否 |
HY-168547S |
AR89-d6 |
Inhibitor |
/ |
否 |
HY-168643 |
Me-(S,R,S)-AHPC-PEG2-OTs |
|
/ |
否 |
HY-168690 |
6-Aminocaproic acid-(S,R,S)-AHPC-Me |
|
/ |
否 |
HY-168766 |
O-Acetylsalicylhydroxamic acid |
Inhibitor |
/ |
否 |
HY-168771 |
gamma-DGG TFA |
Antagonist |
/ |
否 |
HY-168773 |
(R)-AS-1 |
Modulator |
/ |
否 |
HY-168774 |
17(S)-HDoTE |
|
/ |
否 |
HY-168776 |
(S)-C12-200 |
|
/ |
否 |
HY-168779 |
ε-Rhodomycinone |
|
/ |
否 |
HY-168783 |
7(Z),10(Z),13(Z)-Hexadecatrienoic acid methyl ester |
|
/ |
否 |
HY-168788 |
8(S)-Hydroxy-9(R)-hexahydrocannabinol |
|
/ |
否 |
HY-168790 |
8(S)-Hydroxy-9(S)-hexahydrocannabinol |
|
/ |
否 |
HY-168791 |
8(R)-Hydroxy-9(S)-Hexahydrocannabinol |
|
/ |
否 |
HY-168795 |
11-Hydroxy-9(S)-hexahydrocannabinol |
|
/ |
否 |
HY-168796 |
1-Palmitoyl-2-13(S)-HpODE-sn-glycero-3-PC |
|
/ |
否 |
HY-168932 |
Antiangiogenic agent 8 |
Inhibitor |
/ |
否 |
HY-168960 |
ROS inducer 8 |
|
/ |
否 |
HY-16907A |
GSK-364735 potassium |
Inhibitor |
/ |
否 |
HY-16907B |
GSK-364735 sodium |
Inhibitor |
/ |
否 |
HY-169102 |
CHIKV nsP2 protease-IN-1 |
Inhibitor |
/ |
否 |
HY-169127 |
Seganserin |
Antagonist |
/ |
否 |
HY-169132 |
Anti-MRSA agent 17 |
Inhibitor |
/ |
否 |
HY-169350 |
EA-B2L |
Degrader |
/ |
否 |
HY-169354 |
Lariciresinol 4-O-β-D-glucopyranoside |
Control |
/ |
否 |
HY-169485 |
Aspinolide B |
|
/ |
否 |
HY-169521 |
DNA Gyrase-IN-16 |
Inhibitor |
/ |
否 |
HY-169571 |
Antimicrobial agent-38 |
Inhibitor |
/ |
否 |
HY-169603 |
AZ513 |
Inhibitor |
/ |
否 |
HY-169697 |
Thiocillin |
Inhibitor |
/ |
否 |
HY-169780 |
(S)-AMG-628 |
Antagonist |
/ |
否 |
HY-169804 |
ENPP3 Inhibitor 1 |
Inhibitor |
/ |
否 |
HY-169825 |
(S)-PF-04995274 |
Agonist |
/ |
否 |
HY-169838 |
WYneC |
|
/ |
否 |
HY-169848 |
(S)-Batylalcohol |
Inhibitor |
/ |
否 |
HY-169864 |
KRO-105714 |
Antagonist |
/ |
否 |
HY-169894S |
(S)-ADB-BINACA-d5 |
|
/ |
否 |
HY-169919 |
HDM-IN-1 |
Inhibitor |
/ |
否 |
HY-169923 |
HDAC-IN-83 |
Inhibitor |
/ |
否 |
HY-170028 |
NL3 |
Inhibitor |
/ |
否 |
HY-170042 |
5'-Hydroxy-9(S)-hexahydrocannabinol |
|
/ |
否 |
HY-170043 |
10(S)-Hydroxy-9(R)-hexahydrocannabinol |
|
/ |
否 |
HY-170043A |
10(R)-Hydroxy-9(S)-hexahydrocannabinol |
|
/ |
否 |
HY-170047 |
11-Nor-9(R)-carboxy-hexahydrocannabinol |
|
/ |
否 |
HY-170047A |
11-Nor-9(S)-carboxy-hexahydrocannabinol |
|
/ |
否 |
HY-170312 |
Antimicrobial-IN-1 |
Inhibitor |
/ |
否 |
HY-170363 |
Proteasome-IN-6 |
Inhibitor |
/ |
否 |
HY-170367 |
Antimicrobial agent-35 |
Inhibitor |
/ |
否 |
HY-170401 |
Antibacterial agent 260 |
Inhibitor |
/ |
否 |
HY-170493 |
Antiviral agent 66 |
Inhibitor |
/ |
否 |
HY-170527 |
Anticancer agent 260 |
|
/ |
否 |
HY-170547 |
DNA polymerase-IN-6 |
Inhibitor |
/ |
否 |
HY-170666 |
Afubiata |
|
/ |
否 |
HY-170783 |
DXR-IN-4 |
Inhibitor |
/ |
否 |
HY-170920 |
Herbicide safener-4 |
|
/ |
否 |
HY-170940 |
Dyrk1A-IN-12 |
Inhibitor |
/ |
否 |
HY-170974 |
SDH-IN-20 |
Inhibitor |
/ |
否 |
HY-170993 |
Antimicrobial agent-39 |
Inhibitor |
/ |
否 |
HY-171005 |
VPC162134 |
Inhibitor |
/ |
否 |
HY-171229 |
1-Acetyl-DHAP |
Substrate |
/ |
否 |
HY-171233 |
MRSA antibiotic 2 |
Inhibitor |
/ |
否 |
HY-172000 |
(S)-3-Keto sphinganine (d18:0) hydrochloride |
|
/ |
否 |
HY-172009 |
8-Amino-7-oxononanoic acid hydrochloride |
|
/ |
否 |
HY-172011 |
Strychnospermine |
|
/ |
否 |
HY-172109 |
DNA Gyrase-IN-15 |
Inhibitor |
/ |
否 |
HY-172390 |
Florfenicol-propanoate-piperidin |
Inhibitor |
/ |
否 |
HY-172397 |
Mycobacterium Tuberculosis-IN-7 |
Inhibitor |
/ |
否 |
HY-173011 |
RJS308 |
|
/ |
否 |
HY-173026 |
Herbicidal agent 7 |
|
/ |
否 |
HY-173051 |
Antiparasitic agent-24 |
Inhibitor |
/ |
否 |
HY-173054 |
FtsZ-IN-12 |
Inhibitor |
/ |
否 |
HY-173077 |
PD-L1/LpxC-IN-1 |
Inhibitor |
/ |
否 |
HY-17356S2 |
Fenofibrate-13C6 |
|
/ |
否 |
HY-17368S1 |
(Rac)-Rivastigmine-d6 |
Inhibitor |
/ |
否 |
HY-17494B |
Timolol hemimaleate |
Inhibitor |
/ |
否 |
HY-17498A |
(S)-Atenolol |
Inhibitor |
≥95.0% |
否 |
HY-17507E |
S-Pantoprazole sodium trihydrate |
Inhibitor |
/ |
否 |
HY-17628S1 |
Cefiderocol-d6 |
Inhibitor |
/ |
否 |
HY-18039 |
WAY-361789 |
Agonist |
/ |
否 |
HY-18063A |
ML252 hydrochloride |
Inhibitor |
/ |
否 |
HY-18112 |
AZ-4217 |
Inhibitor |
/ |
否 |
HY-18187 |
Ki 23057 |
Inducer |
/ |
否 |
HY-18211 |
CGS 35601 |
Inhibitor |
/ |
否 |
HY-18297 |
ASK1-IN-5 |
|
/ |
否 |
HY-19004 |
711389-S hydrochloride |
|
/ |
否 |
HY-19202 |
rac-Olodanrigan |
Antagonist |
/ |
否 |
HY-19212 |
S-2474 |
Inhibitor |
/ |
否 |
HY-19333A |
OG-L002 hydrochloride |
Inhibitor |
/ |
否 |
HY-19420 |
UK 357903 |
Inhibitor |
/ |
否 |
HY-19562A |
PF-06260933 hydrochloride |
Inhibitor |
/ |
否 |
HY-19646 |
Zoliprofen |
|
/ |
否 |
HY-19652S1 |
(S)-Oxybutynin-d10 |
|
/ |
否 |
HY-19822S1 |
Elacestrant-d4-1 |
Inhibitor |
/ |
否 |
HY-19907 |
Liafensine |
Inhibitor |
/ |
否 |
HY-21291 |
SU-4313 |
Modulator |
99.31% |
否 |
HY-24592 |
(S,E)-Cyclooct-2-enol |
|
/ |
否 |
HY-29268 |
β-Carboline-1-carboxylic acid |
Inhibitor |
/ |
否 |
HY-32721S |
Neratinib-d6 |
Inhibitor |
/ |
否 |
HY-42223 |
(1R,3S)-3-Amino-cyclopentanol |
|
/ |
否 |
HY-43565C |
(1S,9R)-Ac-Exatecan |
|
/ |
否 |
HY-49556 |
(S)-Benzyl 2-cyclopropyl-2-hydroxyacetate |
Control |
98.69% |
否 |
HY-50692 |
CAY10734 |
Agonist |
/ |
否 |
HY-50882A |
ELN318463 racemate |
Inhibitor |
/ |
否 |
HY-76475R |
(S)-(-)-Butane-1,2,4-triol (Standard) |
|
/ |
否 |
HY-78004S1 |
1,2-Diphenylethane-d4 |
|
/ |
否 |
HY-78841S |
(2S,4S)-Sacubitril-d4 |
|
/ |
否 |
HY-78899A |
(4R,5S)-Monomethyl auristatin E intermediate-6 |
|
/ |
否 |
HY-78932C |
(2S,3R)-Dap-NE hydrochloride |
Inhibitor |
/ |
否 |
HY-79491S |
(S)-2-Aminobutyramide-d3 hydrochloride |
|
/ |
否 |
HY-79648S |
Fmoc-Methylalanine-d3 |
|
/ |
否 |
HY-B0007B |
(S)-Baclofen |
Agonist |
/ |
否 |
HY-B0121BS2 |
Sumatriptan-d5 |
Agonist |
/ |
否 |
HY-B0121BS3 |
Sumatriptan-d6 formate |
Agonist |
/ |
否 |
HY-B0130AS |
Perindopril-d3 erbumine |
|
/ |
否 |
HY-B0130S |
Perindopril-d4 erbumine |
Inhibitor |
/ |
否 |
HY-B0161S |
Duloxetine-d7 |
Inhibitor |
/ |
否 |
HY-B0220F |
Erythromycin (glutamate) |
Inhibitor |
/ |
否 |
HY-B0220S |
Erythromycin-d6 |
Inhibitor |
/ |
否 |
HY-B0253A |
Piroxicam olamine |
Inhibitor |
/ |
否 |
HY-B0462D |
(S)-Azelastine |
Inhibitor |
/ |
否 |
HY-B0580D |
Ketorolac hydrochloride |
|
/ |
否 |
HY-B0580S1 |
Ketorolac-d4 |
Inhibitor |
/ |
否 |
HY-B0590D |
(-)-Tetrabenazine |
Inhibitor |
/ |
否 |
HY-B0623AS3 |
Ropinirole-d14 hydrochloride |
Agonist |
/ |
否 |
HY-B0647A |
(3S)-Butylphthalide |
Inhibitor |
/ |
否 |
HY-B0653AS |
Levobupivacaine-d9 hydrochloride |
|
/ |
否 |
HY-B0696AS |
Tiagabine-d4 hydrochloride |
Inhibitor |
/ |
否 |
HY-B1433S |
Perindoprilat-d3 disodium |
Inhibitor |
/ |
否 |
HY-B1864 |
Kasugamycin |
|
/ |
否 |
HY-D2186 |
BTD probe-1 |
|
/ |
否 |
HY-D2476 |
H2S Fluorescent probe 1 |
|
/ |
否 |
HY-G0014S |
Quetiapine Sulfoxide-d8 |
|
/ |
否 |
HY-I0035 |
(S)-N-Glycidylphthalimide |
|
/ |
否 |
HY-N0455AS11 |
L-Arginine-13C6,d14 hydrochloride |
|
/ |
否 |
HY-N0455AS9 |
L-Arginine-15N4,d7 hydrochloride |
Activator |
/ |
否 |
HY-N0565S1 |
Doxycycline-d3 (hyclate) (major) |
|
/ |
否 |
HY-N0650S9 |
L-Serine-15N,d3 |
|
/ |
否 |
HY-N0956 |
(+)-S-Myricanol glucoside |
|
/ |
否 |
HY-N0962A |
(3S)-Hydrangenol 8-O-glucoside pentaacetate |
|
/ |
否 |
HY-N0963 |
(3S,7S)-5,6-Dehydro-4''-de-O-methylcentrolobine |
|
/ |
否 |
HY-N0967 |
(S,E)-Deca-2,9-diene-4,6-diyne-1,8-diol |
|
/ |
否 |
HY-N10082 |
Trigoxyphin A |
|
/ |
否 |
HY-N10365 |
6-(1-Hydroxyethyl)-5,6-dihydrochelerythrine |
Activator |
/ |
否 |
HY-N10607 |
2'-Hydroxy-3,4,4',6'-tetramethoxychalcone |
Inhibitor |
/ |
否 |
HY-N10653 |
Altemicidin |
|
/ |
否 |
HY-N11288 |
Methyl salvionolate A |
Inhibitor |
/ |
否 |
HY-N11699 |
Bequinostatin A |
Inhibitor |
/ |
否 |
HY-N11756 |
Linearmycin A |
|
/ |
否 |
HY-N11778 |
Bequinostatin C |
|
/ |
否 |
HY-N11929 |
(S)-(+)-Imperanene |
|
/ |
否 |
HY-N12068 |
(S)-7-O-Methylpeucedanol 3′-O-β-D-glucopyranoside |
|
/ |
否 |
HY-N12111 |
S-(-)-N-trans-Feruloyl normetanephrine |
|
/ |
否 |
HY-N12152 |
Molluscicidal agent-1 |
|
/ |
否 |
HY-N12208 |
Neohelmanthicin B |
|
/ |
否 |
HY-N12232 |
Carbazomycin D |
Inhibitor |
/ |
否 |
HY-N12261 |
Benastatin B |
Inhibitor |
/ |
否 |
HY-N12384 |
(25S)-Antcin B |
Inhibitor |
/ |
否 |
HY-N12400 |
10-Methyldodec-2-en-4-olide |
Inhibitor |
/ |
否 |
HY-N12416 |
ΔDi6S |
|
/ |
否 |
HY-N12586 |
Pheophytin a |
|
/ |
否 |
HY-N12784 |
(6S,9R)-2-Hydroxy-4-(2,6,6-trimethyl-4-oxo-cyclohex-2-enyl)-butyric acid |
|
/ |
否 |
HY-N12808 |
(E)-4-Methyl-5-styrylbenzene-1,3-diol |
Inhibitor |
/ |
否 |
HY-N12870 |
(7S,8R)-4,9,9'-Trihydroxy-3,3',5-trimethoxy-8,4'-oxyneolignan 4-O-β-D-glucopyranoside |
|
/ |
否 |
HY-N12955 |
8(R),9(S)-EET |
|
/ |
否 |
HY-N12962 |
11S(12R)-EET |
|
/ |
否 |
HY-N12962A |
11R(12S)-EET |
|
/ |
否 |
HY-N12970 |
14S(15R)-EET |
|
/ |
否 |
HY-N13025 |
8-Acetylverrucarin L |
Inhibitor |
/ |
否 |
HY-N13117 |
Pinocembrin 7-O-[4′′,6′′-(S)-HHDP]-β-D-glucoside |
|
/ |
否 |
HY-N13150 |
N-Demethylvancomycin |
Inhibitor |
/ |
否 |
HY-N13150A |
N-Demethylvancomycin hydrochloride |
Inhibitor |
/ |
否 |
HY-N13177 |
25(S)Ruscogenin 3-O-α-L-rhamnopyranoside |
|
/ |
否 |
HY-N13334 |
5,19-Epoxy-19S,25-dimethoxycucurbita-6,23-dien-3-ol |
|
/ |
否 |
HY-N13414 |
(3R,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol |
|
/ |
否 |
HY-N13510 |
(19R,23S)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol |
|
/ |
否 |
HY-N13522 |
7S-O-Methylmorroniside |
|
/ |
否 |
HY-N13530 |
(19S,23S)-5B,19-Epoxy-19,23-Dimethoxycucurbita-6,24-Dien-3B-Ol |
|
/ |
否 |
HY-N13541 |
(19S,23R)-5β,19-Epoxy-19,23-dimethoxycucurbita-6,24-dien-3β-ol |
|
/ |
否 |
HY-N13703 |
(2S)-(+)-2-Hydroxynaringenin-4'-O-β-D-glucopyranoside |
|
/ |
否 |
HY-N13704 |
(19S,23E)-5β,19-Epoxy-19-methoxycucurbita-6,23,25-trien-3β-ol |
|
/ |
否 |
HY-N13713 |
Benzoyl (S)-(-)-malic acid |
|
/ |
否 |
HY-N13872 |
Ammocidin |
Inducer |
/ |
否 |
HY-N14045 |
Celesticetin |
Inhibitor |
/ |
否 |
HY-N14959 |
Deacetylravidomycin N-oxide |
Inhibitor |
/ |
否 |
HY-N15130 |
Cerpegin |
Inhibitor |
/ |
否 |
HY-N15255 |
5-S-Cysteinyldopamine |
Activator |
/ |
否 |
HY-N15270 |
S-Secoantioquine |
|
/ |
否 |
HY-N15304 |
Ent-17α,18-dihydroxy-kauran-19-oic acid |
|
/ |
否 |
HY-N15323 |
Samioside |
Inhibitor |
/ |
否 |
HY-N15344 |
Euryachin E |
Inhibitor |
/ |
否 |
HY-N15367 |
Aklaviketone |
Control |
/ |
否 |
HY-N1569 |
Pteroside D |
|
/ |
否 |
HY-N1686 |
20S,24R-Epoxydammar-12,25-diol-3-one |
|
/ |
否 |
HY-N1772 |
(3S,4S)-3,4-Dihydro-3,4-dihydroxynaphthalen-1(2H)-one |
|
/ |
否 |
HY-N2747 |
2(S)-7-Hydroxy-5,8,2'-trimethoxyflavanone |
|
/ |
否 |
HY-N2841 |
Alnusdiol |
|
/ |
否 |
HY-N3123 |
Oxychelerythrine |
|
/ |
否 |
HY-N3179 |
Norcepharadione B |
|
/ |
否 |
HY-N3622 |
Corchoionoside C |
|
/ |
否 |
HY-N3623 |
Corianin |
Inhibitor |
/ |
否 |
HY-N3660 |
(24S)-Cycloartane-3,24,25-triol 24,25-acetonide |
|
/ |
否 |
HY-N3859 |
Erythro-1-phenylpropane-1,2-diol |
|
/ |
否 |
HY-N4045 |
Hierochin D |
|
/ |
否 |
HY-N5060S |
Estragole-d4 |
|
/ |
否 |
HY-N6994 |
Isoasatone A |
|
99.86% |
否 |
HY-N7163 |
(2S)-5,7,3',5'-Tetrahydroxyflavanone |
|
/ |
否 |
HY-N7784 |
Liriodenine methiodide |
Inhibitor |
/ |
否 |
HY-N7825 |
Gomisin L1 |
|
/ |
否 |
HY-N7960 |
(2S)-Pteroside A |
|
/ |
否 |
HY-N8025 |
Nephthenol |
|
/ |
否 |
HY-N8380 |
(-)-Latifolin |
|
/ |
否 |
HY-N8508 |
Myrothecine A |
|
/ |
否 |
HY-N8575 |
(1S)-Chrysanthemolactone |
|
/ |
否 |
HY-N8584 |
(20S,25S)-20,25-Epoxy-25-methoxy-24,24-dimethyl-26,27-dinordammaran-3-one |
|
/ |
否 |
HY-N8595 |
2(S)-5,7,2'-Trihydroxy-8-methoxyflavanone |
|
/ |
否 |
HY-N8621 |
(11S)-(-)-Hydroxyjasmonic acid |
|
/ |
否 |
HY-N8627 |
(7S,8S)-3-Methoxy-3',7-epoxy-8,4'-oxyneoligna-4,9,9'-triol |
|
/ |
否 |
HY-N8664 |
11(S),16(R)-Dihydroxyoctadeca-9Z,17-diene12,14-diyn-1-yl acetate |
|
/ |
否 |
HY-N8733 |
p-Menth-1-ene-3,6-diol |
|
/ |
否 |
HY-N9101 |
4,4'-Dihydroxy-3,3',9-trimethoxy-9,9'-epoxylignan |
|
/ |
否 |
HY-N9214 |
1-Oxobakkenolide S |
|
/ |
否 |
HY-N9307A |
(S)-8-Acetoxy-15,16-epoxy-8,9-secolabda-13(16),14-diene-7,9-dione |
|
/ |
否 |
HY-N9477 |
Betulinic aldehyde oxime |
Inhibitor |
/ |
否 |
HY-N9522 |
β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate |
|
99.95% |
否 |
HY-N9739 |
(2S)-6,4'-Dihydroxy-7-methoxyflavan |
|
/ |
否 |
HY-N9774 |
(3β,20S)-Pregn-5-ene-3,17,20-triol |
|
/ |
否 |
HY-N9861 |
Kayaflavone |
Inhibitor |
/ |
否 |
HY-N9871 |
(6R,9S)-3-Oxo-α-ionol β-D-glucopyranoside |
|
/ |
否 |
HY-N9936 |
Saikosaponin S5 |
|
/ |
否 |
HY-N9966 |
Sanggenol O |
|
/ |
否 |
HY-P10636 |
Nictide |
|
/ |
否 |
HY-P10658 |
ARF1 (2-17) |
Inhibitor |
/ |
否 |
HY-P10881 |
Ganipatide |
|
/ |
否 |
HY-P1708 |
Enopeptin A |
|
/ |
否 |
HY-P5016A |
CRAMP-18 (mouse) acetate |
Inhibitor |
99.33% |
否 |
HY-P5551 |
TLN-58 |
Inhibitor |
/ |
否 |
HY-P5552 |
Melimine |
Inhibitor |
/ |
否 |
HY-P5553 |
cPcAMP1/26 |
Inhibitor |
/ |
否 |
HY-P5587 |
Dermaseptin-S5 |
Inhibitor |
/ |
否 |
HY-P5588 |
Dermaseptin-S4 |
Inhibitor |
/ |
否 |
HY-P5590 |
Dermaseptin-S3 |
Inhibitor |
/ |
否 |
HY-P5593 |
Dermaseptin-S2 |
Inhibitor |
/ |
否 |
HY-P5596 |
Combi-2 |
Inhibitor |
/ |
否 |
HY-P5715 |
Im6 |
Inhibitor |
/ |
否 |
HY-P5720 |
Peptide 5e |
Inhibitor |
/ |
否 |
HY-P5730 |
Peptide 5g |
Inhibitor |
/ |
否 |
HY-U00051AS2 |
(S)-Propiomazine-d6 hydrochloride |
|
/ |
否 |
HY-U00432B |
S-MTC acetate |
Inhibitor |
/ |
否 |
HY-W001189S |
1,3-Dithiane-d2 |
Inhibitor |
/ |
否 |
HY-W004461 |
S-Methyl thiomethanesulfonate |
Inhibitor |
/ |
否 |
HY-W004812 |
BOC-(1R,3S)-3-aminocyclopentane carboxylic acid |
|
≥98.0% |
否 |
HY-W006202 |
BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid |
|
≥97.0% |
否 |
HY-W010143 |
(R,S)-Norcotinine |
|
/ |
否 |
HY-W010209S |
DL-Histidine-13C6,15N3 |
|
/ |
否 |
HY-W011024 |
(2R,3S)-N-Cbz-6-oxo-2,3-diphenylmorpholine |
|
≥97.0% |
否 |
HY-W011280S |
(S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid-d4 |
|
/ |
否 |
HY-W011309A |
1-O-Hexadecyl-sn-glycerol |
Control |
/ |
否 |
HY-W011360S |
S-(-)-Warfarin-d5 |
Antagonist |
/ |
否 |
HY-W012088 |
(Z)-Methyl tetradec-9-enoate |
|
/ |
否 |
HY-W012440 |
(1S)-(+)-Menthyl chloroformate |
|
/ |
否 |
HY-W012481 |
Nirvanol |
|
≥95.0% |
否 |
HY-W012531S2 |
2-Hydroxycinnamic acid-d4 |
Inhibitor |
/ |
否 |
HY-W013744 |
S-Octylglutathione |
|
/ |
否 |
HY-W013886 |
Captopril EP Impurity J |
|
/ |
否 |
HY-W020576S |
Rivastigmine metabolite-d6 |
|
/ |
否 |
HY-W020788 |
Benoxacor |
Agonist |
99.39% |
否 |
HY-W029600 |
6,7-Dimethylisatin |
Inhibitor |
/ |
否 |
HY-W039386 |
(2S,2′S)-2,2′-Bipyrrolidine |
|
/ |
否 |
HY-W040271 |
N-3-Hydroxydecanoyl-DL-homoserine lactone |
Inhibitor |
/ |
否 |
HY-W048404 |
Bortezomib impurity A |
Control |
/ |
否 |
HY-W057450 |
(S)-3-Oxo-cyclopentanecarboxylic acid methyl ester |
|
/ |
否 |
HY-W061399 |
(S)-Tetrahydrofuran-3-ylamine |
|
/ |
否 |
HY-W063149 |
(1S,3R)-3-Aminocyclopentanol |
Control |
/ |
否 |
HY-W067425 |
2-(4-Hydroxyphenyl)propionic acid |
|
≥98.0% |
否 |
HY-W096114 |
Acid-PEG8-S-S-PEG8-acid |
|
/ |
否 |
HY-W096638A |
Glycerophosphocholine |
|
/ |
否 |
HY-W099352 |
(2R,3S)-3-(tert-Butoxy)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)butanoic acid |
|
/ |
否 |
HY-W108635 |
N-[S-Trityl-L-cysteinyl]glycine |
|
/ |
否 |
HY-W110146 |
(3aS,4S,6aR)-Biotin-PEG4-Alkyne |
|
99.93% |
否 |
HY-W129441 |
N-Acetyl-4-S-cysteaminylphenol |
|
/ |
否 |
HY-W130025 |
p-Xylene bis(pyridinium bromide) |
Inhibitor |
/ |
否 |
HY-W145116 |
[Ru(phen)3]Cl2 |
|
/ |
否 |
HY-W154265 |
2,2′-Dihydroxychalcone |
|
/ |
否 |
HY-W178011 |
Topoisomerase IIα-IN-9 |
Inhibitor |
/ |
否 |
HY-W190737 |
NHS-S-S-dPEG4-biotin (cleavable) |
|
/ |
否 |
HY-W190766 |
dPEG(R)8-SATA |
|
/ |
否 |
HY-W190956 |
(S,R,S)-AHPC-PEG4-acid |
|
/ |
否 |
HY-W214059S |
N-Acetyl-S-methyl-L-cysteine-d3 |
|
/ |
否 |
HY-W276819 |
PLK1-IN-9 |
Inhibitor |
/ |
否 |
HY-W286805 |
Perinaphthenone |
Inhibitor |
/ |
否 |
HY-W289054S |
(S)-Metolachlor metabolite CGA 50720-d3 |
|
/ |
否 |
HY-W292263S |
2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-(hexyloxy)phenol-d5 |
|
/ |
否 |
HY-W297421 |
(S)-Tomoxetine hydrochloride |
Inhibitor |
/ |
否 |
HY-W320685 |
(S)-N-Boc-L-homoserine ethyl ester |
Control |
/ |
否 |
HY-W327027 |
7-(2,4-Dinitrophenoxy)-4-methyl-2H-chromen-2-one |
|
/ |
否 |
HY-W338810 |
S-(5'-Adenosyl)-L-methionine chloride |
|
/ |
否 |
HY-W338810S |
S-(5'-Adenosyl)-L-methionine-13C5 sulfate |
|
/ |
否 |
HY-W339816 |
(S,R)-Bis(monomyristoylglycero)phosphate ammonium |
|
/ |
否 |
HY-W341547 |
3,4-Dihydro-6,7-isoquinolinediol |
Agonist |
/ |
否 |
HY-W344074 |
Cytarabine 5’-monophosphate |
Inhibitor |
/ |
否 |
HY-W345072 |
(S)-2-methoxy-3-(octadecyloxy)propan-1-ol |
|
/ |
否 |
HY-W347669 |
7,17-Dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid |
|
/ |
否 |
HY-W371165 |
C1s-IN-1 trihydrochloride |
Inhibitor |
97.42% |
否 |
HY-W391671 |
Poly[bis(4-phenyl)(2,4,6-trimethylphenyl)amine] |
|
/ |
否 |
HY-W394612 |
(1R,3S)-3-Hydroxycyclopentane carboxylic acid methyl ester |
|
/ |
否 |
HY-W399439 |
Aurantiogliocladin |
Inhibitor |
/ |
否 |
HY-W415004 |
ACHE-IN-38 |
Inhibitor |
/ |
否 |
HY-W422400 |
Fluoroglutamine (2S,4R) |
|
/ |
否 |
HY-W423573 |
N,S-Diacetylcysteine methyl ester |
|
/ |
否 |
HY-W482407 |
1,2-O-Dihexadecyl-sn-glycerol |
|
/ |
否 |
HY-W570889 |
DMT-LNA-5mA phosphoramidite |
|
/ |
否 |
HY-W580836 |
(S)-3-Aminopyrrolidine-2,5-dione |
|
/ |
否 |
HY-W587414 |
Neospiramycin I |
Inhibitor |
/ |
否 |
HY-W587485 |
N-acetyl-S-(trichlorovinyl)-L-cysteine |
|
/ |
否 |
HY-W587542 |
(1S,4S)-N-Desmethyl Sertraline hydrochloride |
Inhibitor |
/ |
否 |
HY-W587878 |
Thujopsene |
|
/ |
否 |
HY-W588247 |
S-(N-Methylsulfinylbutylthiocarbamoyl)-L-cysteine |
|
/ |
否 |
HY-W590669 |
C16-Dihydroceramide |
|
/ |
否 |
HY-W601451 |
3,6-Di-O-acetyl-5-S-acetyl-5-deoxy-1,2-O-isopropylidene-α-D-glucofuranose |
|
/ |
否 |
HY-W653721 |
(R,S)-N-Nitroso anabasine-d4 |
|
/ |
否 |
HY-W653822 |
(2'S)-Nicotine 1-oxide |
|
/ |
否 |
HY-W653930 |
4,4'-Sulfonyldiphenol-13C12 |
|
/ |
否 |
HY-W653962 |
Triclosan-13C6 |
|
/ |
否 |
HY-W654009 |
Loxoprofen-d3 |
Inhibitor |
/ |
否 |
HY-W654010 |
Lurasidone-d8-1 hydrochloride |
|
/ |
否 |
HY-W654013 |
Minocycline-d7 |
|
/ |
否 |
HY-W654139 |
5'-Deoxy-5'-(methylthio)adenosine-d3 |
|
/ |
否 |
HY-W654232 |
L-Hydroxyproline-d4 |
|
/ |
否 |
HY-W654335 |
Rivastigmine-d4 tartrate |
Inhibitor |
/ |
否 |
HY-W654336 |
(S)-Rivastigmine-d4 |
Inhibitor |
/ |
否 |
HY-W655727 |
(-)-2-Phenylpropylamine |
Inhibitor |
/ |
否 |
HY-W674436 |
(S)-Thalidomide-4-OH |
|
/ |
否 |
HY-W675848 |
N4-Bz-C-(S)-GNA phosphoramidite |
|
/ |
否 |
HY-W681822 |
(R,S,S)-Dihydrotetrabenazine |
Inhibitor |
/ |
否 |
HY-W686760A |
Bromamphenicol |
Inhibitor |
/ |
否 |
HY-W688565 |
(2S)-2-Amino-1-hydroxyoctadecan-3-one |
|
/ |
否 |
HY-W698462 |
(S)-3-Hydroxymyristic acid |
|
/ |
否 |
HY-W699163 |
1-Lauroyl-3-chloropropanediol |
|
/ |
否 |
HY-W699983 |
Imidazole-15N2 |
Inhibitor |
/ |
否 |
HY-W700621 |
TCEP-d12 hydrochloride |
|
/ |
否 |
HY-W701858 |
1-Oleoyl-2-stearoyl-3-chloropropanediol |
|
/ |
否 |
HY-W701990 |
Propylcathinone hydrochloride |
Control |
/ |
否 |
HY-W704772 |
S-Methyl-D-penicillamine |
Control |
/ |
否 |
HY-W705415A |
N-Methylcoclaurine |
|
/ |
否 |
HY-W706234 |
Nonanoyl-CoA-d17 |
|
/ |
否 |
HY-W706470 |
(-)-Bornyl ferulate |
Inhibitor |
/ |
否 |
HY-W706955 |
1,2-Dimyristoyl-3-chloropropanediol |
|
/ |
否 |
HY-W707900 |
Erythro-hydro bupropion-d9 (enantiomer)(hydrochloride) |
|
/ |
否 |
HY-W710399 |
2-Hydroxy-3-(palmitoyloxy)propyl stearate |
|
/ |
否 |
HY-W713925 |
Diheptanoyl Thio-PC |
|
/ |
否 |
HY-W714171 |
Propoxycarbazone sodium |
|
/ |
否 |
HY-W714705S |
(S)-Metolachlor metabolite CGA 368208-d3 sodium salt |
|
/ |
否 |
HY-W714837 |
5-Phenyllevulinic acid |
Inhibitor |
/ |
否 |
HY-W721117 |
N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine-d3 |
|
/ |
否 |
HY-W727224 |
1-Oleoyl-3-bromopropanediol |
|
/ |
否 |
HY-W728005 |
Covidcil-19 |
Inhibitor |
/ |
否 |
HY-W728151 |
3-O-Caffeoylshikimic acid |
|
/ |
否 |
HY-W728761 |
Voxelotor-d7 |
|
/ |
否 |
HY-W740088 |
Adrenochrome monoguanylhydrazone methanesulfonate |
|
/ |
否 |
HY-W741165 |
N-Demethyl methylone hydrochloride |
Control |
/ |
否 |
HY-W743379 |
(S)-N-Nitroso anatabine-d4 |
|
/ |
否 |
HY-W745349 |
rel-(1S,2R)-Dihydro bupropion-d9 hydrochloride |
|
/ |
否 |
HY-W748328 |
Ixazomib-13C2,15N |
|
/ |
否 |
HY-W749979 |
(-)-Vernolic acid |
|
/ |
否 |
HY-W754135 |
Indoxacarb-d3 |
|
/ |
否 |
HY-W754878 |
Pemigatinib-d6 |
Inhibitor |
/ |
否 |
HY-W755107 |
(1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester |
Control |
/ |
否 |
HY-W755222 |
(S)-NODAGA-tris(t-Bu ester) |
|
/ |
否 |
HY-W767866 |
N-Acetyl-S-(2-carboxyethyl)cysteine-13C3 dicyclohexylamine |
|
/ |
否 |
HY-W773183 |
Methyl betulonate |
|
/ |
否 |
HY-W777138 |
rel-(1S,2R)-Dihydro bupropion-d9 |
|
/ |
否 |
HY-W779529 |
Cerberin |
Inhibitor |
/ |
否 |
HY-W782236A |
12(S),13(R)-Epoxy-9(Z)-octadecenoic acid |
|
/ |
否 |
HY-W784030A |
(S,E)-N-TCO-L-lysine |
|
/ |
否 |
HY-W792513 |
WAY-620147 |
Inhibitor |
≥98.0% |
否 |
HY-W793613 |
Drimendiol |
Inhibitor |
/ |
否 |
HY-W839261 |
Tyrosine kinase-IN-9 |
Inhibitor |
/ |
否 |
HY-W844796 |
2-Amino-5-methyl-5-hexenoic acid |
Inhibitor |
/ |
否 |
HY-W881216 |
(S)-GNA-T-phosphoramidite |
|
/ |
否 |
HY-W881219 |
N6-Bz-A-(S)-GNA phosphoramidite |
|
/ |
否 |
HY-W881450 |
(2S,3R,E)-2-Aminohexadec-4-ene-1,3-diol |
|
/ |
否 |
HY-W881463 |
N4-Ac-C-(S)-GNA phosphoramidite |
|
/ |
否 |
HY-W929472 |
13(S)-HOTrE |
|
/ |
否 |
HY-W930939 |
(2S,3R,E)-2-Aminopentadec-4-ene-1,3-diol |
|
/ |
否 |
HY-W975966 |
CPDT |
Activator |
/ |
否 |
HY-W992384 |
(S,9E,11Z,14Z)-8-Hydroxyicosa-9,11,14-trienoic acid |
|
/ |
否 |
HY-Y1002S |
Methionol-d3 |
|
/ |
否 |
HY-Z15868 |
5-Hydroxycytidine |
|
/ |
否 |
HY-Z1769 |
S-Desmethyl-S-(2-hydroxy-2-methylpropyl) Rosuvastatin calcium |
|
/ |
否 |
HY-Z7733 |
O-Desmethylcarvedilol |
Inhibitor |
/ |
否 |
HY-120024 |
BMS-986188 |
Modulator |
99.06% |
否 |
HY-N1600 |
16(R/S)-Hydroxy-3,13Z-kolavadien-15,16-olide-2-one |
|
/ |
否 |
HY-15267B |
(24S)-MC 976 |
Activator |
≥95.0% |
否 |
HY-110402 |
(S,R,S)-AHPC TFA |
|
/ |
否 |
HY-111389 |
FAAH-IN-1 |
Inhibitor |
99.93% |
否 |
HY-111583 |
RXFP3/4 agonist 1 |
|
/ |
否 |
HY-111905A |
BRD7-IN-1 free base |
Inhibitor |
/ |
否 |
HY-112147 |
IDO1 and HDAC1 Inhibitor |
Inhibitor |
/ |
否 |
HY-112602 |
PI3K/mTOR Inhibitor-1 |
Inhibitor |
/ |
否 |
HY-112605 |
sPLA2-X Inhibitor 31 |
Inhibitor |
/ |
否 |
HY-112707 |
AM9405 |
Agonist |
/ |
否 |
HY-112908 |
RTS-V5 |
Inhibitor |
/ |
否 |
HY-119370 |
CHMFL-ABL-121 |
|
/ |
否 |
HY-16785B |
Veledimex (S enantiomer) |
|
99.52% |
否 |
HY-P1453 |
CMD178 |
Inhibitor |
/ |
否 |
HY-101489 |
GZD856 |
|
/ |
否 |
HY-110387 |
IDO-IN-9 |
Inhibitor |
/ |
否 |
HY-111234 |
IDO-IN-11 |
Inhibitor |
/ |
否 |
HY-111370 |
mTOR inhibitor-2 |
Inhibitor |
/ |
否 |
HY-112434 |
PF-06733804 |
Inhibitor |
/ |
否 |
HY-112704 |
PDE5-IN-2 |
Inhibitor |
/ |
否 |
HY-117900 |
PF-06250112 |
Inhibitor |
/ |
否 |
HY-123534A |
CYT-1010 hydrochloride |
Agonist |
/ |
否 |
HY-18106 |
BM 957 |
Inhibitor |
/ |
否 |
HY-U00459B |
GSK2850163 hydrochloride |
Inhibitor |
/ |
否 |
HY-100096 |
Emtricitabine S-oxide |
Inhibitor |
/ |
否 |
HY-100125 |
Timegadine |
Inhibitor |
/ |
否 |
HY-100254 |
TAK-024 |
Inhibitor |
/ |
否 |
HY-100302 |
FR183998 free base |
Inhibitor |
98.00% |
否 |
HY-100496 |
Nucleocidin |
|
/ |
否 |
HY-101877 |
Statine |
|
99.83% |
否 |
HY-101955 |
(2S,6S)-Hydroxynorketamine hydrochloride |
|
/ |
否 |
HY-10290 |
MK-0674 |
Inhibitor |
/ |
否 |
HY-103225 |
S-8510 phosphate |
Antagonist |
/ |
否 |
HY-104075 |
R916562 |
Inhibitor |
/ |
否 |
HY-110406 |
13(S)-HPODE |
Activator |
/ |
否 |
HY-111356 |
IIIM-290 |
Inhibitor |
/ |
否 |
HY-111617 |
BTR-1 |
Activator |
99.96% |
否 |
HY-111775 |
LJ570 |
Agonist |
/ |
否 |
HY-111874 |
SNIPER(ABL)-039 |
Inhibitor |
/ |
否 |
HY-111931 |
Indirubin-3'-monoxime-5-sulphonic acid |
Inhibitor |
/ |
否 |
HY-111950 |
(-)-Ibuprofenamide |
Inhibitor |
/ |
否 |
HY-111978 |
ZEN-3862 |
Inhibitor |
98.86% |
否 |
HY-111979 |
ZEN-3411 |
Inhibitor |
/ |
否 |
HY-112164A |
IACS-8968 R-enantiomer |
Inhibitor |
98.48% |
否 |
HY-112653 |
8(S)-HETE |
Activator |
/ |
否 |
HY-112950 |
RET-IN-1 |
Inhibitor |
/ |
否 |
HY-113304 |
(S)-3,4-Dihydroxybutyric acid |
|
/ |
否 |
HY-114330 |
ZK824859 |
Inhibitor |
/ |
否 |
HY-114396 |
BR351 |
Inhibitor |
/ |
否 |
HY-126143 |
CHMFL-ABL-039 |
Inhibitor |
/ |
否 |
HY-13636A |
Fulvestrant (S enantiomer) |
|
/ |
否 |
HY-15594 |
Phen-DC3 |
Inhibitor |
/ |
否 |
HY-16443 |
S-4048 |
Inhibitor |
/ |
否 |
HY-18299B |
(S)-Purvalanol B |
|
≥98.0% |
否 |
HY-18819 |
BCR-ABL-IN-2 |
Inhibitor |
/ |
否 |
HY-19183 |
E-5324 |
Inhibitor |
/ |
否 |
HY-19298 |
S-8921 |
|
/ |
否 |
HY-19487A |
Ribocil B |
Inhibitor |
/ |
否 |
HY-19654B |
(-)-GSK598809 |
Antagonist |
/ |
否 |
HY-78841 |
(2S,4S)-Sacubitril |
|
93.58% |
否 |
HY-78847 |
2R,4S-Sacubitril |
|
97.16% |
否 |
HY-P0220 |
PACAP (6-38), human, ovine, rat |
|
/ |
否 |
HY-P0273 |
Histatin 5 |
Inhibitor |
/ |
否 |
HY-P0323 |
GP(33-41) |
Inhibitor |
/ |
否 |
HY-P1051 |
β-Amyloid (12-28) |
|
/ |
否 |
HY-P1567 |
β-Amyloid (10-35), amide |
|
/ |
否 |
HY-Z0081 |
2S,4R-Sacubitril |
|
/ |
否 |
HY-118236 |
(S)-AZD 6482 |
|
/ |
否 |
HY-15853A |
MK-7246 S enantiomer |
Antagonist |
/ |
否 |
HY-19205A |
CMI-392 |
Inhibitor |
/ |
否 |
HY-43586 |
BR351 precursor |
Inhibitor |
/ |
否 |
HY-U00214 |
Ibafloxacine |
Inhibitor |
/ |
否 |
HY-U00222 |
S3337 |
Inhibitor |
/ |
否 |
HY-U00235 |
SR121566A |
Antagonist |
/ |
否 |
HY-U00333 |
α1 adrenoceptor-MO-1 |
Modulator |
/ |
否 |
HY-U00341 |
ST4206 |
Antagonist |
/ |
否 |
HY-U00364 |
CI-949 |
Inhibitor |
/ |
否 |
HY-U00366 |
S1PR1-MO-1 |
Modulator |
/ |
否 |
HY-U00369 |
FCE 28654 |
Inhibitor |
/ |
否 |
HY-U00403 |
Cipropride (S enantiomer) |
|
/ |
否 |
HY-U00432 |
S-MTC |
Inhibitor |
/ |
否 |
HY-U00457 |
TBK1/IKKε-IN-1 |
Inhibitor |
/ |
否 |
HY-U00459A |
GSK2850163 (S enantiomer) |
|
/ |
否 |